Uncontrolled Copy - Eurofins
-
Upload
khangminh22 -
Category
Documents
-
view
0 -
download
0
Transcript of Uncontrolled Copy - Eurofins
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Eurofins Document Reference Not Applicable Revision May, 2017
Effective Date 5/01/17 Status Effective
Historical/Local Document Number Comprehensive Quality Assurance Manual
Local Document Level ESA-MA
Prepared by Kimberly LaPlante
Reviewed and Approved by (name/date)
Reviewed and Approved by (name/date)
11 ALMGREN DRIVE, AGAWAM, MA
SAMPLE DEPARTMENT
HEALTH AND SAFETY
WET CHEMISTRY/ MICROBIOLOGY DEPARTMENT
SEMI-VOLATILE DEPARTMENT
INORGANIC DEPARTMENT
830 SILVER STREET, AGAWAM, MA
VOLATILE ORGANIC DEPARTMENT AIR DEPARTMENT ADMINISTRATIVE OFFICES QUALITY ASSURANCE DEPARTMENT
Uncon
trolle
d BIOLOGYLOGY
TMENTMENT
MENTMENT
R STREETTREET AA
TILE ORGANE ORGANDEPARTMEEPARTME
DMINISTRANISTRAQUALITY UALITY
Copy
, MAMA
EPA
Christina White, 4/28/17
Nicole Leja, 5/01/17
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page i
COMPANY CONFIDENTIAL
REVIEW AND APPROVAL
This Comprehensive Quality Assurance Manual is designed for use by Eurofins Spectrum Analytical’s in-house guidance and will be furnished to the client upon request. It is not intended for use or distribution to the public.
Modifications and revisions of this manual will be subject to review by the Quality Assurance Manager, Team Managers and final review and approval by the President and Laboratory Director. The dated signature of the President will be the effective date of this version of the Quality Assurance Manual.
Nicole Leja President
Christina White Laboratory Director
Kimberly LaPlante Quality Assurance Manager
Digitally signed by Kimberly LaPlante DN: cn=Kimberly LaPlante, o=Eurofins Spectrum Analytical, Inc., ou=QA Department, [email protected], c=US Date: 2017.04.27 15:45:13 -04'00'
Christina WhiteDigitally signed by Christina White DN: cn=Christina White, o=Eurofins Spectrum Analytical, ou, [email protected], c=US Date: 2017.04.28 11:12:31 -04'00'
Digitally signed by Nicole Leja DN: cn=Nicole Leja, o=Eurofins Spectrum Analytical, Inc., ou=ESAI, [email protected], c=US Date: 2017.05.01 11:25:31 -04'00'
Uncon
trolle
Nicole LNicole PreProl
Unna Wha Wh
ledleedgned ned
Nicole Lejaole Lejtrum Analyticam Analytica
mail=nicoleleja@mail=nicoleleja@=nDate: 2017.05.0Date: 2017.050
Copy
he QQdent and Lnt and
date of this vee of this
Nicole LejaNicole =Euro
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page ii
COMPANY CONFIDENTIAL
TABLE OF CONTENTS Section Page
1.0 POLICY STATEMENT 11.1 Mission Statement…………………………………………………………………1 1.2.1 Internal Employee Support ..................................................................................... 3 1.2.2 Client Support ......................................................................................................... 3 1.2.3 Advertising Policy .................................................................................................. 5 1.3 Complaints .............................................................................................................. 5 1.3.1 Internal .................................................................................................................... 6 1.3.1.1 Operational Related within Department ................................................................. 6 1.3.1.2 Operational Related Outside the Department ......................................................... 6 1.3.1.3 Personnel Issues ...................................................................................................... 61.3.2 External Complaints................................................................................................ 6 1.3.2.1 Service..................................................................................................................... 6 1.3.2.2 Quality of Data........................................................................................................ 7 1.4 Corporate and Individual Ethics ............................................................................. 7 1.5 Confidentiality/Security.......................................................................................... 9 2.0 Organization and Responsibilities 11 2.1 Organizational Structure ....................................................................................... 11 2.2 Training................................................................................................................. 162.3 Quality Assurance Managerial Organization........................................................ 17 2.4 List of Key Personnel and Positions ..................................................................... 18 2.5 Housekeeping Policies .......................................................................................... 18 3.0 Quality Assurance Objectives 19 3.1 Data Quality Objectives........................................................................................ 19 3.2 Quality Assurance Communication Procedure..................................................... 20 3.3 Quality Assurance/Quality Control Review ......................................................... 20 3.4 Quality Control Acceptance/Rejection Criteria .................................................... 21 3.5 Stoppage of Non-Conforming Work .................................................................... 21 3.6 Preventative Action............................................................................................... 21 4.0 Specialized Analytical Methods 24 4.1 Microbiology Analysis.......................................................................................... 24 4.1.1 Standard Operating Procedures............................................................................. 24 4.1.2 Record Maintenance ............................................................................................. 24 4.1.3 Temperature Records ............................................................................................. 24 4.1.3.1 Autoclave .............................................................................................................. 24 4.1.3.2 Incubators............................................................................................................. 25 4.1.4 Laboratory Reagents and Chemicals .................................................................... 25 4.1.5 Laboratory Water .................................................................................................. 25 4.1.6 Laboratory Glassware ........................................................................................... 25 4.1.7 Maintenance of Laboratory Instrumentation and Equipment. .............................. 25 4.1.8 Instrument Calibration Requirements. .................................................................. 25 4.1.9 Sample Collection, Preservation and Handling. ................................................... 25
Uncon
trolle
d..
.................s
...........................................................................
erial Organizal Organiznd Positionsnd Position
es ...........................ce ObjectiveObjectiv
Objectives.....ectives.....urance Commance Com
Assurance/Quurance/Quy Control Acy Control Ac
ppage of Nonppage of Nventative ventativ
lizeli
Copy
....................
............................................................................
..............................................................................................................
..........
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page iii
COMPANY CONFIDENTIAL
4.1.10 Analytical Methodology. ...................................................................................... 25 4.1.11 Sterility of Rinse/Dilution Water and Sample Bottles.......................................... 26 4.1.12 Residue Testing of Glassware............................................................................... 26 4.1.12.1 Inhibitory Residue Test..................................................................................... 26 4.1.12.2 Bromthymol Blue Test...................................................................................... 26 4.1.13 Microbiological Media – Quality Control Measures ............................................ 26 4.1.14 Miscellaneous Quality Control Measures............................................................. 27 4.1.15 Membrane Filter Procedure Quality Control Specifics ........................................ 27 4.2 Air Analysis .......................................................................................................... 27 4.2.1 Standard Operating Procedures............................................................................. 28 4.2.2 Record Maintenance ............................................................................................. 28 4.2.3 Laboratory Standards ............................................................................................ 28 4.2.4 Sample Containers ................................................................................................ 28 4.3 New Jersey Extractable Petroleum Hydrocarbon Method (NJ EPH) ................... 29 4.3.1 Standard Operating Procedures............................................................................. 30 4.3.2 Record Maintenance ............................................................................................. 30 4.3.3 Laboratory Reagents and Chemicals .................................................................... 30 4.3.4 Quality Control ..................................................................................................... 304.3.5 Laboratory Glassware ........................................................................................... 30 4.3.6 Maintenance of Laboratory Instrumentation and Equipment ………………… 30 4.3.7 Instrument Calibration Requirements. .................................................................. 30 4.3.8 Sample Collection, Preservation and Handling. ................................................... 30 4.3.9 Analytical Methodology. ...................................................................................... 31 5.0 Sample Handling 32 5.1 Sample Containers ................................................................................................ 32 5.2 Sample Acceptance Policy.................................................................................... 32 5.3 Sample Receipt Protocols ..................................................................................... 33 5.4 Sample Tracking ................................................................................................... 36 5.5 Storage Conditions................................................................................................ 36 5.6 Sample Disposal.................................................................................................... 37 6.0 Calibration Procedures and Frequency 39 6.1 Equipment Calibration Information...................................................................... 39 6.2 Instrument Calibration Information ...................................................................... 39 6.3 Standard Traceability, Preparation and Handling................................................. 39 7.0 Standard Operating Procedures and Test Methods 41 7.1 Standard Operating Procedure Development and Modification........................... 41 7.2 Documentation of SOPs........................................................................................ 42 7.3 Test Methods......................................................................................................... 43 8.0 Internal Quality Control Checks 44 8.1 Laboratory Quality Control Samples .................................................................... 44 8.2 Method Detection Limits/Reporting Limits/LOD Verification/LOQ................... 44 8.3 Sample Dilution Policy ......................................................................................... 46 8.4 Selectivity ............................................................................................................. 46 8.5 Method Validation ................................................................................................ 46
Uncon
trolle
d..
.............................................
rumentation umentation rements. ......ments. .....
vation and Hion and Hy. .................y. ...............
rs ................................
tance Policy.ce Policy.eipt Protocolpt Protoc
Tracking .......cking ......ge Conditionse Conditions
mple Disposample Dispoibration ibration
men
Copy
...................
...................................Method (NJ EPthod (NJ EP
......................................................................................................................
..........
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page iv
COMPANY CONFIDENTIAL
8.6 Control Charts....................................................................................................... 47 8.7 Estimation of Uncertainty ..................................................................................... 47 9.0 Data Reduction, Validation, Reporting and Records 49 9.1 Data Reduction and Validation............................................................................. 49 9.2 Report Format and Contents ................................................................................. 51 9.3 Records and Document Control............................................................................ 53 9.4 Transfer of Records............................................................................................... 54 10.0 Performance and System Audits 55 10.1 External Performance Audits................................................................................ 55 10.2 External System Audits......................................................................................... 55 10.3 Internal Performance Audits ................................................................................. 56 10.4 Internal System Audits.......................................................................................... 57 10.5 Management Review ............................................................................................ 57 11.0 Facilities, Equipment, Reagents, and Preventative Maintenance 59 11.1 Laboratory Facilities ............................................................................................. 59 11.1.1 11 Almgren Drive – Agawam, MA ...................................................................... 59 11.1.2 830 Silver Street – Agawam, MA......................................................................... 60 11.1.2.1 Volatile Organic (VOC) Department................................................................ 60 11.1.2.2 Air Laboratory .................................................................................................. 60 11.2 Laboratory Reagent Storage ................................................................................. 60 11.3 Equipment and Reference Materials..................................................................... 60 11.4 Documentation and Labeling of Standards and Reagents .................................... 61 11.5 Computers and Electronic Data Requirements ..................................................... 61 11.6 Preventive Maintenance........................................................................................ 62 11.7 Inspection/Acceptance Requirements for Supplies and Consumables ................. 63 12.0 Routine Procedures Used to Evaluate Data Quality 64 12.1 Method Blanks ...................................................................................................... 64 12.3 Surrogate Recoveries ............................................................................................ 64 12.4 Matrix Spikes and Matrix Spike Duplicates (MS/MSD)...................................... 65 12.5 Duplicates ............................................................................................................. 65 13.0 Corrective Actions 66 13.1 Isolated Conditions ............................................................................................... 66 13.2 Systematic Conditions .......................................................................................... 66 13.3 Instrument Checks ................................................................................................ 67 13.4 Departure from Documented Procedures.............................................................. 69 14.0 Review of Requests, Tenders and Contracts 70 14.1 Distribution of project plan among Management Team. ...................................... 70 14.2 Results of Review. ................................................................................................ 71 14.3 Record Maintenance ............................................................................................. 71 15.0 Subcontracting and Support Services and Supplies 72 15.1 Subcontracting Laboratory Services ..................................................................... 72 15.2 Outside Support Services and Supplies ................................................................ 72 Revisions………………………………………………………………………………. 74
Uncon
trolle
d..
nt...........................................
.......................................aterials.........erials........
ing of Standaof Standnic Data Reqnic Data Re
nce..............e..........tance Requirce Requir
edures Used ures Usednks ..............s ............
e RecoveriesRecoveriesx Spikes and Spikes and
plicates .......plicates .....rective Arective
d Cd C
Copy
...................
...................................tive Maintenane Maintena
......................................................................................................................
..........
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page v
COMPANY CONFIDENTIAL
ATTACHMENTS
Appendix A Eurofins Spectrum Analytical State Certifications Massachusetts Laboratory
Appendix B Section 1 Attachments Ethical Conduct and Data Integrity Agreement Typical Ethical and Data Integrity Issues
Appendix C Section 2 Attachments Figure 2.1 Organizational StructureResume of Nicole Leja; President Resume of Christina White: Laboratory Director Initial Demonstration of Capability Form Instrument Demonstration of Capability Form
Appendix D Section 5 Attachments Sample of Chain of Custody Sample of Air Chain of Custody Sample Integrity Form Sample Label and Custody Seal Examples
Appendix E Section 6 Attachments Table 6.1 Calibration for GC/MS Laboratory Table 6.1A BFB Key Ions and Abundance Criteria for Methods 624, 8260 Tuning and Direct Injection Table 6.1B FTPP Key Ions & Ion Abundance Criteria Table 6.2 Calibration Procedures GC Laboratory Table 6.3 Calibration Procedures for Inorganic Laboratory Table 6.4 Calibration Procedures Organic Characterization Lab
Appendix F Section 7 Attachments Standard Operating Procedures Master List SOP Request for Creation or Modification Form
Appendix G Section 11 Attachments Table 11.1 Reagent Storage Table 11.2 Analytical Support Equipment
Appendix H Section 12 Attachments Table 12.1 Concentration Levels for QC Samples Table 12.2 QC Frequency Information: Method Blanks
Uncon
trolle
d ody of Custody of Custody
orm rm nd Custody SCustody
achments hments6.1 CalibratioCalibratio
le 6.1A BFB6.1A BFB260 Tuning 0 Tuning
Table 6.1Bble 6.1BTable 6Table 6TablTabTT
CopyDirector irector
Form m ability Form ability Form
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page vi
COMPANY CONFIDENTIAL
Table 12.3 QC Frequency Information: Blank Spikes (BS) also known as Laboratory Control Samples (LCS) and Standard Reference Materials (SRM) Table 12.4 QC Frequency Information: Matrix Spikes (MS) and Matrix Spike/Duplicates (MSD) Table 12.5 QC Frequency Information: Duplicates
Appendix I Section 13 Attachments Table 13.1 QC Sample Acceptance Criteria & Corrective Action: Method Blanks Table 13.2 QC Sample Acceptance Criteria and Corrective Action: Blank Spikes (BS) also known as Laboratory Control Samples (LCS) and Standard Reference Materials (SRM) Table 13.3 QC Sample Acceptance Criteria and Corrective Action: Matrix Spikes Table 13.4 QC Sample Acceptance Criteria & Corrective Action: Duplicates
Appendix J List of Acronyms
Appendix K Definitions
Appendix L Method References
Uncon
trolle
d
ences ces
Copy
nd CCory ControCont
M) Criteria and Correria and Cor
nce Criteria & ce Criteria
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 1
COMPANY CONFIDENTIAL
1.0 POLICY STATEMENT
Introduction
Eurofins Spectrum Analytical, Inc. (ESA-MA) is an environmental testing laboratory in the Greater Springfield area in Agawam, Massachusetts and staffs over 80 employees. Since its inception in 1990, Eurofins Spectrum Analytical’s objective is to provide quality analytical testing services to consulting firms, industries, municipalities and the private sector in a timely manner. ESA-MA specializes in the performance of organic, inorganic, wet chemistry and microbiology analyses in various matrices including air.
A separate building within the same industrial park, located at 830 Silver Street, Agawam, MA, houses our volatile organics and air laboratories as well as our administrative offices. The laboratory facilities have more than 22,000 square feet of office and laboratory space combined. The designs and layouts of the laboratories were chosen to provide efficient sample processing, alleviate possible cross contamination issues and to provide a safe work environment.
Eurofins Spectrum Analytical has provided quality service and technical support to consultants, industries and the public sector since 1990. First certified in its home state of Massachusetts, in 1993 we expanded our certification throughout New England, New York, New Jersey, Pennsylvania and Florida. Additionally, our quality data is accepted in the states of Michigan, Delaware, Georgia, Maryland, and Virginia. ESA-MA is in compliance with all applicable TNI Standards. New York State is the primary accrediting authority, with secondary accreditation through New Hampshire, New Jersey, Pennsylvania and Florida. ESA-MA has also been granted certification by the American Association for Laboratory Accreditation (A2LA) to perform work under the Department of Defense Quality Systems Manual for Environmental Laboratories. A full listing of our currently accredited test methods is available on our website at www.EurofinsUS.com/Spectrum
ESA-MA exhibits a strong business philosophy that consists of professionalism, communication and leadership. This is continually demonstrated through our commitment to provide its clients with both technical expertise and business experience and has created a unique style, which has enabled this laboratory to achieve a higher level of performance. ESA-MA is committed to meet current environmental strategy and comply with EPA and other state agency regulations. ESA-MA bases its internal quality systems on the NELAC standards.
1.1 Mission Statement
Eurofins Spectrum Analytical is dedicated to servicing the needs of our customers in a consistently dependable manner with high quality, cost effective, and safety based environmental analytical laboratory services. As part of the Eurofins network, we have the stability and structure of an established corporation to support overhead functions while retaining the personal aspects and services of the laboratory that was established in
Uncon
trolle
dality sity
r since 1990ce 199r certificationr certificatio
Florida. AddFlorida. AdGeorgia, Maorgia, M
TNI StandardNI Standarcreditation thditation th
s also been glso been gon (A2LA) t(A2LA) t
anual for Envual for Envethods is avads is ava
xhibits a stroxhibits a stroation and lation and
o pro pr
Copy
0 Ss as welwe
han 22,000 sqn 22,000ayouts of the labuts of the l
e possible crossossible cr
vice anviceFi
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 2
COMPANY CONFIDENTIAL
the early 1990s. Our team remains committed to our clients, our quality, and each other as we focus on future growth and opportunities.
1.2 Quality Policy Statement
We strive to provide the highest quality data achievable by:
Reading and understanding all of the quality documents applicable to each position and implementing the process in our work.
Following all recordkeeping requirements; describing clearly and accurately all activities performed; recording “real time” as the task is carried out; understanding that it is never acceptable to “back date” entries and should additional information be required at a later date, the actual date and by whom the notation is made must be documented.
Ensuring data integrity through the completeness, consistency, and accuracy of the data generated. Complete, consistent, and accurate data should be attributable, legible, contemporaneously recorded, original or a true copy, and accurate (ALCOA). This applies to manual paper documentation and electronic records.
Providing accountability and traceability for each sample analyzed through proper sample handling, labeling, preparation, instrument calibration/qualification/ validation, analysis, and reporting; establishing an audit trail (the who, what, when, and why) that identifies date, time, analyst, instrument used, instrument conditions, quality control samples (where appropriate and/or required by the method), and associated standard material.
Emphasizing a total quality management process which provides accuracy, and strict compliance with agency regulations and client requirements, giving the highest degree of confidence; understanding that meeting the requirements of the next employee in the work flow process is just as important as meeting the needs of the external client.
Providing thorough documentation and explanation to qualify reported data that may not meet all requirements and specifications, but is still of use to the client; understanding this occurs only after discussion with the client on the data limitations and acceptability of this approach.
Responding immediately to indications of questionable data, out-of-specification occurrences, equipment malfunctions, and other types of laboratory problems, with investigation and applicable corrective action; documenting these activities completely, including the reasons for the decisions made.
Uncon
trolle
d ccuccu
iginal or anal orntation and etion and e
aceability forability forreparation, inaration, in
eporting; estaporting; estas date, time, aate, time,
les (where ap(where ard material. material.
ng a total quaa total qunce with agene with age
of confidenof confidene in thee in the
Copy
ied ood additiondditio
e notation is motation is
ss, consistencys, consistente data shote data
rue c
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 3
COMPANY CONFIDENTIAL
Providing a work environment that ensures accessibility to all levels of management and encourages questions and expression of concerns on quality issues to management.
We each take personal responsibility to provide this quality product while meeting the company’s high standards of integrity and ethics, understanding that improprieties, such as failure to conduct the required test, manipulation of test procedures or data, or inaccurate documentation will not be tolerated. Intentional misrepresentation of the activities performed is considered fraud and is grounds for termination.
1.2.1 Internal Employee Support
Eurofins Spectrum Analytical’s commitment extends not only externally to its clients and community, but also internally to support its employees. This commitment focuses on communication and has resulted in the formation of policies of performance and resources for its employees. These policies also enforce the implementation of the quality assurance plan and will correct deficiencies that may develop without jeopardizing the quality of services. This commitment ensures that employees of ESA-MA may perform their job functions without pressures that may adversely affect the quality of their work.
1.2.2 Client Support
ESA-MA is committed to providing its clients with prompt, reliable results at competitive prices. The commitment to support our clients can be demonstrated through the services provided; many at no additional charge. These services include:
a. Rush Service – Eurofins Spectrum Analytical’s standard turn around time for routine analytical parameters is 7-10 business days from sample receipt at the laboratory. Rush service is always available and may be coordinated through the use of our Rush Analysis Request Form. Please ensure that a rush analysis request be sent in advance of sample submittal. This communication will help us prepare for your samples and assure you of the turn around time. Requests may be submitted online via our eServices web page. The availability of rush service is a function of the workload within the laboratory at any given time. Therefore requests for rush services are to be approved by the laboratory prior to sampling. Emergency response services will be handled on a case-by-case basis. Please note that rush service may be subject to a reasonable surcharge. Contact our Quality Services Department for details.
Uncon
trolle
deopeo
of ESA-MESAely affect they affect th
mmitted to prmmitted to pmpetitive prietitive p
nstrated throuated throu. These servhese ser
. Rush Rusharoarof
Copynot only exonly
rt its employees employresulted in the fulted in the
employees. Theemployees. Thssurance plan asurance plardizing the dizing
A ma
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 4
COMPANY CONFIDENTIAL
b. Special Pricing – through the use of Eurofins Spectrum Analytical’s Request for Price Quotation Form (available on our eServices web page). This form allows for further price reductions for particular projects that have more cost-effective requirements.
c. Electronic data deliverable (EDD) - All laboratory reports are posted online and will be securely accessible 24/7 through our eServices web page in pdf format and other EDD formats as requested. These files are automatically generated by our LIMS, and can be used to import into your own software and data management applications. There are several EDD formats available.
d. Sample Containers - Pre-cleaned, pre-preserved sample containers are supplied at no cost provided they return for laboratory analyses. Please allow a minimum of 48 business hours notice to prepare and process your request. Requisitions may be completed online through our web site. Eurofins Spectrum Analytical will ship sample containers to your office at no additional charge provided sufficient notice is given for sample kit preparation and ground shipping or delivery. Additional notice is required for certified low-level air media.
Reliability of any sample data is measured in terms of precision in executing methodologies and accuracy of surrogate and method spike recoveries. Data generated by Eurofins Spectrum Analytical must pass all method-specific and regulatory criteria established under NELAP, the Environmental Protection Agency (EPA) and by each state in which certifications are held. In situations where no criterion has been established, ESA-MA may choose to develop in-house data quality objectives to ensure that reliable data is reported.
Prior to accepting new bid proposals, the Director and the QA Department review the scope of work provided by the client to ensure all specifications can be met by Eurofins Spectrum Analytical. The client is informed at this time if a sub-contract laboratory will be needed to meet scope of work criteria.
The primary QA/QC objective is to develop, implement, improve and maintain procedures for sample receipt, sample preparation, laboratory analysis, data validation and reporting that provides scientifically valid, legally defensible data. Eurofins Spectrum Analytical supports this objective through QA/QC procedures within the laboratory, including all ancillary departments.
Uncon
trolle
dite
s to youro younotice is givtice is giv
or delivery. or delivery. evel air medvel air med
ny sample day sample dethodologiesodologie
s. Data geneData gened-specific andpecific a
ironmental Pnmental ertifications fication
establishedestablishedobjectivobjecti
Pr
Copye-preserved sareserved
hey return for lay return for lamum of 48 businmum of 48 busi
quest. Requisitiuest. RequisEurofins SpEurofins
ffice
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 5
COMPANY CONFIDENTIAL
1.2.3 Advertising Policy
It is the intention of Eurofins Spectrum Analytical to accurately represent its accreditations and certifications and in a manner that does not imply accreditation in areas that are outside the actual scope of current accreditation. The laboratory’s accreditation certificate and scope of accreditation issued by NELAP, A2LA or other Federal or State agencies will be posted on the laboratory website. It is not anticipated that additional advertising with respect to A2LA accreditation status of the laboratory will be required. If management determines that additional advertising is necessary, the laboratory will follow the current A2LA Advertising Policy with respect to the activities under the scope of accreditation and use of the A2LA symbol.
Use of the NELAC Accredited logo is allowable with adherence to the following:
a. Where the NELAC logo is used it shall always be accompanied by Eurofins Spectrum Analytical’s accreditation number.
b. The NELAC logo may be generated electronically provided that the prescribed formats and forms are retained.
c. When promoting or providing proof of accreditation, accredited laboratories should use the scope(s) of accreditation, as this document details the specific tests which are accredited. The certificate should be used for display purposes and should also accompany the scope.
d. When the NELAC logo is used on a business solicitation document such as a proposal or quotation form, the laboratory has the responsibility to distinguish between those proposed tests that fall within the laboratory’s scope of accreditation and those that do not. This is done by attaching a copy of the current Scope of Accreditation sheet and/or a link to Eurofins Spectrum Analytical’s Quality webpage were this information is posted or by noting which tests or calibration is non-accredited.
e. Upon suspension or termination of accreditation, the laboratory will immediately inform affected clients and remove or update certification on the Eurofins Spectrum Analytical website.
1.3 Complaints
Uncon
trolle
dgo is useis usAnalytical’snalytical’s
logo may be go may be bed formats aformats a
n promoting romotinboratories shatories sh
document dcument certificatcertificaaccomacco
d. Wd.
Copy
w thes under thnder t
allowable with allowable wit
it sha
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 6
COMPANY CONFIDENTIAL
1.3.1 Internal
1.3.1.1 Operational Related within Department
Department Managers are available to express department-related disputes, ideas and/or concerns. If an issue deserves research, Laboratory Director attention, or is not resolved immediately, the employee(s) must express the concern in writing in memorandum form to the department manager. (See Standard Operating Procedure for Resolution of Complaints for further information, available upon request)
1.3.1.2 Operational Related Outside the Department
The Laboratory Director and/or QA Manager are available to express laboratory-related disputes, ideas and/or concerns. If an issue deserves research, Laboratory Director attention, or is not resolved immediately, the employee(s) must express concern in writing in memorandum form to the Laboratory Director. The Laboratory Director will respond within 48 hours of written notification.
1.3.1.3 Personnel Issues
The Department Manager is available to express non-operational related disputes, ideas and/or concerns. If an issue deserves research, Laboratory Director attention, or is not resolved immediately, the employee(s) must express concern in writing in memorandum form to the Department Manager or corporate HR. (See Standard Operating Procedure for Resolution of Complaints for further information, available upon request.) All parties will follow company policy set forth in the Eurofins Employee Handbook.
1.3.2 External Complaints
Eurofins Spectrum Analytical puts client support as one of its highest priorities. If a client expresses a complaint or concern it is acted upon immediately. (See Standard Operating Procedure for Resolution of Complaints for further information, available upon request.)
1.3.2.1 Service
Uncon
trolle
de ee
m form formr will responwill respon
ssues ues
Department Mpartmentlated disputed dispute
research, Lasearch, Limmediatimmediamemomem(Se(Sef
Copyment
QA Manager areManager areutes, ideas and/utes, ideas and
oratory Directoratory Direployee(s) mployee(
the L
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 7
COMPANY CONFIDENTIAL
When a client call is received concerning the services provided by Eurofins Spectrum Analytical it is the responsibility of the person receiving the call to notify the Laboratory President immediately.
1.3.2.2 Quality of Data
When a client calls concerning data results the call is forwarded to the Laboratory Director, QA Manager or authorized personnel (refer to SOP). The matter is looked into upon receipt and if the complaint investigation reveals a laboratory error due to non-compliance with internal procedures, the client is notified within three business days or sooner from discovering the error.
1.4 Corporate and Individual Ethics
Eurofins Spectrum Analytical depends upon the quality of the data and services produced and the integrity of the people who generate them. We recognize the need for and have responded with an ethics program that is designed to establish a meaningful context within the environmental laboratory. Our objective is to provide an effective ethics program that involves training, managerial leadership and active dialogue between our staff. All new employees are trained within the first two weeks of employment and signed documentation is attached to the new employee training form, filed with their onsite personnel folder. Eurofins Spectrum Analytical also provides employees with the ability to anonymously report instances of unethical or improper laboratory practices. The QA Manager or their designee will investigate any suspected instances of ethics violations or improper procedures. Continued employee and managerial training will occur once a year in conjunction with the mandatory Annual Company Meeting, for which all attendance is recorded. Periodic monitoring of data integrity is conducted through departmental management validation against the raw data uploaded by the analyst. Additional validation procedures to ensure data integrity are located in Section 9 of this Quality Assurance Manual. Any employee who displays unethical behavior or intentionally jeopardizes data integrity will be subject to discipline up to and including termination.
We, at Eurofins Spectrum Analytical believe that we share common goals and values. These goals and values include protection of the environment, quality of product and personal integrity.
We strive to be honest when we interact with each other and our clients.
We work to achieve high standards in our procedures and with our final product.
Uncon
trolle
dhicsc
nmental mentam that involvhat involv
r staff. All nr staff. All nent and signeand signe
iled with theid with theso provides eso provides
unethical or imthical orwill investigl investig
edures. Contures. Conin conjuncticonjunct
l attendance ttendancucted throughcted through
oaded by theoaded by thocated inocated
s u
Copy
erin
he quality of thehe quality of tho generate them generate th
program tharogramaborat
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 8
COMPANY CONFIDENTIAL
We will continue to create an environment for personal and professional growth that provides employees with an opportunity to grow, excel and develop new skills and challenges.
We will continue to enhance our internal procedures that provide a well-defined background that is both educational and supportive to both our employees and our clients.
We encourage through our internal programs and by example, responsible procedures that address laboratory wastes and health and safety for all our employees and for our environment. Our laboratory waste program has become a training tool to involve our employees in the ethical disposal of chemical and laboratory wastes.
We strive to respect one another for our variety and our similarities.
We strive to respect one another for our origins and our beliefs, our looks and our gender.
Eurofins Spectrum Analytical and its leadership support the maintenance of the facility, the equipment and instrumentation and, by example demonstrate a willingness to invest in new instrumentation.
While it is the goal of Eurofins Spectrum Analytical to lead and teach by example, it is also true that ethics are guidelines within each individual that are supported by company structure. While most individuals strive to attain a high degree of integrity, there are some actions that occur in laboratories that are considered unethical and can result in penalties or punishments to include legal and civil actions. The following are examples of unethical behaviors with their own nicknames that are unique to laboratories.
Peak shaving – The practice of manually integrating a peak from a point within the chromatogram that will decrease the true value of the analytical contaminant. If the manual integration does not begin and end in a valley, the deviation is considered peak shaving.
Dry Labbing – Creating data for an analysis that was not performed.
Time Travel – Changing the time of an extraction, analysis or sampling to make it appear that the analytical procedure performed was done with in the analytical holding time.
Other actions defined as unethical include forging another’s name or initials, signing that data review has been performed when it was not, spiking a “little extra” to improve recoveries or knowingly condoning unethical observed
Uncon
trolle
dand its leaded its leadend instrumennd instrumen
ew instrumenw instrumen
Eurofins Speurofins Speue that ethicsthat eth
mpany structuny structugrity, there ary, there
unethical andethical anactions. Thctions. T
nicknames thicknames th
Peak shaPeak shhin
Copy
e et
ety and our simiand our sim
origins and ouorigins and
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 9
COMPANY CONFIDENTIAL
behavior of others. See Appendix B for typical ethical and data integrity issues.
1.5 Confidentiality/Security
The protection of confidential business information and trade secrets is vital to the interest and success of this organization and its clientele. Confidentiality is an absolute condition of employment with Eurofins Spectrum Analytical. At all times and occasions, it is imperative that all employees maintain confidentiality of all information concerning business practices.
Security includes the use of telephones, computers, facsimiles, and any other electronic media systems. Passwords are assigned to each user and the use of all systems can be monitored. Each employee must agree to the terms set forth and sign an acknowledgement form.
Vendors, clients, site locations, and analytical results even though some such information may become a matter of public record, are considered confidential. Listed below is the protocol initiated in order to maintain and support this confidentiality.
The Client Services Department in coordination with the QA Department is the only authorized representative at Eurofins Spectrum Analytical who may release analytical data after final approval by the Laboratory Director.
Anyone requesting a copy of an analytical report or invoice who is not listed on the original Chain of Custody must:
(1) Submit a written request with specific details for the reason for the request;
(2) Obtain written approval from the individual and/or company who are the client of record on the original Chain of Custody.
Eurofins Spectrum Analytical is protected by a security system, which is only accessible by employees who are issued a current security code. No one other than authorized employees can gain access to this system.
All employees receive Computer Security Training upon hiring and participate in a refresher course annually. Training included the use and protection of individual passwords, the requirement to change LIMS passwords annually and the safe use of individual and group computers.
The storage of analytical data and accompanying invoices are accessible only to the Accounting, Client Services, and QA Departments. No one other than authorized employees can access this documentation.
Uncon
trolle
d too
ment in coordment in coordsentative at Entative at E
after final aper final ap
ng a copy ofa copy oal Chain of Chain of C
mit a writtent a writteequest;uest;
(2) Obtain w(2) Obtainclientclien
Copy
h us to the terthe t
ical results evenical results evblic record, arelic record, ol initiated il initiat
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 10
COMPANY CONFIDENTIAL
The Chains of Custody records are accessible by the Sample and Accounting, Client Services, and QA Departments. Only authorized employees can access this documentation.
Any request for quotation and/or client correspondence is considered confidential documentation and will only be accessible to the Client Services Department and authorized personnel. No other operational department will have access to this documentation.
If a request for quotation is submitted by more than one company for the identical public bid, without any question of deviations, Eurofins Spectrum Analytical has an obligation to provide an equal low discounted price for this project.
Uncon
trolle
d Cop
ySpec
for this pr this
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 11
COMPANY CONFIDENTIAL
2.0 Organization and Responsibilities
Eurofins Spectrum Analytical employs a team of professionals that possess a high-level of training along with at least five years or more technical experience in their related field. Our staff utilizes their scientific and technical expertise to service the analytical and informational needs of our clients and allows us the ability to customize and develop certain scientific procedures that are not part of the existing EPA standard methodologies. These staff diversities enable ESA-MA to produce high-quality data while maintaining our efficiency, quality assurance and effective deliverables and profitability. ESA-MA encourages its staff to revise and develop procedures that will improve the overall function. Present staff qualifications and work experience are on file and can be furnished to a client upon request.
2.1 Organizational Structure
The organizational structure and responsibilities are outlined below and illustrated in Figure 2.1 located in Appendix C for the Massachusetts Laboratories.
President (resume attached in Appendix C) Responsible for assisting with preparation of budget and meeting those goals for each calendar year. Responsible for profits and losses associated with business performance and ensuring operations meet internal and external expectations. Provide technical support and onsite supervision of the operational departments located at 830 Silver St;
Laboratory Director (resume attached in Appendix C) Final review and approval of Microbiology data; The Laboratory Director is responsible for overall supervision of laboratory operations, overseeing all technical and administrative policies and procedures, as well as the enforcement and adherence to said policies by laboratory staff Use tools and processes for performance measurement and benchmarking (KPIs);Assist management and staff with development of cost calculation models (using activity-based costing methodology) such as APPC and capacity modeling;
Is responsible for final data validation and approval of laboratory reports for data generated by both the 11 Almgren Dr and 830 Silver St facilities;
Provide technical support and onsite supervision of the operational departments located at 11 Almgren Drive;
Supervise the revision of and final approval of protocols and methodologies; Ensuring proper data deliverable and client services; Using information collected from all departments and client feedback, the
laboratory director must conduct a review of the laboratory’s quality system and testing activities to ensure their continuing suitability and
Uncon
trolle
ddix C) C) h preparation reparation
nsible for pronsible for prong operationsg operations
support and oport and oated at 830 Sated at 830
tor (resume a(resume aeview and apew and ap
Laboratory Daboratoryaboratory opeoratory o
and procedand procedby laborby laboUse tUse (K
Copy
ies are outlined ies are outlineMassachusettsMassachuse
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 12
COMPANY CONFIDENTIAL
effectiveness, and to introduce necessary changes or improvements. Prepare an annual Management Review with these findings and ensure they are assigned and carried out in an agreed upon timeframe. The President will provide back-up in the absence of the Laboratory Director. If the Lab Director is absent for more than 35 calendar days, the primary AB must be notified.
Senior Operations DirectorShares responsibility with Laboratory Directors for business unit performance in terms of quality, efficiency, and key performance indicators (KPIs) including working within budget and meeting sample TAT expectations; Support overall division and business management to include daily operations, staff scheduling, administrative duties, and policy enforcement; Support the Lean project manager and Lean initiatives; Maintain and repair instrumentation (excluding ICP, ICPMS, and Microwave technologies) and provide internal training to primary analysts; Review current procedures and operational activities and recommend efficiency improvements; Provide oversight and assistance to operational departments on technical issues and aid in professional development; assist LDs with staff training and development and recommend training plans; Stay abreast on current analytical method, technology changes and new techniques and make recommendations for process improvements and upgrades as needed including applicable state programs such as MA DEP CAM and CT DEEP RCP; Recommend, initiate, and support method development to increase instrument sample capacity, maintain or reduce labor costs, and maintain all QC requirements; Assist with data review and validation during high sample volume periods; Support both MA and RI locations for technical improvements and instrument repairs; Must be proactive in prevention and detection of improper, unethical or illegal actions. The Operational Support Manager will be back-up in the absence of the Senior Operations Director.
Quality Assurance Manager Fulfill the role of laboratory Quality Assurance Officer; Implement, maintain and improve upon the overall laboratory quality assurance; Ensure all lab personnel understand their contribution to the quality assurance plan; Conduct initial and annual Ethics and Data Integrity Training; Conduct initial Computer Security Training for new hires: Ensure communication takes place at all levels of the laboratory regarding
Uncon
trolle
dance to ope to oponal developml developm
ecommend trecommend ent analyticat analytic
make recomme recommeeded includided includi
CT DEEP RCDEEP RCmend, initiatend, initiat
ument sampleent sampleQC requiremrequirem
Assist with Assist with Support bSupport instrumstrMuMu
Copy
nt to oties, and po, and
n initiatives; nitiatives; cluding ICP, ICding ICP, IC
e internal trainine internal trainirational activittional act
atio
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 13
COMPANY CONFIDENTIAL
the quality assurance plan; Evaluate the effectiveness of training; Data validation; Conduct annual internal laboratory audits to assure compliance with all aspects of the quality assurance plan; Maintaining the QA/QC database and QA/QC files; Ongoing review and update of QC procedures, QC databases, and protocols; Oversee all aspects of Proficiency Testing including orders, dispersal to the laboratory, ensure operational managers rotate PT analysts, upload results to providers, DMR QA reporting, monitor PT history and corrective actions; Document Control; Maintains Certifications; Oversee and delegate tasks to Quality Assurance Department staff; All responsibilities are conducted in communication with the Laboratory Director and President. The QA Assistant will provide back-up in the absence of the QA Manager.
Operational Support Manager Be available to all laboratory departments for assistance with staff management and training, communications with Client Service and Quality Control, inventory control and maintenance of departmental protocols and procedures.Assist with data processing, review and validation of Organic data as needed;Assist with method updates and maintenance of all instrumentation to include organic (GCs, GCMSs, ECDs) and inorganic instrumentation via communication with Laboratory Director and Senior Operations Director.Assist with Organic (Air, VOC and SVOC) peer review of standards; compilation of LOD/LOQ and MDL studies; other department administrative duties as operationally needed. Responsible for tracking and keeping certifications current for critical laboratory equipment such as weights, thermometers, balances, flow meter, and other devices necessary to operations including sending to vendors for renewal before expiration. Maintenance of the master inventory list updated as new capital items are purchased and older items are taken out of commission. Tracking instrument serial numbers on existing and new equipment and maintaining equipment certifications, as needed. Assist with maintenance of department protocols and procedures and method development. Maintain friendly, working relationships with instrument vendors, salespersons and service personnel keeping the BU up-to-date.
Uncon
trolle
d tory departmtory departmning, communng, commu
ventory contntory conocedures.edures.
ata processinproces
with method h method ude organic (e organic
ommunicatiommunicatioDirector.Director.Assist wAssist compcomadd
Copyurance Departmnce Depart
mmunication wunication
-up in the absup in th
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 14
COMPANY CONFIDENTIAL
Help departments utilize tools and processes for performance measurement and benchmarking (KPIs) to include TAT, productivity, scheduling of staff, and optimization of staff and resources. Standardize operational performance reporting with a clear focus on laboratories production with recommendations for process improvements. On a daily basis communicate with the BUMA, Laboratory Director, Operations Director, and Operational Department Managers. As needed, keep Quality Service Department and the Quality Assurance Department aware of any issues that may affect service or quality of our products. The Operational Support Manager must have a sufficient background to competently support all laboratory processes.The Senior Operations Director will be back-up in the absence of the Operational Support Manager.
Lean Project Manager Responsible for on time completion of milestones Distribute and review tasks, owners and deadlinesResponsible for the long term Continuous Improvement Present results to BU and corporate Lean Coordinator Complete analysis and document outcomes
Continue to gain knowledge of lean tools
Quality Services Department Overall client service management; Preparation of bids and price quotations; Development of flyers, ads, etc. Data reporting; Invoice preparation; Scheduling of courier service via client contact; Publish laboratory data reports; Communicate with clients regarding data deliverable; Maintain laboratory report files; Manager to support Operational Department in manager’s absence; Manager will have a link to Marketing Department. The Client Services Manager will provide back-up in the absence of the Quality Services Deputy Director.
Accounting Department Track all incoming vendor invoices and outgoing client invoices; Track all payables;
Courier Service Department Coordinates daily pick up schedule;
Uncon
trolle
dContinonti
rporate Learate Leocument outcocument outc
wledge of leaedge of lea
tment mentt service manrvice m
on of bids andof bids anopment of flyment of f
a reporting; eporting; nvoice prepaoice prep
SchedulinScheduliPublishublishComCom
Copy
n the he
of milestones f milestones and deadlinesand dead
ous Impous ImC
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 15
COMPANY CONFIDENTIAL
Oversees sample container inventory; Oversees preparation of sample kits for client deliveries; Communicates with Laboratory Director regarding courier service schedule and all incoming samples; Oversees all shipping from facility. The Quality Services Deputy Director will provide back-up in the absence of the Courier Manager.
Operational Departments Manager - Oversees overall data management; Manager - Provides technical support; Manager - Coordinates operational issues to Laboratory Director; Manager - Provides validation support to QA Department as secondary validator.Manager – Supervision of personnel including hiring and training; Performing sample preparation and analysis in accordance with all applicable methodology and internal SOPs; Processing data generated by laboratory instrumentation; Performing daily QA/QC checks on each instrument; Maintaining communication with QA Department regarding quality issues and data deliverable; Adherence to Health and Safety and Chemical Hygiene Plans; Maintain and implement all the department functions stated above with specific responsibilities listed for each position; Review all logbooks within prescribed frequency; Review and implement QA/QC samples and standards as stated in the methods performed on a daily basis; Review the daily backlog for due date, holding time, etc. and assign work order to each analyst; Ensure PT samples are rotated among all trained analysts; Conduct a brief daily meeting with assistants in order to meet daily objectives. The Laboratory Director or Operational Support Manager will provide back-up in the absence of the Operational Department Manager.
Air Department Method development; Marketing air division; Provide technical support such as air presentations; Perform various air analyses; such as TO15 and APH along with customized analyses as requested.
Sample Department Verifies the integrity of all samples received and inspects incoming Chains
Uncon
trolle
daboratoorat
hecks on eas on eation with QAion with QA
th and Safetyand Safetyall the departall the depa
ies listed for isted foll logbooks wgbooks w
w and implemnd implehods performds perform
Review the dview the order to eaorder to eEnsure EnsureConCon
Copy
oratorytorDepartment epartme
cluding hiring ading hirinanalysis in acconalysis in accol SOPs; SOPs;
y instruii
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 16
COMPANY CONFIDENTIAL
of Custody for completeness; Ensure all inter-company communication regarding incoming expedited TAT samples; Ensure data entry accuracy from Chain of Custody into Laboratory Information Management System (LIMS) database; Communicate with clients regarding any COC deviations as defined under NELAC protocol and our Comprehensive Quality Assurance Manual; Identify incoming samples with their unique identification provided by the LIMS database; Preparation of samples for subcontracting laboratory when applicable. The Quality Services Deputy Director will provide back-up in the absence of the Sample Department Manager.
Health and Safety Department Implementation of Eurofins Spectrum Analytical’s Chemical Hygiene Plan and enforcement of laboratory safety rules; Coordination of safety related staff training; Sample/waste disposal and storage. The Lean Project Manager will provide back-up in the absence of the H&S Manager.
Information Systems Department Maintenance of all internal network functions; Program development; Assists with marketing strategies. Eurofins NSC will provide back-up in the absence of onsite IT.
2.2 Training
Eurofins Spectrum Analytical’s training program applies to all employees. All job functions are fully described in a formal job description, which is kept on file in the lab. To be hired or promoted, an employee must meet all job description requirements. All hiring and subsequent changes in personnel are documented in the individual’s permanent personnel file. Various training programs are provided for new employees or employees transferred to a new position. Additionally, certain positions require auxiliary training, including training videotapes, on-site training classes, or off-site attendance of specialized training or certification courses. Each analyst hired must perform an Initial Demonstration of Capability (see Appendix C) before processing and reporting data. This study is used to demonstrate the precision and accuracy of the individual analyst.
All hiring, training and position changes follow the policies and procedures set forth in the Eurofins Employee Handbook. Training is arranged and planned by
Uncon
trolle
drage. ge.
will provideprovid
rtment ment all internal ninternal
elopment; pment; th marketingmarketing
ns NSC will pNSC will p
ng ng
ofins Speofins Spctioti
Copy
Analytical’s Chelytical’s Cheafety rules; afety rules;
training; aining;
ac
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 17
COMPANY CONFIDENTIAL
the operational department, reviewed by the Quality Assurance Department and approved by the Laboratory Director. Before commencing employment with Eurofins Spectrum Analytical, all potential staff members are informed of their ethical and legal responsibilities. This includes client confidentiality, health and safety procedures, and communication within the laboratory. The employee must review and sign the Eurofins Employee Handbook before starting as an employee. This handbook details all company policies and penalties for not complying with the procedures and policies. Along with the Handbook, each employee is required to review the laboratory’s Comprehensive Quality Assurance Manual, specifically the sections that are pertinent to their job responsibilities. Once this section has been reviewed, the employee will sign the training form stating that he/she has read and understands the information provided. Upon completion of a revised QA Manual, all personnel are assigned the updated revision in the online SOP program. They must read and electronically sign off on the updated QA Manual, acknowledging they have read and understand the most recent revision.
2.3 Quality Assurance Managerial Organization
The managerial team under the direct supervision of the Laboratory President and QA Manager will enforce the implementation of the Comprehensive Quality Assurance Manual. Listed below are routine quality organization functions:
a. Daily communication occurs between the Laboratory Director and Managers. The Laboratory Director is kept up to date regularly throughout the day for any immediate executive decisions. The Operational Support Manager (communicates data deliverable information and any technical or instrument issues for the Organic Sections). All departments have daily Flash Meetings to discuss current and future workload, KPIs and operational issues.
b. Weekly Performance Meetings are held with senior management to discuss lab status. A weekly status update is emailed to the Laboratory Director by each department manager detailing any performance issues.
c. Monthly Performance Review - this meeting is held on a monthly basis (or as needed) and is under the direct supervision of the Laboratory Director. Managers for all departments attend this meeting.
d. Quarterly BU Performance Review: this meeting is under the direct supervision of the Laboratory Director and each operational manager in order to evaluate the operational plans developed by each department and their efficiency at meeting goals during the year.
Employee Performance Evaluation - all employees are evaluated on a yearly basis by the department managers and the Laboratory Director.
Uncon
trolle
dsuperviupervementation mentation
w are routinew are routine
ion occurs boccurs bLaboratory DLaboratory
ny immediatimmedi(communicatmmunica
ment issues fot issues h Meetings tMeetings
perational isrational
Weekly WeekldiscudiscDi
Copy
d. Updated revised rev
gn off on the uoff on theerstand the mostand the mos
n
on of
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 18
COMPANY CONFIDENTIAL
2.4 List of Key Personnel and Positions
Employee Name Position Held Nicole Leja President
Christina White Laboratory Director Dulce Litchfield Deputy Director of Quality Services Kimberly LaPlante Quality Assurance Manager Patrick Sullivan Senior Operations Director Kevin White Lean Project Manager Wes Bryon Operational Support Manager Rebecca Merz Quality Services Manager Emily Kinney Air & Volatile Organic Manager
Sandra Mateega Semi-Volatile Organic Manager Jackie Clement Metals Manager
Raquel Thomas Wet Chemistry Manager John Miller Health & Safety Manager Joel Navaroli Information Technology Kathryn Wilkinson Sample Receiving Manager
2.5 Housekeeping Policies
The laboratory follows stringent housekeeping procedures both utilizing internal policies performed by employees and contracting with an external cleaning group.
Internally, all employees are responsible for the cleanliness of their own area. This includes reagents, cleaning and placement of glassware, etc. The Laboratory Director routinely oversees all procedures.
The Health and Safety Manager performs an internal audit of the entire laboratory on a monthly basis and reports his findings to the Laboratory Director with suggested comments.
In addition, a cleaning company has been contracted who performs a thorough cleaning for both facilities three times per week or on an “as needed” basis following the necessary precautions as to not interfere with the efficiency of the laboratory.
Uncon
trolle
d foro
Sample mple
ringent houseent houseemployees anmployees a
ployees are ryees are rreagents, cleagents, cl
utinely oversnely over
Health and Saealth and Saa monthly baa monthly b
ested coested c
Copy
anaggrganic Manic M
Organic Managanic Ma
opr ger
emistry Manageemistry Managh & Safety Man& Safety M
ation Technation Teeceiv
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 19
COMPANY CONFIDENTIAL
3.0 Quality Assurance Objectives
Eurofins Spectrum Analytical follows the well-defined EPA standards for validation and data accuracy as the foundation of our QA/QC effort. The primary QA/QC objective is to develop, implement and maintain procedures for sample receiving, sample preparation, laboratory analysis, data validation and reporting that provide scientifically valid, legally defensible data. ESA-MA supports this objective through QA/QC procedures throughout the laboratory, including all ancillary departments.
Clients are encouraged to submit a blind duplicate sample at no additional charge, which will be tested as part of the routine samples. Testing the blind sample enables ESA-MA to check the accuracy and consistency of our procedures and gives our clients the utmost possible degree of confidence in the data.
ESA-MA is so confident in its accuracy that when applying for certification renewals, the required proficiency tests are run on a rush basis. This is done because 70% of our projects require an expedited turnaround time; therefore if we can run and pass the all-important proficiency tests using our rush procedures, we have further proven the accuracy of our ongoing technique.
Our use of reliable and technically sound instrumentation, the experience of our chemists, and our well-trained support staff are additional components to our QA/QC program.
3.1 Data Quality Objectives
Data quality objectives (DQOs) are quantitative and qualitative statements specifying the quality of the environmental data required to support the decision-making process. DQOs define the total uncertainty in the data that is acceptable for each specific activity during sample analysis. This uncertainty includes both sampling error and analytical error.
The parameters that are used to specify data quality requirements and to evaluate the analytical system performance are precision, accuracy, representativeness, completeness, and comparability (PARCC). Definitions for these parameters are presented below:
Precision: a measure of the reproducibility of measurements under a given set of conditions.
Accuracy: a measure of the bias that exists in a measurement system.
Representativeness: the degree to which sample data accurately and precisely represent selected characteristics.
Uncon
trolle
d dud
nd instrumennd instrumene additional cadditional c
s s
ctives (DQOves (DQOquality of thality of
cess. DQOs ss. DQOspecific activecific ac
ing error andng error and
parametparamelyt
Copy
es o
ying for certificag for certificis is done becauis is done beca
efore if we can fore if we ces, we have s, we h
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 20
COMPANY CONFIDENTIAL
Completeness: a measure of the amount of the valid data obtained from the measurement system compared to the amount that is required.
Comparability: a measure of confidence with which one data set can be compared with another.
3.2 Quality Assurance Communication Procedure
ESA-MA has instituted a Quality Assurance Communication Procedure (QACP) in order to strengthen the quality organization within the laboratory. The effectiveness of this procedure enables a timely response to problem situations and the creation of innovate concepts, enhancing the quality of both the analyses and the services provided by ESA-MA.
The following outlines specific quality assurance communication activities.
Managerial communication is conducted between the Laboratory Director and the team leaders: (Operational Departments, Quality Assurance, Quality Service, Sample, Courier, Technical Service Departments, and Air Division) to handle the overall daily laboratory functions (see Section 2.0 – Organization Structure and Responsibilities).
Data deliverable communication deadlines: all operational departments report to the Laboratory Director regarding the status of their data deliverable no later than 11:30 AM via the daily rush program.
Data validation communication updates: the validation team is in constant communication with the Operational Departments regarding data quality issues that may require immediate action. The Laboratory Director will immediately be notified.
Departmental communication update: the department manager must meet with his/her assistant and/or coordinator on a daily basis to discuss various actions such as: daily workload, quality control issues, instrumentation issues, personnel and others.
3.3 Quality Assurance/Quality Control Review
It is necessary to continually review and evaluate all laboratory procedures to ensure compliance with state and federal regulations. This includes procedures for data validation, daily laboratory operation, and corrective actions. The Laboratory Director, along with the QA Department and Directors, meet frequently to discuss if procedures need to be changed in order to meet compliance. If any procedure is changed a written memorandum is sent to all
Uncon
trolle
dartm
cal ServiServoratory functtory funct
ResponsibilitResponsibili
munication dnication dDirector regarirector rega
AM via the dM via the
ation commuon commnication withation wit
s that may rehat may mmediately bmediately b
DepartmDepartmhe
Copy
ity
e communicatioommunicatio
d between the Lbetween thents, Qualitnts, Qu
e Dep
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 21
COMPANY CONFIDENTIAL
pertinent laboratory personnel. These memorandums are issued a control document number, stored on the network and backed up regularly.
The Laboratory President, Director and QA Department meet at the end of each calendar year to discuss the quality systems in place. The Department Managers are evaluated on the quality systems within the laboratory during the end of the year performance review. If necessary, managers meet with the Director and QA Manager more frequently to address quality issues.
3.4 Quality Control Acceptance/Rejection Criteria
Acceptance and rejection criteria are based on methodology and instrumentation. Eurofins Spectrum Analytical will use method guidelines for criteria levels. Quality control samples are charted periodically to determine upper and lower acceptance levels for in-house method acceptance and rejection criteria. The Laboratory Director is responsible for final decisions regarding data acceptability.
3.5 Stoppage of Non-Conforming Work
When quality control data falls outside of the laboratory’s acceptance criteria, the Laboratory Director, QA Manager, Validation Team and department managers have the authority to halt the analysis of samples. QA Department staff has the authority to halt work if any compliance issues are found with a laboratory method or process. Before any work can resume, laboratory personnel must identify the non-conformity. Once the issue has been identified, the client must be contacted to inform them of the non-conformity and how their data may be affected. After a thorough investigation, the data may be narrated or, if deemed appropriate, a corrective action may be enacted. Once satisfied that the non-conformity has been sufficiently addressed, the Laboratory Director, QA Manager, Validation Team or department managers may authorize work to resume.
3.6 Preventative Action
All employees are empowered and encouraged to use the concept of Preventive Action to avoid a problematic situation. The company supports, embraces and drives the process for continuous quality improvement by several means, such as: Ethics Hotline, open door policy for suggestions and training classes that include Ethics and "Essential Technical Training for Laboratory Personnel". If an employee identifies a potential problem or an area of concern or it should be brought to the attention of his/her supervisor, Human Resources, QA Director or the Ethics Hotline.
The laboratory also utilizes a formal program to encourage preventive action through development of lean processes. The goal of this program is to optimize
Uncon
trolle
dtside of the lde of the ger, Validatioger, Validatio
analysis of snalysis of sny complianccomplian
fore any worfore any woformity. Oncrmity. O
rm them of ththem of thr a thorough ihorough
, a correctivecorrectivity has been has been
ger, Validatiger, Validatiume. um
tati
Copy
gy anes for crifor c
determine uppermine upe and rejection and rejection
ecisions regardinecisions regard
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 22
COMPANY CONFIDENTIAL
processes to ensure efficiency and operational improvements while maintaining compliance. The efficiency gains are inherently coupled with minimizing errors and rework. Teams of employees learn the tools and techniques to evaluate a process, identify potential sources of errors, delays or problems in an operation, determine system changes that will minimize these and work to implement the improvements. Each project includes thorough documentation of the evaluation, measurement, and implementation phases. The process is continually monitored to ensure that the anticipated results are sustained.
Employees are also encouraged to communicate to their supervisor any area(s) or operation(s) that they believe could be streamlined, make their job easier, would provide a quality improvement, or could provide a cost savings to the company.
Described below are some of the systems available to employees to assist with building quality and efficiency into their daily jobs. They stress a proactive approach/environment to problem solving and to review quality systems and operational efficiencies.
Ethics Training is a seminar required for all employees to teach the laboratory’s Statement of Values by examining how it translates to our everyday jobs and ethical decision making. Topics discussed include: Statement of Values, ethical paradigms, and ethical decision making. Mandatory ethics training refresher seminars are offered on an annual basis.
The laboratory has contracted with an Ethics Hotline to provide an anonymous means of reporting ethics concerns or issues. The issue is forwarded by the service to the QA Director who will communicate internally with those who need to address the issue. All communication and actions are documented in a secure web interface managed by the hotline service company.
The QA staff prepares monthly program status reports for management. The reports include a variety of metrics which are used to evaluate trends in laboratory performance across all quality and compliance areas. Management responds to any negative trends by developing a corrective action plan.
QA staff undergoes intensive training including how to perform internal audits, review internal investigations for thorough root cause analysis and corrective action and Eurofins seminars "Follow the Yellow Brick Road to Quality Management" and "Top 10 Suggestions For Being A Better QAO". Eurofins encourages collaboration between all US QAOs to share experience and best practices to improve laboratory quality and efficiency.
Operational Departments continuously monitor control charts to look for trends and out-of-control situations. When an adverse trend or out-of-control
Uncon
trolle
ded for d fo
es by examiexamcision makincision makin
cal paradigmsal paradigming refresher refreshe
as contracted contracted eans of repors of repor
by the servicethe service who need tho need
mented in a seed in a sempany. mpany.
The QA stThe QA stports ports
Copy
vin
o employees employeebs. They stress They stress
to review qualieview qu
ll emploll emng
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 23
COMPANY CONFIDENTIAL
condition is indicated on a control chart, the nature of the condition is used to determine the type and extent of corrective action (if required). Corrective actions can include, but are not limited to, instrument maintenance, replacing a degrading standard or recalibrating an instrument that is showing repeated problem.
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 24
COMPANY CONFIDENTIAL
4.0 Specialized Analytical Methods
4.1 Microbiology Analysis
There are several critical elements for analysis of microbiological samples. The department supervisor must have completed at minimum one college-level course in which environmental microbiology was covered. Academic transcripts and resumes are available upon request for the supervisor and analysts.
The operational room for microbiological analyses has sufficient storage and bench-top space and is equipped with fluorescent lighting. It is separated from other operational work areas and authorized personnel only are permitted in the laboratory area.
4.1.1 Standard Operating Procedures
Necessary equipment is available to perform the analyses. This includes pH meter, balance, an incubator unit, hot air oven, colony counter, conductivity meter, and an autoclave for disposal of microbiological samples. Support equipment is also available, such as culture dishes, pipettes, culture tubes and closures, inoculating equipment, membrane filtration equipment, sample containers and glassware, and an ultraviolet lamp. Specific care and maintenance of this equipment is detailed in the Standard Operating Procedures (SOPs) for methods performed.
4.1.2 Record Maintenance
Record maintenance follows the normal procedures of Eurofins Spectrum Analytical Refer to Sections 9.3 and 11.5 of this manual.
4.1.3 Temperature Records
Daily records of the incubator are maintained for each day of use. The temperature for the incubator is recorded from a thermometer immersed in liquid and placed on a shelf. The temperature is recorded twice a day with a minimum of four hours between each reading.
Refrigerators used to store samples, media and reagents are maintained at a temperature range of 1 C to 5 .
4.1.3.1 Autoclave
The date, time, temperature and duration for each sterilization cycle are recorded. A list of materials
Uncon
trolle
dunu
toclave flavent is also avis also av
nd closures, ind closures, isample contample conta
re and maintend mainteting Proceduing Proced
aintenance tenance
ord maintenad maintenAnalytical Realytical R
3 Temper3 Tempe
Da
Copy
ly a
perform the anperform thehot air ovehot air
r disp
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 25
COMPANY CONFIDENTIAL
sterilized is maintained and initialed by the analyst who has performed the work.
4.1.3.2 Incubators
The temperature of each incubator is recorded twice daily with a minimum of four hours between each reading. The temperature is documented in the appropriate logbook.
4.1.4 Laboratory Reagents and Chemicals
Analytical reagent grade chemicals are used for all analyses performed. Procedures for receipt at the laboratory, labeling reagent bottles and preparation of standards is detailed in Section 11 and the corresponding SOP.
4.1.5 Laboratory Water
Distilled water is prepared in the operational laboratory room and meets the requirements for Type II water as defined by the ASTM. Water quality is verified daily for conductivity and monthly and annually for suitability according to method requirements. This is also referenced in the method SOP. Reagent-grade water quality is monitored in accordance with Standard Method 9020 B Inter-laboratory Quality Control Guidelines.
4.1.6 Laboratory Glassware
Sterile sample containers are commercially prepared. Glassware used within the operational laboratory is cleaned according to method requirements. Specific details can be found in the SOP.
4.1.7 Maintenance of Laboratory Instrumentation and Equipment - Please refer to Section 11.3 and method specific SOPs.
4.1.8 Instrument Calibration Requirements - Please refer to Section 6.0 and method specific SOPs.
4.1.9 Sample Collection, Preservation and Handling - Please refer to Section 5.0 and method specific SOPs.
4.1.10 Analytical Methodology – Methods performed are accepted and approved by the EPA for the matrices and analytes of interest. These methods are referenced in laboratory SOPs.
Uncon
trolle
dthe operopeII water as dwater as d
for conductivfor conductivto method remethod re
Reagent-gradagent-gradMethod 9020Method 9020
atory Glassway Glassw
terile samplerile sampwithin the within the requiremrequire
M
Copy
ll ang reagenteagen
on 11 and the c1 and the
ional
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 26
COMPANY CONFIDENTIAL
4.1.11 Sterility of Rinse/Dilution Water and Sample Bottles
Preparation of sterile rinse water is detailed in the SOP. Sterilization is checked using Tryptic Soy Broth. Each lot of sample containers received for microbiology analyses is checked for sterility by selecting one container. Containers are not used until satisfactory results are obtained from the tested bottle.
4.1.12 Residue Testing of Glassware
4.1.12.1 Inhibitory Residue Test
The cleaning process of glassware using a detergent or similar product is checked to ensure it is free from toxic material after rinsing based on the use of the Inhibitory Residue Test as specified by Standard Method section 9020 B (3), Inter-laboratory Quality Control Guidelines, Laboratory Supplies.
4.1.12.2 Bromthymol Blue Test
Each batch of clean glassware is tested for residual alkaline or acid residue using bromthymol blue indicator. If the results of the indicator test are not acceptable corrective action is immediately taken. Refer to Section 13.0 and/or method SOP for corrective actions.
4.1.13 Microbiological Media – Quality Control Measures
Media is used in the order that it is received. The date, type, amounts, and date opened is recorded for each media received by the laboratory. Media is kept no longer than one year after opening and is stored in a dessicator.
The media dispensing apparatus is checked for accuracy before each sample batch analysis using a graduated cylinder. Accuracy is checked again with each change in volume or periodically throughout extended runs.
Documentation is kept for sterilization of all media, including analyst, lot number, date, sterilization time and temperature and the final pH.
Water sources with known contaminants shall be used on each new lot of medium to determine performance with previously acceptable medium.
Uncon
trolle
d iese
l Blue Test Blue Test
batch of cleanch of cleanacid residue uresidue u
results of theesults of theaction is imaction ismethodmethod
robiological biologica
Media is uMedia is udate opedate opis kepis ke
Copyare using ausing
ensure it is fresure it is d on the use of tn the use of
ed by Standard ed by Standardy Quality ContQuality Co
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 27
COMPANY CONFIDENTIAL
4.1.14 Miscellaneous Quality Control Measures
A minimum of one bottle per lot of sterilized sample containers supplied with sodium thiosulfate is checked for residual chlorine using standards at 5 mg/l and 15 mg/l. The sodium thiosulfate tablet must be able to remove both low and high levels of chlorine residual. If testing shows that sodium thiosulfate inadequately removes the chlorine, the vendor will be contacted and the lot will be rejected.
Heat sensitive tape is used along with a thermometer to verify stabilization temperatures in the autoclave.
Water baths are used to temper media. Please refer to SOP for cleaning procedures.
The optic and stage of the microscope is cleaned before each use.
4.1.15 Membrane Filter Procedure Quality Control Specifics
Documentation is kept to record lot numbers and date of receipt for all membrane filters.
A sterility media check for each filter unit is performed at the beginning and end of each sample analysis batch. If the control indicates contamination all data for affected samples is rejected and an immediate re-sample is requested.
Verification of Membrane Filter Colonies – see method SOPs. E-Coli bacteria are used for positive control and S. Epidermis is used for negative control.
Each analyst must prove method proficiency by analyzing quality control samples yearly for known and unknown performance samples. Duplicate analyses are performed once per month per analyst on positive samples.
4.2 Air Analysis
Air analysis may be performed for various parameters using different methods and instrumentation. The parameters that may be tested include volatile organic compounds, air phase petroleum hydrocarbons, sulfur, fixed gases and metals. The Air Department is run under the supervision of a well-experienced chemist.
Sources of samples can vary from residential or commercial locations, factories, ambient air, stacks, soil vapor points, vapor extraction systems, landfills, and other location where contamination is suspected.
Uncon
trolle
dlity
ecord lot numord lot nu
heck for eacck for each sample analsample ana
on all data forall data fis requestedrequested
fication of Mation of acteria are uteria are
control.control.
EachEachsa
Copyrefer to SOer to
is cleaned befois cleaned bef
Control SpeControl
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 28
COMPANY CONFIDENTIAL
The volatile air laboratory instruments are comprised of two Agilent 5973 and two Agilent 5975 mass spectrometers interfaced with an Entech 7100 pre-concentrator and a 7016 autosampler. There is an inventory of over 200 passivated sampling canisters and 100 passivated flow regulators. Canisters are cleaned by an Entech 3100 sixteen position cleaner that heats the cans to 100 degrees C during the process.
Metals are analyzed using a ICP and a modified microwave digestion procedure.
The two prominent gases used extensively are helium, used as a carrier gas, and. liquid and vapor nitrogen, used frequently for instrument cool down, flushing systems and as a diluent gas. All gases are located in the storage garage of laboratory and plumbed into laboratory sections. The air laboratory also has a dedicated air handling system for AC and in laboratory air filtration.
4.2.1 Standard Operating Procedures
All analytical procedures have documented Standard Operating Procedures (SOPs). The SOPs are written and updated as modifications to the methods are accepted and performed.
4.2.2 Record Maintenance
Record maintenance follows the procedures outlined in Sections 9.3 and 11.5 of this manual.
4.2.3 Laboratory Standards
Laboratory standards are purchased as certified standards at 1 PPMv. They are then diluted to lower concentration using the Dynamic Diluter. The most common dilution is the internal standard to 50 PPBv, the calibration gas to 50 PPBv and 10 PPBv and the quality control gas to 10 PPBv.Other standards for special analytical work such as formaldehyde or haloethane are made from neat standards using the static dilution (expansion flask) technique. It is then introduced into the sampling container using the dynamic diluter.
4.2.4 Sample Containers
Sample may be collected in either passivated stainless steel canisters or tedlar bags. Two size canisters are used; 3.2 liters and 6.0 liters. Both canister and tedlar bags can be attached to the auto sampler for analysis. Tedlar bags supplied by the laboratory are one-liter bags with a non-metal fitting. Other size bags with different fittings may also be analyzed.
e documocumOPs are writPs are wri
d and performd and perform
ce
ntenance follonance fos manual. manual.
oratory Standatory Stan
LaboratoryLaboratoryare thenare themost mosga
Copy
coohe storagestorag
he air laboratorair laboraoratory air filtrattory air filtra
nted S
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 29
COMPANY CONFIDENTIAL
Passivated stainless steel containers are coated with a polymer coating that allows for the most inert surface possible (Normal summa canisters are just stainless steel). The passivated process is either called Silcosteel or Silonite. All canisters have vacuum gages attached to their valves for monitoring the vacuum before, during and after sampling takes place.
Flow regulators, which attach to the canisters, can be set for sampling from 0.5 hour through to a 1-week timeframe. These have also undergone the passivating process.
All canisters are cleaned after analysis and before reuse. The can cleaner has sixteen positions and has the ability to heat the cans to 100 degrees C. The cans are attached to the cleaner, pressurized with N2 and heated. After about one hour the can cleaner will evacuate and pressurize the cans three times using a roughing pump. After the third cycle, a molecular drag pump is activated which will vacuum the can to < 50 militorr. It runs with the molecular drag pump overnight. After completion, the canister which had the most contamination detected during analysis is pressurized with N2 and analyzed. All analytes must be below the detection limit for a batch to be considered properly cleaned. If any analytes are above detection limit then the whole batch is re-cleaned.
All flow controllers are cleaned by flowing N2 through them at 2-5 psi for 10 Minutes.
4.3 New Jersey Extractable Petroleum Hydrocarbon Method (NJ EPH)
The NJ EPH analysis is conducted in the Semi-Volatile Department. Soil samples are extracted by sonication utilizing method SW846 3545A and water samples are extracted by Separatory Funnel Extraction utilizing method SW846 3510C. Both soil and water samples are extracted using methylene chloride as the solvent and 1-chlorooctadecane and ortho-terphenyl as extraction surrogates. All water samples and soil samples known to contain #2 fuel oil (2FO) are then analyzed by GCFID. Soil samples of unknown contamination are solvent exchanged to hexane. Fractionation surrogate, 2-bromonaphthalene and 2-fluorobiphenyl, are added and the sample is fractionated through silica gel into aliphatic and aromatic portions. The aliphatic is analyzed by GCFID. The aromatic is analyzed by GCMS.
It is the clients’ responsibility to inform the lab if there is known 2FO contamination in soil samples. If there is no communication, all soil samples will undergo fractionation.
Uncon
trolle
dghtg
etected dcted ytes must bes must be
roperly cleanroperly cleanhe whole batcwhole bat
llers are clealers are clea
xtractable Petctable P
EPH analysisH analysxtracted by soracted by so
racted by Seracted by Sand wateand wat
oo
Copy
reuthe cans e can
ized with N2 ad with Nevacuate and pacuate and p
fter the third cyfter the third cm the can to < 5m the can to After compAfter co
ring a
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 30
COMPANY CONFIDENTIAL
4.3.1 Standard Operating Procedures
All analytical procedures have documented Standard Operating Procedures (SOPs). The SOPs are written and updated as modifications to the methods are accepted and performed.
4.3.2 Record Maintenance
Record maintenance follows the procedures outlined in Section 9.0 of this manual.
4.3.3 Laboratory Reagents and Chemicals
Analytical reagent grade chemicals are used for all analyses performed. Procedures for receipt at the laboratory, labeling reagent bottles and preparation of standards are detailed in Section 11 and the corresponding SOP.
4.3.4 Quality Control
Every NJ EPH batch contains (20 samples or less) contains the following lab QC samples:
DFTPP every 12 hours 100ppb Continuing Calibration Check (CCC)Lab Solvent Extract Blank Lab Control Spike (LCS) Lab Control Spike Dup (LCSD) Silica-gel Fractionation Check Matrix Spike (Aqueous if provided enough sample volume) Duplicate (Aqueous if provided enough sample volume)
4.3.5 Laboratory Glassware
Glassware used within the operational laboratory is cleaned according to method requirements. Specific details can be found in the SOP.
4.3.6 Maintenance of Laboratory Instrumentation and Equipment - Please refer to Section 11.3 and method specific SOPs.
4.3.7 Instrument Calibration Requirements - Please refer to Section 6.0 and method specific SOPs.
4.3.8 Sample Collection, Preservation and Handling - Please refer to Section 5.0 and method specific SOPs.
Uncon
trolle
d ntains (20 samntains (20 sam
y 12 hours hours ontinuing Cantinuing Ca
lvent Extractnt ExtraControl Spikntrol Spik
Lab Control SControl Silica-gel Filica-gel Matrix MatrixDupDup
LabLab
Copyfor all analyser all analy
abeling reagent eling reagentn Section 11 andn Section 11 a
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 31
COMPANY CONFIDENTIAL
4.3.9 Analytical Methodology – NJ EPH Method performed is accepted and approved by the NJ Department of Environmental Protection for the matrices and analytes of interest. This method is referenced in laboratory SOP.
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 32
COMPANY CONFIDENTIAL
5.0 Sample Handling
The validity of a sample analyzed is, at best, only as good as the techniques used when collecting and handling said samples. Proper sample collection, handling and preservation techniques are imperative in order to impede the biological and chemical transformations that occur once a sample is removed from its parent source. The following summarizes steps taken to maintain sample validity.
5.1 Sample Containers
Pre-cleaned “Class A” sample containers, as required by EPA and the TNI Standards, are provided by the laboratory at no charge to the client via Eurofins Spectrum Analytical’s online system or Sample Container Request Form (see Appendix D). Each shipment has available a certificate of analysis documenting that the glassware is reagent free for target compounds of environmental analyses. The certificates of analysis are scanned, kept on file electronically and backed up by IT. Sample containers are purchased pre-preserved from the vendor or are preserved and tested by lot as needed by the laboratory before being delivered.
5.2 Sample Acceptance Policy
Eurofins Spectrum Analytical is committed to maintaining the integrity of all samples submitted for laboratory analyses. If there is any question or concern regarding the integrity of a sample, the Laboratory Director is notified and immediate action is taken.
All samples submitted must have durable labels attached to each container identifying the sample ID, site location, and/or project number and the collection date written in indelible ink. The ESA-MA employee receiving samples must review the information on the Chain of Custody for completeness and inspect all the sample containers to ensure proper labeling and sample integrity. Any corrections to COC information must be made by using a single horizontal line to strike through the incorrect entry and they must initial and date the correction. The COC is then signed and the date and time of possession are recorded. The duplicate copy of the COC is given to the client as documentation of receipt. Eurofins Spectrum Analytical retains the original COC for the final client report and laboratory files. Please see Appendix D for an example of the Chain of Custody, sample label and Custody Seal.
The acceptance of any sample is based on the following criteria:
Full and complete documentation, including sample collector’s name on the COC The identification of a sample container is not questionable or unidentifiable
Uncon
trolle
d th
al is committs committoratory analytory analy
of a sample, of a sampletaken. en.
ubmitted musmitted muthe sample IDe sample
tten in indelibn in indew the informa the inform
sample contsample conections tections
hro
Copy
the iner Requr Req
cate of analyse of analounds of environds of enviro
on file electronion file electron-preserved frompreserved frlaboratory laborato
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 33
COMPANY CONFIDENTIAL
The sample collection date is within the holding time of analysis specified There is sufficient sample The sample is properly preserved and it is in the appropriate container VOA vials do not contain air bubbles of sizes greater than 1% of the vial volume
Please refer to Eurofins Spectrum Analytical’s website under Sampling for the “Table Recommended Containers, Preservation, Storage & Holding Times” for correct sample containers, preservation, and holding times.
The Sample Department will contact clients in regards to any samples considered to be of unsatisfactory condition. Documentation of this notification will be attached to the COC for record keeping purposes.
Analysis of any samples deemed unsatisfactory will be conducted only with client approval and will be documented in the following manner:
The unsatisfactory condition will be noted on the COC and supporting documentation The condition of the samples as received in the laboratory will be noted on the final report.
5.3 Sample Receipt Protocols
The following checks are performed upon laboratory receipt of samples:
(1) Check the temperature of samples:
ESA-MA determines the temperature of samples. A notation of the temperature reading will be recorded on the Chain of Custody record along with a notation of how the samples were received (e.g: on ice, refrigerated, ambient).
(2) Verify the integrity and condition of all sample containers:
Check for leakage, cracked or broken closures or containers, evidence of grossly contaminated container exteriors or shipping cooling interiors, obvious odors, etc. The VOC department does a check for air headspace or bubbles in VOC containers and samples are qualified if detected. Were cooler custody seals present? Were custody seals intact?
Any compromised conditions will be noted on the COC and supporting Sample Integrity Form (See Appendix D).
Uncon
trolle
dl bb
es as receiveas receiv
ks are performare perfo
the temperattemper
ESA-MA ESA-MAA notatA notaCustCurer
Copy
noti
will be conductel be conductwing manner: wing manner:
noted on thnoted on
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 34
COMPANY CONFIDENTIAL
(3) Verify COC information for completeness:
Clients name in the Report To section Site name and location Sample identification, collection date, and matrix Type and number of each sample container Sample preservation All requested analyses should be clearly indicated The COC is relinquished by the sampler
(4) Verify receipt of complete documentation on the label for each sample container:
Sample identification Collection date and time Site name and/or client project number Verify that the sample information on the label corresponds to the sample information on the COC
(5) Verification of Sample Preservation
Field preservation of any sample must be clearly documented on the COC. Any preservation should be performed in accordance with the tables within this section. Any sample preservations that are inadequate or not performed by the sampler are corrected prior to assigning samples to laboratory departments with the exceptions noted below.
In order to maintain sample integrity and alleviate possible volatile loss, samples for the determination of Volatile Organic Compounds will be checked for pH and chlorine residual (EPA 524.2) after the samples have been analyzed. The results will be documented in the appropriate logbook and the correct qualifier will be indicated on the final report.
The pH will not be checked on any samples for microbiology testing. All bacteria sample bottles are tested to insure that adequate dechlorinating agents are present. This information is documented along with the sterility of the containers.
The Inorganic Department will conduct any necessary pH adjustments of samples for the determination of Trace Elements by ICP or ICP/MS after sample filtration if necessary.
Uncon
trolle
d foro
n the COe CO
Preservation Preservation
of any sampany sampon should be n should be
ctionon.. Any And by the sampy the samp
ory departmey departm
In order toIn order loss, saloss, sawill wilsa
Copy
labe
ect number ct number mation on thation on
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 35
COMPANY CONFIDENTIAL
Samples submitted for the petroleum hydrocarbon analysis such as method 1664B will be checked by the analyst for pH. In the event that the sample contains noticeable hydrocarbons, the Pasteur pipette will be rinsed with the method solvent to insure that no hydrocarbons have been inadvertently removed.
The Log-In Analyst will conduct all other laboratory preservation of samples.
An aliquot is tested against litmus paper by touching a disposable pipette to litmus paper to verify the sample pH. Litmus paper is never inserted into the sample.
(6) Evidentiary Samples
Samples received with a legal Chain of Custody are logged-in in the same manner as non-evidentiary samples, with the exception that they are stored in a secure location. Access is monitored by designated personnel. Sample movement is tracked by the LIMS. Eurofins Spectrum Analytical’s sample disposal policy is not applicable to evidentiary samples; clients are notified prior to storage time expiration for direction to hold or dispose of remaining samples. Clients must notify the laboratory that a sample must be handled under legal COC procedures prior to receipt. See the SOP for Sample Documentation and Login for specific details.
(7) Sample Confirmation Email
Upon entry into the Laboratory Information Management System (LIMS), the sample receipt conditions are emailed to the client. Below is an example of information included in this notification.
The following outlines the condition of samples for the attached Chain of Custody upon receipt.
Were cooler custody seals present? Answered Yes or No
Were custody seals intact? Answered Yes, No or N/A
Were samples received at a temperature of 6°C? Answered Yes or No
Were samples cooled on ice upon custody transfer to laboratory representative?
Answered Yes or No
Were samples refrigerated upon custody transfer to laboratory representative?
Answered Yes or No
Were sample containers received intact? Answered Yes or No
Uncon
trolle
dlese
monitoronitoe LIMS. EurIMS. Eur
plicable to evplicable to evge time expitime expi
s. Clients mulients muer legal COCr legal COC
umentation aentation
e Confirmatioonfirma
Upon entry inon entry the samplethe sampleexampleexamp
s thth
Copy
e pH
n of Custody arof Custodywith the excwith the
d by d
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 36
COMPANY CONFIDENTIAL
Were samples properly labeled (labels affixed to sample containers and include sample ID, site location, and/or project number and the collection date)?
Answered Yes or No
Were samples accompanied by a Chain of Custody document? Answered Yes or No
Does Chain of Custody document include proper, full, and complete documentation, which shall include sample ID, site location, and/or project number, date and time of collection, collector's name, preservation type, sample matrix and any special remarks concerning the sample?
Answered Yes or No
Did sample container labels agree with Chain of Custody document? Answered Yes or No
Were samples received within method-specific holding times? Answered Yes or No
5.4 Sample Tracking
Upon receipt of samples, the information listed on the Chain of Custody is transferred into the Laboratory Information Management System (LIMS). The computer then assigns a unique, sequential laboratory identification number for each Chain of Custody with a unique identifier extension for each sample and container. In order to ensure that there may be no confusion regarding the identity of any sample, it is henceforth identified as this number. A sequential log is maintained for all samples received to assist in tracking purposes.
5.5 Storage Conditions
Samples are stored in the receiving area refrigerator or freezer until sample log in is complete. At this time, the Log-In analyst will properly label each sample container with the unique laboratory ID number and distribute them to the appropriate operational department(s) after verifying sample integrity and preservation. Security within the facility is maintained at all times so that only authorized personnel have access to samples. The facility is equipped with a state of the art alarm system. Important notes about storage are listed below:
Laboratory refrigerator temperature is maintained at a temperature of <6°C and not frozen; freezers are maintained at <-10oC. Refrigerator and freezer temperature is monitored continuously with hourly readings by electronic probe to ensure compliance with this guideline. Two consecutive readings are taken at 6:00 AM and 6:30 AM and again at 7:00 PM and 7:30 PM. If the two consecutive readings are out of compliance, a temperature exceedance alert is generated and corrective action is taken.
ation ionuential labtial lab
que identifiee identifiehat there mayhat there m
henceforth idnceforth iples receivedes received
s
stored in the d in thee. At this timAt this tim
er with the uwith the uopriate operapriate oper
servation. servation. rized prized
CopyAA
yyyyyyysted on the Ched on thManagemeManage
ato
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 37
COMPANY CONFIDENTIAL
Sample fractions, extracts, eluates, leachates, digestates, etc. are stored in accordance to EPA guidelines as specified in the applicable method utilized to prepare or analyze the sample.
Samples and all sub-samples, sample fractions, extracts, eluates, leachates, and digestates are stored separately from all standards, reagents, and cleaning supplies.
Samples to be analyzed for VOCs are stored in a separate refrigerator specified for VOC samples only.
Storage blanks are placed in all refrigerator and freezer units that hold VOC samples in both the sample login area and VOC lab. The blanks are appropriate to the type of samples being stored (e.g. Deionized Water blank held in the low level VOC freezer) and are stored in each unit for 14 days. At that point, they are removed, logged into the LIMS system and analyzed for VOCs and GRO in a batch with all necessary QC samples. The data is validated by the QA Department and evaluated for any potential laboratory contamination. Detections in a VOC storage blank may result in qualification of that analyte in affected samples, narration, client contact and/or maintenance action to eliminate the source of the contamination. The QA Department will notify the VOC department and Validation Team of detections as necessary to coordinate any corrective actions.
5.6 Sample Disposal
All samples are disposed of after 30 days unless otherwise specified for return to the client. Samples are kept refrigerated for 14 days. They are then removed from the refrigerators, boxed and labeled with the appropriate disposal date, and kept in the sample staging area for the remaining 16 days. Sample fractions, extracts, eluates, leachates, digestates, etc. are refrigerated for 40 days before being disposed of.
The Sample Disposal Technician, under the supervision of the Health & Safety manager, is responsible for all sample disposals. All samples and sub-samples are disposed of in a manner consistent with all applicable federal, state, and local regulations and in accordance with Eurofins Spectrum Analytical’s Chemical Hygiene Plan, available upon request.
International soils are disposed of in accordance with the United States Department of Agriculture (USDA) soil permit requirements, as indicated in the Eurofins Spectrum Analytical’s International Soil Disposal SOP. International soil samples are kept in a locked refrigerator for a minimum of 14 days. They are
Uncon
trolle
dDe
ation. on. DeDof that anthat analyaly
ntenance acntenance acQA DepartmeDepartme
f detections etections
s are disposedre disposet. Samples aSamples
the refrigerathe refrigeratt in the sampt in the samacts, eluaacts, elu
isp
Copy
eezd VOC laC
red (e.g. Deion(e.g. Deiand are stored id are stored
logged into the logged into thatctch with all neh with allartment andartment
ection
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 38
COMPANY CONFIDENTIAL
then removed under the supervision of the Health & Safety manager into a lock box located near the refrigerator. After 30 days from receipt, the soil samples are moved to a locked disposal storage cabinet for the Microbiology department to autoclave prior to disposal. When the samples are removed from the locked disposal storage cabinet, the analyst enters the IDs into a logbook identified as the International Soil Sterilization Record. This record includes the sample ID and the date and time of sterilization.
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 39
COMPANY CONFIDENTIAL
6.0 Calibration Procedures and Frequency
Laboratory equipment and instrumentation must be calibrated at periodic intervals as outlined by governing agencies, applicable methodology, and/or by the manufacturer’s recommendations. The nature and frequency of such checks are summarized in each applicable SOP. All calibrations are traceable to primary standards of measurement. Where the concept of traceability of measurement to primary standards is not applicable, the laboratory provides evidence of correlation or accuracy of test results. The laboratory maintains appropriate records of all calibrations, instrument tunes, and in-service checks of instruments and other equipment.
Each operational department keeps a maintenance logbook for each instrument to track routine maintenance due to instrument malfunction and/or troubleshooting. The Department Manager and the QA Department review these maintenance logbooks periodically.
6.1 Equipment Calibration Information
Measurement devices, such as balances and thermometers, are verified using standards whose calibrations are traceable to the National Institute of Standards Traceability (NIST). A certificate of the calibration is generated by the certifying agency and maintained on our network. Balance calibrations are verified daily using S-Grade, Ultra Class weights and independently on an annual basis through by an ISO accredited vendor. All refrigerator thermometers are substantiated annually against the laboratory’s NIST certified thermometer. The NIST thermometer and reference weights are verified and certification is renewed on an annual basis by an ISO accredited vendor.
6.2 Instrument Calibration Information
General calibration information for laboratory instrumentation is listed in Tables 6.1-6.4 in Appendix E. For specific information regarding calibration procedures, please refer to laboratory SOPs.
6.3 Standard Traceability, Preparation and Handling
All standards used for calibrations are either ISO certified or certified by the supplier through analysis with EPA certified or NIST traceable weights and measurements.
The commercially prepared stock standards require dilution to the working concentration. Comparing the new working level concentration against the previously prepared lot checks the accuracy of the dilution. The preparation of working standards may be tracked through the LIMS and Standard Preparation Logbook by date of preparation and/or assigned ID. The analyst preparing the
Uncon
trolle
des and thand aceable ble to tho t
ate of the calate of the calur network. Bnetwork. B
s weights aneights anendor. All reendor. All r
laboratory’sboratoryreference weerence we
y an ISO accn ISO ac
nt CalibratioCalibrat
neral calibraneral calibr6.4 in Ap6.4 in A
ref
Copy
ach ubleshooteshoo
maintenance laintenanc
rmom
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 40
COMPANY CONFIDENTIAL
working standard records the weight/volume, concentration and vendor lot number of stock standards used, the type of solvent used, his or her initials, the date of preparation and the date of expiration. The vendor reference codes may be cross-referenced to a separate inventory logbook that lists all neat or stock standards received by the laboratory, the date of receipt, vendor, and lot number.
New volatile working standards are prepared from these stocks each week. Semi-volatile stock standards are prepared every seven weeks and working level standards are prepared every four to six weeks, depending on the laboratory consumption rate. Pesticide stock standards are prepared yearly; working level standards are prepared every two to four weeks, depending on the laboratory consumption rate. Alachlor standard stocks are also prepared yearly, with working level standards prepared approximately every two to three months, but not to exceed six months.
Copy
aredhree monte mon
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 41
COMPANY CONFIDENTIAL
7.0 Standard Operating Procedures and Test Methods
Standard Operating Procedures (SOPs) have been created in accordance with EPA approved methods and state developed methods, such as the MA DEP EPH/VPH and NJ TPH methodology. For procedures that do not have specific method references, Eurofins Spectrum Analytical has developed and tested the procedures followed and then created the corresponding SOP. Eurofins Spectrum Analytical reserves the right to designate select SOPs containing technical knowledge of methods and technology as proprietary information. Complete copies of proprietary SOPs are not provided outside of the lab. Copies of the cover page may be provided if clients require evidence an SOP is in place.
Standard Operating Procedures (SOPs) are in place within each department in the laboratory for each method and/or procedure performed. They are designed to outline the procedures to be followed for the applicable method or administrative function. The Master List of all SOPs is maintained and kept within the QA Department. A copy of the SOP Master List, current at the time of this revision of this QA Manual is located in Appendix F. An updated copy is available upon request.
7.1 Standard Operating Procedure Development and Modification
It is the QA department’s responsibility to initiate updates in SOPs due to change in protocols, EPA and state method modifications, state regulatory agency correspondence, method cancellations or new methods. Included in each SOP are references for the method performed. Each operational department reviews SOPs at the beginning of the calendar year for possible revision and on an as needed basis through the rest of the year. Comments on possible modification or revision are due to the QA Manager within one month. SOP revision consists of the following steps:
A. The Laboratory Director, QA Manager or Department Manager will assess the need to update, revise, or create a SOP. In all cases a standardized form must be completed stating the name of the SOP and the modifications that wish to be made or the reason for creating a new SOP. The form must also explain why this is occurring; i.e. method changes, internal procedure changes, or new instrumentation. This form is kept on file within the QA Department. See Appendix F for example of SOP Modification Form.
If the form originates from the Laboratory Director or QA Manager, it is given to the Department Manager. The Manager must then modify or develop the applicable SOP and return it to the QA Manager for review within the designated timeframe.
If the form originates from the Department Manager, it must be given to the QA Manager for evaluation. The QA Manager and Laboratory
Uncon
trolle
d opment ament
nsibility to innsibility to inmethod modithod modi
cancellations cellations od performeod performe
he calendar ycalendarest of the yt of the y
QA ManagerA Managteps: s:
The LaboraThe Laborthe needhe neeform formmo
Copy
depay are desire de
ministrative funistrative fe QA DepartmeQA Departm
of this QA Manuof this QA Maquest.ue
d Mo
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 42
COMPANY CONFIDENTIAL
Director will either approve or deny the request. When approved, the Department Manager must complete the modification or development within the designated timeframe and return the SOP to the QA Manager for approval. When denied, the form is kept on file by the QA Department.
B. The Laboratory Director will conduct the final review of the SOP revision for approval and implementation. The SOP must include the date of revision and be signed and dated by the analyst or manager that has created or modified the document, secondary reviewer and the Laboratory Director. The date of implementation is the date the SOP is signed by the Laboratory Director.
Once finalized, a controlled copy is uploaded in the SOP program and assigned to the applicable analyst(s). All assigned personnel must immediately read and sign the updated SOP. The SOP program maintains a record in the Compliance Grid of who read each SOP revision and when. The QA Manager uploads and assigns the controlled copy and immediately inactivates the old revision. Old SOP revisions are archived electronically. The changes made to the SOP are documented in the Revisions section of each SOP.
Updates to Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual are similarly performed. Changes are documented in the Revisions section. Once a new revision is finalized and signed by senior management, all laboratory personnel are notified that the QAM has been updated. The QAM is uploaded into the SOP program. All SAI personnel are instructed to read the sections that apply to them and sign-off in the SOP program attesting that they have read, understand and agree to abide by the requirements detailed in the QAM. This acknowledgment is retained within the SOP program.
7.2 Documentation of SOPs
The QA department maintains the original SOPs electronically in a folder on the network with restricted access. The current revision is uploaded into the lab’s SOP program and all applicable personnel are assigned the SOP to read. An automatic email is sent to the assigned personnel and the department management to alert them that an SOP has been assigned to them to read. An individual may review the SOP and acknowledge that they have read and understood the document through the program. In addition, the program maintains a record of who has or has not read an assigned SOP, if any pages from the SOP have been posted in the lab, the date of the last annual review and will notify the user when the next annual review is due. It is the responsibility of the QA department to update SOPs in the program when a new revision is
Uncon
trolle
dsigs
d revisioreviss made to themade to th
h SOP. h SOP.
ns Spectrum pectrum ual are similual are simi
s section. Onection. Onagement, algement, al
en updated. Tupdated.onnel are insnel are in
ff in the SOPin the SOto abide byto abide byis retains retai
men
Copyd in the SOP pn the SOP
assigned personsigned persond SOP. The SOPd SOP. The SO
who read each who read eacs the contros the co
. Old
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 43
COMPANY CONFIDENTIAL
created and replace any posted pages with the updated version. Only the most current revision of each SOP is available to personnel at any time.
When modifications are made, the revision number must be changed to reflect this. SOPs are numbered sequentially.
SOPs must be kept within the laboratory unless the Laboratory Director gives permission for them to be taken off the premises.
SOPs are available to clients upon request and are marked as an ‘Uncontrolled Copy’. The QA department is not responsible for collecting ‘Uncontrolled Copies’ when a revision is made.
All of the SOPs are copied onto a 4.7GB DVD. One copy is kept in fire-resistant safe and another copy is stored off-site. The DVD is updated with each new SOP or modification.
7.3 Test Methods
Experienced analysts perform test methods. The complete procedure, including standard preparation, extraction/digestion, sample preparation, instrumentation used, calculations, and data interpretation/validation is documented in Standard Operating Procedures (SOPs). An electronic copy of the current method is maintained on our network and the SOP Master List references the version currently used for each method. When a method version is changed, the out-dated copy is removed from the network by the QA department and replaced with the updated version. In this way, the departments will only have access to the current method revision.
Uncon
trolle
dt methods. Tmethods. n/digestion, sn/digestion, s
interpretatioterpretatioOPs). An eles). An ele
work and thework and theach method.h metho
moved from tved from ted version. version
method reviethod rev
Copyne copy is kepcopy is k
VD is updated wis updated w
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 44
COMPANY CONFIDENTIAL
8.0 Internal Quality Control Checks
The analytical and quality control requirements for each sample are performed via the Laboratory Information Management System (LIMS). The LIMS is accessible from any workstation. A system of specific analysis codes is used to schedule the appropriate analytical procedures and the QC samples required to be processed with each batch of samples.
8.1 Laboratory Quality Control Samples
Various quality control (QC) procedures are associated with the methods run by the laboratory. These procedures are defined in the laboratory SOP for each method. The type and frequency of QC samples are specified by methods and detailed in each SOP. Such methods include CLP Organic and Inorganic SOW methods, Test Methods for the Evaluation of Solid Waste (SW-846, most current update), Standard Methods for the Examination of Water and Waste, ASTM or methodologies as listed in the Federal Register (40 CFR Part 136 and 141, most current update)
All quality control checks meet the minimum requirements outlined below.
A. The laboratory will follow the minimum quality control requirements specified by each method.
B. In the event that no quality control requirements are listed in the method, or if the method quality control requirements are less stringent than those listed below, the laboratory will follow the minimum guidelines:
1. method reagent blanks 2. matrix spikes 3. quality control check samples 4. quality control check standards 5. duplicates or matrix spike duplicates 6. surrogates
8.2 Method Detection Limits/Reporting Limits/LOD Verification/LOQ
Described here are ESA-MA’s policies for the determination of MDLs, RLs, LOD and LOQ. For specific details, please refer to our SOP for MDL/LOD/LOQ and the analytical SOPs. These documents are available upon request. The Method Detection Limit (MDL) also known as the Limit of Detection (LOD) is defined as “the minimum concentration of a substance that can be measured and reported with 99% confidence that the analyte concentration is greater than zero” and is determined from analysis of a minimum of seven prepared blank spikes. Method detection limits are determined according to procedures given in 40 CFR
Uncon
trolle
ddu
de minimum rminimum
ollow the minow the minified by eachd by each
that no qualitt no quamethod qualithod qualit
isted below, d below
. methometh2. mat2. ma3. q3.4.4.5
Copy
boraare specifspec
nclude CLP Oude CLPpyluation of So
opCophods for the E
Coas listed in t
Cate)C
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 45
COMPANY CONFIDENTIAL
Part 136, Appendix B. http://www.ecfr.gov/cgi-bin/text-idx?SID=2bad19ea8d6db04e2c8f7666ddb00943&node=ap40.23.136_17.b&rgn=div9 MDL studies are performed during method validation studies to establish a base value. Updates to the MDL on all instruments/methods will be performed every twelve months by carrying out a new study or by completion of a Limit of Detection (LOD) Verification analysis. MDL updates are also done when new instruments are put on-line, if the configuration of the instrumentation is significantly changed, or if the sample preparation method is modified.
Limit of Detection (LOD) Verification is defined as an estimate of the minimum amount of a substance that an analytical process can reliably detect. An LOD verification is analyte, matrix, extraction and instrument specific and may be laboratory dependent. ESA-MA uses the concentration of the Detection Check Standard (DCS) for the LOD verification. The LOD verification must be spiked at a concentration no more than 3 times the MDL for single analyte tests, no more than 4 times the MDL for multiple analyte tests and no greater than the RL. LOD verifications are analyzed either quarterly or annually, depending on the accrediting agency’s requirements.
Limit of Quantitation (LOQ) is defined as the minimum levels, concentrations, or quantities of a target variable (e.g., target analyte) that can be reported with a specified degree of confidence or the lowest concentration that produces a quantitative result within specified limits of precision and bias. For DoD projects, the LOQ shall be set at or above the concentration of the lowest initial calibration standard. ESA-MA defines the LOQ = RL. A minimum of four consecutive replicates are analyzed at a concentration of the lowest initial calibration standard; however, LOQ may be analyzed as high as 2 times the reporting limit. LOQs are analyzed either quarterly or annually, depending on the accrediting agency’s requirements.
In general, the lowest value ESA-MA may use, (for non-DOD) as a reporting limit is the method detection limit. However, because the MDL as defined above is known to allow the reporting of false negatives, ESA-MA generally uses a value that is greater than the MDL. For organic and general chemistry tests, a standard at the reporting limit is generally included in the initial calibration. For metals tests, the reporting limit is a set value greater than the MDL (ideally three to five times the MDL). If samples are analyzed for compliance with regulatory programs that have requirements for reporting limits that are greater than normal reporting limits, the reporting limit may be adjusted up to the regulatory limit. The MDL based on the above discussion, are dynamic values, which are expected to vary as a result of the periodic detection limit studies. The reporting limit is a static value (as a general rule) with the flexibility to be adjusted to meet project requirements provided that it is not lower than the most recently determined MDL. Although standard policies may be set for determination of normal report
Uncon
trolle
dfined as the med as the .g., target an.g., target an
ce or the lowor the lowspecified limcified lim
or above theor above thdefines the Lfines the
lyzed at a coed at a coQ may be anaay be ana
ther quarterlyr quarterments. ts.
general, the lgeneral, thet is the mt is the m
wn
Copy
specn of the Df the D
D verification merificationor single analytesingle analyt
ts and no greatets and no grear annually, depannually, d
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 46
COMPANY CONFIDENTIAL
limits, the specific report limit for each target must be reconsidered for every sample by viewing the applicable analytical data.
Detection and reporting limits are adjusted to reflect dilutions, reductions in the initial aliquot of sample prepared (due to limited volume/mass of original sample or reduction in volume/mass prepared based on knowledge of the sample) or in the case of soil samples, moisture content (unless directed otherwise by the client, e.g., DoD). Dilutions are required to analyze samples within instrument or calibration constraints, and the presence of moisture in soil samples always results in increased limits.
8.3 Sample Dilution Policy
When possible, based on in-house screening results and physical characteristics of the sample/sample extract, samples are analyzed without dilution to achieve the lowest reporting limits feasible for the method requested. Data from in-house screening is not performed with all method required QA/QC and therefore is not reported. If screen data and/or physical characteristics note significant concentrations of target compounds may be present the original analytical run is performed at a dilution.
Additional runs are performed if over or under dilutions are initially performed on a client sample. The analytical run with the lowest reporting limit is included in the final report and multiple runs may be reported if target compounds exceed the instrument calibration range in the original run.
Samples containing target compounds that exceed the instrument calibration range generally cannot be analyzed with a lower dilution factor, however depending on the sample matrix, target compound and final concentration, and method requested additional runs can sometimes be attempted. Please contact your laboratory representative on the feasibility of this deviation for a specific project or sample location.
8.4 Selectivity
All data is thoroughly checked by the analyst and the manager for each department. Unusual or inconsistent results are confirmed either by running a duplicate or by other procedures specific to each method. These procedures are listed in the method SOPs. Also contained in the method SOPs are the acceptance criteria for calibration and mass spectral tuning.
8.5 Method Validation
chmay be py be p
ed if over or uif over or uytical run wital run wi
ltiple runs mtiple runs mon range in thrange in
ining target cng target rally cannot by cannot
ng on the samon the saod requested d requested
ur laboratoryur laboratorect or samect or sa
Copyand physical cd physica
without dilutionthout dilutiod requested. Dad requested. D
required QA/Qequired QAacteristics nacterist
sent t
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 47
COMPANY CONFIDENTIAL
Before using any method, an initial demonstration of capability must be completed successfully. This includes MDL/LOD studies, IDC studies, and any other procedures specific to each method.
8.6 Control Charts
Control charts are a useful tool when monitoring the quality system within the lab. Spike recoveries are plotted on quality control charts on a continuous basis as a means of ascertaining whether an out-of-control condition is a result of systematic or random (statistical) error. Eurofins Spectrum Analytical has a Control Chart program that automatically searches the LIMs for trending analytes. It emails the department when any analyte is trending ± 5% of the acceptance range. A minimum of 30 data points are used to generate the charts and also show standard deviation, the mean, 2S and 3S lower and upper limits for review. Data points will only be excluded when there is a scientifically valid reason to do so. Department managers, or their designee, will review the control chart for trending and out-of-control situations. When an out-of-control condition is indicated on a control chart, the nature of the condition is used to determine the type and extent of corrective action (if required). An explanation for each out-of-control data point will be documented into the control chart program. Corrective actions can include, but are not limited to, instrument maintenance, replacing a degrading standard or recalibrating an instrument that is showing repeated problem. Statistically based limits will only be applied when the control limit range is at least as tight as the appropriate regulated or EPA-approved method-specified range. See the analytical SOP for specific details.
Upper and Lower Control Warning Limits = 2 sigma Upper and Lower Control Limits = 3 Sigma (used for in-house limits)
Where: y = each individual value used to calculate the mean y = the mean of n values
n = the total number of values
8.7 Estimation of Uncertainty
Estimation of Uncertainty consists of the sum (combining the components) of the uncertainties of the numerous steps of the analytical process, including, but not limited to: sample plan variability, spatial and temporal sample variation, sample heterogeneity, calibration/calibration check variability, extraction variability and weighing variability.
Unce: e:
ncon
trolle
dree
on (if re(if rdocumented umented
but are not lbut are not ard or recalibd or recalib
ically based ly based as tight as thes tight as th
ange. See thege. See t
ower Controlr ContrControl Limontrol Lim
Copy
endsed to gend to g
d 3S lower andS lower ahen there is a scn there is a s
eir designee, wileir designee, wions. When an ons. When f the conditithe con
uired)
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 48
COMPANY CONFIDENTIAL
Estimation of Uncertainty in Measurements (Laboratory portion) shall be provided to clients upon request. Calculation of this uncertainty estimation may be done using the “Quality Control-based nested approach Uncertainty Spreadsheet” (DoD Navy Document). For those analyses that do not include all the QC types needed to use the nested approach (i.e. various Inorganic analyses), the standard deviation of 20 LCS points may be multiplied by a factor of 2 to achieve the uncertainty estimation.
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 49
COMPANY CONFIDENTIAL
9.0 Data Reduction, Validation, Reporting and Records
9.1 Data Reduction and Validation
Data generated from the analyses of samples is reduced according to protocols outlined in each operational department’s SOPs and the SOP for Departmental Validation Procedures. Each data reduction process for each laboratory is slightly different, but all follow a similar core procedure. The instrument operator first reviews the data generated at the instrument. This includes review of raw data and verification of all method and project specific QC requirements. In addition, the operator is responsible for adding data flag qualifiers and a notation on the bench sheet of any unusual situations or observations. The operator has a variety of data and format checker programs to aid in review. The data is uploaded automatically from the instrument to a Laboratory Information Management System (LIMS). Data undergoes 100% review by the analyst and 100% validation by the manager. The final validation is done by the Laboratory Director, or their designee, who reviews the data for overall quality/administrative completeness and signs off on the report. All laboratory samples undergo this procedure. In addition, clients that request data deliverable packages are subject to the review detailed in section 10.3.
No results may be released in any form unless the work has undergone the validation procedures as described below, up to and including, the team validation step. The transmissions of any results subsequent to final validation are identified as a draft or are qualified by the following statement: ‘Please Note: Data contained within this report has undergone primary validation but may be subject to change pending final validation and QC review.’
Data validation occurs at each step during sample processing.
Sample integrity is documented in Sample Reception (i.e. containers, preservation, and temperature). All criteria listed on the Sample Integrity Form is documented and initialed by Sample Department personnel.
Once the information has been logged into the LIMS, another member of the Sample Department verifies the information entered into the LIMS against the Chain of Custody. This step insures that all information, including collection date and time, matrix, preservation, due dates and special instructions have been entered into the LIMS system correctly. The Quality Services Deputy Director oversees this process.
Uncon
trolle
dt
erall quall qreport. All lat. All l
nts that requets that requein section 10n section 1
sed in any fosed in any fs as describes descri
The transmisstransmisdentified as ntified as
‘Please Noteease Notvalidation buidation bu
C review.’ C review.’
a validatia valida
Copy
onf any unuun
y of data and ff data anloaded automataded automa
anagement Systanagement Syt and 100% valiand 100% v
LaboratoryLaborality/adit /
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 50
COMPANY CONFIDENTIAL
Each analyst verifies the information on the sample container against the bench sheet or applicable backlog. The analyst must initial the bench sheet, indicating that the sample information has been noted and is correct and that the method hold-times have been met. In addition, the analyst is indicating that method guidelines have been met and that quality control is within criteria. Other items checked include the data file upload, result accuracy, dilutions, surrogates, and, if applicable, sample qualifiers. Electronic signatures may be used to denote analyst review of raw data. Access to electronic employee signatures is controlled by employee ID and password. An electronic signature is considered equivalent to a hand-written signature. Once data is entered and reviewed in the LIMS the status is updated to analyst reviewed.
The Department Manager or Assistant Manager will validate the batch for quality control/quality assurance, accuracy, data consistency and proper use of applicable data qualifiers. Each work order will be checked to ensure that regulatory limits have been met. In addition the Manager will verify that only requested compounds are reportable and ensure that the proper results have been selected. The Manager or Assistant Manager will sign the bench sheet indicating this review has been conducted and update the status of the samples to Validated in the LIMS.
The Quality Service Department will check all information on the report for accuracy against the chain of custody. Once again, the data listed on the chain of custody will be compared to the information logged into the LIMS. All special requests (i.e. method detection limits, specific methods and special sample requirements) will be checked against the final report. In addition, the Quality Service Department will verify that all forms (i.e. state report forms, VPH, CAM or RCP forms) are accurately completed and attached to the final report.
The Laboratory Director, or their designee, will review the final report for overall data quality and consistency. The Laboratory Director will sign all reports and pertinent forms. In the Laboratory Director’s absence, authorized senior management will review and initial the report with the Laboratory Director’s electronic signature. Higher management has access to only their own electronic signature on the network for signing electronic documents. Authorized senior management has access to the laboratory director’s signature solely to sign lab reports in their absence. The status of the samples will then be updated in the LIMS to Reported.
Each step in the data reduction and validation procedure can be tracked through the audit trail in the LIMS.
Uncon
trolle
dad
ble and andr Assistant Mistant M
een conducteden conducted
e DepartmentDepartmenthe chain of e chain
ll be comparee comparuests (i.e. mets (i.e. me
requirementsuirementy Service DService D
PH, CAM or PH, CAM or report.report.
e LaL
Copy
atus
ger will validatewill validaty, data consisten, data consist
rder will be cheder will be cition the Mantion the
nsure th
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 51
COMPANY CONFIDENTIAL
9.2 Report Format and Contents
The results of each analysis are provided in a report and include all of the following information.
Name and address of laboratory
Each laboratory report is uniquely identified by the work order number, and the date and time of report issue. The pages of each laboratory report are identified as the number of the total report pages.
Name and address of client, project name and contact person
Identification of the samples including client sample identification
Date and time of sample receipt and sample collection (if needed for analysis with a holding time of 48 hours or less)
Date of sample preparation/extraction and analysis
Identification of test methods used
Sample and/or analyte qualifiers
Correct reporting units (i.e. ug/L, mg/Kg, mg/Kg dry, ppbv, etc.)
Method MRL (adjusted for dilution factors and/or, if necessary, % solids)
Identification of all analyses supplied by subcontracted laboratories
A listing of current laboratory certification is maintained in the LIMS. This information is pulled through onto the laboratory report in the form of a checkmark in the certification column on the laboratory report. A checkmark denotes the laboratory was currently certified for the analysis/analyte at the time of analysis.
The signature and title of the person accepting responsibility for the content of the laboratory report
A statement that the laboratory report shall not be reproduced except in full, without the written approval of the laboratory
Uncon
trolle
du
raction and on and
ods used ds used
yte qualifiersyte qualifier
ing units (i.eg units (i.e
MRL (adjustRL (adjus)
IdentificatioIdentificat
istini ti
Copyact persoers
sample identificmple identif
mple collection ple collectioor less) or less)
l
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 52
COMPANY CONFIDENTIAL
The transmission of any tests results, in any form, including electronic, will be within the guidelines described within this section and section 1.2 to insure that confidentiality is preserved.
Amendments made to any analytical report after issue is made only in the form of a further document, which includes the statement “Revised Report”.
Drinking water samples submitted for total coliform analyses that show a positive presence are confirmed for E.coli. Clients are notified immediately by both telephone and, if applicable, facsimile or e-mail, to notify them of the positive result. They are informed to not use water from the sample source until disinfection and confirmation for negative coliform has been performed.
Clients are also notified via facsimile or e-mail of all National Primary Drinking Water Exceedances or results that identify the presence of regulated microbiological organisms in Potable Water. Eurofins Spectrum Analytical will ensure Potable Water samples of the following:
Upon obtaining valid sample data, Eurofins Spectrum Analytical will notify its clients of the results of all samples that exceed any EPA or MADEP-established maximum contaminant level (MCL), maximum residual disinfectant level or reportable concentration, or that identify the presence of regulated microbiological organisms in potable water. The notification will clearly indicate that a regulatory limit has been exceeded. The date, time, and manner of notification will be documented and kept on file with the lab. Eurofins Spectrum Analytical will notify its client public water systems of the results of all samples that exceed a regulatory limit. Data indicating an exceedance of a regulatory limit will be validated and the validated data reported as soon as possible, not to exceed 24 hours after the completion of sample analysis. This includes non-regular business days. Notification will be given within 24 hours of the completion of the analysis of the sample whether or not the sample was subcontracted to another laboratory. Eurofins Spectrum Analytical Subcontract Work Orders will identify, in writing, those samples needing special reports (e.g., MCL exceedance) and date results are needed by. See section 15.1 for a full description of our Subcontract Work Order procedures. Eurofins Spectrum Analytical will make every effort to ensure that analytical data, analyzed for the purpose of determining regulatory compliance, are reported in a timely manner to meet their clients’ reporting requirements. Regulatory compliance samples subcontracted to Eurofins
Uncon
trolle
dy
Water. Waterhe followinglowing
sample data,ample dataf the results oe results o
ished maximshed maximnfectant levelctant lev
of regulated megulated mation will clen will cle
date, time, ate, time, le with the lath the
Eurofins SpEurofins Spthe resuthe resexceeexcerep
Copy
le oo not useus
n for negativefor negati
mail of all Natioail of all Nahe presence e prese
EurofinE
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 53
COMPANY CONFIDENTIAL
Spectrum Analytical from another laboratory will be reported to the client laboratory within the timeline pre-arranged by the two laboratories.
Laboratory reports for finished drinking water samples note the maximum contaminant level, maximum residual disinfectant level, secondary maximum contamination level and/or Massachusetts Office of Research and Standards Guidelines (ORSG). See www.mass.gov/eea/agencies/massdep/water/drinking/standards/standards-and-guidelines-for-drinking-water-contaminants.html for additional information.
9.3 Records and Document Control
Chains of Custody forms, bench sheets, hand-written logs and other original documentation are scanned and saved electronically for easy access. All original, hardcopy records are physically archived for a minimum of five years, per Eurofins Environment Testing US policy. Electronic files are backed up by the IT department. Data that has been archived (i.e. no longer in direct possession of the applicable department) is controlled by the IT department or senior management. Laboratory personnel may view electronically archived data via a searchable, read-only archive. Direct access to electronically archived data that involves moving or restoring files is restricted to IT only and documented by an access log. Access to physically archived hardcopy data is restricted to authorized senior management and documented by an access log.
All sample data produced is written to the file server. This data backed up onto magnetic tape daily and remains on the file server for a two month time period. After which, the files are backed up onto 4.7 GB DVD-R discs monthly as defined in the SOP for Laboratory Computers.
One copy of each monthly backup disc is stored in the IT Department at the Silver Street facility. The other copy is stored in a fireproof cabinet by the Laboratory Director at the Almgren Drive facility. The discs are kept for a period of ten years. The IT Manager is responsible for all data archiving, maintenance and retrieval.
All instructional materials posted within the laboratory space are subject to Eurofins Spectrum Analytical’s document control system. A controlled copy of the document is issued by the Quality Assurance department and a record of the document name, any relevant page numbers, the issue date and its location is maintained. Posted instructions are reviewed by the applicable department on an annual basis for accuracy. Posted materials that are not instructional in nature are exempt from the document control policy. Examples of exempt materials include non-instructional posters, regulatory limits, notes regarding sample preparation
Uncon
trolle
dde
ession oion senior manaor man
lly archived dly archived dtronically arconically arc
ed to IT onlyto IT onlychived hardcchived hard
and documendocum
a produced isroduced istic tape dailytape dail
od. After wh After whmonthly as demonthly as de
copy of copy ofacif i
Copyn logs and othogs and o
ectronically for onically forsically archived sically archive
onment Testing nment Testiartment. Datrtment.
the appth
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 54
COMPANY CONFIDENTIAL
status such as what time a step will be completed, reminders not related to an analysis such as to check that doors are closed, current lot numbers of reagents in use and instrument out-of-service signs. Postings of an instructional nature would include excerpts from SOPs, checklists, calculations, method criteria, reminders that apply to an analysis such as how long a leachate sample may rotate, logbooks and emails with directions how to handle a sample or project. ESA-MA personnel may consult the QA department with any questions if a document is instructional in nature.
9.4 Transfer of Records
In the event Eurofins Spectrum Analytical (Agawam, MA Division) changes ownership or closes, the transfer of ownership of client records would be required.
If Eurofins Spectrum Analytical transfers the ownership of the laboratory to a new owner, ESA-MA would expect that record retention would be negotiated and made part of any purchase contract, and that the new company would maintain all required NELAP and other certifying agency documentation. The responsibility for maintenance, control, storage and eventual disposal at the end of the appropriate time period, of all records, including client data and QA/QC files, will transfer to the new owners. Since NELAP and other agency certification would likely be one of the attractive aspects of the laboratory to a purchaser, it is unlikely that a new owner would not want to maintain the appropriate records and certifications. In the event a new owner did not want to maintain past records, Eurofins Spectrum Analytical would notify all clients and make these records available to them for a reasonable fee. Clients would be given a minimum of 30 days to determine if documents are needed or not.
In the event Eurofins Spectrum Analytical decides to cease operations, clients will be notified prior to the cessation of operations and their files/records will be made available to them for a reasonable fee. Clients would be given a minimum of 30 days to determine if documents are needed or not. If the client determines they do not want to maintain the records, these will be disposed of properly.
Uncon
trolle
dt
agencyencynd eventual ventual
ecords, includcords, includSince NELAPnce NELAP
ive aspects oaspects oner would noer would n
event a new ent a nem Analytical Analytical
em for a reasofor a reasrmine if documine if do
event Eurofievent Eurofinotified priornotified prilable to tlable to
ded
CopyMA DiviDiv
ent records wt records
ownership of theownership of retention wouldetention wout the new comthe new
ocume
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 55
COMPANY CONFIDENTIAL
10.0 Performance and System Audits
Both the internal and external audits are conducted regularly to maintain the quality objectives of the laboratory, to develop analysts’ proficiency and to evaluate management performance. Internal audits are conducted throughout the year and managed by the QA Manager. External audits are initiated by clients in the form of spiked samples or by other outside agencies through proficiency tests and on-site assessments.
10.1 External Performance Audits
Eurofins Spectrum Analytical performs all necessary external audits to meet NELAP, DoD and State certification requirements. On occasion external performance audits are in the form of Proficiency evaluation samples submitted by clients as regular samples. In addition we perform the following scheduled performance studies:
Air (AE), Water Supply (WS), Water Pollution (WP) and Soil/Hazardous waste studies are performed twice a year as indicated in the TNI Standards. In order that we may report multiple methods, Eurofins Spectrum Analytical uses an approved commercial vendor for all chemical PT studies.
Microbiological PT studies are performed for the New York Environmental Laboratory Approval Program. In addition, an approved commercial vendor is used to meet the criteria of the Massachusetts Department of Environmental Protection.
All PTs are treated in the same manner as client samples, including being logged into our LIMS, assigned to staff, analyzed and reported. PT reports are submitted to our various accrediting agencies within 21 days of the study closing. Any Unacceptable PT results are investigated for the cause and a detailed corrective action with root cause analysis is presented, as required by the TNI Standards and the DoD QSM. Upon completion of the follow-up audit and within 30 days of the final study report being issued, copies of all PT corrective action reports are forwarded to our accrediting agencies as required.
10.2 External System Audits
State certification officers, other laboratories, and potential clients regularly audit Eurofins Spectrum Analytical. Any state that ESA-MA holds certification in or is currently obtaining certification from is eligible to conduct an audit at any time during normal business hours. Notification of a scheduled audit is requested to ensure that staff is available.
indicatedicatds, Eurofinsurofin
r all chemicar all chemica
s are performre performrogram. In arogram. In
eria of the Ma of the
treated in theated in thLIMS, assignMS, assign
various accrvarious accracceptable PTacceptable on with roon with
D QD Q
Copy
rnaoccasionsio
valuation sampuation saform the followim the follow
ion (WP) anon (WPin thei t
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 56
COMPANY CONFIDENTIAL
Each department manager and the QA Manager record deficiencies noted during an audit. Corrections are made to comply with the regulations. Upon receiving the results of any audit, a meeting of all department managers is arranged to discuss the results. Unsatisfactory results are addressed and corrective actions presented. Any modifications that were initiated due to the audit are finalized as part of the new QA/QC procedure and are included as a revision to the appropriate SOP. This ensures compliance with the agency-mandated regulations.
10.3 Internal Performance Audits
The QA Department conducts an annual Internal Audit according to a schedule issued at the beginning to the year. Any changes to the schedule must be documented along with the reason why. The Internal Audit reviews all aspects of our quality system from sample pick up through the entire analytical process. Audits are conducted in addition to the daily QA procedures. Audits reflect laboratory performance under normal operating conditions. This review may include the analysis of blind samples. Blind samples submitted for the audit are prepared by the QA Department or purchased through an approved vendor. The samples are logged in under a fictitious client. The Laboratory Director and QA Department are the only personnel aware of the audit samples. The QA Department compiles all data and submits an audit report to the Laboratory Director. If requested, the Laboratory Director and/or the QA Manager will hold a meeting with the department managers to discuss the results and any corrective actions that may be necessary. The results and any necessary corrective action reports are then filed with the QA Department. The QA Department itself is audited by a third party to ensure impartiality. This audit covers documents control, corrective actions and their effectiveness, review of data packages for completeness and accuracy, and compliance with regulatory agencies and internal policies.
In addition to the annual Internal Audit, Observational Audits are performed on a regular basis. Each month, the QA Department selects an analysis from each operational department for review. The auditor observes the analyst performing the analysis to ensure they are following all steps in accordance with the SOP and method. The results and any necessary corrective action reports are then filed with the QA Department.
In depth laboratory performance monitoring is also done on a continual basis by the review of data deliverable packages. ESA-MA routinely provides these packages to clients, which includes Sample Receipt Documentation, CLP-like summary forms, copies of instrument calibrations, raw Batch QC and sample data, standards preparation sheets, analytical run logs, laboratory bench sheets and a case narrative. At a minimum, 10% of all level 4 data deliverable packages are
Uncon
trolle
de
Blind slind purchased thased
ctitious clienctitious clienonnel aware nnel aware
ata and submand submthe Laboratothe Laborat
partment manment mbe necessary.necessary
n filed with thled with ta third party third party
corrective actrective acteteness and aeteness and a
icies.icies.
tionti
Copyaccordinord
the schedule mscheduleernal Audit revieal Audit rev
gh the entire anagh the entire ay QA procedureQA procedting conditioing con
mples l
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 57
COMPANY CONFIDENTIAL
thoroughly reviewed for technical completeness and accuracy. Packages are prepared by the analysts, reviewed by the departments and reviewed again by the QA manager or a designee from sample receipt to the final report. The Quality Assurance department monitors that method requirements are being strictly followed. Any QC failures, deviations or analysis issues are thoroughly documented in the case narrative and noted by the QA department.
A client question regarding their results will prompt an investigation by the QA department. Clients are informed of the results of the investigation and if their data is affected in any way. If a quality issue is detected, a corrective action is presented and the client is notified within three business days or sooner.
10.4 Internal System Audits
The Managerial Team conducts internal system audits a minimum of once per year to ensure that all departments are operating accurately and observing all QA requirements. The following items are verified during an internal system audit:
Standard Operating Procedures being followed
Computer system/network archival done on schedule
LIMS is inspected to ensure the integrity of electronic data
Chemical hygiene/safety practices being followed
Sample handling/storage/disposal practices followed
Logbooks recorded and stored in correct manner
Gas storage and inventory kept according to internal policy
Department managers are apprised of any deficiencies in their department detected during the internal system audit. These are recorded and discussed at the next management team meeting. Corrective Action Reports issued for Internal Systems Audit deficiencies are documented and filed with the QA Department.
10.5 Management Review
Results of both internal and external audits are verified by the QA Manager and submitted to the Laboratory Director for final review. Any data that falls outside established acceptance criteria results in an investigation. The outcome of the investigation, along with suggested corrective actions, is documented and submitted to the Laboratory Director for review and final action. A follow-up
Uncon
trolle
de
being follog follo
k archival doarchival do
o ensure the o ensure the
iene/safety pe/safety p
handling/storndling/st
ogbooks recogbooks reco
Gas storaGas stor
Copy
ay
m audits a minimm audits a minating accuratelyting accuratfied during aed duri
d
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 58
COMPANY CONFIDENTIAL
audit is done afterwards to ensure that the corrective action has been implemented and is effective. A response indicating corrective actions to be taken may be required when errors or deviations are found in proficiency tests or during laboratory audits. Reports generated in response to external audits will address any problems found and the corrective actions to be taken. These will then be submitted to the agency conducting the audit, if applicable, and all appropriate laboratory departments for implementation.
On an annual basis all Standard Operating Procedures (SOPs) are reviewed by departmental management and modified as necessary for continuing suitability and effectiveness. Method SOPs are compared to the method being performed upon annual review. The outcome and corrective actions from all internal audits and assessments from external bodies are included in a Memo to the laboratory director. The resulting corrective actions are reviewed at a minimum annually to ensure they are being enforced. The following items are recorded and addressed weekly in the Weekly Performance Meeting: feedback from clients, complaints, changes in the volume & type of work undertaken, resources, staffing and training. All departmental managers are reviewed on the QA activities of their department within their annual performance review. The objective here is to continually improve the effectiveness of the management system.
The laboratory director in conjunction with the QA staff, taking the following factors into account, prepares an annual Management Review:
Suitability of SOPs, policies and procedures; Reports from weekly performance meetings, internal audits and departments manager’s updates Clients feedback and complaints; Reports from external audits; Corrective Action Reports PT results; Changes in volume and type of work; Recommendations for improvement; Other relevant factors such as quality control activities, resources and staff training;
The Annual Management Review report will be discussed at a meeting with the Laboratory President, Director, QA manager, corporate President and corporate QA Director. Action items from the Management Review are recorded and addressed within an agreed upon time frame. If any actions are not completed within that time frame, the reason for an extension will be documented.
Uncon
trolle
dd
re reviereviformance reance re
eness of the eness of the
olle
njunction epares an annepares an an
y of SOPs, pof SOPs, pos from weeklom week
artments manments maClients feedbaents feedReports froReports fCorrectCorrecPT rPT rC
Copy
hodns from aom
n a Memo to tMemo tewed at a minimed at a mini
items are recoritems are recg: feedback from feedback frtaken, resoutaken, r
wed on d
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 59
COMPANY CONFIDENTIAL
11.0 Facilities, Equipment, Reagents, and Preventative Maintenance
ESA-MA utilizes two state-of-the-art facilities in Massachusetts that include high-tech instrumentation and data processing equipment for organic, inorganic, wet chemistry, microbiology and mixed waste. All electronic data is controlled by ESA-MA’s Laboratory Information Management System (LIMS). Laboratory personnel access the LIMS database via individual usernames and passwords at computer terminals located throughout the facility.
After hours access to the building is restricted to authorized personnel only. The burglar and fire alarms are monitored by an outside security agency, which will contact the appropriate laboratory personnel and local agencies in the event of an emergency. Each employee has a personal identification code for after-hour entry and exit through the main entrance.
The heating and cooling environmental controls activate and deactivate automatically to maintain temperature control in each of the separate building zones. All temperature critical equipment, such as refrigerators, freezers, incubators, analytical instrumentation, and ovens are monitored regularly to ensure proper and consistent temperature. All refrigerators, freezers, incubators and select ovens are monitored by electronic probe thermometer 24 hours a day/7 days a week. Temperature readings are recorded hourly with two consecutive readings recorded at 6:00 & 6:30 AM and at 7:00 & 7:30 PM to monitor performance. If either of the two consecutive AM or PM readings are outside the acceptance limits, an email alert is sent to upper management to ensure that any needed service is conducted promptly. During unstaffed hours (evenings, weekends, holidays), temperature exceedances will trigger a phone alert system that texts assigned personnel who will come in to address any out of control situations. Readings are documented in the laboratory’s Temperature Probe Program; specific details can be found in the laboratory’s SOP. Electronic probes are calibrated quarterly against a NIST certified thermometer.
Each operational department (volatile, semivolatile, inorganic, wet chemistry, microbiological) has separate rooms, which are equipped with fume hoods, chemical storage cabinets, and all required safety equipment.
Eurofins Spectrum Analytical’s management team is dedicated to providing a healthy and safe working environment for all employees and visitors by taking all necessary measures to achieve and maintain compliance with Occupational Safety and Health Administration (OSHA) standards. The OSHA Hazard Communication SOP and a complete Health and Safety Plan is available upon request.
11.1 Laboratory Facilities
11.1.1 11 Almgren Drive – Agawam, MA
This building consists of approximately 12,000 square feet utilized by the Sample Login,
Uncon
trolle
ds, is,
proper anper act ovens are ovens are
eek. Tempereek. Temperded at 6:00 &d at 6:00 &
the two constwo consrt is sent to ut is sent to u
tly. During unDuring will trigger ll trigger
ddress any ouess any erature Probeture Prob
probes are cobes are
tional departtional depaical) hasical) ha
s
Copy
of anry and exiand ex
ate and deactivaate and deactie building zonebuilding zocubators, ancubators
d cons
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 60
COMPANY CONFIDENTIAL
Semivolatile, Inorganic, Wet Chemistry and Microbiology Departments, in addition to a training center and cafeteria. For security reasons, floor plans may only be viewed onsite.
11.1.2 830 Silver Street – Agawam, MA
A 10,000 square-foot building, located at 830 Silver Street, Agawam, houses the following departments: all administrative offices to include: Laboratory Director, Marketing, Quality Service Department, Quality Assurance, Accounting, IT Departments and two state-of-the-art laboratories; namely the Volatile Organic Department and Air Division. This building is 1500 feet from our 11 Almgren Drive location. For security reasons, floor plans may only be viewed onsite. The following description indicates the square footage of the two operational departments at this location.
11.1.2.1 Volatile Organic (VOC) Department
An area consisting of 1,037 square feet houses a new state-of-the-art VOC Laboratory. This area has counter tops, hoods, proper ventilation and assigned cubicles for analyst’s data processing.
11.1.2.2 Air Laboratory
An area consisting of 610 square feet houses a new state-of-the-art Air Laboratory. This area has counter tops, proper ventilation, explicit piping for the instrumentation and cubicles for analyst’s data processing.
11.2 Laboratory Reagent Storage
Laboratory reagents are stored according to the chemical hygiene plan (available upon request). All storage areas are properly ventilated and meet all safety guidelines. All reagents are labeled with the date received. See Table 11.1 in Appendix G.
11.3 Equipment and Reference Materials
Records are kept for each piece of equipment in the laboratory. Logbooks are kept for each instrument to document maintenance performed. Detailed records are kept by the administration, which include such information as serial numbers; dates received and date placed in service. All laboratory logbooks (both hardcopy and electronic) are peer reviewed for completeness, accuracy, proper format and documentation of corrections on a periodic basis.
Uncon
trolle
dg og
C Laboraaborer ventilationventilatio
data processdata process
LaboratoryboratoryoAn area coAn area of-the-aof-the-apropproana
atory Reagentory Reagen
oratory roratory qu
Copy
onsitwo operao ope
) Department ) Department
Cop1,037 squar1,037 sq
ry. Th
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 61
COMPANY CONFIDENTIAL
Please refer to the specific analytical SOP for hardware maintenance and troubleshooting and the IT SOPs for software maintenance.
11.4 Documentation and Labeling of Standards and Reagents
Standards and reagents are entered into the LIMS and printed upon receipt. Recorded are vendor name, date of receipt, expiration date, and lot number. The standard pages can be retrieved from the LIMS. In addition all certificates of analysis received from vendors are scanned into the LIMS with the associated unique standard/reagent ID assigned by the LIMS. Reagents are kept in their original containers whenever possible. If transferred, they are put into clearly labeled containers and marked with name of reagent/standard, date received, date opened, lot number, concentration, and expiration date.
All standards and/or reagents used for calibration are either ISO certified or certified by the supplier through analysis with EPA certified or NIST traceable weights and measurements. The commercially prepared standards require dilution to the working concentration. Comparing the new working level concentration against the previously prepared lot checks the accuracy of the dilution. The preparation of working standards may be tracked through the Standard Preparation Logbook by date of preparation. The analyst preparing the working standard records the weights, volumes, concentrations, vendor lot number of neat standards, type of solvent used, initials, date of preparation and date of expiration. The vendor reference codes may be cross-referenced to the logbook/LIMS that lists receipt of all standards and reagents received into the laboratory.
Working level volatile standards are prepared weekly. Semi- volatile stock standards are prepared every seven weeks and working level standards are prepared every four to six weeks, as needed. Pesticide stock standards are prepared yearly and working level standards are prepared every two to four weeks, as needed. Alachlor stock standards are prepared yearly and working standards prepared approximately every two to three months.
11.5 Computers and Electronic Data Requirements
ESA-MA’s data is managed by a laboratory information management system (LIMS) called Element DataSystem, produced by Promium. It manages the data for all samples being processed by the lab, and operates on a Microsoft SQL Server.
The LIMS is an all-inclusive data management system for the lab. Each sample is logged into the system upon receipt, and the LIMS tracks its progress as it travels throughout the lab. Backlog reports, QA/QC data reporting, data import from the instruments and final client reports is all possible using the LIMS. A detailed
Uncon
trolle
dComCo
preparedpareng standardstandard
by date of prby date of pre weights, voweights, vo
type of solvpe of solve vendor refevendor refe
lists receipt os receipt
vel volatile svolatile s are preparere prepa
red every foued every foupared yearlypared yearlks, as neks, as n
ds
Copy
dard.
n are either ISO re either ISOEPA certified oEPA certified
ally prepared stlly preparedparing the nparing th
ot che
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 62
COMPANY CONFIDENTIAL
instruction manual on its use and operation is available in the IT Department. Clients would be notified of any software updates or changes to the LIMS configuration that could adversely affect their electronic data.
The LIMS also features configurable user rights and privileges, which protect data from accidental damage by an employee. Each employee is given only rights to the portions of the program that they need to complete their job. This ensures that no employee can change or manipulate data that they do not have the responsibility to change.
Internet access is made available exclusively to administrative personnel for research purposes. This research may consist of access to the DEP, other regulatory agencies, or instrument manufacturers. Internet access also allows for e-mail communication with clients, and allows ESA-MA to serve their website on an in-house server.
In addition to hard copies, clients with email access can receive final reports and Electronic Data Deliverable (EDDs) in a variety of electronic file formats. These include Microsoft Access, Excel, Word, PDF, and simple text. These files are automatically generated by the LIMS. Clients may request EDDs in customized formats. The IT Department reviews specialized EDD formats and tests the deliverables using data and format checkers to ensure accuracy. Example EDDs may be sent for client approval prior to implementation.
Raw data created by the instruments is organized by month and stored on the file server. Each month, the IT Department is responsible for archiving one month’s worth of data as part of the backup procedure. All data produced within the last two months remains on the file server at any given time.
All vital computer data is backed up nightly to both onsite and removable media. This includes all data from the LIMS database, file server, accounting software database, and web server.
11.6 Preventive Maintenance
The operational condition of instruments is one of the keys to successful completion of analytical tasks. ESA-MA commitment to instrument maintenance assures clients that equipment will be available to generate the required data
Each department has their own contingency plan as well as backup instrumentation, which virtually eliminates downtime. In order to prevent any possible cross contamination, instruments that are dedicated to volatile compound detection are physically separated from all other laboratory departments.
a vvrd, PDFPDF
MS. Clients m. Clients views speciaviews specia
ormat checkemat checkeroval prior toal prior to
y the instrumee instrumnth, the IT Dthe IT D
as part of thepart of th remains on mains on
tal computeral computers includes als includes base, andbase, an
Copy
o theernet acceet acc
A-MA to serve MA to serv
il access can reaccess caniety of eleciety of e
and sim
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 63
COMPANY CONFIDENTIAL
Preventive maintenance as well as major instrument repairs can be accomplished on site. An in-house stock of critical spare parts allows for complete and rapid repair. ESA-MA maintains service agreements with instrument manufacturers to further assure the operational viability of all in-house equipment. In case of major equipment failure, approved subcontractor laboratories are available to perform analyses on short notice.
The hardware tunes and calibration of the instruments are documented in the instrument logbooks kept in each area. If an instrument fails tuning or calibration criteria, hardware adjustments and/or appropriate maintenance is performed and documented. The analyst repeats the tune and calibration attempt. If the second attempt is successful, this is noted in the sequence logbook and sample analysis may proceed. Sample analyses may not proceed without an acceptable calibration.
Qualified senior analysts perform routine preventive maintenance adeptly as part of the training program. A vendor-provided manual outlining the proper use of each instrument is maintained within the operational department. Included in these manuals are procedures for calibrating and performing preventive and routine maintenance.
Preventive maintenance checks and services required for all instrumentation may be found in the specific SOP. Maintenance log books and service records are maintained permanently in each department.
Ancillary equipment, balance, ovens, refrigerators, etc. are monitored and maintained on a daily basis to assure operational readiness.
11.7 Inspection/Acceptance Requirements for Supplies and Consumables
Chemical standards are ordered and received from various vendors and are examined for damage or missing ampules. Each standard is individually logged into the LIMS indicating the date received, vendor, product name, lot number and expiration date. All packaging slips are also initialed for accuracy and maintained with the accounting department. The Certificate of Analyses is scanned into the LIMS and attached to the assigned Standard ID number. The Material Safety Data Sheets (MSDS) are then given to the Health and Safety Manager and filed in a binder for right-to-know purposes. All chemicals used within the laboratory (such as methylene chloride, hexane, etc.) are checked for damage and missing items and are then released to the manager of the department for their use.
e oe obrating aating
cks and servis and serviOP. Mainten Mainten
y in each depy in each de
ment, balance,, balancea daily basisdaily bas
on/AcceptancAccepta
emical standemical stanmined fomined fo
L
Copy
ok anout an accan ac
ventive maintenventive mainted manual outlinmanual outerational derationa
d perf
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 64
COMPANY CONFIDENTIAL
12.0 Routine Procedures Used to Evaluate Data Quality
Acceptance criteria used are established within the specific method, or by Eurofins Spectrum Analytical’s QA Department. Eurofins Spectrum Analytical may establish acceptance criteria for any method performed that does not have recommended acceptance ranges. If QC data falls outside the acceptance range the information is documented and the QC standard must be rerun to verify that all data analyzed is valid.
Quality control samples used to verify the data include method blanks, laboratory control spikes, calibration check samples, matrix spikes, matrix spike duplicates, and field duplicates. See Table 12.1 in Appendix H for Concentration Levels for QC Samples.
12.1 Method Blanks
A method blanks is prepared at the frequency specified by the reference method. The purpose of the method blank is to ensure that the glassware, reagents, standards, and personnel or sample preparation environment do not introduce contaminants. For volatile analyses an instrument blank is analyzed during each sample set to confirm that contaminants are not being introduced by components of the instrumentation or the analytical laboratory. See Table 12.2 in Appendix H for QC Frequency of Method Blanks.
Laboratory Control Samples, Blank Spikes, Standard Reference Material and Calibration Checks
Most Laboratory control samples are analyzed at a continuing frequency equivalent to 5% of the samples of the analytical set (i.e., one every twenty samples). The data is reviewed and entered into the LIMS as part of the QA procedure. See Table 12.3 in Appendix H for the QC Spike Frequency.
A calibration check sample is analyzed with each batch of samples. The check sample is compared to the original curve and the relative percent deviation is calculated.
12.3 Surrogate Recoveries
Minimums of three surrogate standards are added to each organic sample requiring GC/MS analysis for volatile and acid/base neutral compounds. Samples are fortified prior to extraction, purging, and digestion or distillation. For pesticide analysis, at least one surrogate is added to each sample. Inorganic and organic matrix spikes and LCS spikes are similarly fortified with spike standard solutions containing target analytes of interest. The recovery of these standards is quantitatively measured during analysis, and historical records of the percent recovery for each sample are maintained in the control chart database. Surrogate
an instrunstr
nants are noare noalytical laborlytical labor
Blanks. Blanks.
, Blank SpikBlank Spi
ry control sacontrol sao 5% of the s% of the
. The data is he data is dure. See Tabdure. See Tab
alibrationalibratioisi
Copy
els
specified by thespecified by tre that the glasse that the glion environmon envi
ment blat
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 65
COMPANY CONFIDENTIAL
and spike compound recoveries must meet acceptance criteria before the analytical data will be reported and released. In some instances the sample matrix may produce interference, which adversely affects recoveries. Surrogate recovery interference must be confirmed by preparing and analyzing the sample again for confirmation. When a matrix spike test fails spike recovery criteria, the LCS must be analyzed. If the LCS analysis fails, the batch must be reprocessed; if it passes, the matrix effect is confirmed and a QA notice qualifies the affected data. Depending on the type of discrepancy identified, corrective action may involve reporting the data as is with a laboratory qualifying notice. When an analyte does not meet criteria for RPD in inorganic duplicates, a data qualifying flag accompanies the analyte result in accordance with the CLP reporting convention.
12.4 Matrix Spikes and Matrix Spike Duplicates (MS/MSD)
At least one sample from a set of samples (or 5%, whichever is greater) of a similar matrix will be prepared and analyzed by a specific method. See Table 12.4 in Appendix H for MS/MSD Spike QC Frequency.
12.5 Duplicates
At least one sample in a set with a similar matrix will be selected and analyzed in duplicate. Field duplicates are run when provided by the client. See Table 12.5 in Appendix H for Duplicate QC Frequency.
Uncon
trolle
d with a similarh a similar
s are run where run whate QC Frequate QC Freq
Copy
P r
SD) )
5%, whichever i5%, whicheved by a specific mby a specifquency. uency.
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 66
COMPANY CONFIDENTIAL
13.0 Corrective Actions
Conditions that adversely affect the quality of analyses are classified as either isolated conditions or systematic conditions. A third condition is referred to as a bias or random error. The corrective actions implemented are determined by this classification. Random errors are unavoidable circumstances, which are reflected in the unpredictable fluctuations that occur during analytical sequences.
Corrective action procedures are also referred to in each method specific SOP. Due to specifics of methodologies, the corrective actions for quality control issues for microbiology are detailed in the SOPs.
13.1 Isolated Conditions
Most isolated conditions are identified during routine data validation, and are restricted to single samples, batches, or data reports. Data validation includes surrogate and spike standard recoveries, relative percent differences between duplicates, internal standard response variations, and method blank contamination. If the quality control acceptance criteria are exceeded, the corrective action is limited to the affected sample or batch. (See Tables 13.1 through 13.4 in Appendix I)
13.2 Systematic Conditions
Systematic conditions adversely affect entire analytical systems, projects, data integrity, sample integrity, security and safety. These assessments are made by the Laboratory Director or QA Manager during review of summary QA/QC reports or during an internal or external audit. An unacceptable result on a Performance Evaluation (PE) study or internal blind study may also be an indication of a systematic problem. The following is a list of other sources of systematic conditions:
Variations in temperature on successive days in a sample storage refrigerator
Unsatisfactory spike recoveries on multiple laboratory control samples
Glassware, sample or standard storage contamination
A noncompliance with SOP
Deviations in documentation or procedures
Obliterations, write-overs, or other improperly corrected data
Uncon
trolle
de
variatioariatol acceptancceptan
e affected same affected sam
ions adversens adversele integrity, integrity,
ory Director y Director during an inuring an in
mance Evalumance Evaluication of a sication of aematic coematic c
Copy
routine data valroutine data va reports. Data reports. Daative percenttive per
s, and
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 67
COMPANY CONFIDENTIAL
Expired standards in the refrigerator
Open or unlabeled waste containers
Inadequate hood velocity
Recurring, inconsistent conditions observed on control charts
Unsatisfactory internal quality checks for positive and negative controls for microbiological analysis
The systematic conditions are documented and corrective actions are initiated. This indicates who is responsible for correcting the problem, the root cause of the problem, what action is taken, and a date for implementation. If client data is affected, all applicable clients are notified within three business days or sooner from the discovery of the issue. The noncompliance issue is closed once laboratory management has determined that all corrective actions are in effect.
For failed proficiency test results managers are responsible for determining why the parameter failed and, if necessary, implementing revised procedures to ensure the error does not occur again. In the case of analyst error, the managers must document specific details and may have the analyst repeat precision and accuracy and initial demonstration of capability studies.
Any changes to approved corrective actions developed to address findings during DoD assessments must be approved by DoD accreditation body.
13.3 Instrument Checks
Initial calibration verifications (ICV) are analyzed after the initial calibration and prepared from a source different than used for initial calibration. An acceptable ICV must be obtained before sample analysis can begin. They verify the accuracy of the calibration. If the percent recoveries of the known analytes do not meet the method or ESA-MA’s internal QC requirements, the following procedures are implemented:
Locate and correct source of the problem
Reanalyze the ICV
Recalibrate the system
System and solvent blanks are run before any samples to ensure that the system is functioning properly. This also ensures the system is free of contaminants. If the
Uncon
trolle
dmanagers aregers arssary, implemssary, implem
n. In the caseIn the caseand may havd may hav
on of capabilin of capabi
pproved corroved corrnts must be amust be a
nt Checks hecks
ial calibratioial calibratpared frompared fro
ustt
Copyve actioncti
problem, the roblem, thlementation. If mentation. I
hin three businehin three busimpliance issue ipliance issu
all correctivall corre
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 68
COMPANY CONFIDENTIAL
blank fails, another will be run. If the blank fails a second time, the following corrective actions will be taken:
A notation will be made in the sequence logbook
Check the reagent blank for background/cross contamination
Check deionized water for contamination
Check/prepare new internal standards
Use fresh solvents
Rinse syringes using appropriate solvent
For purge and trap systems:
Bake the trap
Clean spargers/tubes
For GC systems:
Bake the column
Clean and bake injectors and detectors
Continuing calibration check (CCC) standards are run after the blank. They verify the precision of the system and also validate the continuing calibration of the method. If the percent recoveries of the known analytes do not meet the method or ESA-MA’s internal QC requirements, the following procedures are implemented:
Check if quantitation procedures are properly followed (i.e., retention times, peak areas, response factors, internal standard references)
Rerun QC standard from the same batch to determine if the problem was because of the analyst’s performance or instrument malfunction
Run a fresh QC from a different standard to verify the calibration
Recalibrate the system
Uncon
trolle
d
bake injectorke injector
ng calibrationcalibratioecision of theecision of the
thod. If the pthod. If theSA-MA’SA-MA
men
Copy
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 69
COMPANY CONFIDENTIAL
13.4 Departure from Documented Procedures
The Laboratory Director and Quality Assurance Manager have the right to deviate from documented Standard Operating Procedures. This may occur when the normal corrective action procedures are not followed due to the type of analysis or clients needs. All deviations are noted on bench sheets for record keeping purposes. An example of when this may occur is if a client is trying to determine field-type qualitative data rather than quantitative results. These deviations are documented and the client is notified of laboratory procedures prior to data being released. All associated work orders are narrated in the final report.
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 70
COMPANY CONFIDENTIAL
14.0 Review of Requests, Tenders and Contracts
All proposed plans for new work are directed to the Quality Assurance Manager, the plan is then reviewed in its entirety. The plan is broken down to the appropriate management staff to ensure that the requirements of the plan can be attained.
14.1 Distribution of project plan among Management Team.
Quality Assurance Manager reviews that all required certifications and quality controls can be met. The Quality Assurance Manager also reviews any necessary Quality Assurance Manuals and certifications from subcontract laboratories.
The Laboratory Director, Operational Support Manager and Department Manager reviews the organic requirements to ensure that instrumentation, personnel, methods, analyte lists and detection limits can be met. The Laboratory Director, Operational Support Manager and Department Manager determine and initiate any calibrations, standards, MDL studies and proficiency testing if necessary. If project data quality limits are not specified, current laboratory reporting limits will be applied.
The Laboratory Director and Department Manager reviews the inorganic requirements to ensure that instrumentation, personnel, methods, analyte lists and detection limits can be met. The Laboratory Director and Department Manager determine and initiate any calibrations, standards, MDL studies and proficiency testing if necessary.
Laboratory Director assesses the number of samples and analyses to determine an appropriate turn around time sufficient to the required quality control parameters of the project. The Laboratory Director and Courier Manager also oversee sample pickup and glassware requests for new projects.
Deputy Director of Quality Services reviews any reporting formats or electronic data deliverable (EDD) necessary for the project and provides pricing to the client. If changes are necessary from our standard format, the Deputy Director of Quality Services will coordinate with the IT Manager to make the changes. The Deputy Director of Quality Services reviews all analyses for sub-contract. The sub-contract laboratory certifications and Quality Assurance Manual are verified at this time and updated if necessary. See Section 15 for Laboratory Sub-Contract procedures.
Uncon
trolle
dppp
tions, stans, sy. If project df project
limits will blimits will b
tor and Depaand Depasure that instrure that inst
mits can be ms can be rmine and inine and in
y testing if nesting if
oratory Directory Diren appropriateappropria
parameters parametersversee sversee
Copy
ns
rt Manager and Manager ands to ensure that s to ensure tha
tection limits cection limitrt Manager t Manag
dards
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 71
COMPANY CONFIDENTIAL
14.2 Results of Review.
a. Based on the final review of the Management Team, the client is notified of any potential conflicts, deficiencies, lack of appropriate accreditation status or any other inability to meet the client’s request. This notification will occur in writing or by telephone. Once conflicts have been resolved, final agreements will be documented in writing. The Laboratory Director makes the final decision for work to commence.
b. If all project requirements can be accomplished, the Laboratory Director makes the final decision for work to commence.
c. If a contract needs to be amended after work has commenced, either by the client or by changes within the laboratory, the same contract review process shall be repeated and any amendments shall be communicated to all affected personnel.
14.3 Record Maintenance
a. The Quality Assurance Manager maintains records of review and Quality Assurance Project Plans.
b. All other documents are held within the office of the Laboratory Director.
Uncon
trolle
d ager maintainager maintain
s are held wis are held w
Copy commenced,ommence
e same contract me contracll be communicll be commun
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 72
COMPANY CONFIDENTIAL
15.0 Subcontracting and Support Services and Supplies
15.1 Subcontracting Laboratory Services
Any analyses not performed by Eurofins Spectrum Analytical will be sent only to an approved subcontract laboratory certified for the analysis. This includes ensuring that the subcontracted laboratory holds the appropriate certification, when certifiable, for the type of samples; for example: DoD, ISO or NELAP accreditation. The selection of subcontractors is approved upon evaluation conducted by the Laboratory Director, Quality Assurance and Quality Service Departments in order to ensure quality, deliverable, and service. When a new subcontract laboratory is selected, Quality Services enters the sub lab’s information into LIMS but leave the status inactive until all documentation is received. The Quality Assurance Department initiates a request to the sub lab for all the required documentation. Upon receipt of the sub lab’s certification and Quality Assurance Manual (if applicable), the QA Department makes the sub lab active in LIMS. The Quality Assurance Department requests that subcontract laboratories submit updated certifications and revised Quality Assurance Manuals (if applicable) on an annual basis. See ESA-MA’s SOP for Subcontracted Analyses for details.
Upon designating analyses to be subcontracted a Subcontract Work Order is generated through the LIMS. A Subcontract Work Order identifying the receiving laboratory, site location, client project number, laboratory sample id, collection date and time, number and type of sample containers, preservation, due date and the subcontracted analyses will accompany every sample. Any special reporting requests, such as State reporting forms, Data Deliverable packages, MCL exceedance reports or project specific/regulatory reporting limits will be highlighted in the comment section of the Subcontract Work Order. The following information regarding subcontracted analyses is kept on file:
A copy of the subcontract laboratory’s certification A copy of the subcontract laboratory’s Quality Assurance Manual (if applicable) A copy of the subcontract laboratory report including the Chain of Custody document.
A notation of any subcontracted analysis is documented on the final laboratory report provided by Eurofins Spectrum Analytical.
15.2 Outside Support Services and Supplies
Uncon
trolle
de
ons andns anSee ESA-MAESA-M
s to be subcobe subcoLIMS. A SubIMS. A Su
ion, client pr, client mber and typer and typ
ted analyses analyses ch as State reas State
nce reports orreports orghted in the cghted in the c
ormation regaormation re
opy
Copy
ervers the suhe
until all documil all dociates a request tes a request
of the sub lab’s cf the sub lab’he QA Departme QA Depaartment requartment
revisedi
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 73
COMPANY CONFIDENTIAL
Eurofins Spectrum Analytical utilizes only reputable service technicians and vendors whose services meet the internal standards of quality. A listing of all support services and suppliers are kept on file and are available for review.
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 74
COMPANY CONFIDENTIAL
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual Revisions
Revised March 2017 Section 1.2: Quality Policy Statement – Updated with current Eurofins Quality Statement. Section 1.2.3: Team Alliance Strategy and Community Support – Removed entire text and renumbered subsequent sections. Section 2.1: Organizational Structure – Christina White made Laboratory Director and removed Technical Director position. Added Senior Operations Director position and description of responsibilities. Added onsite supervision of Silver St lab to President’s responsibilities.Section 2.3: Quality Assurance Managerial Organization – Updated type and frequency of meetings. Section 2.4: List of Key Personnel and Positions – Christina White made Laboratory Director and removed Technical Director position. Added Senior Operations Director. Changed Lab Manager to Operational Support Manager and included responsibilities. Section 5.6: Sample Disposal – Changed disposal timeframe from 60 to 30 days. Section 8.2: Method Detection Limits/Reporting Limits/LOD Verification/LOQ – Removed text “For DOD projects, the requirement is that the LOQ be equal to or no greater than 3 times the LOD verification and that the lowest calibration standard determines the LOQ.”. Updated LOD and LOQ spiking criteria. Section 9.1: Data Reduction and Validation – Updated validation procedure to note managers update sample status from Analyst Review to Validated. Removed Validation Team step. Section 9.2: Report Format and Contents – Added sample preparation/extraction date/time are included on lab reports. Added detailed requirements when reporting drinking water samples with exceedances. Section 9.3: Records and Document Control – Updated record archive policy to match Eurofins US policy. Original, hardcopy records are physically archived for 5 years. Section 15.1: Subcontracting Laboratory Services – Added “due date” to information specified on subcontract work orders. Updated subcontract lab approval procedure. Replaced Technical Director with Laboratory Director throughout document. Revisions: Removed all but two most recent revision logs. Appendix B – Updated Eurofins Ethics Policy Statement and Quality Policy Statement. Appendix C – Updated organizational structure with current staff. Replaced Lab Director resume with Christina White. Appendix E – Updated Tables with current criteria for:
o Table 6.1, 524 minimum number of standards and concentration range o Table 6.1, 624 minimum number of standards and concentration range o Table 6.1, 8260 minimum number of standards and concentration range o Table 6.2, GRO separated from VPH and added specific criteria. o Table 6.3, ICP Metals minimum number of standards and concentration range o Table 6.3, ICP-MS Metals minimum number of standards
Uncon
trolle
d sal tal
rting Limig Limquirement is rement is
ion and that tion and thaOD and LOQ and LOQ
Validation –alidation –us from Analyfrom Anal
mat and Conat and Cod on lab repon lab rep
mples with exes with eecords and Drds and D
S policy. Origolicy. Ori1: Subcon1: Subcon
ubcoubco
Copypdated typted ty
stina White madna White madAdded Senior Opdded Senior O
nager and incluager and inmeframe frmefram
/LO
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 75
COMPANY CONFIDENTIAL
o Table 6.3, Mercury minimum number of standards o Table 6.4, TOC minimum number of standards and concentration range
Appendix F – Updated with current SOP Master List. Appendix G – Updated Table 11.2 with current equipment inventory list. Appendix H – Updated Tables with current criteria
o Added Bromide by 300.0 to all tables. o Table 12.2, Added footnote “Note that QC frequency may vary depending on
matrix and/or specific federal or state agency requirements (as noted in QC box on Chain of Custody).”
Appendix I – Updated Tables with current criteriao Table 13.1, Added corrective action “narrate as appropriate” to all methods. o Table 13.1, Updated method blank acceptance criteria to match current limits for
TO-15, TO-18, 524, 624, 8260, VPH, GRO, 625, 8270, TPH/EPH/DRO, NJ-EPH. o Added Bromide by 300.0 to all tables. o Table 13.2, Updated LCS acceptance criteria to match current limits for TO-15,
524, TOC. o Table 13.3, Updated MS acceptance criteria to match current limits for TOC. o Table 13.4, Updated Duplicate acceptance limits to match current criteria for 524,
624, 8260.
Revised October 2016 Section 2.1: Organizational Structure - Added Lean Project Manager position and description of responsibilities. Updated Information Systems Department description of responsibilities. Replaced Wet Chemistry Manager with Raquel Thomas. IT no longer a managerial position and replaced with Joel Navaroli. Section 2.3.a: Quality Assurance Managerial Organization – Updated positions with current titles. Section 2.4: List of Key Personnel and Positions – Added Kevin White as Lean Project Manager.Section 3.6: Preventative Action – Added entire new section. Section 5.2: Sample Acceptance Policy – Added sample label and custody seal as examples. Section 5.5: Storage Conditions – Revised lab refrigerator temp range from 4oC +/- 2oCto <6°C and not frozen. Section 6.1: Equipment Calibration Information – Clarified balance weights are certified annually by an ISO 17025 accredited calibration vendor. Section 7.0: Standard Operating Procedures and Test Methods – Added ESA will not distribute proprietary SOPs. Section 9.2: Report Formats and Contents – Added finished drinking water lab reports include the MCL, SMCL and ORSG values. Section 9.3: Records and Document Control – Added archived data is monitored by an access log.Revisions: Removed all but two most recent revision logs. Appendix A – Updated website link.
Uncon
trolle
d erier
tance limce li
ture - Addede - AddedUpdated InfUpdated In
Wet Chemistrt Chemisreplaced witlaced wit
y Assurance Msurance
t of Key Perf Key Pe
6: Preventat6: PreventatSamplSampl
Copy
ate” to match matc
270, TPH/EPH, TPH/EP
to match currento match curre
to match cuto matcts to m
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17 Page 76
COMPANY CONFIDENTIAL
Appendix C – Updated organizational structure with current staff. Appendix D – Added example of sample label and custody seal. Appendix E: Table 6.3 – Updated chart with current ICV criteria for ICP metals and Mercury. Updated CCV criteria for mercury and Anions by 300.0. Added footnotes for Mercury and 200.7 Metals. Removed all references to 525.2 and 552.2, as those methods have been discontinued. Appendix F – Updated with current SOP Master List. Appendix H – Updated chart with current MS/MSD frequency for 608, 200.7, 200.8 and 245.1. Removed all references to 525.2 and 552.2. Appendix I – Table 13.2:
o Updated chart to see lab for specific analyte control limits for 608, 624, 625. o Updated with current BS/BSD RPD for 1664. o Updated with current BS/BSD control limit for Cyanide, 524. o Removed all references to 525.2 and 552.2.
Appendix I – Table 13.3 o Updated chart to see lab for specific analyte control limits for 608, 624, 625, o Updated with current MS/MSD control limits and RPD for 1664. o Updated with current MS/MSD control limit for Cyanide. o Removed all references to 525.2 and 552.2.
limlimrol limit flimit
nd 552.2. 552.2.
Copy
ts foror
anide, 524. de, 524.
e control limitscontrol lims and RPDs and R
Cy
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX A
STATE CERTIFICATIONS
Please refer to our website for a posting of our current certifications. They are available at the following link: www.eurofinsus.com/environment-testing/laboratories/eurofins-spectrum-analytical/resources/certifications/Unc
ontro
lled
ur website fr websitefollowingfollowing
es/eues/eu
Copy
NSS
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX B
SECTION 1 ATTACHMENTS
Uncon
trolle
d Cop
yENTSTS
Document Title: Eurofins' Ethics Policy Statement
Eurofins Document Reference: N/A Revision: 2 Historical Reference: N/A
Effective date : 05/01/2015 Status: Effective
Page 1 of 1
Our Company was built on the foundation of high integrity and ethical laboratory practices. To preserve this standard we have a clear expectation that each of us take personal responsibility to do the right thing and uphold the highest level of ethics and quality in all of our dealings. Here are the ethical responsibilities required of us:
• Each and every one of us is expected to adhere to the highest professional and ethical standards. Each employee commits to honest and ethical practices in all daily actions.
• No one will intentionally improperly manipulate or falsify activities in any way.
• Ethical performance and data integrity MUST supersede any other objective of laboratory operations.
• Each employee bears ultimate responsibility for the validation and accuracy of his or her documentation. The analyst’s signature signifies that the action taken to generate the data and the documentation are accurate and authentic, and confirm that all proper procedures were followed in the generation of the data in real time.
• Eurofins takes a zero tolerance stance for illegal, unethical, and improper practices affecting the testing process. Each employee is responsible for safeguarding the Lab’s ethical practices. For this reason, each employee is responsible to report any situation that may be adversely affecting the quality and integrity of the data produced.
• It is vital that all employees take responsibility to preserve our ethical business practices. Employees who know of, or witness any violation of business, quality, or data integrity policy are required to report the activity to an Ethics Officer, Quality Management, or member of Senior Management. A timely and thorough investigation will occur to remedy any situation regarding these allegations.
• Any employee who knows of or witnesses any violation of business, quality, or data integrity policy, but fails to report it will be subject to disciplinary action.
• During a thorough investigation, the Ethics Officer, and/or Senior Management, will assess the situation and resolve the matter. Since data integrity is so vital to our business practices, any employee found willfully falsifying or manipulating data will be released from employment.
• The Ethics Officer, or Senior Management, in collaboration with appropriate staff, will complete a corrective action plan addressing the root causes. The action plan will be put in place and may include additional training or changes in policies and procedures. All those involved will receive confidential communication regarding corrective action steps taken to remedy the situation.
I understand and commit to these responsibilities. I understand the critical importance of data and business integrity compliance. I realize that any infractions of laboratory integrity procedures could lead to serious consequences including employment separation, debarment, or civil/criminal prosecution. I take personal responsibility to uphold the highest ethical business practices and report any concerns to help preserve Eurofins’ integrity.
______________________________________________ _______________ _________________ Name (Print) Employee Number Company Name
______________________________________________ ______________ Signature Date
Return signed document to [email protected]
Uncon
trolle
d sas
port any t any
ility to preseility to presey violation of iolation of
hics Officer, s Officer,gh investigainvestig
or witnessewitnessesubject to dibject to di
estigation, thegation, the the matter.he matte
willfully falsifywillfully falsify
icer, or Seniicer, or Senn plan adn plan a
trait
Copyd accuracccura
on taken to genaken to gt all proper procl proper pro
hical, and imprcal, and imguarding thguardin
tuatio
Document Title: Eurofins US Quality Policy Statement
Eurofins Document Reference:1-P-QM-FOR-9007879
Revision: 6 Historical Reference: Form 2787
Effective date: Jul 7, 2014 Status: Effective
As an organization, all personnel are committed to high quality professional practice, testing and data, and service to our clients.
We strive to provide the highest quality data achievable by:
Following all documentation requirements; describing clearly and accurately all activities performed; documenting “real time” as the task is carried out; understanding that it is never acceptable to “back date” entries and should additional information be required at a later date, the actual date and by whom the notation is made must be documented.
Providing accountability and traceability for each sample analyzed through proper sample handling, labeling, preparation, instrument calibration/qualification/validation, analysis, and reporting; establishing an audit trail that identifies date, time, analyst, instrument used, instrument conditions, quality control samples (where appropriate and/or required by the method), and associated standard material.
Emphasizing a total quality management process which provides accuracy, and strict compliance with agency regulations and client requirements, giving the highest degree of confidence; understanding that meeting the requirements of the next employee in the work flow process is just as important as meeting the needs of the external client.
Providing thorough documentation and explanation to qualify reported data that may not meet all requirements and specifications, but is still of use to the client; understanding this occurs only after discussion with the client on the data limitations and acceptability of this approach.
Responding immediately to indications of questionable data, out-of-specification occurrences, equipment malfunctions, and other types of laboratory problems, with investigation and applicable corrective action; documenting these activities completely, including the reasons for the decisions made.
Providing a work environment that ensures accessibility to all levels of management and encourages questions and expression of concerns on quality issues to management.
We each take personal responsibility to provide this quality product while meeting the company’s high standards of integrity and ethics, understanding that improprieties, such as failure to conduct the required test, manipulation of test procedures or data, or inaccurate documentation will not be tolerated. Intentional misrepresentation of the activities performed is considered fraud and is grounds for termination.
I understand the expectations and commit to implementation of all applicable policies and procedures and to providing quality data.
Name (printed) Employee Number
Signature
Date
Page 1 of 1
Uncon
trolle
dreportedporte this occurs occurs
able data, oute data, olems, with invms, with in
ons for the deons for the d
res accessibilaccessibiues to manags to manag
ility to providey to providding that improng that impr
urate documeurate documud and is grud and is
Copy
ol samam
y, and strict compd strict comence; understande; underst
important as meimportant as me
ata th
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix B Revision 9/29/15
TYPICAL LABORATORY PROBLEMS AND UNACCEPTABLE AND ACCEPTABLE SOLUTIONS
Problem UNACCEPTABLE SOLUTION ACCEPTABLE SOLUTION
Lack of time or resources to perform testing
Making up Data or Other Information – Creating data for an analysis that was not performed or creating information that is not true.
Analytical results for all samples and quality control (QC) must be based on actual analyses performed. Documented data must match actual data. Sampling information must be based on actual sampling events.
Hold time near or past
Improper Clock Setting (Time Traveling) or Improper Date/Time Recording – resetting the internal clock on an instrument to make it appear that a sample(s) was analyzed within a specified hold time when, in fact, it was not. Changing the actual time or recording a false time to make it appear that hold times were not met, or changing the times for sample collection, extractions, or other steps to make it appear that they were performed at the correct time when, in fact, they were not.
The recorded date and time of collection, preparation, or analysis must match the actual date and time that the action was performed. Documented dates and times must represent actual dates and times. Samples exceeding hold times must be reported as such; a case narrative is recommended.
DFTPP or BFB not meeting acceptance criteria
Improper GC/MS Tuning – artificially manipulating GC/MS tuning data to produce an ion abundance result that appears to meet specific QC criteria when, in fact, the criteria were not met.
GC/MS tuning data must be generated and reported according to proper techniques without manipulation of the peak or mass spectrum. Preventive/corrective action must be taken concerning data not meeting required criteria.
Calibration or QC data not meeting acceptance criteria
Improper Peak Integration (Peak Shaving or Enhancing) – artificially subtracting or adding peak area to produce an erroneous area that forces data to meet specific QC criteria when, in fact, the criteria were not met.
Instrument peaks must be consistently integrated and reported according to proper techniques, generally baseline-to-baseline, valley-to-valley, or a combination of the two. Pear area cannot be subtracted or added to force data to meet specified criteria. Preventive corrective action must be taken on instrument data not meeting required criteria.
Calibration or QC data not meeting acceptance criteria.
Improper Calibration/QC Analysis – a) Performing multiple (more than two) calibrations or
QC runs (including calibration verifications, LCS, spikes, duplicates, and blanks) until one analysis barely meets criteria, rather than taking needed preventive/corrective action after the second failed analysis, and not documenting or retaining data for the other unacceptable data.
b) Using the incorrect (previous) initial calibration to make calibration verification data appear to be acceptable when, in fact, they were not acceptable when compared to the correct initial calibration.
c) Discarding points in the initial calibration to force the calibration to meet acceptance criteria.
d) Discarding points from an MDL study to force the calculated MDL to be higher or lower than the actual value.
a) All calibration and QC data associated with sample analyses must be documented. Preventive/corrective action must be taken and documented if calibration and/or other QC criteria are not met.
b) Acceptance of calibration verification data must be based on the correct initial calibration.
c) Calibration points can only be rejected for inclusion in the calibration curve if a known error was made or if a statistical evaluation indicates that a point can be discarded. When multiple target analytes are included in each calibration standard, it might be necessary to discard selected upper or lower points for individual target analytes. Points can be discarded at the upper end of the curve if the linear range of the detector has been exceeded. For these cases, dilute samples that exceed the highest point of the calibration curve. Points can be discarded at the lower end of the curve if the detector is not producing a response. For these cases, the laboratory reporting limit must be adjusted accordingly.
d) Data points for MDL studies can only be rejected for inclusion in the MDL calculation if a known error was made or if a statistical evaluation indicates that a point can be discarded.
QC Analysis – Analysis – ntro
lled
, theth
dEnhancing) – ancing) – to produce an to produce an
specific QC cific QC e not met. ot met.
edd
ultiple (more thae (more thncluding calibratding calibra
uplicates, and btes, andy meets criteria, eets criteria,
ventive/correctientive/correctanalysis, and noanalysis, and n
e other unae other un
nt
Copy
eporteted.
GC/MS tuning datGC/MS tuningaccording to praccordingpeak or masspeak or m
taken cCopC
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix B Revision 9/29/15
TYPICAL LABORATORY PROBLEMS AND UNACCEPTABLE AND ACCEPTABLE SOLUTIONS
Problem UNACCEPTABLE SOLUTION ACCEPTABLE SOLUTION
QC samples or spikes not meeting acceptance criteria
Misrepresentation of QC samples and spikes – misrepresenting QC samples or spikes as being digested or extracted when, in fact, they were not actually digested or extracted. For example: a) Adding surrogates after sample extraction rather
than prior to sample extraction.
b) Reporting post-digested spikes or duplicates as pre-digested spikes or duplicates.
c) Not preparing or analyzing method blanks and laboratory control samples (LCSs) the same way that samples are prepared or analyzed in order to make it appear that method blank or LCS results are acceptable when, in fact, they are not.
QC samples and spikes must be prepared, analyzed, and reported according to appropriate procedures.
a) Surrogates must be added prior to sample extraction.
b) Post-digestion spikes and duplicates must be reported as post-digested and must not be misrepresented as pre-digestion spikes and duplicates.
c) Method blanks and LCSs must be prepared and analyzed the same way that samples are prepared
and analyzed. Any QC results outside acceptance criteria must be reported as such; a case narrative is recommended.
Calibration or QC data not meeting acceptance criteria
File Substitution – substituting previously generated files (runs) for a non-compliant calibration or QC run to make it appear that an acceptable run was performed when, in fact, it was not.
Data must be generated and reported for actual analyses performed. Reported dates and times for all analyses must match actual dates and times. Substitution of files is not permitted.
Calibration or QC data not meeting acceptance criteria
Unwarranted Manipulation of Computer Software – unwarranted manipulation of computer software to force calibration or QC data to meet criteria, and removing computer operational codes, such as “M” flag.
Computer manipulation is allowed only for warranted reasons, and any manipulation should be minimal and traceable. Removal of computer operational codes is not permitted.
Analytical conditions for standards do not work for samples
Improper Alteration of Analytical Conditions – improperly altering analytical conditions, such as changing the instrument conditions for sample analyses from those used for standard analyses. Using different procedures to process sample data than those used for standards.
All sample analyses must be performed under the same conditions as those used for standard analyses. Any alteration of analytical conditions must be allowable under the method requirements. All sample data must be processed by the same procedures as those used for processing standard data. Any discrepancies must be documented.
Sample not analyzed at appropriate level or not reported at correct detection limit
Over dilution of Samples or Misrepresentation of Detection Limits – intentionally diluting a sample to such an extent that no analytes (target or non-target) are detected without justification as to why the high dilution was made. Reporting a detection limit that does not represent the sample analysis (e.g., not including dilution factor in sample detection limit).
Dilutions must be made on a reasonable basis, such as high concentrations of target or non-target analytes, matrix interferences, oily samples, and other components in the sample that could harm the instrument. Include details concerning the reason for the dilution in a case narrative. Sample detection or reporting limits must include dilution factors.
Noncompliance data Deletion of Noncompliant Data – intentional deletion or non-recording of noncompliant data to conceal the fact that analyses were noncompliant.
All data associated with sample collection and analysis, including any out-of-control events or noncompliant data, must be documented and retained. Preventive/corrective action must be taken and documented for any noncompliant data.
Undesirablesituation with analysis or sample; knowledge of unethical conduct
Concealment of a Known Problem – concealing a known analytical or sample problem from laboratory management and/or client. Concealing a known unethical behavior or actions from laboratory or corporate management.
Any knowledge of analytical or sample problems must be communicated to laboratory management and the client. Any knowledge of unethical behavior or actions must be fully communicated to laboratory or corporate management.
UncoSamples or Misrmples or Mi
mits – intentionalintentionalhat no analytes (o analytes (
without justificwithout justifimade. Reportingmade. Reportin
ent the sampent the sam
ontro
lled
n n
dre – are to force o force
removing removing ” flag. flag.
CCddonditions – tions –
ditions, such as ons, such as ions for sample ons for sample
analyses. Usinglyses. Usimple data than thdata than th
lle
samplesample
oU
Copy
blanks ksed the same whe sam
analyzed. Any Qlyzed. Anacceptance criteria ptance criteria
case narrative isse narrativData must be geneData must be geneperformed. Repperformematch actual match ac
rmitted.CopC
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX C
Section 2 Attachments
Uncon
trolle
d Cop
ynts nts
Eu
rofi
ns
Sp
ectr
um
An
alyt
ical
, In
c.
Nic
ole
Lej
aP
resi
dent
(S
)E
urof
ins
Spe
ctru
m A
naly
tical
, In
c.
Qu
alit
y S
erv
ices
Re
becc
a M
erz
Man
ager
(S
)
Qu
alit
y A
ss
ura
nc
eK
imbe
rly
La
Pla
nte
Man
ager
(S
)
Sa
mp
le R
ec
eiv
ing
Ka
thry
n W
ilkin
son
Man
ager
(A
)
Pau
l A
. W
ise
Pre
side
ntE
urof
ins
Env
ironm
ent
Tes
ting
US
Qu
alit
y S
erv
ices
Du
lce
Litc
hfie
ldD
ep
uty
Dir
ect
or
(S)
Co
uri
erE
lie M
akh
oul
Man
ager
(A
)
Met
als
Jack
ie C
lem
ent
Ma
nag
er
(A)
Se
miv
ola
tile
sS
an
dra
Ma
teeg
aM
an
age
r (A
)
Mic
rob
iolo
gy
(A)
Wes
Bry
on
Op
era
tiona
l Su
ppo
rt
Ma
nag
er (
S)
Air
/Vo
lati
le O
rga
nic
sE
mily
Kin
ne
yM
an
age
r (S
)
Bu
sin
es
s D
eve
lop
me
nt
Hea
lth
& S
afe
tyJo
hn
Mill
er
Ma
nag
er (
A)
Acc
ou
nti
ng
Ch
rist
ina
Wh
ite
La
bora
tory
Dire
ctor
(A
)
Kev
in W
hit
eL
ea
n P
roje
ct
Ma
na
ger
(S)
A =
11
Alm
gre
n D
rive
La
b
S =
83
0 S
ilve
r S
tre
et L
ab
We
t C
hem
istr
yR
aqu
el T
hom
as
Ma
nag
er
(A)
Info
rmat
ion
Tec
hn
olo
gy
Joe
l Na
varo
li (S
)
Pa
tric
k S
ulli
va
nS
enio
r O
per
atio
ns
Dire
ctor
(A
)
Uncon
troll
roro
con
oll
onon
Un
ollolledd
doll
Copy
opy
opy
s me
ntA
CoCocr
ob
iolo
y
Nicole Leja
11 ALMGREN DR., 830 SILVER STREET, AGAWAM, MA 01001
(413) 789-9018FAX 413-789-4076
Summary
Over twenty years of experience working in multiple departments of a full service environmental laboratory including VOC analysis, QA/QC, customer service and operations. Diverse skills include technical aptitude, excellence at handling multiple projects at one time, and positive communication with staff and clients. Performs data correlation and validation and assists with assessing the cost-benefits for projects and proposals as well as communicating on a corporate level with senior staff from the Rhode Island and Florida divisions. Works to prepare the capital budget and reviews the monthly financial statements to evaluate company performance.
Professional Experience
Eurofins Spectrum Analytical, Inc. – Agawam, MA September 2015 President
Responsible for assisting with preparation of budget and meeting those goals for each calendar year. Responsible for profits and losses associated with business performance and ensuring operations meet internal and external expectations.
Spectrum Analytical featuring Hanibal Technology – Agawam, MA 2010 to September 2015 Laboratory Director and Vice President of Corporate Operations
Daily responsibilities include data validation and final review of reports, technical support to in-house staff and clients, and ensuring high priority jobs meet deadlines. Additional responsibilities include authorization of purchase orders, leading team manager meetings on a weekly basis, and communicating with managers regarding staff schedules and work volume. Supervises management and staff of over 85 employees and responsible for decision making in a team environment. Communicate with Laboratory Directors in the Rhode Island and Florida divisions to ensure optimum efficiency and productivity in all facilities and that corporate procedures are consistently followed.
2000 – 2010 Operations Manager Manage all operational areas of the laboratory including organic and inorganic departments, assist with technical review of documents and data interpretation with clients. Data validation and review of reports are done on a daily basis. Key member of a team that implemented changing the Laboratory Information Management Software (LIMS) in 2002.
1998 – 2000 Assistant QA/QC Officer Responsible for maintaining all state and laboratory certification for laboratory approved methods. Maintained and controlled QA Manual and all Standard Operating Procedure (SOP) manuals for the laboratory. Conducted internal audits and prepared official responses for outside audits by certifying agencies and clients.
March 1996 – 1998 Analyst and Manager of VOC Department Operated and maintained GC and GCMS instrument for the analysis of Volatile Organic compounds using purge and trap methodologies. Supervised staff and managed the daily workload for the department. Assisted the Laboratory Director with development and training for the MADEP VPH method.
Uncon
trolle
d et and meetingt and meetingth business pebusiness pe
l Technology Technology oratory Directtory Direc
a validation analidation ahigh priority jpriority j
ders, leading s, leading staff scheduleff schedu
sible for decisible for decde Island andde Island anporate prporate p
Copy
ssinenior stafsta
iews the monthws the mo
ce e
Scientific Research Council, Energy Department – Kingston, Jamaica West Indies 1994-1995 TechnicianWorked with a European based company researching methane gas technology. Operated pilot plants for anaerobic water treatment and analyzed wastewater samples. Collected and organized data with a team of international and Jamaican scientists to review and evaluate waste programs.
Education
December 1993 Holyoke Community College Holyoke, MA A.S. Environmental Science
Spring 2010 Westfield State College B.S. Environmental Science
Spring 2015 University of Phoenix MBA
Additional courses including Biology, Biochemistry, Inorganic Chemistry I and IIReferences available upon request
Uncon
trolle
d ganic Cnic C Cop
ymistry Ii t
CHRISTINA WHITE LABORATORY DIRECTOR
EDUCATION B.A. in Chemistry Mount Holyoke College, South Hadley, MA
Additional Biology and Microbiology classes Springfield Technical Community College, Springfield, MA
PROFESSIONAL EXPERIENCE
Eurofins Spectrum Analytical, Inc. – Laboratory Director 2017 to present Responsibilities:
Final review and approval of Microbiology data; The Laboratory Director is responsible for overall supervision of laboratory operations, overseeing all technical and administrative policies and procedures, as well as the enforcement and adherence to said policies by laboratory staff;Use tools and processes for performance measurement and benchmarking (KPIs); Assist management and staff with development of cost calculation models (using activity-based costing methodology) such as APPC and capacity modeling;
Is responsible for final data validation and approval of laboratory reports for data generated by both the 11 Almgren Dr and 830 Silver St facilities; Provide technical support and onsite supervision of the operational departments located at
11 Almgren Drive; Supervise the revision of and final approval of protocols and methodologies; Ensuring proper data deliverable and client services; Using information collected from all departments and client feedback, the Laboratory Director
must conduct a review of the laboratory’s quality system and testing activities to ensure their continuing suitability and effectiveness, and to introduce necessary changes or improvements. Prepare an annual Management Review with these findings and ensure they are assigned and carried out in an agreed upon timeframe.
Eurofins Spectrum Analytical, Inc. – Technical Director 2015 to 2017
Responsibilities:Oversee four departments Ensure data is completed accurately and in a timely manner Assist in development of methods and procedures Review data and logbooks Assist with pertinent business metrics Assist with tests when needed
Spectrum Analytical, Inc. – Inorganic Section Team Leader 2007 to 2015
Responsibilities:Oversee three departments Ensure data is completed accurately and in a timely manner Assist in development of methods and procedures Review data and logbooks Assist with tests when needed
Uncon
trolle
d modemod
oval of laboof lab0 Silver St facilver St fa
rvision of the rvision of th
approval of prroval of pand client serand client se
rom all departm all depahe laboratory’aboratory
nd effectiveneffectivenanagement Reagement R
greed upon timed upon ti
Analytical, InAnalytical, In
Copylaboratory opeoratory o
dures, as well as t, as well as
nd benchmarkingnd benchmarkingcalculation moalculatio
ng; ng;tory
Spectrum Analytical, Inc. – Treatability Manager 2005 to present
Responsibilities:Adaptation of proposals to lab implementation Organization of laboratory data for projects Development of methods as needed by clients Writing project reports Supervision of 2 staff members
Spectrum Analytical, Inc. – Inorganic Manager 1995 to 2005
Responsibilities:Data validation ICP instrument troubleshooting Preparation and analysis of EPA methods Developed several methods (EPA 200.7 and 245.1) for quantitative analysis of metals by ICP and mercury analyzer Performed all quality control and method detection limit studies related to methods used Supervision of 10 staff members Member of team of professionals responsible for decision-making within the laboratory
Spectrum Analytical, Inc. 1994 to 1995 Laboratory Technician
Responsibilities:Sample extraction TPH GC (modified 8100), TPH-IR
Copyalysis of metis of m
related to methodated to method
making within thaking within
F:\data\comp quality assurance manual\Appendix C Section 2 Attachment Demonstration of Capability Rev 9-29-15.doc
Demonstration of CapabilityCertification Statement
Date: Laboratory Name: Eurofins Spectrum Analytical,Address: 830 Silver St, Agawam, MA 01001Laboratory Department: Analyst(s) Name(s): Matrix:Analyte / Class of Analytes: Method #: SOP Revision #:
We CERTIFY that:
The analysts identified above, using the cited test method(s), which is in use at this facility for the analyses of samples under the National Environmental Laboratory Accreditation Program, have met the Demonstration of Capability.
The test method(s) was performed by the analyst(s) identified on this certification.
A copy of the test method(s) and the laboratory-specific SOPs are available for all personnel on-site.
The data associated with the demonstration capability are true, accurate, complete and self-explanatory. (Attached Precision and Accuracy studies and/or MDL studies.)
All raw data (including a copy of this certification form) necessary to reconstruct and validate these analyses have been retained at the facility and the associated information is well organized and available for review in the QA department by authorized assessors.
______ Department Manager’s Name Signature Date
Kimberly LaPlante Quality Assurance Manger’s Name Signature Date
Section Leader or Technical Director’s Name Signature Date
Uncon
trolle
d c SOPs SOP
ility are true, ay are true, cy studies and/cy studies and
rtification formcation formcility and ility and the asthe a
partment by autment by au
coName me
nte nte U
Copyuse at this facile at this f
ccreditation Prograditation Prog
d on this certificaton this certifi
e availab
We, the undersigned, CERTIFY that:
Department Manager's Name Date
Kimberly LaPlante
Quality Assurance Manager's Name Date
Section Leader or Technical Director’s Name DateSignature
SOP Date and Revision #:
Eurofins Spectrum Analytical
Signature
Signature
The data associated with the demonstration capability are true, accurate, complete and self-explanatory (attachedMDL studies).
All raw data (including a copy of this certification form) necessary to reconstruct and validate these analyseshave been retained at the facility and that the associated information is well organized and available for reviewby authorized assessors.
Laboratory Department:
Instrument:
The instrument identified above, using the cited test method(s), which is in use at this facility for the analyses ofsamples under the National Environmental Laboratory Accreditation Program, have met the Demonstration ofCapability.
Instrument Demonstration of Capability
Date:
Laboratory Name:
Address:
Certification Statement
The test method(s) was/were performed via this instrumentation.
A copy of the test method(s) and the laboratory-specific SOPs are available for all personnel on-site.
Make:
Model:
Serial Number:
Matrix:
Analyte / Class of Analytes:
Method #:
F:\data\comp quality assurance manual\Appendix C Section 2 Attachment Instrument Demonstration of Capability1 Revision 9/29/15
Uncon
trolle
d
ted with the dted with the d
he cited test mee cited test mmental Laborattal Labo
e performed viaormed via
hod(s) and the d(s) and the
ddCop
yypypy
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX D
Section 5 Attachments
Uncon
trolle
d Cop
yents ents
Sta
ndar
d T
AT
- 7
to 1
0 bu
sine
ss d
ays
Rus
h T
AT
- D
ate
Nee
ded:
All
TA
Ts
subj
ect t
o la
bora
tory
app
rova
lP
age
ofM
in.
24-h
r no
tifi
cati
on n
eede
d fo
r ru
shes
Sam
ples
dis
pose
d af
ter
60 d
ays
unle
ss o
ther
wis
e in
stru
cted
.
Rep
ort T
o:In
voic
e T
o:
Tel
epho
ne #
:
Pro
ject
Mgr
:P
.O N
o.:
Quo
te #
:
F=
Fie
ld F
ilte
red
1
=N
a 2S
2O3
2=
HC
l 3
=H
2SO
4 4
=H
NO
35=
NaO
H 6
=A
scor
bic
Aci
d
7=C
H3O
H
8=
NaH
SO
4 9
=D
eion
ized
Wat
er10
=H
3PO
412
=
DW
=D
inki
ng W
ater
GW
=G
roun
dwat
erS
W=
Sur
face
Wat
erW
W=
Was
te W
ater
MA
DE
P M
CP
CA
M R
epor
t?Y
esN
o
CT
DP
H R
CP
Rep
ort?
Yes
No
O=
Oil
SO
=S
oil
SL
=S
ludg
eA
=In
door
/Am
bien
t Air
SG
=S
oil G
as
X1=
X2=
X3=
Oth
er:
Sta
te-s
peci
fic
repo
rtin
g st
anda
rds:
ED
D f
orm
at:
E-m
ail t
o:
Con
diti
on u
pon
rece
ipt:
C
usto
dy S
eals
:P
rese
ntIn
tact
Bro
ken
Lab
ID
:
Sp
ecia
l Han
dli
ng:
QA
/QC
Rep
orti
ng
Not
es:
*ad
diti
onal
cha
rges
may
app
ply
CH
AIN
OF
CU
ST
OD
Y R
EC
OR
D
Sam
pler
(s):
Soi
l Jar
Fro
zen
# of Plastic
Sit
e N
ame:
Loc
atio
n:
Lis
t P
rese
rvat
ive
Cod
e b
elow
:
An
alys
is
DI
VO
A F
roze
nIc
edR
efri
gera
ted
Am
bien
tIR
ID
#
Cor
rect
ed
Cor
ecct
ion
Fac
tor
Dat
e:T
ime:
Tem
p °
C
Obs
erve
d
Sta
te:
Check if chlorinated
Pro
ject
No:
# of Clear Glass
11=
Con
tain
ers
Dat
e:S
amp
le I
D:
Tim
e:
Type
Matrix
# of VOA Vials
# of Amber Glass
G=
Gra
b C
=C
omps
ite
Rel
inq
uis
hed
by:
Rec
eive
d b
y:
Sta
ndar
d
ASP
A*
No
QC
ASP
B*
Tier
II*
Tier
IV*
NJ
Redu
ced*
NJ
Full*
DQ
A*
Sam
ple
sh
ipp
ing
ad
dre
ss:
11 A
lmg
ren
Dri
ve •
Ag
awam
, MA
010
01 •
413
-789
-901
8 •
ww
w.E
uro
fin
sUS
.co
m/S
pec
tru
mRe
v. S
ep 2
015
Uncon
trolle
d
PP
55=N
aOH
=N
aOH
6
Wat
erW
ater
# of Cl # of Cl
f VOA Vials f VOA Vials
# of Amber G # of Amb
ncncU
ntrro
lleedd
U
lleeddddd
CoCCoCoCCooppopCCCCoopypypypypyyppyyyy
Ch
ain
of
Cu
stod
y R
ecor
d/F
ield
Tes
t D
ata
Sh
eets
for
Air
An
alys
esP
age
____
_ of
___
__
Invo
ice
To:
Pro
ject
No.
:
Sit
e N
ame:
Loc
atio
n:
Sta
te:
Tel
#:
Att
n:
Sam
ple
r(s)
:
Pro
ject
Man
ager
:P
.O. N
o.:
RQ
N:
Can
ID
Can
Siz
e (L
)
Out
goin
gC
anis
ter
Pre
ssur
e("
Hg)
(L
ab)
Inco
min
gC
anis
ter
Pre
ssur
e("
Hg)
(L
ab)
Flo
w R
eg. I
D
Flo
wC
ontr
olle
rR
eado
ut(m
l/m
in)
Lab
Id:
Sam
ple
Id:
Sam
ple
Dat
e(s)
Tim
e S
tart
(2
4 hr
clo
ck)
Tim
e S
top
(24
hr c
lock
)
Can
iste
rP
ress
ure
in
Fie
ld (
"Hg)
(S
tart
)
Can
iste
rP
ress
ure
in
Fie
ld (
"Hg)
(S
top)
Inte
rior
Tem
p. (
F)
(Sta
rt)
Inte
rior
Tem
p. (
F)
(Sto
p)
Dat
e of
Req
uest
:T
otal
# C
anis
ters
:Q
A/Q
C R
epor
tin
g L
evel
:
Req
uest
ed b
y:#
LL
Can
iste
rs:
Sta
ndar
dN
Y A
SP
A*
TIE
R I
I*M
A D
EP
CA
M
Com
pany
:#
Flo
w C
ontr
olle
rs:
NO
QC
NY
AS
P B
*T
IER
IV
*C
T D
PH
RC
PS
tart
Loc
atio
n:F
low
Rat
e/S
etti
ng:
DQ
A*
Sto
p
Dat
e N
eede
d:O
rder
#:
Pre
pare
d by
:S
pec
ial I
nst
ruct
ion
s/Q
C R
equ
irem
ents
& C
omm
ents
:
Sig
ned:
Dat
e:
Pri
nted
:
Dat
e:T
ime:
ED
D F
orm
at
E-m
ail R
esul
ts to
Sam
ple
sh
ipp
ing
ad
dre
ss:
11 A
lmg
ren
Dri
ve ·
Ag
awam
, MA
010
01 ·
413
-789
-901
8 ·
ww
w.E
uro
fin
sUS
.co
m/S
pec
tru
m
LABORATO
RYUSE
ONLY
Client
Use
Spe
cial
Han
dlin
g:S
tand
ard
TA
T -
7 to
10
busi
ness
day
sR
ush
TA
T -
Dat
e N
eede
d: _
____
____
____
· A
ll T
AT
s su
bjec
t to
labo
rato
ry a
ppro
val.
· M
in. 2
4-ho
ur n
otif
icat
ion
need
ed f
or r
ushe
s.
Rep
ort
To:
Soil Gas
Indoor /Ambient Air
Checkboxifcanisterisreturnedunused
Mat
rix
An
alys
is
I at
test
that
all
med
ia r
elin
quis
hed
from
Eur
ofin
s S
pect
rum
Ana
lyti
cal,
Inc.
hav
e be
en
rece
ived
in g
ood
wor
king
con
diti
on, b
ased
on
visu
al o
bser
vati
on, a
nd a
gree
to th
e te
rms
and
cond
itio
ns a
s li
sted
on
the
back
of
this
doc
umen
t.
Rel
inq
uis
hed
by:
Rec
eive
d b
y:
Am
bie
nt
Pre
ssu
re(i
nch
es o
f H
g)
Am
bie
nt
Tem
per
atu
re(F
ahre
nh
eit)
* ad
diti
onal
cha
rges
may
app
ly c
onta
ct S
A's
QA
Dep
artm
ent f
or f
urth
er in
fo.
Ple
ase
con
tact
ES
AI’
s A
ir D
epar
tmen
t im
med
iate
ly a
t (80
0) 7
89-9
115
if y
ou e
xper
ien
ce a
ny
tech
nic
al d
iffi
cult
ies
or s
usp
ect a
ny
QC
issu
e(s)
wit
h a
ir m
edia
.
Revised
Sep2015
Uncon
tro
co
Sam
ple
I
cocoonntt
rotroo
Un
rollolled
roololleededdddd
rod
UUUU
CoCoCCCCCoCopy
o TIE
R I
I*T
IER
II*
TIE
R I
V*
ER
IV
*
act S
A's
QA
ct S
A's
Coyyy
TERMS AND CONDITIONSDue to the high costs of media used for air sampling, the following terms and conditions are summarized below foryour information and our laboratory’s use.1. Media shall be returned in the same condition as received, if not, full replacement costs will be invoked to
client.2. Media will be returned to the laboratory within ten days of receipt.3. Media not returned to the laboratory for any reason will be charged a rental fee as described below.
Summa Canisters not returned after ten days $ 50.00 rental fee per week per canister
Summa Canisters not returned $900.00 per canister – plus rental fee
Passive Flow Controller $600.00 per controller
Stainless steel tubing attachment not returned $ 15.00 per canister
In line Air Sampling Filter not returned $100.00 per filter4. Cleaning fee for media returned unused $ 50.00 per canister
CHAIN OF CUSTODY RECORD INSTRUCTIONSGENERAL1. All applicable information must be completed.2. Forms must be completed legibly and in indelible ink.3. Any errors must be corrected by a single line strikethrough along with the date and initials of the individual
making the correction.FORM COMPLETION4. Page Numbering Enter the total number of pages and the page number of each individual page.5. Special Handling – Check whether standard or rush turn around time is needed. For rush TAT indicate date.6. Report To Enter the company name, address, phone and fax numbers.7. Project Mgr. Enter the Project Manager’s name.8. Invoice To Enter the company name, address, phone and fax numbers.9. P.O. No. Enter P.O. number to appear on invoice.10. RQN List quotation number if applicable.11. Project Number/Site Name/Location/State Enter project number (if applicable). The project name and
location/state must be completed.12. Sampler(s) Print name(s) of sampler(s) and the organization by which they are employed.13. SAMPLE INFORMATION
a. Sample ID Enter the field sample ID number(s) of each unique sample (s).b. Sample Date(s) Enter the date(s) sampled.c. Time Start Enter the start time of sample collection. Military time preferred.d. Time Stop Enter the stop time of sample collection. Leave blank for grab sample.e. Canister Pressure Start Enter pressure at time of start of sample.f. Canister Pressure Stop Enter pressure at time of end of sample.g. Interior Temp. Start Enter temperature at time of start of sample.h. Interior Temp. Stop Enter temperature at time of end of sample.i. Analyses Specify the test(s) to be requested by method number(s).j. Matrix Enter a matrix type.k. Check box if canister is returned unused Check if no analysis required for canister.
14. QA/QC Reporting Level – Check appropriate reporting level15. Temperature/Pressure Complete as necessary16. Special Instructions/QC Requirements Pertinent remarks about the sample or sample condition may be
noted as well. List any applicable limits to be met.17. SIGNATURES FOR CUSTODY PURPOSES Use as many lines as necessary to show transfer and receipt of
samples.a. Relinquished by Signature of person who relinquishes samples.b. Received by Signature of person who accepts samples.c. Date/Time List date and time of sample transfer.
18. REPORT DELIVERY Indicate whether results are to be emailed and list email address. Also indicate EDDformat if one is needed in addition to PDF of laboratory report.
Uncon
trolle
d pageage
aroundund timetime andnd faxfax numbnum
phoneone andand faxfnvoice.ce.
e./Stateate EnterEnt
mpler(s)ler(s) andand tht
fieldd samplesample IInterr thethe date(date
erer thethe startstart timtEnterEnt thehe stopstopureure Startar
StSt
Copy
thh thethe datedate andnd in
mbermber ofne
Sample Acceptance PolicyEurofins Spectrum Analytical is committed to maintaining the integrity of all samples submitted for laboratory analyses. All samples
submitted must have durable (waterproof) labels attached to each container identifying the sample ID, site location, and/or project
number and the collection date written in indelible ink and also must be accompanied by a Chain of Custody (COC) document. The COC
must include proper, full, and complete documentation, which shall include sample identification, the location, date and time of
collection, collector's name, preservation type, sample type and any special remarks concerning the sample.Samples may be rejected for any of the following reasons pending client notification:
Outside surfaces of sample containers have not been properly decontaminated after sample collection.There is incomplete or missing documentation.The identification of a sample container is questionable or unidentifiable.The sample is received outside the holding time for the analysis requested.Inadequate sample volume/amount to perform all analyses requested.The sample is preserved improperly or in an inappropriate container.There are discrepancies between the COC and sample labels.VOA vials contain air bubbles of sizes greater than 1% of the vial volume.Samples have high levels of polychlorinated dibenzo p dioxins/dibenzofurans (PSDD/PCDFs) or high levels of radiation.
CHAIN OF CUSTODY RECORD INSTRUCTIONSGENERAL1. All applicable information must be completed.2. Shaded fields are for laboratory use only.3. Forms must be completed legibly and in indelible ink.4. Any errors must be corrected by a single line strikethrough along with the date and initials of the individual making the correction.FORM COMPLETION4. Page Numbering Enter the total number of pages and the page number of each individual page.5. Special Handling – Turn Around Time (TAT) Indicate date needed.6. Report To Enter the company name, address and phone number.7. Project Mgr. Enter the Project Manager’s name.8. Invoice To Enter the company name, address and phone number.9. P.O. No. Enter P.O. number or additional information to appear on invoice.10. Quote # List quotation number if applicable.11. Project Number/Site Name/Location/State Enter project number (if applicable). The project name and location/state must be
completed.12. Sampler(s) Print name(s) of sampler(s) and the organization by which they are employed.13. SAMPLE INFORMATION It is the intent of this form that each unique sample taken from the same location at the same time be listed
per line.a. Lab Id For laboratory use only.b. Sample Id Enter the field sample identification of each unique sample(s).c. Date and Time Enter the date and time sampled. Military time preferred.d. Type Enter whether a grab (“G”) or composite (“C”) sample.e. Matrix Enter a matrix code (see codes listed on COC).f. Containers Enter number of containers provided under the appropriate container type(s).g. Analyses Specify the test(s) to be requested including any required method number(s) and analyte list.h. Preservatives Enter a preservative code in the cell above the test requested (see codes listed on COC). Indicate any containers which
were field filtered with an "F".i. Check if Chlorinated Check box if sample is collected from a chlorinated source. Note that chlorine may interfer with some test
methods and dechlorination must be performed at time of sample collection prior to the addition of any necessary preservative. Notify the
laboratory when ordering sample containers if collecting from a chlorinated source.j. QA/QC Reporting Notes – Check appropriate reporting level and indicate any applicable limits to be met as well as any additional State
certifications required (i.e. samples for disposal out of State from where they were collected). Pertinent remarks about the sample or sample
condition may be noted.14. REPORT DELIVERY Indicate EDD format if one is needed in addition to PDF of laboratory report and list email address(es) of recipients.15. Condition Upon Receipt For laboratory use only.16. SIGNATURES FOR CUSTODY PURPOSES Use as many lines as necessary to show transfer and receipt of samples.a. Relinquished by Signature of person who relinquishes samples.b. Received by Signature of person who accepts samples.c. Date/Time List date and time of sample transfer.d. Temp Sample temperature will be recorded by laboratory personnel upon laboratory receipt of samples.
Rev. Jan 2014
Uncon
trolle
d ofof e
mber.ber.appearpear onon invoinv
projectoject numbenumbe
he organizatiorganizatthis formform thattha
ee identificationidentificationee andd timetime samsG”)G”) or comco
codecode
Copy
andand initialsinitia ofof thehe
hh individuaindivi
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX E
Section 6 Attachments
Uncon
trolle
d Cop
ynts s
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.1
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
GC
/MS
Lab
orat
ory
Met
hod
Tun
ing
Fre
quen
cyT
unin
gC
rite
ria
Init
ial C
alib
rati
on
Fre
quen
cy a
nd
Con
cent
rati
onR
ange
Min
. # o
f S
tand
ards
for
Init
ial
Cal
ibra
tion
Init
ial C
alib
rati
on
Acc
epta
nce
Cri
teri
a C
CC
Fre
quen
cy
and
Con
cent
rati
onR
ange
CC
CA
ccep
tanc
eC
rite
ria
Cor
rect
ive
Act
ion
524
ever
y 12
ho
urs
or
20 sam
ples
See
Tab
le6.
1A
Whe
n C
CC
fai
ls;
CR
: 0.5
0-10
0 ug
/L**
*
5R
SD
20%
or
Lin
ear/
Non
-lin
ear
Reg
ress
ion
>0.
99fo
r al
l tar
get
com
poun
ds.
ICV
+20
%
Eve
ry 1
2 ho
urs
or 2
0 sa
mpl
es
CR
: 20
ug/L
; L
OD
run
wit
h al
l TH
M
bact
ches
.
%D
30%
for
all
co
mpo
unds
; RT
w
ithi
n ±
30
seco
nds
from
in
itia
l cal
ibra
tion
; M
eeti
ng r
espo
nse
rang
e fo
r ea
ch
targ
et c
ompo
und.
Rea
naly
ze. I
f C
CC
fai
ls a
gain
, pe
rfor
m s
yste
m
mai
nten
ance
and
re
cali
brat
e.
624
ever
y 12
ho
urs
or
20 sam
ples
See
Tab
le6.
1A
Whe
n C
CC
fai
ls;
CR
: 1-1
00
ug/L
***
5R
SD
20%
or
Lin
ear/
Non
-lin
ear
Reg
ress
ion
>0.
99fo
r al
l tar
get
com
poun
ds
Eve
ry 1
2 ho
urs
or 2
0 sa
mpl
es
CR
: 20
ug/L
%D
wit
hin
met
hod
set c
ontr
ol li
mit
s R
eana
lyze
. If
CC
C f
ails
aga
in,
perf
orm
sys
tem
m
aint
enan
ce a
nd
reca
libr
ate.
504.
1 ev
ery
12
hour
s or
20 sa
mpl
es
See
Tab
le6.
1B
Whe
n C
CC
fai
ls;
CR
: 0.0
1-2.
0ppb
5 R
SD
2
0%
ICV
+20
%;
reca
libr
ate
if I
CV
fa
ils.
Eve
ry 1
2 ho
urs
or 2
0 sa
mpl
es
CR
: 0.2
ppb
Rec
over
y 70
-13
0%R
eana
lyze
. If
CC
C f
ails
aga
in,
perf
orm
sys
tem
m
aint
enan
ce a
nd
reca
libr
ate.
Uncon
trolle
d
and
and
trat
ion
rati ee
Ca
ls;
l5
for
f com
pco IC
V +
ICV
+
ol
2020
nnnnn
d
n
20%
or
20%
or
on-l
inea
n-li
ne>
0
Copy
99CC E
very
12
hE
very
12
or 2
0 sa
mpl
eor
20
sam
p
y
R: 0
.2pp
bR
: 0.2
pp
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.1
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
GC
/MS
Lab
orat
ory
Met
hod
Tun
ing
Fre
quen
cyT
unin
gC
rite
ria
Init
ial C
alib
rati
on
Fre
quen
cy a
nd
Con
cent
rati
onR
ange
Min
. # o
f S
tand
ards
for
Init
ial
Cal
ibra
tion
Init
ial C
alib
rati
on
Acc
epta
nce
Cri
teri
a C
CC
Fre
quen
cy
and
Con
cent
rati
onR
ange
CC
CA
ccep
tanc
eC
rite
ria
Cor
rect
ive
Act
ion
625
ever
y 12
ho
urs
See
Tab
le6.
1B
Whe
n C
CC
fai
ls;
CR
: 5-1
50 u
g/L
5
RS
D35
% o
r L
inea
r/N
on-l
inea
rR
egre
ssio
n >
0.99
for
all t
arge
t co
mpo
unds
.
ICV
+20
%
Eve
ry 1
2 ho
urs
CR
: 100
ug/
L
%D
20%
for
all
co
mpo
unds
. R
e-tu
ne a
nd
reru
n C
CC
. If
C
CC
fai
ls, t
hen
reru
n in
itia
l ca
libr
atio
n.
8270
ever
y 12
ho
urs
See
Tab
le6.
1B
Whe
n C
CC
fai
ls;
CR
: 5-1
50
ug/L
***
5R
SD
20%
or
Lin
ear/
Non
-lin
ear
Reg
ress
ion
>0.
99fo
r al
l tar
get
com
poun
ds.
ICV
+20
% e
xcep
t +
60%
for
*di
ffic
ult
anal
ytes
. Rec
alib
rate
if
IC
V h
as >
10%
of
all a
naly
tes
fail
.
Eve
ry 1
2 ho
urs
CR
: 100
ug/
L
%D
20%
for
all
co
mpo
unds
. R
e-tu
ne a
nd
reru
n C
CC
. If
C
CC
fai
ls, t
hen
reru
n in
itia
l ca
libr
atio
n.
Uncon
trolle
and
and
trat
ion
rati ee
Ca
s;5
for
f com
pco IC
V +
ICV
+
ol
2020
nnnnn
ed
n
RS
DD20
% o
20%
ear/
Non
-lin
ear
/Non
-si
on >
sion
>d0.99
0.99
get et
Copy
cept
pt ul
t e
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.1
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
GC
/MS
Lab
orat
ory
Met
hod
Tun
ing
Fre
quen
cyT
unin
gC
rite
ria
Init
ial C
alib
rati
on
Fre
quen
cy a
nd
Con
cent
rati
onR
ange
Min
. # o
f S
tand
ards
for
Init
ial
Cal
ibra
tion
Init
ial C
alib
rati
on
Acc
epta
nce
Cri
teri
a C
CC
Fre
quen
cy
and
Con
cent
rati
onR
ange
CC
CA
ccep
tanc
eC
rite
ria
Cor
rect
ive
Act
ion
8260
ever
y 12
ho
urs
or
20 sam
ples
See
Tab
le6.
1A
Whe
n C
CC
fai
ls;
CR
: 1-2
00
ug/L
***
5R
SD
20%
or
Lin
ear/
Non
-lin
ear
Reg
ress
ion
>0.
99fo
r al
l tar
get
com
poun
ds. *
*Min
R
F p
er 8
260C
.
ICV
+20
%;
reca
libr
ate
if I
CV
ha
s >
10%
of
all
anal
ytes
fai
l.
LC
V +
30%
Eve
ry 1
2 ho
urs
CR
: 20
ug/L
; %
D20
% f
or a
ll
com
poun
ds.
Rea
naly
ze. I
f C
CC
fai
ls a
gain
, pe
rfor
m s
yste
m
mai
nten
ance
and
re
cali
brat
e
Not
es:
CR
= C
once
ntra
tion
Ran
ge
RF
= R
espo
nse
Fac
tor
RP
D =
Rel
ativ
e P
erce
nt D
iffe
renc
e
CC
C =
Cal
ibra
tion
Che
ck C
ompo
unds
IC
V =
Ini
tial
Cal
ibra
tion
Ver
ific
atio
n
*625
/827
0 D
iffi
cult
Ana
lyte
s: 4
-Chl
oroa
nili
ne, 4
-Nit
roph
enol
, Phe
nol,
2,4-
Din
itro
phen
ol
**M
inim
um R
F o
f 0.
05 f
or th
e lo
wes
t cal
ibra
tion
sta
ndar
d an
d fo
r th
e av
erag
e R
F.
Ana
lyte
s w
hich
are
exe
mpt
fro
m th
ese
crit
eria
due
to
po
or p
urgi
ng e
ffic
ienc
y ar
e ke
tone
s, a
lcoh
ols
and
diox
anes
.
**
*Ana
lyte
con
cent
rati
on r
ange
s m
ay v
ary.
See
lab
for
spec
ific
CR
.
Un
and
and
trat
ion
rati ee
Ca
nncon
trolle
d
s;5
for
f com
pco R
F p
er 8
RF
per
8
ICV
+IC
V +
oll
20%
;20
%ca
libr
ate
if I
Cal
ibra
te i
10%
of
all
0% o
f al
fail
. ai
l
nnnnn
Copy
C
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix E Rev 3/27/17
Table 6.1A BFB Key Ions and Abundance Criteria
524, 624, 8260 and Direct Injection
Mass Ion Abundance Criteria
50 15.0 - 40.0% of the base peak
75 30.0 - 60.0% of the base peak
95 base peak, 100% relative abundance
96 5.0 - 8.0% of the base peak
173 less than 2.0% of mass 174
174 Greater than 50.0% of the base peak
175 5.0 - 8.0% of mass 174
176 > 95.0%, but < 101.0% of mass 174
177 5.0 - 8.0% of mass 176
Uncon
trolle
d % of masof ma
r than 50.0%than 50.0%
0 - 8.0% of m8.0% of
> 95.0%, b> 95.0%,
5.0 - 5.0 -
Copypeak k
tive abundance tive abundanc
ase peak se peak
174
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix E Rev 3/27/17
Table 6.1B DFTPP Key Ions and Ion Abundance Criteria
GCMS SVOC’s 525.2, 625, SW846 8270
Mass Ion Abundance Criteria
51 30.0 – 60.0% of mass 198
68 less than 2.0% of mass 69
70 less than 2.0 % of mass 69
127 40.0 - 60.0 % of mass 198
197 less than 1.0 % of mass 198
198 base peak, 100% relative abundance
199 5.0 - 8.0 % of mass 198
275 10.0 - 30.0 % of mass 198
365 greater than 1.00 % of mass 198
441 Present, but less than mass 443
442 greater than 40.0 % of mass 198
443 17.0 – 23.0 % of mass 442
Notes:All ion abundances must be normalized to m/z 95, the nominal base peak, even though the ion abundance of m/z 174 may be up to 120% that of m/z 95.
f mf m
.0 % of mas% of ma
peak, 100% reak, 100%
.0 - 8.0 % of- 8.0 % o
10.0 - 3010.0 -
greagre
44242
44344U
Copy
9
mass 69 ass 6
s 198 s 198
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.2
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
GC
Lab
orat
ory
Met
hod
Min
imum
#
of
Sta
ndar
dsfo
r In
itia
l C
alib
rati
on
Cal
ibra
tion
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
CC
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
VP
H5
whe
n C
CC
fa
ils;
CR
= 1
-200
ppb
25%
RS
D o
r “r
” 0
.99
for
all t
arge
ts a
nd c
hain
s.
ICV
+20
% f
or a
ll a
naly
tes;
re
cali
brat
e if
IC
V f
ails
.
Ope
ning
and
cl
osin
g w
ith
ever
y ba
tch
of 2
0 sa
mpl
es, C
R =
50
ppb
% D
2
5% f
or a
ll ta
rget
s an
d ra
nges
wit
h th
e ex
cept
ion
of n
-non
ane
%D
30%
.
Rea
naly
ze C
CC
; if
unac
cept
able
, rep
eat
init
ial c
alib
rati
on
GR
O5
whe
n C
CC
fa
ils;
CR
= 5
0-20
00pp
b
20%
RS
D o
r “r
” 0
.99
ICV
+20
% f
or a
ll a
naly
tes;
re
cali
brat
e if
IC
V f
ails
.
Ope
ning
and
cl
osin
g w
ith
ever
y ba
tch
of 2
0 sa
mpl
es, C
R =
50
0ppb
% D
2
0%R
eana
lyze
CC
C; i
f un
acce
ptab
le, r
epea
t in
itia
l cal
ibra
tion
DR
O
5 W
hen
need
ed
CR
= 0
.2-
20m
g/kg
“r”
> 0
.99
Ope
ning
and
cl
osin
g w
ith
ever
y ba
tch
of 2
0 sa
mpl
es, C
R =
10
mg/
kg
Rec
over
y w
ithi
n 40
–
140%
.R
eana
lyze
CC
C, i
f un
acce
ptab
le r
epea
t in
itia
l cal
ibra
tion
Uncon
trolle
d
Acc
eA
c
SD
or
“r”
SD
or
“r”
0s
and
chai
nss
and
chai
all a
naly
tes;
l a
naly
tes
fail
s.
ls.
50p
50
coco
Ope
ning
Ope
clos
ing
wcl
osin
g w
very
ba
very
b Cop
y
ch o
fch
of
es, C
R =
, C
R =
pb
g an
d d hf
20
f20
Rec
140%
14
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.2
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
GC
Lab
orat
ory
Met
hod
Min
imum
#
of
Sta
ndar
dsfo
r In
itia
l C
alib
rati
on
Cal
ibra
tion
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
CC
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
NJ
EP
H/
MA
EP
H
5w
hen
CC
C
fail
s;
CR
= 5
-200
ppb
25%
RS
D f
or C
arbo
n C
hain
s an
d 15
% f
or a
ll
targ
ets;
or
“r”
0.9
9 fo
r al
l ta
rget
s an
d ch
ains
.
ICV
+20
% f
or a
ll a
naly
tes;
re
cali
brat
e if
IC
V h
as
>10
% o
f al
l ana
lyte
s fa
il.
Ope
ning
and
cl
osin
g w
ith
ever
y ba
tch
of 2
0 sa
mpl
es, C
R =
10
0ppb
% D
< 2
0% f
or a
ll ta
rget
s an
d <
25%
for
car
bon
chai
ns.
Rea
naly
ze C
CC
; if
unac
cept
able
, rep
eat
init
ial c
alib
rati
on
608
3w
hen
CC
C
fail
s;
CR
= 0
.02-
5ppb
Lin
eari
ty s
tand
ards
mus
t be
10%
RS
D; D
BC
dri
ft
mus
t be
2%
, DD
T a
nd
endr
in d
egra
dati
on
20%
co
mbi
ned;
% R
T d
rift
2%
for
a p
acke
d co
lum
n or
1.
5% f
or a
cap
illa
ry
colu
mn.
10%
RS
D f
or P
CB
and
P
esti
cide
s; o
r “r
” 0.
995
for
PC
B a
nd P
esti
cide
s.
ICV
+20
% f
or P
CB
and
P
esti
cide
s; r
ecal
ibra
te if
IC
V f
ails
.
10%
per
sam
ple
batc
h of
20
or 1
2 ho
ur s
hift
, w
hich
ever
is
mor
e fr
eque
nt;
CR
= 0
.5pp
b
RS
D15
%; D
BC
dri
ft
mus
t be
2%
; D e
ndri
n de
grad
atio
n 2
0% o
f %
R
T d
rift
2
% f
or a
pa
cked
col
umn
or
.5%
fo
r a
capi
llar
y co
lum
n.
CC
C %
D <
15%
for
all
co
mpo
unds
.
Sep
tum
cha
nge
and
colu
mn
mai
nten
ance
; re
anal
yze
CC
C; i
f un
acce
ptab
le, r
epea
t in
itia
l cal
ibra
tion
.
Uncon
trolle
d
Acc
eA
c
D f
or C
arbo
D f
or C
ar15
% f
or a
ll15
% f
or
0.9
9 fo
r al
l 0
.99
for
lyte
s;
lyte
s;
100
10
coco
% p
e%
pCop
y
sam
plsa
mpl
of 2
0 or
12
f20
or
1sh
ift, ft, er is
en
t;
RT
pack
epa
cfo
r a
cafo
r a
c
CC
CC
C
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.2
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
GC
Lab
orat
ory
Met
hod
Min
imum
#
of
Sta
ndar
dsfo
r In
itia
l C
alib
rati
on
Cal
ibra
tion
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
CC
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
8081
/808
25
whe
n C
CC
fa
ils;
8081
CR
=5-
500p
pb
8082
CR
0.0
2-5p
pb
Lin
erit
y st
anda
rds
mus
t be
10%
RS
D; D
BC
dri
ft
mus
t be
2%; D
DT
and
E
ndri
n de
grad
atio
n 30
%co
mbi
ned;
% R
T d
rift
2%
for
a pa
cked
col
umn
or
1.5%
for
a c
apil
lary
co
lum
n.
20%
RS
D f
or P
CB
and
P
esti
cide
s; o
r “r
” 0.
995
for
PC
B a
nd
0.99
for
P
esti
cide
s.
ICV
+20
% f
or P
CB
and
P
esti
cide
s; r
ecal
ibra
te if
IC
V f
ails
.
5% p
er s
ampl
e ba
tch
of 2
0 or
12
hour
shi
ft,
whi
chev
er is
m
ore
freq
uent
; C
R =
0.5
ppb
DB
C d
rift
mus
t be
2%;
DD
T a
nd e
ndri
n de
grad
atio
n20
%co
mbi
ned;
% R
T d
rift
2%
for
a p
acke
d co
lum
n or
1.5%
for
cap
illa
ry
colu
mn.
CC
C %
D <
15%
for
all
co
mpo
unds
.
Rea
naly
ze s
tand
ard;
if
unac
cept
able
, rep
eat
init
ial c
alib
rati
on.
Unco
Acc
eA
c cococont
rolle
d
tand
ards
mu
tand
ards
D
BC
dri
ft
DB
C d
rif
DD
T a
nd
DD
T a
nd
nn30
%30
%ftt
2%2%ww m
orm C
R =
0C
R
co
Copy
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.2
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
GC
Lab
orat
ory
Met
hod
Min
imum
#
of
Sta
ndar
dsfo
r In
itia
l C
alib
rati
on
Cal
ibra
tion
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
CC
Fre
quen
cy
and
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
8151
5w
hen
CC
C
fail
s;
CR
= .0
1-5p
pb
20%
RS
D f
or a
ll a
naly
tes
or “
r”
0.99
;1.
5% R
T
drif
t fro
m in
itia
l sta
ndar
d.
ICV
+20
% f
or a
ll a
naly
tes;
re
cali
brat
e if
IC
V f
ails
.
10%
per
sam
ple
batc
h of
20
or 1
2 ho
ur s
hift
, w
hich
ever
is
mor
e fr
eque
nt;
CR
= 0
.1pp
b; 1
5 pp
b fo
r M
AD
EP
M
CP
CA
M
CC
C %
D <
15%
for
all
co
mpo
unds
. DB
C d
rift
m
ust b
e 2%
; DD
T a
nd
endr
in d
egra
dati
on
20%
com
bine
d; %
RT
dri
ft
2% f
or a
pac
ked
colu
mn
or1.
5% f
or c
apil
lary
co
lum
n
Sep
tum
cha
nge
and
colu
mn
mai
nten
ance
; re
run
init
ial c
alib
rati
on
if r
eana
lysi
s fa
ils
Uncon
trolle
d
Acc
eA
c
D f
or a
ll a
naD
for
all
1.
5% R
T
1.5%
Ral
sta
ndar
d.
l sta
ndar
anal
ytes
; al
ytes
ss
ww mor
m CR
= 0
CR
pp
b fo
r M
ppb
for
MM
CP
CA
MC
P C
A
coco
d ddCop
yCCC
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.3
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
Inor
gan
ic L
abor
ator
y
Met
hod
Min
imum
# o
f S
tand
ards
for
In
itia
lC
alib
rati
on
Cal
ibra
tion
Fre
quen
cy a
nd
Con
cent
rati
onR
ange
Met
hod
of
Cur
ve G
ener
atio
n A
ccep
tanc
eC
rite
ria
CC
CF
requ
ency
and
C
once
ntra
tion
Ran
ge
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
ICP
Met
als
5D
aily
/ w
ith
each
us
e; 0
- 5
ppm
or
0-50
0 de
pend
ing
on th
e an
alyt
e
Fiv
e po
int c
urve
w
ith
auto
mat
ic
inst
rum
ent s
oftw
are
calc
ulat
ion
Cor
rela
tion
Coe
ffic
ient
>0.
998
ICV
+/-
5%
of
true
val
ue b
y E
PA
200
.7**
. IC
V +
/- 1
0% o
f tr
ue v
alue
by
EP
A 6
010
Eve
ry 1
0 sa
mpl
es o
r le
ss
+/-
10%
R
eana
lyze
d C
CV
; if
una
ccep
tabl
e,
repe
at in
itia
l ca
libr
atio
n
ICP
-MS
Met
als
6D
aily
/ w
ith
each
us
e; 0
- 1
00 p
pbL
inea
r re
gres
sion
; au
tom
atic
in
stru
men
t sof
twar
e ca
lcul
atio
n
Cor
rela
tion
Coe
ffic
ient
>0.
998
ICV
+/-
10%
of
true
val
ue
Eve
ry 1
0 sa
mpl
es o
r le
ss
+/-
10%
R
eana
lyze
d C
CV
; if
una
ccep
tabl
e,
repe
at in
itia
l ca
libr
atio
n
Mer
cury
6D
aily
/ w
ith
each
us
e; 0
- 1
0 pp
b L
inea
r re
gres
sion
; au
tom
atic
in
stru
men
t sof
twar
e ca
lcul
atio
n
Cor
rela
tion
Coe
ffic
ient
>0.
995
ICV
+/-
5%
of
true
val
ue*
Eve
ry 1
0 sa
mpl
es o
r le
ss
+/-
10%
* R
eana
lyze
d C
CV
; if
una
ccep
tabl
e,
repe
at in
itia
l ca
libr
atio
n
Uncon
trolle
d
onon and
and
Cur
veC
ur e po
int c
urve
e po
int c
uut
omat
ic
utom
atic
nt
sof
twar
e nt
sof
twar
II true
tr
uE
PA
2E
PA
ICV
+/-
1IC
V +
/tr
ue v
alue
bru
e va
lue
A 6
0A
60
coco
Copy
atio
nonie
nttsa
mp E
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.3
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
Inor
gan
ic L
abor
ator
y
Met
hod
Min
imum
# o
f S
tand
ards
for
In
itia
lC
alib
rati
on
Cal
ibra
tion
Fre
quen
cy a
nd
Con
cent
rati
onR
ange
Met
hod
of
Cur
ve G
ener
atio
n A
ccep
tanc
eC
rite
ria
CC
CF
requ
ency
and
C
once
ntra
tion
Ran
ge
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
Cya
nide
6D
aily
/ w
ith
each
us
e; 0
- 3
00 p
pb
Lin
ear
regr
essi
on
Cor
rela
tion
coef
fici
ent
>0.
997
ICV
+/-
10%
of
true
val
ue
10%
or
ever
y 2
hour
s,
whi
chev
er is
m
ore
freq
uent
, 0.
50 p
pm
+ 1
0%
Tru
e V
alue
R
ecal
ibra
te a
s ne
eded
. R
erun
all
sa
mpl
es n
ot
prec
eded
and
/or
foll
owed
by
acce
ptab
leIC
V/I
CB
,C
CV
/CC
B
Flu
orid
eE
PA
300
.0
4W
ith
each
use
0.
10 -
5.0
ppm
L
inea
r R
egre
ssio
n C
orre
lati
onco
effi
cien
t>
0.99
7
10%
or
ever
y 2
hour
s,
whi
chev
er is
m
ore
freq
uent
, 0.
40 -
2.5
0 pp
m
+ 1
0%
Tru
e V
alue
R
erun
all
sam
ples
no
t pre
cede
d an
d/or
fo
llow
ed b
y ac
cept
able
ICV
/IC
B,
CC
V/C
CB
Sul
fate
sE
PA
300
.0
6W
ith
each
use
1.
0 -
50 p
pm
Lin
ear
regr
essi
on;
each
cho
rd is
ca
lcul
ated
&
repo
rted
sep
arat
ely
Cor
rela
tion
coef
fici
ent
>0.
997
10%
or
ever
y 2
hour
s,
whi
chev
er is
m
ore
freq
uent
, 4.
0 -
25 p
pm
+ 1
0%
Tru
e V
alue
R
erun
all
sam
ples
no
t pre
cede
d an
d/or
fo
llow
ed b
y ac
cept
able
ICV
/IC
B,
CC
V/C
CB
.
Uncon
trolle
d
and
an ononC
uC
Lin
ear
regr
esL
inea
r re
g
oo
nnnncnc
dorre
lati
rrel
atfi
Copy
ntnt7
w mor
em 0.
40 -
20.
40pp
m
ppm
10%
o10
%
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.3
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
Inor
gan
ic L
abor
ator
y
Met
hod
Min
imum
# o
f S
tand
ards
for
In
itia
lC
alib
rati
on
Cal
ibra
tion
Fre
quen
cy a
nd
Con
cent
rati
onR
ange
Met
hod
of
Cur
ve G
ener
atio
n A
ccep
tanc
eC
rite
ria
CC
CF
requ
ency
and
C
once
ntra
tion
Ran
ge
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
Chl
orid
esE
PA
300
.0
6W
hen
need
ed
0.10
- 5
.0 p
pm
Lin
ear
regr
essi
on;
each
cho
rd is
ca
lcul
ated
&
repo
rted
sep
arat
ely
Tot
al c
urve
co
rrel
atio
nco
effi
cien
t>
0.99
5
10%
or
ever
y 2
hour
s,
whi
chev
er is
m
ore
freq
uent
, 10
ppm
+ 1
0% T
rue
Val
ueR
erun
all
sam
ples
no
t pre
cede
d an
d/or
fo
llow
ed b
y ac
cept
able
ICV
/IC
B, C
CV
, C
CB
Not
es:
CB
= C
onti
nuin
g C
alib
rati
on B
lank
C
CV
= C
onti
nuin
g C
alib
rati
on V
erif
icat
ion
ICV
= I
niti
al C
alib
rati
on V
erif
icat
ion
ICB
= I
niti
al C
alib
rati
on B
lank
pp
m =
Par
ts P
er M
illi
on
ppb
= P
arts
Per
Bil
lion
*Mer
cury
IC
V/C
CV
: At l
east
one
of
thes
e sa
mpl
es, p
refe
rabl
y th
e IC
V, m
ust f
all w
ithi
n 5%
of
its
true
val
ue, w
hile
the
othe
r on
e m
ay b
e w
ithi
n 10
% o
f tr
ue v
alue
. **
Aqu
eous
200
.7 I
CV
mus
t be
+/-
5%
of
true
val
ue f
or in
itia
l QC
cri
teri
a; s
ubse
quen
t IC
V m
ust b
e +
/- 1
0% o
f tr
ue v
alue
.
Uncon
trolle
and
an ononC
uC
Lin
ear
regr
esL
inea
r re
gh
chor
d is
h
chor
d is
ated
&
ted
&
sepa
rate
ly
sepa
rate
ly
nnnncnc
olled
olle
Copy
whi
le th
e ot
her
e th
e ot
heue
val
ueue
va
Eur
ofin
s S
pect
rum
Ana
lyti
cal
Com
preh
ensi
ve Q
uali
ty A
ssur
ance
Man
ual
App
endi
x E
R
ev 3
/27/
17
Tab
le 6
.4
Cal
ibra
tion
Pro
ced
ure
s fo
r A
nal
ytic
al E
qu
ipm
ent
Org
anic
Ch
arac
teri
zati
on L
abor
ator
y
Met
hod
Min
imum
#
of
Sta
ndar
dsfo
r In
itia
l C
alib
rati
on
Cal
ibra
tion
Fre
quen
cy a
nd
Con
cent
rati
onR
ange
Acc
epta
nce
Cri
teri
a
CC
CF
requ
ency
and
Con
cent
rati
on
Acc
epta
nce
Cri
teri
aC
orre
ctiv
eA
ctio
n
Oil
&
Gre
ase/
TP
H
1664
6W
hen
need
ed,
scal
es a
re
chec
ked
dail
y w
ith
2mg
to
1000
mg
Cla
ss
“S”
wei
ghts
.
±10%
at 2
mg
and
±0.5
% a
t 10
00m
g
Che
ckba
lanc
eca
libr
atio
npr
ior
to a
nd
afte
rw
eigh
ing
sam
ple
batc
h.
±10%
at 2
mg
and
±0.5
% a
t 100
0mg
Re-
cali
brat
e sc
ale;
rew
eigh
sam
ple
batc
h.
TP
H 8
100M
/8
015D
5W
hen
need
ed
+ 2
% d
iffe
renc
e fo
r 2
inje
ctio
ns;
corr
elat
ion
coef
fici
ent
0.99
5
one
ever
y 20
an
alys
esC
R =
10p
pm
QC
rec
over
y 40
-14
0%R
erun
cal
ibra
tion
. I
f co
ntin
uing
ca
libr
atio
n fa
ils,
rea
naly
ze s
ampl
es
run
befo
re c
onti
nuin
g ca
libr
atio
n fa
iled
Tot
alO
rgan
icC
arbo
n
2D
aily
/wit
h ea
ch
use
0 -
100
ppm
Cor
rela
tion
coef
fici
ent m
ust
be >
0.0
997
one
ever
y 10
an
alys
es C
R =
5
ppm
+ 1
5%
Rer
un C
alib
rati
on. I
f co
ntin
uing
ca
libr
atio
n fa
ils,
rea
naly
ze s
ampl
es
run
befo
re c
onti
nuin
g ca
libr
atio
n fa
iled
.
Uncon
trolle
d
ndd
Acc
epA
c Cri
teri
Cri
t
2mg
2mg t
Ch
C bala
ncba ca
libr
atio
cali
brat
iopr
ior
to a
nd
prio
r to
an
ererhi
ngng batc
h.
tch.
onon
Copy
QC
rec
ovQ
C r
ec14
0%14
0%
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX F
Section 7 Attachments
Uncon
trolle
d Cop
ynts s
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
Acc
ount
ing
and
HR
Cli
ent C
redi
t App
lica
tion
For
ms
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\HR
and
A
ccou
ntin
g\S
OP
for
Cli
ent C
redi
t App
lica
tion
For
ms,
07-
22-1
3 R
ev.
3.do
cR
ev 3
-7/
22/1
37/
29/1
3 -
JF
Acc
ount
ing
and
HR
Hum
an R
esou
rces
& A
ccou
ntin
g F
unct
ions
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Adm
in\S
OP
for
H
uman
Res
ourc
es a
nd A
ccou
ntin
g F
unct
ions
, 10-
26-1
6 R
ev. 1
6.do
cR
ev 1
6 -
10/2
6/16
10/2
6/16
- J
F
Acc
ount
ing
and
HR
SO
P f
or W
ork
Rel
ated
Inc
iden
ts, A
ccid
ents
and
In
juri
esS
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\HR
and
A
ccou
ntin
g\S
OP
for
Wor
k R
elat
ed I
ncid
ents
, Acc
iden
ts, I
njur
ies,
6-
17-1
4 R
ev. 4
Rev
4 -
6/
17/1
46/
24/1
4 -
MS
Dis
cont
inue
d6/
09/1
6
Adm
inis
tati
onS
OP
for
Dep
artm
enta
l Val
idat
ion
Pro
cedu
res
for
SA
I A
gaw
am D
ivis
ion
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Adm
in\D
epar
tmen
tal V
alid
atio
n P
roce
dure
s fo
r E
SA
I-M
A, 7
-22
-16
Rev
. 6.d
ocR
ev 6
-7/
22/1
67/
22/1
6 -
KL
Adm
inis
tati
onS
OP
for
Man
ual I
nteg
rati
ons
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Adm
in\S
OP
for
M
anua
l Int
egra
tion
of
Chr
omat
ogra
phic
Pea
ks, 1
-09-
14 R
ev. 4
.doc
Rev
. 4 -
1/09
/12
1/14
/14
- W
B
Adm
inis
tati
onS
OP
for
Bri
ngin
g a
New
Met
hod
Onl
ine
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Adm
in\S
OP
for
B
ring
ing
a N
ew M
etho
d O
nlin
e, 7
-22-
16 R
ev. 3
.doc
Rev
3 -
7/
22/1
67/
22/1
6 -
KL
Adm
inis
tati
onB
alan
ce C
alib
rati
on C
heck
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\Adm
in\S
OP
for
B
alan
ce C
alib
rati
on C
heck
, 8-0
8-13
Rev
. 3.d
ocR
ev 3
-
8/08
/13
8/08
/13
- K
L
Air
Div
isio
nC
anis
ter
Tra
ckin
g an
d C
lean
ing
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Air
\SO
P f
or
Can
iste
r T
rack
ing
and
Cle
anin
g, 9
-21-
15 R
ev. 5
.doc
Rev
5 -
9/
21/1
59/
21/1
5 -
BF
Air
Div
isio
nD
eter
min
atio
n of
Air
-Pha
se P
etro
leum
Hyd
roca
rbon
sM
assa
chus
etts
DE
P A
PH
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Air
\SO
P f
or
AP
H, 0
3-14
-16
Rev
. 9.d
ocR
ev 9
-
3/14
/16
3/16
/16
- E
K
Air
Div
isio
nD
eter
min
atio
n of
Sul
fur
Com
poun
ds u
sing
SC
DE
PA
44A
/AS
TM
D55
04F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\A
ir\S
OP
for
S
ulfu
r by
Mod
ifie
d 44
A, D
5504
, 4-1
5-13
Rev
. 1.d
ocR
ev 1
-
4/15
/13
4/24
/13
- K
L D
isco
ntin
ued
7/10
/15
Air
Div
isio
nD
eter
min
atio
n of
Vol
atil
e O
rgan
ic C
ompo
unds
in A
irE
PA
Met
hod
TO
-15
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Air
\SO
P f
or T
O-
15, 6
-28-
16 R
ev. 2
1.do
cR
ev 2
1 -
6/28
/16
6/28
/16
- B
F
Air
Div
isio
nD
eter
min
atio
n of
Vol
atil
e O
rgan
ic C
ompo
unds
in A
irE
PA
18
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Air
\SO
P f
or M
odif
ied
EP
A 1
8 T
PH
-BT
EX
in A
ir, 0
3-20
-15
Rev
. 8.d
oc
Rev
8 -
3/20
/15
3/25
/15
- E
K
Air
Div
isio
nD
eter
min
atio
n of
Vol
atil
e O
rgan
ic C
ompo
unds
in
Am
bien
t Air
EP
A M
etho
d T
O-1
4AF
:\D
ata\
QA
QC
\NE
LA
C\S
OP
for
TO
-14A
Rev
3 -
6/
30/0
407
/06/
04 -
WB
Dis
cont
inue
d1/
1/12
Air
Div
isio
nIn
stru
ctio
ns f
or U
sing
Flo
w C
ontr
olle
rsS
A P
olic
yF
:\D
ata\
QA
QC
\NE
LA
C\S
OP
for
Usi
ng F
low
Con
trol
ler
Rev
0 -
9/
5/02
DG
Air
Div
isio
n
Mod
ifie
d E
PA
3C
/RS
KS
OP
-175
Det
erm
inat
ion
of
Fix
ed G
ases
and
Dis
solv
ed g
ases
in G
aseo
us a
nd
Aqu
eous
pha
se m
atri
ces
by T
CD
EP
A 3
C/R
SK
SO
P-1
75
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Air
\SO
P f
or
Fix
ed G
ases
& D
isso
lved
Gas
es M
od. 3
C-R
SK
-175
by
TC
D, 2
-23-
15 R
ev. 5
.doc
Rev
5 -
02
/23/
15
02/2
4/15
- E
K
Air
Div
isio
nR
espi
rabl
e P
arti
cula
tes
NIO
SH
060
0F
:\D
ata\
QA
QC
\NE
LA
C\S
OP
for
Res
pira
ble
Par
ticu
late
sR
ev 1
5/
23/0
211
/04/
02 -
NB
OB
SO
LE
TE
; nev
er r
an
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 1
R
evis
ion
4/27
/201
7
Unco
and
and
ures
for
SA
I ur
es f
or S
AI
SA
Po
SA
Pol
icy
SA
Pol
icy
ncUncon
t
licycynt
rolB
aB
a
lolledF
:\da
ta\Q
F:\
daC
anis
ter
Tra
Can
iste
lleed
:\da
ta\Q
AQ
C\N
data
\QA
QC
\NH
, 03-
14-1
, 03-
14-
edQ
AQ
cont
oledd
Cop
C\N
EL
AC
SO
Ps\
NE
LA
AC
SO
Ps\
21.d
ococ
CNE
LA
C S
ON
EL
AC
Sod
ifie
d 44
A, D
55if
ied
44A
, D
Cev. 9 op
y
SO
Ps\
NE
LA
C S
OP
s 20
OP
s\N
EL
AC
S3-
20-1
5 R
ev. 8
.do
Rev
. 8.d
o
yCCop
y
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Air
Div
isio
nT
otal
Par
ticu
late
sN
IOS
H 0
500
F:\
Dat
a\Q
AQ
C\N
EL
AC
\SO
P f
or T
otal
Par
ticu
late
sR
ev 1
5/
23/0
211
/04/
02 -
NB
OB
SO
LE
TE
; nev
er r
an
Cli
ent S
ervi
ces
Ent
erin
g S
ubou
t Dat
a S
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
12\C
lien
t S
ervi
ces\
SO
P f
or E
nter
ing
Sub
out D
ata,
1-1
9-12
Rev
. 3.d
ocR
ev 3
-
01/1
9/12
1/24
/12
- G
P
Dec
omis
sion
ed. R
epla
ced
byS
OP
for
Sub
cont
ract
ed
Ana
lyse
s.
Cli
ent S
ervi
ces
Lab
orat
ory
Rep
ort I
nvoi
cing
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Cli
ent
Sev
ices
\SO
P f
or R
epor
t Inv
oici
ng, 6
-06-
16 R
ev. 7
.doc
Rev
7 -
6/
06/1
66/
06/1
6 -
JH
Cli
ent S
ervi
ces
Lab
orat
ory
Rep
ort M
aili
ng
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Cli
ent S
ervi
ces\
SO
P f
or
Lab
orat
ory
Rep
ort M
aili
ng, 7
-13-
16 R
ev. 1
3.do
c
Rev
13
- 7/
13/1
67/
13/1
6 -
LC
Cli
ent S
ervi
ces
Lab
orat
ory
Rep
ort P
ubli
shin
g S
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Cli
ent
Ser
vice
s\S
OP
for
Lab
orat
ory
Rep
ort P
ubli
shin
g, 1
2-22
-15
Rev
. 9.
doc
Rev
9 -
12
/22/
1512
/22/
15 -
JH
Cli
ent S
ervi
ces
Res
olut
ion
of C
ompl
aint
sS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\C
lien
t S
ervi
ces\
SO
P f
or R
esol
utio
n of
Com
plai
nts,
10-
03-1
3 R
ev. 2
.doc
Rev
2 -
10
/03/
1310
/03/
13 -
DL
Cli
ent S
ervi
ces
SO
P f
or S
cann
ing
Lab
orat
ory
Wor
k O
rder
Fil
e C
opie
sS
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Cli
ent
Ser
vice
s\S
OP
for
Sca
nnin
g W
ork
Ord
er F
ile
Cop
ies,
7-0
8-16
R
ev.4
.doc
Rev
4 -
7-08
-16
7/08
/16
- L
C
Cli
ent S
ervi
ces
SO
P f
or S
ubco
ntra
cted
Ana
lyse
sS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\C
lien
t S
ervi
ces\
SO
P f
or S
ubco
ntra
cted
Ana
lyse
s, 5
-28-
14 R
ev. 1
.doc
Rev
1 -
5/
28/1
45/
29/1
4 -
RM
Cli
ent S
ervi
ces
Dat
a P
acka
ge P
repa
rati
onS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
17\C
lien
t S
ervi
ces\
SO
P f
or D
ata
Pac
kage
Pre
para
tion
, 2-2
2-17
Rev
. 1.d
ocR
ev 1
-
2/22
/17
2/22
/17
- A
PM
Cou
rier
Dep
t.C
ouri
er P
olic
ies
and
Pro
cedu
res
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Cou
rier
\SO
P f
or
Cou
rier
Pol
icie
s an
d P
roce
dure
s, 1
-29-
15 R
ev. 1
8.do
cR
ev 1
8 -
1/29
/15
1/30
/15
- E
M
Cou
rier
Dep
t.G
lass
war
e P
rese
rvat
ion
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Cou
rier
\SO
P f
or
Gla
ssw
are
Pre
serv
atio
n, 3
-18-
15 R
ev. 1
4.do
cR
ev 1
4 -
3/18
/15
3/18
/15
- E
M
Cou
rier
Dep
t.U
PS
/Fed
Ex
Shi
pmen
ts f
or b
oth
Inte
rnat
iona
l and
D
omes
tic
Ser
vice
s S
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Cou
rier
D
ept\
SO
P f
or U
PS
-Fed
Ex
Shi
pmen
ts f
or b
oth
Inte
rnat
iona
l and
D
omes
tic
Ser
vice
s, 9
-30-
14 R
ev. 3
.doc
Rev
. 3 -
9/30
/14
9/30
/14
- E
M
Cou
rier
Dep
t.S
OP
for
Pre
pari
ng th
e B
utan
ol O
dor
Inte
nsit
y T
est K
itS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\C
ouri
er
Dep
t\S
OP
for
But
anol
Odo
r In
tens
ity
Kit
, 10-
29-1
3 R
ev. 1
.doc
Rev
1 -
10
/29/
1310
/31/
13 -
CW
Dis
cont
inue
d
Hea
lth
and
Saf
ety
Che
mic
al H
ygie
ne P
lan
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\Hea
lth
&
Saf
ety\
Che
mic
al H
ygie
ne P
lan,
3-2
7-17
Rev
. 17.
doc
Rev
13
- 3/
27/1
73/
27/1
7 -
JM
Hea
lth
and
Saf
ety
Con
ting
ency
Pla
nS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\H
ealt
h &
S
afet
y\S
OP
for
Con
ting
ency
Pla
n, 3
-14-
16 R
ev. 7
.doc
Rev
7 -
3/
14/1
63/
14/1
6 JM
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 2
R
evis
ion
4/27
/201
7
Unco
SA
Po
SA
Pol
icy
SA
Pol
icy
ncUncon
t
licycynt
rolR l
rolle
dF
:\da
ta\Q
F:\
daS
ervi
ces\
SO
PS
ervi
ce
lleeddata\QA
QC
\Nta
\QA
QC
ces\
SO
Pce
s\S
O
e
cont
rol e
dCo
AQ
C\N
EL
AC
SO
Ps\
N\N
EL
AC
Sci
es a
nd P
roce
dure
s, 1
and
Pro
cedu
r
Copy
LA
C S
OP
s\N
EL
AC
SC
SO
Ps\
NE
Ln,
3-1
8-15
Rev
. 14.
doc
3-18
-15
Rev
.
CDat
a P
Dat
a P
py
SO
Ps\
NE
LA
C S
OP
s\N
EL
AC
SO
Phi
pmen
ts f
orip
men
ts f
ov.
3.d
oyCCop
yy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Hea
lth
and
Saf
ety
Gas
Tan
k C
hang
ing,
Ord
erin
g an
d S
tora
geS
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2011
\Hea
lth
&
Saf
ety\
SO
P f
or G
as T
ank
Ord
erin
g, S
tora
ge a
nd C
hang
ing,
8-2
0-11
R
ev.2
.doc
Rev
2 -
8/
20/1
18/
24/1
1 -
DS
Hea
lth
and
Saf
ety
Inte
rnat
iona
l Soi
l Han
dlin
g an
d D
ispo
sal
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Hea
lth
&
Saf
ety\
SO
P f
or R
egul
ated
Soi
l Han
dlin
g an
d D
ispo
sal,
7-13
-16
Rev
. 7.
doc
Rev
7 -
7/
15/1
67/
13/1
6 -
KL
Hea
lth
and
Saf
ety
OS
HA
Haz
ard
Com
mun
icat
ion
Sta
ndar
dO
SH
A &
SA
Pol
icie
s
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\Hea
lth
&
Saf
ety\
SO
P f
or O
SH
A H
azar
d C
omm
unic
atio
n S
tand
ard,
3-2
7-17
R
ev. 4
.doc
Rev
4 -
3/
27/1
73/
27/1
7 -
JM
Hea
lth
and
Saf
ety
Use
and
Ope
rati
on o
f G
rind
ing
Mil
lS
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Hea
lth
&
Saf
ety\
SO
P f
or U
se a
nd O
pera
tion
of
Gri
ndin
g M
ill,
10-1
5-14
Rev
. 2.
doc
Rev
2 -
10
/15/
1410
/16/
14 -
KL
Hea
lth
and
Saf
ety
Was
te D
ispo
sal
SA
Pol
icy
F:\
Dat
a\Q
AQ
C\N
EL
AC
\SO
P W
aste
Dis
posa
lR
ev 1
7/18
/06
Dis
cont
inue
d; in
fo in
CH
P,
7/21
/06
- C
B
Hea
lth
and
Saf
ety
Use
and
Ope
rati
on o
f th
e G
lass
Cru
sher
and
Pla
stic
S
hred
der
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2011
\Hea
lth
&
Saf
ety\
SO
P f
or U
se a
nd O
pera
tion
of
the
Gla
ss C
rush
er a
nd P
last
ic
Shr
edde
r, 8
-26-
11 R
ev. 0
.doc
Rev
08/
26/1
18/
30/1
1 -
JM
Inor
gani
c -
Met
als
Ana
lyti
cal p
roce
dure
for
NIO
SH
met
hod
7300
(m
odif
ied)
NIO
SH
met
hod
7300
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
16\M
etal
s\S
OP
for
Met
als
byN
iOS
H 7
300
ICP
1-0
6-16
Rev
2.d
ocR
ev. 2
-1/
06/1
61/
07/1
6 -
JCD
isco
ntin
ued
4/13
/16
Inor
gani
c -
Met
als
Aut
oBlo
ck P
lus
Mai
nten
ance
and
Ope
rati
onN
/AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\M
etal
s\S
OP
for
A
utoB
lock
Plu
s M
aint
enan
ce a
nd O
pera
tion
, 8-0
4-16
Rev
2.d
ocR
ev. 2
-
8/04
/16
8/04
/16
- JC
Inor
gani
c -
Met
als
Dig
esti
on o
f B
iolo
gica
l Tis
sue-
US
GS
B-9
001-
95U
SG
S B
-900
1-95
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
06\M
etal
s\S
OP
for
Bio
logi
cal
Tis
sue
Dig
esti
ons
7-12
-06
Rev
.0.d
ocR
ev. 0
-
7/12
/06
Dis
cont
inue
d
7/1
4/06
-
JC
Inor
gani
c -
Met
als
Dig
esti
on o
f N
on-A
queo
us S
ampl
es v
ia M
icro
wav
e,
SW
846
3051
AS
W84
6 30
51A
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Met
als\
SO
P f
or
Dig
esti
on o
f N
on-A
queo
us S
ampl
es v
ia M
icro
wav
e S
W84
6 30
51A
, 6-0
6-1 6
Rev
. 5.d
oc
Rev
5 -
6/
06/1
66/
06/1
6 -
JC
Inor
gani
c -
Met
als
Sam
ple
Pre
para
tion
for
Met
als
Det
erm
inat
ion
SW
846
3005
A/3
050B
/SM
2340
B, E
PA
20
0.7,
EP
A 2
00.8
F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\M
etal
s\S
OP
for
Sam
ple
Pre
para
tion
for
Met
als
Det
erm
inat
ion,
7-1
1-16
Rev
. 4.d
oc
Rev
4 -
7/
11/1
67/
11/1
6 -
JC
Inor
gani
c -
Met
als
Mer
cury
Sam
ple
Dig
esti
onE
PA
245
.1/S
W 8
46 7
470A
and
74
71B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Met
als\
SO
P f
or
Mer
cury
Sam
ple
Dig
esti
on b
y E
PA
245
.1, S
W84
6 74
70A
and
74
71B
, 1-0
6-16
Rev
. 5.d
ocR
ev. 5
-
1/06
/16
1/11
/16
- JC
Inor
gani
c -
Met
als
Mer
cury
Ana
lysi
sE
PA
245
.1/S
W 8
46 7
470A
and
74
71B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\Met
als\
SO
P f
or M
ercu
ry
Ana
lysi
s by
EP
A 2
45.1
, SW
846
7470
A a
nd 7
471B
, 03-
20-1
7 R
ev. 2
2.do
c
Rev
22
- 3/
20/1
73/
20/1
7 -
JC
Inor
gani
c -
Met
als
Met
als
by I
nduc
tive
ly C
oupl
ed P
lasm
a-A
tom
ic
Em
issi
on S
pect
rom
etry
EP
A 2
00.7
F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\M
etal
s\S
OP
for
M
etal
s by
200
.7, 6
-06-
16 R
ev. 1
4.do
cR
ev 1
4 -
6/06
/16
6/06
/16
- JC
Inor
gani
c -
Met
als
Met
als
by I
nduc
tive
ly C
oupo
led
Pla
sma-
Mas
s S
pect
rom
etry
(IC
P-M
S)
EP
A 2
00.8
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Met
als\
SO
P f
or
ICP
-MS
by
200.
8, 8
-19-
16 R
ev. 1
4.do
cR
ev 1
4 -
8/19
/16
8/19
/16
- E
T
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 3
R
evis
ion
4/27
/201
7
Uncon
trolle
d
SA
P
SA
Pol
icy
SA
Pol
icy
licycy
hod
7300
d 73
00
F:\
dF
:\d
Aut
oBl
Aut
oF
:\da
ta\Q
AF
:\da
taT
issu
e D
iges
tT
issu
e D
F:\
data
\QA
QC
\NE
LF
:\da
ta\Q
AQ
C\N
Ees
tion
of
Non
tion
of
Ndo
cdo
c
nc
lle
Uncon
ttroollee
dCop
y
ueo
QC
\NE
LA
C S
OP
s\N
EL
AN
EL
AC
SO
Ps\
Nr
Met
als
Det
erm
inat
ion,
7al
s D
eter
min
a
NE
LA
C S
OP
s\N
EL
AC
AC
SO
Ps\
NE
Lig
esti
on b
y E
PA
245
.1io
n by
EP
A
5.do
cdo
c
Copy A
C S
O
py
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Inor
gani
c -
Met
als
Met
als
by I
nduc
tive
ly C
oupo
led
Pla
sma-
Mas
s S
pect
rom
etry
(IC
P-M
S)
SW
846-
6020
AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\M
etal
s\S
OP
for
Met
als
by I
CP
-MS
SW
846
6020
A, 0
6-06
-16
Rev
. 10.
doc
Rev
10
- 6/
06/1
66/
06/1
6 -
KL
Inor
gani
c -
Met
als
SO
P f
or L
abw
are
Cle
anin
g fo
r T
race
Met
als
Ana
lysi
sS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\M
etal
s\S
OP
for
L
abw
are
Cle
anin
g fo
r T
race
Met
als
Ana
lysi
s, 8
-04-
16 R
ev. 2
.doc
Rev
2 -
8/
04/1
68/
04/1
6 -
JC
Inor
gani
c -
Met
als
SO
P f
or M
etal
s by
Ind
ucti
vely
Cou
pole
d P
lasm
a (I
CP
) S
W84
6 60
10C
, SM
2340
BS
W84
6 60
10C
, SM
2340
BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\M
etal
s\S
OP
for
M
etal
s by
IC
P S
W84
6 60
10C
and
SM
2340
B, 6
-06-
16 R
ev. 1
2.do
cR
ev 1
2 -
6/06
/16
6/06
/16
- JC
Inor
gani
c -
Met
als
SO
P f
or th
e O
pera
tion
of
the
Hyd
ra P
rep
Aut
omat
ed
Mer
cury
Pre
para
tion
Sys
tem
N/A
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2008
\Met
als
Rev
0 -
08
/28/
08D
isco
ntin
ued
9/8/
08 -
JC
Inor
gani
c -
Met
als
Mer
cury
Ana
lysi
s in
Air
by
Mod
ifie
d N
IOS
H 6
009
NIO
SH
600
9
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\Met
als\
SO
P f
or
Mer
cury
Ana
lysi
s in
Air
by
Mod
ifie
d N
IOS
H 6
009,
7-0
8-13
Rev
. 0.
doc
Rev
0 -
7/
08/1
37/
08/1
3 -
JCD
isco
ntin
ued
4/13
/16
ITIn
stru
men
t Dat
a B
acku
p P
roce
dure
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2011
\IT
\SO
P f
or
Inst
rum
ent D
ata
Bac
kup
Pro
cedu
re, 7
-08-
11 R
ev.4
.doc
Rev
4 -
7/
08/1
1D
isco
ntin
ued
7/14
/11
- JN
ITL
abor
ator
y C
ompu
ters
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\IT
\SO
P f
or
Lab
orat
ory
Com
pute
rs, 2
-08-
16 R
ev. 9
.doc
Rev
9 -
2/
08/1
62/
10/1
6 -
JN
ITA
gaw
am I
T S
yste
m M
aint
enan
ce P
roce
dure
sS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
17\I
T\S
OP
for
A
gaw
am I
T S
yste
m M
aint
enan
ce P
roce
dure
s, 4
-07-
17 R
ev. 6
.doc
Rev
6-
4/07
/17
4/07
/17
- JN
ITS
oftw
are
Sys
tem
Cha
nge
Con
trol
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\IT
\SO
P f
or
Sof
twar
e S
yste
m C
hang
e C
ontr
ol, 2
-08-
16 R
ev. 0
.doc
Rev
0 -
2/
8/16
2/10
/16
- JN
Mic
robi
olog
yA
naer
obic
Bac
teri
a fo
r U
TC
Pow
er S
pace
Shu
ttle
W
ater
SA
Pro
cedu
reF
:\P
DF
Doc
umen
ts\N
EL
AC
SO
Ps
in P
DF
- U
ncon
trol
led
Cop
ies\
Mic
robi
olog
y\O
ld S
OP
s\S
OP
Ana
erob
ic B
acte
ria
Rev
0 -
5/
07/0
7D
isco
ntin
ued
on 1
0/6/
10
Mic
robi
olog
y
Con
firm
atio
n fo
r T
otal
Col
ifor
m u
sing
Lau
ryl T
rypt
ose
Bro
th &
Bri
llia
nt G
reen
Lac
tose
Bil
e B
roth
and
E. C
oli
Usi
ng N
utri
ent A
gar
wit
h M
UG
SM
9222
BS
M92
22G
, MI
Aga
rF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps
2009
\Mic
robi
olog
y\S
OP
for
Tot
al
Col
ifor
m C
onfi
rmat
ion.
doc
Rev
5 -
1/
14/0
9D
isco
ntin
ued
1/22
/09
-CB
Mic
robi
olog
yF
ecal
Col
ifor
m M
embr
ane
Fil
trat
ion
SM
9222
D
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Mic
robi
olog
y\S
OP
for
Fec
al C
olif
orm
Fil
trat
ion
by S
M92
22D
, 4-
14-1
6 R
ev. 1
6.do
cR
ev 1
6 -
4/14
/16
4/14
/16
- V
IA
Mic
robi
olog
yG
ener
al M
icro
biol
ogy
Req
uire
men
tsN
/A
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Mic
robi
olog
y\S
OP
for
Gen
eral
Mic
robi
olog
y R
equi
rem
ents
, 9-
27-1
6 R
ev. 2
5.do
cR
ev 2
5 -
9/27
/16
9/27
/16
- K
L
Mic
robi
olog
yH
etro
toph
ic P
late
Cou
ntS
M92
15B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\Mic
robi
olog
y\S
OP
for
SM
921
5 H
eter
otro
phic
Pla
te C
ount
, 3-
15-1
7 R
ev. 1
3.do
cxR
ev 1
3 -
3/15
/17
3/15
/17
- JO
C
Mic
robi
olog
y
Met
hod
1600
: E
nter
ococ
ci in
Wat
er b
y M
embr
ane
Fil
trat
ion
usin
g m
embr
ane-
Ent
eroc
occu
s In
doxy
l--D
-G
luco
side
Aga
rE
PA
160
0F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
15\M
icro
biol
ogy\
SO
P f
or M
etho
d 16
00, 4
-15-
15 R
ev. 5
.doc
R
ev. 5
4/15
/15
4/17
/15
- V
A
Mic
robi
olog
yP
etro
leum
Deg
rade
r B
acte
ria
SA
I S
OP
F:\
data
\QA
QC
\NE
LA
C S
OP
S 2
006\
Mic
robi
olog
y\P
etro
leum
D
egra
der
Bac
teri
a T
est 7
-17-
06.d
ocR
ev 1
-
7/17
/06
7/21
/06
- S
CD
isco
ntin
ued
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 4
R
evis
ion
4/27
/201
7
Uncon
trolle
d
asm
a as
ma
Aut
omat
ed
Aut
omat
ed
N/A
N NIO
SH
600
9O
SH
600
9
icycy
La
La
F:\
data
\QA
F:\
dat
Aga
wam
IT
SA
gaw
am
F:\
data
\QA
QC
\NF
:\da
ta\Q
AQ
C\N
ftw
are
Sys
tem
war
e S
yst
Doc
Do
nc
lle
Unconn
t oledd
Copy
han
nts\
NE
Lnt
s\N
EL
obio
logy
\Old
SO
biol
ogy\
Old
QC
\NE
LA
C S
OP
s 20
09N
EL
AC
SO
Ps
rmat
ion.
doc
on.d
oc
LA
C S
OP
s\N
EL
AC
SO
SO
Ps\
NE
LA
OP
for
Fec
al C
olif
orm
Ffo
r F
ecal
Col
i
CCoppy
\NE
LA
C S
\NE
LA
eral
py
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Mic
robi
olog
yT
otal
Col
ifor
m M
embr
ane
Fil
trat
ion
SM
9222
B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2010
\Mic
robi
olog
y\S
OP
Tot
al C
olif
orm
Mem
bran
e F
iltr
atio
n S
M92
22B
4-5
-10
Rev
.8.d
ocR
ev.8
4/5/
10D
isco
ntin
ued
4/10
/10
- JO
C
Mic
robi
olog
y
Tot
al C
olif
orm
s an
d E
. Col
i in
wat
er b
y M
embr
ane
Fil
trat
ion
Usi
ng a
Sim
ulta
neou
s D
etec
tion
Tec
hniq
ue
(MI
Med
ium
)M
etho
d 16
04F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
17\M
icro
biol
ogy\
SO
P f
or M
etho
d 16
04, 2
-15-
17 R
ev. 1
3.do
cR
ev 1
3 -
2/15
/17
2/15
/17
- JO
C
Mic
robi
olog
y
Met
hod
1603
: Esc
heri
chia
col
i (E
.col
i) in
Wat
er b
y M
embr
ane
Fil
trat
ion
Usi
ng M
odif
ied
Mem
bran
e-T
herm
otol
eran
t Esc
heri
chia
col
i Aga
r (m
odif
ied
mT
EC
)M
etho
d 16
03..\
QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Mic
robi
olog
y\S
OP
for
E
.col
i by
Met
hod
1603
, 8-0
7-15
Rev
. 2.d
ocR
ev 2
-
8/07
/15
8/11
/15
- JO
C
Mic
robi
olog
ypH
Ori
on E
A94
0 fo
r M
icro
biol
ogic
al M
edia
sS
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Mic
robi
olog
y\S
OP
for
pH
Ori
on E
A94
0 M
icro
biol
ogic
al
Med
ias,
05-
26-1
5 R
ev. 2
.doc
Rev
2 -
5/
26/1
55/
26/1
5 -
VIA
Mic
robi
olog
yT
otal
and
E.c
oli b
y S
M92
223B
usi
ng I
DE
XX
Col
iler
tS
M92
223B
Col
iler
tF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\M
icro
biol
ogy\
SO
P f
or
IDE
XX
Col
iler
t SM
9223
B R
ev. 1
, 10-
12-1
6.do
c
Rev
1 -
10
/12/
1610
/12/
16 -
VIA
Qua
lity
Ass
uran
ceS
OP
for
Lab
orat
ory
Sup
port
Equ
ipm
ent C
alib
rati
onS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\A
dmin
\SO
P f
or
Lab
orat
ory
Sup
port
Equ
ipm
ent C
alib
rati
on, R
ev. 0
, 2-2
2-16
Rev
. 0 -
2/
22/1
62/
22/1
6 -
SM
R
Qua
lity
Ass
uran
ceR
efri
gera
tor
The
rmom
eter
s an
d T
empe
ratu
re P
robe
P
rogr
amS
A P
olic
y
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\Adm
in\S
OP
for
R
efri
gera
tor
The
rmom
eter
s an
d T
empe
ratu
re P
robe
Pro
gram
, 1-1
7-17
Rev
. 8.d
ocR
ev. 8
-
1/17
/17
1/17
/17
- K
L
Qua
lity
Ass
uran
ceE
stab
lish
men
t and
Rep
orti
ng o
f D
etec
tion
Lim
its
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Adm
in\S
OP
for
E
stab
lish
men
t and
Rep
orti
ng o
f D
etec
tion
Lim
its,
7-1
8-16
Rev
. 4.
doc
Rev
. 4 -
7/
18/1
67/
18/1
6 -
KL
R&
D /
Tre
atab
ilit
yE
thyl
ened
diam
inet
etra
acet
ate
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
08\R
&D
-Tre
atab
ilit
y\S
OP
ED
TA
11
-17-
08 R
ev.1
.doc
Rev
1 -
11-1
7-08
11-1
7-08
-CW
Dis
cont
inue
d5/
07/1
5 pe
r C
W
R&
D /
Tre
atab
ilit
yH
ydro
gen
Per
oxid
eF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
09\R
&D
-
Tre
atab
ilit
y\S
OP
for
Hyd
roge
n P
erox
ide
Rev
.2. 8
-21-
09.d
ocR
ev 2
-
8/21
/09
8/25
/09
- M
L
R&
D /
Tre
atab
ilit
yIn
orga
nic
Dep
artm
ent f
or U
N O
xidi
zer
Tes
t By
Met
hod
SW
846
1040
SW
846
1040
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2007
\Wet
C
hem
istr
y\S
OP
for
Ino
rgan
ic D
epar
tmen
t UN
Oxi
dize
r T
est R
ev.0
. 313
-07.
doc
Rev
. 0 -
3/
13/0
73/
13/0
7 -
JOC
Dis
cont
inue
d5/
07/1
5 pe
r C
W
R&
D /
Tre
atab
ilit
yIn
orga
nic
Dep
t. fo
r O
xidi
zer
Tes
tS
A S
OP
F:\
data
\QA
QC
\NE
LA
C S
OP
s in
PD
F -
Unc
ontr
olle
d C
opie
s\W
et
Che
m\S
OP
for
Ino
rgan
ic D
epar
tmen
t Oxi
dize
r T
est R
ev.2
. 7-2
1-06
Rev
2 -
7/
21/0
67/
21/0
6 -
JOC
Dis
cont
inue
d9/
20/1
3 pe
r C
W
R&
D /
Tre
atab
ilit
yP
ersu
lfat
e by
Spe
ctro
phot
omet
erF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\T
reat
abil
ity
and
For
ensi
cs\S
OP
for
Per
sulf
ate,
1-2
0-14
Rev
. 2.d
ocR
ev 2
-
1/20
/14
1/24
/14
- C
W
R&
D /
Tre
atab
ilit
yS
OP
for
Bul
k D
ensi
ty A
ST
M D
189
5BA
ST
M D
189
5BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
10\T
reat
abil
ity
&
For
ensi
cs\S
OP
for
Bul
k D
ensi
ty A
ST
M D
189
5B 7
-21-
10 R
ev. 0
Rev
. 0
7/27
/10
7/27
/10
CW
R&
D /
Tre
atab
ilit
yS
OP
for
Fer
rous
Iro
nA
ST
M D
106
8-03
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2007
\R&
D -
T
reat
abil
ity\
SO
P F
erro
us I
ron
AS
TM
.doc
Rev
0 -
1/
16/0
701
/19/
07 -
CW
D
isco
ntin
ued
R&
D /
Tre
atab
ilit
yS
OP
for
Oxi
dati
on-R
educ
tion
Pot
enti
al
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\Tre
atab
ilit
y an
d F
oren
sics
\SO
P f
or O
xida
tion
-Red
ucti
on P
oten
tial
, 2-0
7-13
R
ev.4
.doc
Rev
4 -
2/07
/13
2/08
/13
- M
L
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 5
R
evis
ion
4/27
/201
7
Unc
bran
e-br
ane
mod
ifie
d od
if
SA
Pol
icy
SA
Po
ncUnconM
9222
3B C
olil
ert
M92
223B
Col
i
cont
rnt
rollR 17
R17
R
llolledF
:\da
ta\Q
F:\
dE
stab
lish
mE
stab
li4.
doc
4.do
c
lleeddata\QA
QC
\Nta
\QA
QC
-08
Re
-08
R
e
connt
rolle
d Co
C\N
EL
AC
SO
P\N
EL
AC
Sy\
SO
P f
or H
ydro
gen
OP
for
Hyd
r
Cop
QC
\NE
LA
C S
OP
s\N
EL
NE
LA
C S
OP
sP
for
Ino
rgan
ic D
epar
tmno
rgan
ic D
e
CAdo
cdo
c
opy
SO
Ps
in P
DF
- U
nco
SO
Ps
in P
DF
- U
nep
artm
ent O
xid
artm
ent O
xid
CCoopy E
LAy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
R&
D /
Tre
atab
ilit
yS
OP
for
Ozo
ne in
Wat
er b
y In
digo
Col
orm
etri
c M
etho
d S
M45
00-O
3B R
ev. 0
12-
3-09
SM
4500
-O3B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2009
\R&
D -
T
reat
abil
ity\
SO
P f
or O
zone
in W
ater
by
Indi
go C
olor
met
ric
Met
hod
SM
4500
-O3B
Rev
. 0 1
2-3-
09.d
ocR
ev 0
-12
-3-0
912
-4-0
9 -
CW
Dis
cont
inue
d5/
07/1
5 pe
r C
W
R&
D /
Tre
atab
ilit
yS
OP
for
Pot
assi
um P
erm
anga
nate
in W
ater
SM
450
0-K
MnO
4F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\T
reat
abil
ity
and
For
ensi
cs\S
OP
for
Pot
assi
um P
erm
anga
nate
1-2
2-14
Rev
. 3R
ev 3
-1/
22/1
41/
27/1
4 -
CW
R&
D /
Tre
atab
ilit
yS
OP
for
Spe
cifi
c G
ravi
ty o
f S
oil/
Sol
ids
by W
ater
P
ycno
met
er b
y A
ST
M D
854-
02A
ST
M D
854-
02
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Tre
atab
ilit
y an
d F
oren
sics
\SO
P f
or S
peci
fic
Gra
vity
Soi
l by
AS
TM
D 8
54-0
2, 1
-23-
14 R
ev. 1
.doc
Rev
1 -
1/23
/14
1/27
/14
- C
W D
isco
ntin
ued
4/26
/17
R&
D /
Tre
atab
ilit
yS
OP
for
Spe
cifi
c G
ravi
ty o
f W
ater
Pyc
nom
eter
by
AS
TM
D14
29-9
5 (1
999)
AS
TM
D14
29-9
5 (1
999)
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Tre
atab
ilit
y an
d F
oren
sics
\SO
P f
or S
peci
fic
Gra
vity
Wat
er b
y A
ST
M D
142
9-95
, 1-
23-1
4 R
ev. 1
.doc
Rev
1 -
1/23
/14
1/27
/14
- C
W D
isco
ntin
ued
4/26
/17
R&
D /
Tre
atab
ilit
yS
OP
for
Vis
cosi
ty b
y A
ST
M D
2196
-99
AS
TM
D21
96-9
9F
:\da
ta\Q
AQ
C\N
EL
AC
SO
PS
200
9\T
reat
abil
ity
and
For
ensi
cs\V
isco
sity
12-
3-09
Rev
. 0R
ev. 0
-
12/3
/09
1/5/
10 -
CW
Dis
cont
inue
d5/
07/1
5 pe
r C
W
R&
D /
Tre
atab
ilit
yD
aily
Con
duct
ivit
y C
heck
s on
Lab
orat
ory
Rea
gent
G
rade
Wat
erS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\T
reat
abil
ity
and
For
ensi
cs\S
OP
for
Dai
ly C
ondu
ctiv
ity
Che
cks,
1-2
0-14
Rev
. 3.d
ocR
ev 3
-1/
20/1
41/
24/1
4 -
ML
Sam
ple
Dep
t.D
aily
Con
duct
ivit
y C
heck
s on
Lab
orat
ory
Rea
gent
G
rade
Wat
erS
A P
olic
y
SO
P r
e-is
sued
und
er
Tre
atab
ilit
y D
ept e
ffec
tive
4/
04/1
3
Sam
ple
Dep
t.S
ampl
e S
elec
tion
, Pre
para
tion
and
Com
posi
ting
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Sam
ple
Dep
artm
ent\
SO
P f
or S
ampl
e S
elec
tion
, Pre
para
tion
and
Com
posi
tin g
3-12
-14
Rev
. 6R
ev 6
-
3/12
/14
3/12
/14
- C
W
Sam
ple
Dep
t.S
ampl
e D
ocum
enta
tion
Pro
cedu
res
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
S 2
010\
Sam
ple
Dep
artm
ent\
SO
P
Sam
ple
Doc
umen
tati
on R
ev. 3
3-1
-10
Rev
3 -
3/1/
10
3/31
/10
KE
WD
isco
ntin
ued,
con
soli
date
d w
ith
Sam
ple
Log
in S
OP
10
/25/
13
Sam
ple
Dep
t.S
ampl
e H
andl
ing
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Sam
ple
Dep
artm
ent\
SO
P f
or S
ampl
e H
andl
ing,
2-1
3-14
Rev
. 7.d
ocR
ev 7
-
2/13
/14
2/25
/14
- K
EW
Dis
cont
inue
d, c
onso
lida
ted
wit
h S
ampl
e D
ocum
enta
tion
an
d L
ogin
Pro
cedu
re
4/03
/15
Sam
ple
Dep
t.S
ampl
e D
ocum
enta
tion
and
Log
in P
roce
dure
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Sam
ple
Dep
t\S
OP
for
Sam
ple
Doc
umen
tati
on a
nd L
ogin
, 8-0
5-16
Rev
. 24
.doc
Rev
24
- 8/
05/1
68/
05/2
016
- K
W
Sem
i-V
olat
ile
Org
anic
Dep
tS
OP
for
SV
OC
Sam
ple
Pre
para
tion
s35
10C
, 358
0A, 3
550C
, 354
0C,
3545
A, 3
546
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\SV
OC
\SO
P f
or
SV
OC
Sam
ple
Pre
para
tion
s, 2
-03-
17 R
ev. 1
9.do
cR
ev 1
92/
03/1
72/
03/1
7 -
SM
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 6
R
evis
ion
4/27
/201
7
Unc
y W
ater
y
Wa
eter
by
ter
by
AS
TM
DA
ST
M
ncUncon
AS
TM
D21
96-9
9T
M D
2196
ncon
trollellelle
dF
:\da
ta\Q
AQ
F:\
data
\D
epar
tmen
t\S
OD
epar
tm3-
12-1
4 R
ev. 6
3-12
-14
Rev
. 6
lle
ncon
rolle
d dCo
C\N
EL
AC
SO
P\N
EL
AC
Soc
umen
tati
on R
ev. 3
m
enta
tion
R
Copy
C S
OP
s\N
EL
AC
SO
Ps
SO
Ps\
NE
LA
Cpl
e H
andl
ing,
2-1
3li
ng, 2
-1
Coy
NE
LA
CN
Ei
py
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Sem
i-V
olat
ile
Org
anic
Dep
tD
eter
min
atio
m o
f P
olyc
ycli
c H
ydro
carb
ons
in A
mbi
ent
Air
TO
-13A
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2008
\SV
OC
\SO
P T
O-
13A
03-
20-0
8 R
ev.0
Rev
0-
04/2
2/08
Dis
cont
inue
d08
/29/
08 -
JG
Sem
i-V
olat
ile
Org
anic
D
ept.
Org
anic
Lea
d by
GA
S C
hrom
atog
raph
y M
ass
Spe
ctro
met
ry: C
apil
lary
Col
umn
Tec
hniq
ueS
W84
6 82
70C
Mod
.F
:\D
ata\
QA
QC
\NE
LA
C S
OP
S 2
005\
SO
P f
or O
rgan
ic L
ead
By
Mod
ifie
d 82
70C
3-1
-05.
doc
Rev
0-
3/14
/05
Dis
cont
inue
d3/
14/0
5 -
CW
Sem
i-V
olat
ile
Org
anic
D
ept.
Pol
ychl
orin
ated
Bip
heny
ls (
PC
Bs)
by
Gas
C
hrom
atog
raph
y (G
C/E
CD
)E
PA
Met
hods
608
, SW
846
8082
A..\
QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\SV
OC
\SO
P f
or P
CB
s by
808
2A-6
08, 2
-03-
17 R
ev. 2
7.do
cR
ev 2
7 -
2/03
/17
02/0
3/17
- S
M
Sem
i-V
olat
ile
Org
anic
D
ept.
1,2-
Dib
rom
etha
ne (
ED
B),
1,2
-Dib
ro-3
-Chl
orop
ropa
ne
(DB
CP
) in
Wat
er b
y M
icro
extr
acti
on a
nd G
as
Chr
omat
ogra
phy
(GC
/EC
D)
EP
A M
etho
d 50
4.1
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\SV
OC
\SO
P f
or
504.
1, 1
1-22
-16
Rev
. 12.
doc
Rev
12
- 11
/22/
1611
/22/
16 -
SM
Sem
i-V
olat
ile
Org
anic
D
ept.
Chl
orin
ated
Her
bici
des
Aci
ds a
nd E
ster
s by
Gas
C
hrom
atog
raph
y/E
CD
SW
846
8151
AS
W84
6 81
51A
..\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
17\S
VO
C\S
OP
for
H
erbi
cide
s by
815
1A, 2
-03-
17 R
ev. 1
7.do
cR
ev 1
7 -
2/03
/17
2/03
/17
- S
M
Sem
i-V
olat
ile
Org
anic
D
ept.
Det
erm
inat
ion
of G
lyco
l/A
lcoh
ol in
Soi
l and
Wat
erS
W84
6 80
15D
Mod
.F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\S
VO
C\S
OP
for
G
lyco
ls-A
lcoh
ols
by 8
015D
, 8-0
4-16
Rev
. 10.
doc
Rev
10
- 8/
04/1
68/
04/1
6 -
SM
Sem
i-V
olat
ile
Org
anic
D
ept.
Det
erm
inat
ion
of P
etro
leum
Ran
ge H
ydro
carb
ons
(FL
-P
RO
)F
L-P
RO
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\SV
OC
\SO
P f
or
FL
PR
O, 1
-23-
14 R
ev. 5
.doc
Rev
5 -
1/23
/14
1/27
/14
- S
MD
isco
ntin
ued
Sem
i-V
olat
ile
Org
anic
D
ept.
DR
O M
odif
ied
8015
D80
15D
Mod
ifie
dF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
17\S
VO
C\S
OP
for
D
RO
by
8015
D, 2
-03-
17 R
ev. 7
.doc
Rev
7 -
2/
03/1
72/
03/1
7 -
SM
Sem
i-V
olat
ile
Org
anic
D
ept.
Ext
ract
able
Pet
role
um H
ydro
carb
ons
(EP
H)
Mas
sach
uset
ts D
EP
Met
hod
for
EP
H..\
QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\SV
OC
\SO
P f
or M
A
CA
M E
PH
, 2-2
2-17
Rev
. 22.
doc
Rev
22
- 2/
22/1
72/
27/1
7 -
SM
Sem
i-V
olat
ile
Org
anic
D
ept.
Ext
ract
able
Tot
al P
etro
leum
Hyd
roca
rbon
s (C
T-E
TP
H)C
T-E
TP
HF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\S
VO
C\S
OP
for
C
T E
TP
H, 1
-23-
14 R
ev. 7
.doc
Rev
7 -
1/
23/1
41/
24/1
4 -
SM
Sem
i-V
olat
ile
Org
anic
D
ept.
Gel
Per
mea
tion
Chr
omat
ogra
phy
(GP
C)
Met
hod
3640
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
06\S
VO
C\S
OP
GP
C C
lean
up 8
-25-
06 R
ev N
o. 0
.doc
Rev
. 0 -
8/
25/0
6D
isco
ntin
ued
9/22
/06
- JD
Sem
i-V
olat
ile
Org
anic
D
ept.
Hal
oace
tic
Aci
ds in
Dri
nkin
g W
ater
by
Liq
uid-
Liq
uid
Ext
ract
ion
and
Der
ivat
izat
ion
by G
C/E
CD
- E
PA
552
.2E
PA
Met
hod
552.
2..\
QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\SV
OC
\SO
P f
or H
AA
by
552
.2, 6
-02-
15 R
ev. 6
.doc
Rev
. 6 -
6/02
/15
6/02
/15
- S
M
Sem
i-V
olat
ile
Org
anic
D
ept.
Lab
war
e C
lean
upS
A P
olic
yF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
15\S
VO
C\S
OP
for
L
ab W
are
Cle
anup
, 08-
12-1
5 R
ev. 3
.doc
Rev
. 3 -
8/
12/1
58/
12/1
5 -
SM
Sem
i-V
olat
ile
Org
anic
D
ept.
Mai
ne D
RO
ME
DR
OF
:\D
ata\
QA
QC
\NE
LA
C\S
OP
for
ME
DR
OR
ev 1
-
3/31
/03
4/04
/03
- N
BD
isco
ntin
ued
Sem
i-V
olat
ile
Org
anic
D
ept.
Oil
& G
reas
e/T
otal
Pet
role
um H
ydro
carb
ons
(TP
H)
EP
A M
etho
d 16
64B
G
ravi
met
ric
Pro
cedu
reF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\S
VO
C\S
OP
for
E
PA
166
4B, 1
0-20
-16
Rev
. 12.
doc
Rev
12
- 10
/20/
1610
/20/
16 -
KL
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 7
R
evis
ion
4/27
/201
7
Uncon
t
as
as
opro
pane
pr
opan
e
EP
A M
etho
d A
Met
46 8
151A
815
ncUncon
troMod
.M
odrolleF
:\da
F:\
daF
L P
RO
FL
llelled
F:\
data
\QA
QC
\NF
:\da
ta\Q
AQ
C\N
DR
O b
y 80
15D
, 2D
RO
by
8015
D,
lled C
\NC
\
ntro
llled
Cop
C\N
EL
AC
SO
Ps\
NE
LA
AC
SO
Ps\
14 R
ev. 7
.doc
ev. 7
.doc
CAC
SO
Ps\
NA
C S
OP
s\N
2-22
-17
Rev
. 22.
d22
-17
Rev
. opy
AC
SO
Ps
2006
\SV
OC
\S
OP
s 20
06\S
V
Coppy
AC
SO
Ps
AC
Spy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Sem
i-V
olat
ile
Org
anic
D
ept.
Org
anic
Com
poun
ds in
Dri
nkin
g W
ater
by
Liq
uid-
Sol
id E
xtra
ctio
n an
d C
apil
lary
Col
umn
GC
/MS
EP
A M
etho
d 52
5.2
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\SV
OC
\SO
P f
or
525.
2, 1
2-02
-13
Rev
. 10.
doc
Rev
10
-12
/02/
1312
/03/
13 -
SM
Dis
cont
inue
d5/
09/1
6
Sem
i-V
olat
ile
Org
anic
D
ept.
Org
anoc
hlor
ine
Pes
tici
des
by G
as C
hrom
atog
raph
y (G
C/E
CD
) E
PA
Met
hod
608
& S
W-8
46 M
etho
d 80
81B
EP
A M
etho
ds 6
08S
W84
6 80
81B
..\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
17\S
VO
C\S
OP
for
P
esti
cide
s by
808
1B-6
08, 2
-03-
17 R
ev. 2
3.do
cR
ev 2
3 -
2/03
/17
2/03
/17
- S
M
Sem
i-V
olat
ile
Org
anic
D
ept.
Org
anoc
hlor
ine
Pes
tici
des
by G
as C
hrom
atog
raph
y (G
C/E
CD
) in
Am
bien
t Air
EP
A M
etho
d T
O-4
AF
:\da
ta\Q
AQ
C\ N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
10\S
VO
C\S
OP
TO
-4A
Org
anoc
hlor
ine
Pes
tici
des
in A
ir 3
-16-
10 R
ev. 0
Rev
0 -
3/
16/1
03/
16/1
0 -
DS
D
isco
ntin
ued
Sem
i-V
olat
ile
Org
anic
D
ept.
Pol
ychl
orin
ated
Bip
heny
ls (
PC
Bs)
by
Gas
C
hrom
atog
raph
y (G
C/E
CD
) in
Am
bien
t Air
EP
A T
O-4
AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
08\S
VO
C\S
OP
for
T
O-4
A P
olyc
hlor
inat
ed B
iphe
nyls
in A
mbi
ent A
irR
ev 1
-
3/20
/08
3/20
/08
- T
GD
isco
ntin
ued
Sem
i-V
olat
ile
Org
anic
D
ept.
Sem
ivol
atil
e O
rgan
ic C
ompo
unds
by
GA
S
Chr
omat
ogra
phy
Mas
s S
pect
rom
etry
: Cap
illa
ry
Col
umn
Tec
hniq
ue E
PA
625
EP
A M
etho
d 62
5F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\S
VO
C\S
OP
for
EP
A 6
25M
etho
d, 1
0-21
-16
Rev
. 8.d
oc
Rev
8 -
10
/21/
1610
/21/
16 -
KL
Sem
i-V
olat
ile
Org
anic
D
ept.
Sem
ivol
atil
e O
rgan
ic C
ompo
unds
by
GA
S
Chr
omat
ogra
phy
Mas
s S
pect
rom
etry
: Cap
illa
ry
Col
umn
Tec
hniq
ue S
W84
6 82
70D
EP
A M
etho
d S
W84
6 82
70D
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\SV
OC
\SO
P f
or
SW
846
8270
D, 2
-03-
17 R
ev. 2
7.do
cR
ev 2
7 -
2/03
/17
2/03
/17
- S
MS
emi-
Vol
atil
e O
rgan
ic
Dep
t.S
OP
for
801
1M
etho
d 80
11F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\S
VO
C\S
OP
for
E
DB
and
DB
CP
by
8011
, 11-
18-1
3 R
ev. 2
.doc
Rev
. 2 -
11/1
5/13
11/1
8/13
- D
S
Sem
i-V
olat
ile
Org
anic
D
ept.
SO
P f
or D
eter
min
atio
n of
Pet
role
um R
ange
H
ydro
carb
ons
(OQ
A-Q
AM
-025
-Rev
isio
n: 7
, 2-2
5-08
) N
J T
PH
OQ
A-Q
AM
-025
-Rev
isio
n: 7
, 2-
25-0
8F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\S
VO
C\S
OP
for
N
J-T
PH
Met
hod,
1-2
3-14
Rev
. 4.d
ocR
ev. 4
-
1/23
/14
1/24
/14
- S
M D
isco
ntin
ued
Sem
i-V
olat
ile
Org
anic
D
ept.
SO
P f
or F
lori
sil C
lean
upM
etho
d 36
20C
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\SV
OC
\SO
P f
or
Flo
risi
l Cle
anup
, 3-2
0-14
Rev
. 2.d
ocR
ev. 2
-
3/20
/14
3/27
/14
- S
M
Sem
i-V
olat
ile
Org
anic
D
ept.
SO
P f
or N
J D
EP
Ext
ract
able
Pet
role
um H
ydro
carb
ons
(EP
H)
NJ
DE
P M
etho
d fo
r th
e D
eter
min
atio
n of
Ext
ract
able
P
etro
leum
Hyd
roca
rbon
s (E
PH
), O
ctob
er, 2
009
Rev
isio
n:2
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\SV
OC
\SO
P f
or
NJ
EP
H, 1
-23-
14 R
ev. 6
.doc
Rev
. 6 -
1/
23/1
41/
24/1
4 -
SM
Sem
i-V
olat
ile
Org
anic
D
ept.
SO
P f
or S
emi-
Vol
atil
e O
rgan
ic C
ompo
unds
in
Bio
logi
cal T
issu
e by
Gas
Chr
omat
ogra
phy
SW
846
8270
C 8
081A
and
808
2F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps
2006
\SV
OC
\SO
P B
iolo
gica
l Tis
sue
for
Sem
i-V
olat
ile
Ana
lysi
s R
ev.0
10-
04-0
6R
ev.0
-10
/04/
06D
isco
ntin
ued
11/0
3/06
CW
Sem
i-V
olat
ile
Org
anic
D
ept.
SO
P f
or T
exas
TP
H 1
005
1005
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
08\S
VO
C\S
OP
for
Tex
as T
PH
100
52-
11-0
8 R
ev. 0
Rev
. 0-
2 -11
-08
2-11
-08
JGD
isco
ntin
ued
Sem
i-V
olat
ile
Org
anic
D
ept.
SO
P f
or T
exas
TP
H 1
006
1006
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
08\S
VO
C\S
OP
for
Tex
as T
PH
100
62-
11-0
8 R
ev. 0
Rev
. 0-
2-11
-08
2-11
-08
JGD
isco
ntin
ued
Sem
i-V
olat
ile
Org
anic
D
ept.
Sul
fur
Cle
anup
usi
ng C
oppe
rM
etho
d 36
60B
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
06\S
VO
C\S
OP
Cop
per
Cle
anup
9-
11-0
6 R
ev N
o.0.
doc
Rev
. 0 -
9/
11/0
69/
22/0
6 -
JD
Sem
i-V
olat
ile
Org
anic
D
ept.
Sul
furi
c A
cid
Cle
anup
Met
hod
3665
AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps
2006
\SV
OC
\SO
P f
or M
etho
d 36
65A
S
ulfu
ric
Aci
d C
lean
up
Rev
. 0 -
9/
13/0
69/
13/0
6 -
JD
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 8
R
evis
ion
4/27
/201
7
Uncon
trolle
d
mat
ogra
phy
mat
ogra
phy
E EP
A T
O-4
AE
PA
T Met
hod
625
Met
hod
625
SW
846
8270
DW
846
8270
DF
:\d
F:\
ED
B a
ED
B
, 2-2
F:\
data
\QA
QC
F:\
data
\N
J-T
PH
Met
hod,
NJ-
TP
H M
etho
d\d
ata\
QA
QC
\Nta
\QA
QC
il C
lean
il C
lea
nc
lle
Uncon
troolle
ddCop
y
3-20
-13-
20-1
C\N
EL
AC
SO
Ps\
NE
LA
LA
C S
OP
s\R
ev. 6
.doc
. 6.d
ocA
C S
OP
s 20
06\S
VO
C\
OP
s 20
06\S
Vys
is R
ev.0
10-
04-0
6si
s R
ev.0
10-
0O
Ps
2008
\SV
OC
\8\
SV
OC
Coppyy 08
\Sy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Sem
i-V
olat
ile
Org
anic
D
ept.
Tot
al E
xtra
ctab
leP
etro
leum
Hyd
roca
rbon
s (S
W84
6 81
00M
)S
W84
6 81
00M
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\SV
OC
\SO
P f
or
TP
H b
y 81
00, 1
-27-
14 R
ev. 5
.doc
Rev
. 5 -
1/27
/14
1/27
/14
- S
M
Sem
i-V
olat
ile
Org
anic
D
ept.
Tot
al P
etro
leum
Hyd
roca
rbon
s an
d 82
70 S
tand
ard
Pre
para
tion
SA
Pro
cedu
reF
:\da
ta\Q
AQ
C\N
EL
AC
SO
PS
200
5\S
VO
C\S
OP
EP
H-T
PH
Sta
ndar
d P
repa
rati
on P
roce
dure
.doc
Rev
3 -
09/2
3/05
Dis
cont
inue
d3/
30/0
6-S
MS
emi-
Vol
atil
e O
rgan
ic
Dep
t.S
VO
C L
ogbo
ok P
repa
rati
onS
A P
roce
dure
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2012
\SV
OC
\SO
P f
or
SV
OC
Log
book
s P
repa
rati
on, 1
2-17
-12
Rev
. 0.d
ocR
ev 0
-
12/1
7/12
12/1
8/12
- S
MV
olat
ile
Org
anic
D
epar
tmen
t S
OP
for
VP
H a
nd G
RO
MA
DE
P W
SC
-CA
M-I
V A
and
G
RO
by
8015
DF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
15\V
OC
\SO
P f
or
MA
DE
P V
PH
, 4-0
7-15
Rev
. 11.
doc
Rev
11
-4-
07-1
54/
07/1
5 -
EK
Vol
atil
e O
rgan
ic
Dep
artm
ent
Ana
lysi
s of
1,4
-Dio
xane
E
PA
826
0C M
od.
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\VO
C\S
OP
for
V
OC
Ana
lysi
s of
1,4
-Dio
xane
by
Mod
ifie
d 82
60C
, 3-0
6-13
R
ev.7
.doc
Rev
7 -
3/
06/1
33/
07/1
3 -
GA
Vol
atil
e O
rgan
ic
Dep
artm
ent
Ana
lysi
s of
Mai
ne G
asol
ine
Ran
ge O
rgan
ics
(ME
G
RO
) by
Mai
ne H
ealt
h na
d E
nvir
onm
enta
l Tes
ting
L
abor
ator
yM
E G
RO
F:\
QA
QC
\NE
LA
C S
OP
s 20
04\M
E G
RO
SO
P 2
004
8-02
-04.
doc
Rev
0 -
8/
02/0
4D
isco
ntin
ued
02/0
8/05
- K
W
Vol
atil
e O
rgan
ic
Dep
artm
ent
Ana
lysi
s of
Gas
olin
e R
ange
Org
anic
s (G
RO
) C
6-C
10G
RO
by
8015
DF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\V
OC
\SO
P f
or
Gas
olin
e R
ange
Org
anic
s (G
RO
), 1
1-30
-16
Rev
.0.d
ocR
ev 0
-
11/3
0/16
11/3
0/16
- E
K
Vol
atil
e O
rgan
ic
Dep
artm
ent
Ana
lysi
s of
Vol
atil
e O
rgan
ic C
ompo
unds
by
EP
A 6
24
and
the
Mas
sach
uset
ts W
ater
Res
ourc
e A
ct
EP
A 6
24F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\V
OC
\SO
P f
or
624,
10-
24-1
6 R
ev. 1
1.do
cR
ev 1
1 -
10/2
4/16
10/2
4/16
- K
L
Vol
atil
e O
rgan
ic
Dep
artm
ent
Ana
lysi
sof
Vol
atil
e O
rgan
ic C
ompo
unds
by
EP
A 5
24. 2
& M
AD
EP
WS
C-C
AM
-II
AE
PA
Met
hods
524
.2
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\VO
C\S
OP
for
52
4.2,
10-
24-1
6 R
ev. 1
3.do
cR
ev 1
3 -
10/2
4/16
10/2
4/16
- E
K
Vol
atil
e O
rgan
ic
Dep
artm
ent
VO
C b
y E
PA
826
0C &
MA
DE
P S
C-C
AM
-II-
AS
W 8
46 8
260C
MA
DE
P W
SC
-C
AM
-II
AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\V
OC
\SO
P f
or
SW
846
8260
C 6
-06-
16 R
ev. 1
8.do
cR
ev 1
8 -
6/06
/16
6/06
/16
- K
L
Vol
atil
e O
rgan
ic
Dep
artm
ent
Z-N
ose
Scr
eeni
ng o
f A
queo
us S
ampl
esS
A P
roce
dure
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2008
\VO
C\S
OP
for
Z-
Nos
e S
cree
ning
Rev
0 -
3/
26/0
8D
isco
ntin
ued
3/26
/08
- W
B
Vol
atil
e O
rgan
ic
Dep
artm
ent
Ele
ctro
nic
Log
book
s in
VO
C D
epar
tmen
tS
A P
roce
dure
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\VO
C\S
OP
for
E
lect
roni
c L
ogbo
oks
in th
e A
ir a
nd V
OC
Dep
artm
ent,
1-27
-16
Rev
. 1.
doc
Rev
1 -
1/
27/1
62/
02/1
6 -
SB
Wet
Che
mis
try
% N
itri
c A
cid
% H
ydro
fluo
ric
Aci
dM
CA
- 2
23 S
A S
OP
Met
hod
disc
onti
nued
as
of 0
5/15
/08
per
JOC
- S
OP
Rem
oved
fro
m
Dep
t.R
ev 3
-
7/21
/06
7/21
/06
- JO
Dis
cont
inue
d
Wet
Che
mis
try
Aci
dity
SM
2310
BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\W
et C
hem
\SO
P
for
Aci
dity
SM
2310
B, 9
-16-
13 R
ev.7
.doc
Rev
7 -
9/16
/13
9/20
/13
- N
L
Wet
Che
mis
try
Alk
alin
ity
SM
2320
BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\W
et
Che
mis
try\
SO
P f
or A
lkal
init
y by
SM
2320
B, 8
-04-
16 R
ev. 1
1.do
cxR
ev 1
1 -
8/04
/16
8/04
/16
- C
W
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 9
R
evis
ion
4/27
/201
7
Unc
EP
A 8
26E
PA
ncUUncon
ME
GR
OE
GR
O
ncon
tro5DDtrolleF
:\da
taF
:\da
624,
10-
262
4,
lleled
F:\
data
\QA
QC
\NF
:\da
ta\Q
AQ
C\N
.2, 1
0-24
-12,
10-
24-
led
ncon
troled
CoQ
C\N
EL
AC
SO
Ps
\NE
LA
C S
60C
6-0
6-16
Rev
. 18.
d6-
06-1
6 R
ev
Copy
EL
AC
SO
Ps\
NE
LA
C
C S
OP
s\N
EL
Cv.
py
SO
Ps\
NE
LA
C S
OP
sS
OP
s\N
EL
AC
SO
Air
and
VO
C D
r an
d V
OC
yCCop
yy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Wet
Che
mis
try
Am
mon
ia b
y F
low
inje
ctio
nE
PA
350
.1F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\W
et C
hem
\SO
P
for
Am
mon
ia b
y E
PA
350
.1 &
LA
CH
AT
, 10-
14-1
6 R
ev. 7
.doc
Rev
7 -
10/1
4/16
10/1
4/16
- C
W
Wet
Che
mis
try
Am
mon
ia N
itro
gen
as N
SM
4500
-NH
3-B
,C, 2
0th
Edi
tion
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Wet
Che
m\S
OP
fo
r A
mm
onia
Nit
roge
n by
SM
4500
-NH
3-B
,C, 1
-22-
14 R
ev. 1
0R
ev 1
0 -
1/22
/14
1/27
/14
- C
W
Wet
Che
mis
try
AS
TM
Lea
chin
g by
Mod
ifie
d A
ST
M D
398
7-06
A
ST
M D
398
7-06
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Wet
Che
m\S
OP
fo
r A
ST
M L
each
ing,
5-3
0-14
Rev
. 0.d
ocR
ev 0
-
5/30
/14
6/03
/14
- C
W
Wet
Che
mis
try
Bio
chem
ical
Oxy
gen
Dem
and
SM
5210
BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\W
et
Che
mis
try\
SO
P f
or B
OD
by
SM
5210
B, 1
0-12
-16
Rev
. 12.
doc
Rev
12
- 10
/12/
1610
/12/
16 -
RT
Wet
Che
mis
try
Cal
cium
Har
dnes
sS
M35
00-C
a-B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2010
\Wet
Che
m\S
OP
fo
r C
a H
ardn
ess
SM
3500
-Ca-
B R
ev.1
11-
22-1
0.do
cR
ev 1
-
11/2
2/10
11/2
9/20
10D
isco
ntin
ued
Wet
Che
mis
try
Car
bon
Dio
xide
& F
orm
s of
Alk
alin
ity
(cal
c)S
M45
00-C
O2D
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2009
\Wet
C
hem
istr
y\S
OP
Car
bon
Dio
xide
and
For
ms
of A
lkal
init
y by
C
aluc
lati
on S
M45
00-C
O2D
R
ev 0
-6/
8/09
6/08
/09
- C
W
Wet
Che
mis
try
Che
mic
al O
xyge
n D
eman
dH
AC
H 8
000
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
Che
m\S
OP
fo
r C
OD
by
HA
CH
800
0, 1
0-17
-16
Rev
. 8.d
ocR
ev 8
-
10/1
7/16
10/1
8/16
- C
W
Wet
Che
mis
try
Chl
orid
eS
M45
00-C
l BF
:\D
ata\
QA
QC
\NE
LA
C S
OP
s 20
06\W
et C
hem
istr
y\S
OP
C
HL
OR
IDE
.doc
Rev
3 -
7/
11/0
67/
18/0
6 -
YV
Dis
cont
inue
d
Wet
Che
mis
try
Col
or b
y C
olor
imet
ric-
Pla
tinu
m-C
obal
tS
M 2
120B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Wet
Che
m\S
OP
fo
r C
olor
by
SM
2120
B, 9
-26-
14 R
ev.3
.doc
Rev
3 -
9/
26/1
49/
30/1
4 -
TD
Wet
Che
mis
try
Cor
rosi
vity
as
Lan
gali
er S
atur
atio
n In
dex,
Agg
ress
ive
Inde
x, R
yzna
r In
dex
SM
18-
19 2
330B
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
13\W
et C
hem
istr
y\S
OP
for
C
orro
sivi
ty a
s L
ange
lier
Sat
urat
ion
Inde
x, A
ggre
ssiv
e In
dex,
Ryz
nar
Sta
bili
ty I
ndex
11-
12-1
3 R
ev. 1
Rev
1 -
11
/12/
1311
/14/
13 -
CW
Wet
Che
mis
try
Cya
nide
(aqu
eous
&dr
inki
ng w
ater
)by
EP
A33
5.4/
9012
B (
Tot
al C
yani
de, E
xtra
ctab
le C
yani
de a
s T
CL
P/S
PL
P, W
AD
, Am
enab
le, P
AC
, and
Sol
uble
C
yani
deE
PA
335
.4/9
012B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Wet
Che
m\S
OP
fo
r C
yani
de b
y 33
5.4-
9012
B, 8
-06-
15 R
ev. 1
4.do
cR
ev 1
4 -
8/06
/15
8/10
/15
- R
T
Wet
Che
mis
try
Cya
nide
Tie
r P
acka
ge D
ata
Upl
oad
and
Pre
para
tion
for
A
SP
-B a
nd C
LP
-Lik
e D
eliv
erab
les
SA
Pol
icy
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2011
\Wet
C
hem
istr
y\S
OP
for
Cya
nide
Tie
r P
acka
ge D
ata
Upl
oad
and
Pac
kage
P
repa
rati
on 2
-24-
11 R
ev. 2
.doc
Rev
2 -
2/24
/11
3/01
/11
- E
E
Dis
cont
inue
d
Wet
Che
mis
try
Cya
nide
s A
men
able
to C
hlor
inat
ion
SM
4500
CN
G/ E
PA
335
.1O
bsol
ete,
com
bine
d in
to 3
35.4
and
901
2AD
isco
ntin
ued
Wet
Che
mis
try
Det
erm
inat
ion
of %
Sol
ids
SM
2540
G M
odif
ied
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Wet
Che
m\S
OP
D
eter
min
atio
n of
% S
olid
s R
ev. 3
07-
09-1
5.do
cR
ev 3
-
07/0
9/15
07/1
0/15
- T
D
Wet
Che
mis
try
Dis
solv
ed O
xyge
nS
M 4
500-
O G
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Wet
Che
m\S
OP
D
isso
lved
Oxy
gen
by S
M45
00-O
G, 2
-11-
14 R
ev. 2
.doc
R
ev 2
-
2/11
/14
2/11
/14
- D
B
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 10
R
evis
ion
4/27
/201
7
Uncon
trolle
d
3987
-06
AS
3987
-06
SM
5210
SM
5
SM
3500
-Ca-
BS
M35
00-C
00-C
O2D
0-C
O2D
F CH
LC
HL
F:\
data
\QA
F:\
data
for
Col
or b
y S
for
Col
o
\dat
a\Q
AQ
C\N
ta\Q
AQ
Csi
vity
asi
vity I
nc
lle
Unnccon
ttroolle
dCop
y
ngel
ier
ngel
ier
x 11
-12-
13 R
e11
-12-
13 R
C\N
EL
AC
SO
Ps\
NE
LA
LA
C S
OP
s\35
.4-9
012B
, 8-0
6-15
R90
12B
, 8-0
6-
SO
Ps\
NE
LA
C S
OP
sS
OP
s\N
EL
AC
SO
e T
ier
Pac
kage
er
Pac
kage
Copyy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Wet
Che
mis
try
Dry
Pre
para
tion
Of
Soi
l Sam
ples
for
Par
ticl
e S
ize
Ana
lysi
s (G
rain
Siz
e A
naly
sis)
AS
TM
D 4
21/4
22F
:\Q
AQ
C\N
EL
AC
SO
PS
201
0\W
et C
hem
\Gra
in S
ize
AS
TM
D42
1-42
2.do
cR
ev 2
-
7/12
/10
7/15
/10
- JC
Wet
Che
mis
try
Fer
rous
Iro
n (P
hena
nthr
oile
Met
hod)
SM
3500
-Fe
BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\W
et C
hem
\SO
P
for
Fer
rous
Iro
n by
SM
3500
-Fe-
B, 1
1-13
-14
Rev
. 4.d
ocR
ev. 4
-
11/1
3/14
CW
- 1
2/02
/14
Wet
Che
mis
try
Fla
sh P
oint
by
Pen
sky-
Mar
tens
Clo
sed
Cup
SW
846
1010
AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\W
et C
hem
\SO
P
for
Fla
shpo
int b
y S
W84
6-10
10A
, 9-2
6-13
Rev
. 9.d
ocR
ev 9
-
9/26
/13
9/27
/13
- T
D
Wet
Che
mis
try
Flu
orid
eS
M45
00-F
CF
:\D
ata\
QA
QC
\NE
LA
C\S
OP
for
Flu
orid
eR
ev 2
-
4/15
/02
Dis
cont
inue
d01
/25/
05 -
YV
Wet
Che
mis
try
For
mal
dehy
de b
y N
IOS
H 3
500
NIO
SH
350
0F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\W
et C
hem
\SO
P f
or
For
mal
dehy
de b
y N
IOS
H 3
500,
6-2
0-14
Rev
. 0.d
oc
Rev
. 0 -
6/
20/1
49/
20/1
4 -
CA
W
Wet
Che
mis
try
Hex
aval
ent C
hrom
ium
for
Soi
lsA
lkal
ine
Dig
esti
on M
etho
d S
W84
6 71
96A
/306
0AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
12\W
et C
hem
\SO
P
for
Hex
aval
ent C
hrom
ium
in S
oils
1-2
7-12
Rev
.9.d
ocR
ev 9
-
1/27
/12
2/1
/12
- C
W
Wet
Che
mis
try
Hex
aval
ent C
hrom
ium
for
Wat
er -
Col
orim
etri
c M
etho
dS
M35
00-C
r B
/SW
846
7196
AF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\W
et C
hem
\SO
P
for
Hex
aval
ent C
hrom
ium
in W
ater
, 3-1
3-14
Rev
. 8.d
ocR
ev 8
-
3/13
/14
3/14
/14
- C
W
Wet
Che
mis
try
Hyd
roge
n S
ulfi
de U
n-io
nize
d F
ract
ion
by C
alcu
lati
on
Usi
ng S
M45
00-S
2- H
. S
M45
00-S
2- H
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2010
\Wet
Che
m\S
OP
fo
r H
ydro
gen
Sul
fide
Fra
ctio
n B
y C
alcu
lati
on b
y S
M45
00-S
2-3
-10
Rev
.0.d
ocR
ev. 0
-
2/3/
10 2
/8/1
0 -
CW
Wet
Che
mis
try
Igni
tabi
lity
40 C
FR
261
.21
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2011
\Wet
C
hem
istr
y\S
OP
for
Ign
itab
ilit
y by
40
CF
R 2
61.2
1 R
ev 0
, 3-0
7-11
.doc
Rev
0 -
3/
07/1
1D
isco
ntin
ued
03/1
0/11
- J
O
Wet
Che
mis
try
Igni
tabi
lity
SW
846
1030
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
C
hem
istr
y\S
OP
for
Ign
itab
ilit
y by
SW
846
1030
, 6-0
6-16
Rev
. 4.d
ocR
ev 4
-
6/06
/16
6/06
/16
- C
W
Wet
Che
mis
try
Inor
gani
c A
nion
s by
Ion
Chr
omat
ogra
phy
EP
A M
etho
d 30
0.0
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\Wet
C
hem
istr
y\S
OP
for
Ani
ons
by I
on C
hrom
atog
hy E
PA
300
.0, 4
-21-
1 7R
ev. 1
8.do
cR
ev 1
84/
21/1
74/
21/1
7 -
CW
Wet
Che
mis
try
Iodi
neE
PA
345
.1F
:\D
AT
A\Q
AQ
C\N
EL
AC
\SO
P I
odin
eR
ev 1
6/
19/0
3D
isco
ntin
ued
02/0
1/05
- A
W
Wet
Che
mis
try
Los
s of
Ign
itio
n A
ST
MA
ST
M D
2974
/
AA
SH
TO
T
267
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2006
\Wet
C
hem
istr
y\S
OP
Los
s on
Ign
itio
n A
ST
M R
ev. 4
03-
18-0
8.do
cR
ev 4
-
3/18
/08
7/22
/08
- JO
Wet
Che
mis
try
Los
s of
Ign
itio
n S
M 2
540
GS
M 2
540G
(no
long
er in
use
, usi
ng T
otal
, Fix
ed, V
olat
ile
Sol
ids
SO
P a
s of
11
/15/
06)
Rev
1
2/19
/03
01/2
6/05
- L
N D
isco
ntin
ued
Wet
Che
mis
try
Nit
rate
Nit
roge
n M
anua
l Cad
miu
m R
educ
tion
SM
4500
-NO
3-E
Met
hod
disc
onti
nued
as
of 0
5/15
/08
per
JOC
Rev
4 -
7/
19/0
611
/15/
06 -
JO
Dis
cont
inue
d
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 11
R
evis
ion
4/27
/201
7
Uncon
trol
Cup
Cup
SM
45
NIO
SH
350
0N
IOS
H 3
50
alin
e D
iges
tion
Me
alin
e D
iges
tio
7196
A/3
060A
7196
A/3
060A
W84
6 71
96A
W84
6 71
96A
for
for
nc
l
Unccon
t olledF
:\da
tF
:\da
for
Hyd
rofo
rR
ev.0
.doc
Rev
.0.d
lleed
F:\
data
\QA
QC
\F
:\da
ta\Q
AC
hem
istr
y\S
OP
fC
hem
istr
y\S
OP
do
coced
oledd
CoA
QC
\NE
LA
C S
OP
s\N
\NE
LA
C S
SO
P f
or I
gnit
abil
ity
by
for
Igni
tabi
lit
Copy
NE
LA
C S
OP
s\N
EL
AC
AC
SO
Ps\
NE
r A
nion
s by
Ion
Chr
omio
ns b
y Io
n C
CCCopy
OP
Iod
ine
PIo
dinypyy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Wet
Che
mis
try
Nit
rate
/Nit
rite
-N b
y F
low
Inj
ecti
on A
naly
sis
EP
A 3
53.2
10-
107-
04-1
-B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Wet
Che
m\S
OP
fo
r N
itra
te &
Nit
rite
by
EP
A 3
53.2
& 1
0-10
7-04
-1-B
, 4-2
4-14
Rev
. 6.
doc
Rev
6 -
4/24
/14
5/08
/14
- R
T
Wet
Che
mis
try
Nit
rite
Nit
roge
n C
olor
imet
ric
Met
hod
SM
4500
NO
2, B
Obs
olet
e, r
emov
ed f
rom
use
1/0
5/11
Dis
cont
inue
d
Wet
Che
mis
try
Pai
nt F
ilte
r/F
ree
Liq
uids
E
PA
909
5BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
06\W
et
Che
mis
try\
SO
P P
aint
Fil
ter
9095
B 7
-31-
06 R
ev. 1
.doc
Rev
. 1 -
7/
31/0
67/
31/0
6 -
JO
Wet
Che
mis
try
pH in
Soi
lS
W 8
46 9
045D
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
C
hem
istr
y\S
OP
for
pH
in S
oil S
W84
6 90
45D
, 10-
14-1
6 R
ev. 6
.doc
Rev
6 -
10
/14/
1610
/14/
16 -
CW
Wet
Che
mis
try
pH b
y A
ST
M 1
293-
99B
AS
TM
129
3-99
BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\W
et C
hem
\SO
P
for
pH b
y A
ST
M 1
293-
99B
, 10-
15-1
3 R
ev. 9
.doc
Rev
9 -
10
/15/
1310
/17/
13 -
TD
Wet
Che
mis
try
Pho
spho
rous
EP
A M
etho
d 36
5.2
Met
hod
disc
onti
nued
as
of 0
5/15
/08
per
JOC
Rev
3 -
7/
5/06
Dis
cont
inue
d7/
6/06
- A
W
Wet
Che
mis
try
Pho
spho
rous
by
Flo
w I
njec
tion
Ana
lysi
s10
-115
-01-
1-D
F:\
Dat
a\Q
AQ
C\N
EL
AC
\SO
P f
or P
hosp
horo
us b
y L
acha
tR
ev 1
-
6/5/
2003
Dis
cont
inue
d02
/01/
05 -
AW
Wet
Che
mis
try
Pho
spho
rous
Fra
ctio
nati
on o
f S
edim
ents
for
Loo
sely
-S
orbe
d an
d Ir
on-B
ound
Pho
spho
rous
Ext
ract
ion
Pro
cedu
re w
ith
AS
TM
D51
5-88
A C
olor
imet
ric
Ana
lysi
sF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\W
et C
hem
\SO
P
for
Pho
spho
rus
Fra
ctio
nati
on, 1
-15-
13 R
ev. 2
.doc
Rev
2 -
1/
15/1
3D
isco
ntin
ued
1/09
/14
1/17
/13
- JO
C
Wet
Che
mis
try
Pho
spho
rous
in W
ater
Col
orim
etri
c A
scor
bic
Aci
d R
educ
tion
Met
hod
AS
TM
D51
5-88
(A)
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2017
\Wet
Che
m\S
OP
fo
r P
hosp
horu
s in
Wat
er A
ST
M D
515-
88(A
) 4-
07-1
7 R
ev.7
.doc
Rev
7 -
4/
07/1
7 4
/07/
17 -
RT
Wet
Che
mis
try
Phy
siol
ogic
ally
Ava
ilab
le C
yani
de (
PA
C)
SA
SO
PO
bsol
ete,
com
bine
d in
to 3
35.4
and
901
2AD
isco
ntin
ued
Wet
Che
mis
try
Rea
ctiv
ity
(Cya
nide
and
Sul
fide
)S
W 8
46 7
.3F
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
16\W
et
Che
mis
try\
SO
P f
or R
eact
ivit
y, 8
-04-
16 R
ev. 6
.doc
Rev
6 -
8/
04/1
68/
04/1
6 -
CW
Wet
Che
mis
try
Sal
init
yS
M 2
520
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\Wet
Che
m\S
OP
fo
r S
alin
ity
by S
M25
20, 1
2-18
-13
Rev
. 1.d
oc
Rev
1 -
12
/18/
1312
/30/
13 -
CW
Wet
Che
mis
try
Set
tlea
ble
Sol
ids
SM
2540
FF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
13\W
et C
hem
\SO
P
for
Set
tlea
ble
Sol
ids
SM
2540
F, 9
-17-
13 R
ev. 1
.doc
Rev
1 -
9/
17/1
39/
20/1
3 -
TD
Wet
Che
mis
try
Soi
l Ext
ract
ion
and
FID
Cla
ssif
icat
ion
of S
oil S
ampl
es
for
VO
C A
naly
sis
SW
846
5030
and
SW
846
5035
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
06\W
et C
hem
istr
y\S
OP
Soi
l E
xtra
ctio
n an
d F
ID C
lass
ific
atio
n of
Soi
L S
ampl
es f
or V
OC
A
naly
sis
Rev
.1 0
7-10
-06.
doc
Rev
1
7/10
/06
7/10
/06
- JO
C
Wet
Che
mis
try
Spe
cifi
c C
ondu
ctan
ce u
sing
Acc
umet
Met
erS
M25
10B
obso
lete
- c
ombi
ned
wit
h S
even
Mul
ti S
OP
8-2
0-09
Rev
2 -
7/
19/0
6D
isco
ntin
ued
Wet
Che
mis
try
Sul
fate
EP
A M
etho
d 37
5.4
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
06\W
et C
hem
istr
y\S
OP
SU
LF
AT
E
7-21
-06
Rev
.3.d
ocR
ev 3
-
7/21
/06
11/1
5/06
- J
OD
isco
ntin
ued
Wet
Che
mis
try
Spe
cifi
c C
ondu
ctan
ce u
sing
Sev
enM
ulti
Met
tler
-T
oled
oS
M25
10B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
C
hem
istr
y\S
OP
for
Spe
cifi
c C
ondu
ctan
ce S
M25
10B
, 10-
12-1
6 R
ev.
5.do
cR
ev 5
-
10/1
2/16
10/1
2/16
- K
L
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 12
R
evis
ion
4/27
/201
7
Uncon
trolle
d
SW
8
AS
TM
129
3-99
AS
TM
129
Met
hod
365.
2M
etho
d 36
5
1-D
1-D ce
dure
wit
h ce
dure
wit
h A
Col
orim
etri
c ol
orim
etr
F:\
F:\
for
Ph
for
P
F:\
data
\QA
QC
\F
:\da
ta\Q
Afo
r P
hosp
horu
s in
for
Pho
spho
rus
i
lete
, com
lete
, co
QA
nc
lle
Uncon
ttrooll
ddCop
ed in
toed
into
C\N
EL
AC
SO
\NE
LA
C S
SO
P f
or R
eact
ivit
y,P
for
Rea
cti
AQ
C\N
EL
AC
SO
Ps\
NE
NE
LA
C S
OP
sy
SM
2520
, 12-
18-1
3 R
e25
20, 1
2-18
CCoopy
AC
SO
Ps\
NE
LA
C S
OP
OP
s\N
EL
AC
M25
40F
, 9-1
7-13
Rev
.25
40F
, 9-1
7-1
py2006
\We
2006 of
oppy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Wet
Che
mis
try
Sul
fide
SM
450
0-S
2F /
EP
A 3
76.1
F:\
data
\QA
QC
\NE
LA
C S
OP
s 20
06\W
et C
hem
istr
y\S
OP
SU
LF
IDE
37
6.1
Rev
. 3 0
7-19
-06.
doc
Rev
3 -
7/
19/0
611
/16/
06 -
JO
Dis
cont
inue
d 4/
12/1
6
Wet
Che
mis
try
Sul
fide
SM
4500
S2D
/ E
PA
376
.2
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
C
hem
istr
y\S
OP
for
Sul
fide
by
SM
4500
-S2-
D &
EP
A 3
76.2
, 6-1
5-16
R
ev. 6
.doc
Rev
6 -
6/
15/1
66/
15/1
6 -
TD
Wet
Che
mis
try
Sul
fite
SM
450
0 S
O3(
-2),
B 1
9th
Ed.
SO
P f
or S
ulfi
te S
M45
00-S
O3
B
Rev
3 -
07
/19/
0611
/15/
06 -
JO
Wet
Che
mis
try
Syn
thet
ic P
reci
pita
tion
Lea
chin
g P
roce
dure
(S
PL
P)
SW
846
1312
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\Wet
Che
m\S
OP
fo
r S
PL
P b
y 13
12, 1
1-26
-13
Rev
. 11.
doc
Rev
11
-11
/26/
1312
/02/
13 -
CW
Wet
Che
mis
try
Thr
esho
ld O
dor
SM
215
0BF
:\D
ata\
QA
QC
\NE
LA
C S
OP
s 20
06\W
et C
hem
istr
y\S
OP
for
O
dor2
.doc
Rev
2 -
7/
7/06
7/13
/06-
ES
Wet
Che
mis
try
Fix
ed a
nd T
otal
Vol
atil
e S
olid
s in
Sol
id M
atri
ces
SM
254
0G
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Wet
Che
m\S
OP
fo
r F
ixed
and
Tot
al V
olat
ile
Sol
ids
in S
olid
s by
SM
2540
G, 1
0-23
-14
Rev
. 4.d
ocR
ev 4
-
10/2
3/14
10/2
7/14
- C
W
Wet
Che
mis
try
Tot
al a
nd F
ree
Res
idua
l Chl
orin
eH
ach
8167
/802
1
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2011
\Wet
C
hem
istr
y\S
OP
for
Tot
al a
nd F
ree
Chl
orin
e by
HA
CH
816
7-80
21 1
-24
-11
Rev
.4.d
ocR
ev 4
-
1/24
/11
1/31
/11
- T
D
Dis
cont
inue
d
Wet
Che
mis
try
Tot
al a
nd F
ree
Res
idua
l Chl
orin
eS
M 4
500
Cl-
GF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\W
et C
hem
\SO
P
for
Chl
orin
e R
esid
ual S
M45
00-
Cl-
G, 9
-08-
14 R
ev. 7
.doc
Rev
7 -
9/
08/1
49/
08/1
4 -
TD
Wet
Che
mis
try
Tot
al C
yani
de, W
AD
, Am
enab
le C
yani
de &
PA
C b
y F
low
Inj
ecti
on A
naly
sis
for
Soi
l & S
olid
Pro
duct
sS
W 8
46 9
012B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2015
\Wet
Che
m\S
OP
fo
r C
YA
NID
E in
Soi
l by
SW
846
9012
B, 8
-06-
15 R
ev. 1
4.do
cR
ev 1
4 -
8/06
/15
8/10
/15
- R
T
Wet
Che
mis
try
Tot
al D
isso
lved
Sol
ids
SM
254
0CF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\W
et C
hem
\SO
P
for
Tot
al D
isso
lved
Sol
ids
by S
M25
40C
, 10-
15-1
4 R
ev. 1
1.do
cR
ev. 1
1 -
10/1
5/14
10/1
7/14
- C
W
Wet
Che
mis
try
Tot
al D
isso
lved
Sol
ids
EP
A 1
60.1
F:\
Dat
a\Q
AQ
C\N
EL
AC
SO
Ps
2006
\Wet
Che
mis
try\
SO
P T
DS
EP
A
160-
SM
2540
C.d
ocR
ev 5
-
7/7/
06D
isco
ntin
ued
4-2-
08 m
etho
d re
mov
ed b
y E
PA
MU
R
Wet
Che
mis
try
Tot
al H
ardn
ess
SM
2340
CF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
09\W
et
Che
mis
try\
SO
P f
or T
otal
Har
dnes
s by
SM
2340
C R
ev.5
. 8-1
3-09
.doc
Rev
5 -
8/
13/0
98/
21/0
9 -
CK
Wet
Che
mis
try
TO
TA
L K
JED
AH
L N
ITR
OG
EN
By
Flo
w I
njec
tion
A
naly
sis
Col
orim
etri
c E
PA
351
.2 L
acha
t Qui
kChe
m
Met
hod
10-1
07-0
6-2-
EE
PA
351
.2, 1
0-10
7-06
-2-E
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
C
hem
istr
y\S
OP
for
TK
N b
y F
low
Inj
ecti
on A
naly
sis,
351
.2, L
acha
t, 12
-30-
16 R
ev. 8
.doc
Rev
8 -
12
/30/
1612
/30/
16 -
RT
Wet
Che
mis
try
Tot
al K
jeld
ahl N
itro
gen
Org
anic
Nit
roge
nS
M45
00-N
H3-
C, S
M45
00-
Nor
gBF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
17\W
et C
hem
\SO
P
for
TK
N b
y S
M45
00-N
H3
C, 4
-10-
17 R
ev. 9
.doc
Rev
9 -
4/
10/1
74/
10/1
7 -
RT
Wet
Che
mis
try
Tot
al O
rgan
ic a
nd I
norg
anic
Car
bon
by L
loyd
Kah
n M
etho
dL
loyd
Kah
n M
etho
d
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
C
hem
istr
y\S
OP
for
TO
C b
y L
loyd
Kah
n M
etho
d, 0
6-14
-16
Rev
. 6.
doc
Rev
66/
14/1
66/
14/1
6 -
RT
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 13
R
evis
ion
4/27
/201
7
Un
dure
(S
PL
P)
ure
(SP
LP
)
SM
2
nUUncon
SM
254
0GM
254
0G
ncon
tr
/802
180
21trollF
:\F
:\fo
r C
hfo
r C
llolledF
:\da
ta\Q
AQ
F:\
data
\fo
r C
YA
NID
E
for
CY
AN
I
lleed da
ta\Q
AQ
C\
ta\Q
AQ
Cal
Di
alD
non
trolle
dCop
QC
\NE
LA
C S
OP
s 20
0N
EL
AC
SO
Ps
docCL
Ave
d S
olid
ved
Sol
id opy
AC
SO
Ps\
NE
LA
C S
OP
SO
Ps\
NE
LA
Cl H
ardn
ess
by S
M23
4H
ardn
ess
by S
M2
pys\N
EL
AC
S\N
EL
AC
w I
nj
Coppy
Eur
ofin
s S
pect
rum
Ana
lytic
alC
ompr
ehen
sive
Qua
lity
Ass
uran
ce M
anua
lA
ppen
dix
F
Dep
artm
ent
Sta
nd
ard
Op
erat
ing
Pro
ced
ure
Met
hod
s P
erfo
rmed
Fil
e N
ame
Rev
isio
nN
o.
Eff
ecti
ve R
evie
w
Dat
e/In
itia
ls o
f re
view
er/C
omm
ents
EU
RO
FIN
S S
PE
CT
RU
M A
NA
LY
TIC
AL
Mas
sach
use
tts
Mas
ter
Lis
t S
tan
dar
d O
per
atin
g P
roce
du
re
Wet
Che
mis
try
Tot
al O
rgan
ic &
Ino
rgan
ic C
arbo
nS
W84
6 90
60, S
M 5
310B
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
Che
m\S
OP
fo
r T
OC
by
SW
846
9060
& S
M53
10B
, 7-1
9-16
Rev
. 15.
doc
Rev
15
- 7/
19/1
67/
19/1
6 -
RT
Wet
Che
mis
try
Tot
al S
olid
s (T
S)
SM
2540
BF
:\da
ta\Q
AQ
C\N
EL
AC
SO
Ps\
NE
LA
C S
OP
s 20
14\W
et C
hem
\SO
P
for
Tot
al S
olid
s by
SM
2540
B, 1
0-15
-14
Rev
. 7.d
ocR
ev 7
-
10/1
5/14
10/1
7/14
- C
W
Wet
Che
mis
try
Tot
al S
uspe
nded
Sol
ids
SM
2540
D
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2016
\Wet
C
hem
istr
y\S
OP
for
Tot
al S
uspe
nded
Sol
ids
by S
M25
40D
, 11-
18-1
6 R
ev. 1
2.do
cR
ev 1
2 -
11/1
8/16
11/1
8/16
- C
W
Wet
Che
mis
try
Tot
al V
olat
ile,
Vol
atil
e S
uspe
nded
, and
F
ixed
Sol
ids
in A
queo
us M
atri
ces
SM
2540
E
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2014
\Wet
Che
m\S
OP
fo
r T
otal
Vol
atil
e, V
olat
ile
Sus
pend
ed a
nd F
ixed
Sol
ids
in A
queo
us
by S
M25
40E
, 10-
22-1
4 R
ev. 1
.doc
Rev
1 -
10
/22/
1410
/27/
14 -
CW
Wet
Che
mis
try
Tox
icit
y C
hara
cter
isti
c L
each
ing
proc
edur
e (T
CL
P)
SW
846
1311
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2013
\Wet
Che
m\S
OP
fo
r T
CL
P b
y 13
11, 1
1-18
-13
Rev
. 13.
doc
Rev
14
-3/
27/1
53/
30/1
5 -
TD
Wet
Che
mis
try
Tur
bidi
tyS
M 2
130B
, EP
A 1
80.1
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2012
\Wet
Che
m\S
OP
fo
r T
urbi
dity
by
SM
2130
B a
nd 1
80.1
, 7-2
3-12
Rev
. 6.d
ocR
ev 6
-
7/23
/12
7/24
/12
- JO
C
Wet
Che
mis
try
wc-
Ash
AS
TM
D29
74-C
F:\
data
\QA
QC
\NE
LA
C S
OP
s\N
EL
AC
SO
Ps
2008
\Wet
Che
mis
try\
w
c-A
shR
ev 0
-
3/25
/08
7/22
/08
- D
R
F:\
DA
TA
\com
p qu
alit
y as
sura
nce
man
ual\
sect
ion
7 at
tach
men
t MA
ST
ER
LIS
T F
OR
SO
Ps
Pag
e 14
R
evis
ion
4/27
/201
7
Unco
SM
2540
ES
M25
ncUco
n
SW
846
1311
W84
6 13
1
cont
r
B, E
PA
180
.1E
PA
180
.1 trolw l
rolle
d
coont
rrol
Copy
Eurofins Spectrum Analytical, Comprehensive Quality Assurance Manual
Appendix F Revised 9/29/15
SOP REQUEST FOR CREATION OR MODIFICATION
Date:
SOP:
Requested by:
APPROVED or DENIED
New revision number:
Expected Date of Completion:
Please provide a brief description for why SOP needs to be created or modified:
Laboratory Director Date
QA Manager Date
Uncncon
trolle
d dleolltrontr
onconc
Copyed or modior moypyopCoC
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX G
Section 11 Attachments
Uncon
trolle
d Cop
ynts s
Eurofins Spectrum Analytical, Comprehensive Quality Assurance Manual
Appendix G
Table 11.1 Reagent Storage
Reagent Container Storage Area
Hexane Stored in 4-liter amber glass bottles Vented, flammable storage cabinets 1,3
Methylene Chloride Stored in 4-liter amber glass bottles Vented, flammable storage cabinets 1,3
Pentane Stored in 4-liter amber glass bottles Vented, flammable storage cabinets 1
Ethyl Acetate Stored in 4-liter amber glass bottles Vented, flammable storage cabinets 1
Acetonitrile Stored in 1-liter amber glass bottles Vented, flammable storage cabinets 1
1 Sooctone Stored in 4-liter amber glass bottles Vented, flammable storage cabinets 1
Ethyl Ether Stored in 4-liter TinVented, flammable storage cabinets 1
Nitric Acid Stored in 2.5 Liter glass bottles Vented, cabinets designed for acid storage 1
Hydrochloric Acid Stored in 2.5 Liter glass bottles Vented cabinet designed for acid storage 1
Sulfuric Acid Stored in 2.5 Liter glass bottles Vented cabinet designed for acid storage 1,3
Acetone Stored in 4 Liter Plastic bottles Vented cabinet designed for volatile storage 1
Acetone Stored in 4 Liter Amber bottles Vented, flammable storage cabinets 1
Potassium Permanganate Stored in a 500 gm amber glass bottle Cabinet 1 *
Hydrogen Peroxide Stored in a 500 ml plastic bottle Cabinet 1 *
Stannous Chloride Stored in a 500 gm plastic bottle Cabinet 1 *
Potassium Persulfate Stored in a 500 gm Plastic bottle Cabinet 1 *
Magnesium Perchlorate Stored in a 500 gm amber glass bottle and a 2.5 Kg Plastic bottle
Cabinet 1 *
Sodium Bisulfate Stored in a 500 gm Plastic bottle Cabinet 1 *
glass boss b
TinTind
.5 Liter glassLiter glasolle
red in 2.5 Litin 2.5 Litr
UnnStored inStored inonUnUnSSUnnUU
CopyVeVstorastopyttles ttlesVpypy
les l Co
Eurofins Spectrum Analytical, Comprehensive Quality Assurance Manual
Appendix G
Table 11.1 Reagent Storage
Reagent Container Storage Area Sodium Chloride Stored in a 5 gm Plastic bottle Cabinet 1 *
Hydroxylamine Sulfate Stored in a 500 gm Plastic bottle Cabinet 1 *
Methanol Stored in a 500 ml amber glass bottle Vented, flammable storage cabinets 2
Notes: 1 Located at 11 Almgren Dr Lab 2 Located at 830 Silver St Lab
3 Bulk storage is in a designated area in original shipping containers and packaging. * Reactive and oxidizing reagents are stored separately from corrosive reagents
Uncon
trolle
d Cop
yyy
Inst
rum
ent
Use
r D
escr
ipti
on
M
aker
Mo
del
Ser
ial
In u
seR
oo
mR
oo
m D
Dep
artm
ent
Bu
ildin
gL
oca
tio
nA
utos
ampl
er (
Can
iste
r)A
ir-1
EN
TE
CH
7016
CA
0220
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Aut
osam
pler
(C
anis
ter)
Air-
3M
arke
sC
IA A
dvan
tage
GB
00H
1010
21
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AA
utos
ampl
er (
Can
iste
r)A
ir-4
EN
TE
CH
7016
A11
761
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AA
utos
ampl
er (
Can
iste
r)S
tora
geE
NT
EC
H70
16C
A02
230
no14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Can
iste
r C
lean
erS
tora
geE
NT
EC
H31
00A
1114
0no
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AC
anis
ter
Cle
aner
C
C1
EN
TE
CH
3100
-16
Pos
ition
0141
0no
143
Sto
rage
AIR
Silv
erA
gaw
am,M
AC
anis
ter
Cle
aner
#1
CC
1E
NT
EC
H31
00D
1679
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Can
iste
r C
lean
er #
2C
C2
EN
TE
CH
3100
A12
471
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AC
once
ntra
tor
Air-
3M
arke
sU
nity
2E
1129
031
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AD
ynam
ic D
ilute
rD
ilute
r 1
EN
TE
CH
4600
0110
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Dyn
amic
Dilu
ter
Dilu
ter
2E
NT
EC
H46
0010
91
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AD
ynam
ic D
ilute
rD
ilute
r 3
EN
TE
CH
4600
1162
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Flo
w C
ontr
olle
rs20
5 U
nit
EN
TE
CH
CS
120
0 E
S-S
iloni
teV
ario
usB
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phA
ir-3
Agi
lent
7890
AC
N10
7250
481
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AG
as C
hrom
atog
raph
Air-
4A
gile
nt68
90N
CN
1063
3094
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phA
ir-1
HP
6890
US
0002
0055
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phA
ir-2
HP
6890
US
0004
2889
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phA
ir-5
Per
kin
Elm
erC
laru
s 50
065
0N30
5190
11
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AM
ass
Flo
w C
alib
rato
r (0
-10m
ls)
AA
llica
t Sci
entif
icV
-10-
CC
M-D
1246
61
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AM
ass
Flo
w C
alib
rato
r (1
0-10
0mls
)B
Alli
cat S
cien
tific
V-1
00vC
CM
-D12
468
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Mas
s F
low
Cal
ibra
tor
(10-
100m
ls)
CA
llica
t Sci
entif
icV
-100
-CC
M-D
1186
01
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AM
ass
Spe
ctro
met
erA
ir-1
Agi
lent
5973
US
9142
2439
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Mas
s S
pect
rom
eter
Air-
2A
gile
nt59
73U
S10
4417
721
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AM
ass
Spe
ctro
met
erA
ir-3
Agi
lent
5975
CU
S73
3176
651
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AM
ass
Spe
ctro
met
erA
ir-4
Agi
lent
5975
US
5444
1865
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Ope
n-A
ir P
latfo
rm S
hake
rsO
rbita
l rot
ator
Bar
nste
adM
axq
2000
1410
0610
0816
61
yes
124
AIR
Lab
AIR
Silv
erA
gaw
am,M
AO
ven
Sto
rage
Fis
her
516G
6020
0029
0no
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AO
ven
#1 fo
r C
anis
ter
Cle
aner
#1
CC
1E
NT
EC
H35
1312
04-1
191
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Ove
n #2
for
Can
iste
r C
lean
er #
1C
C1
EN
TE
CH
3108
0119
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Ove
n #1
for
Can
iste
r C
lean
er #
2C
C2
EN
TE
CH
3513
EN
T14
8207
0562
349
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Ove
n #2
for
Can
iste
r C
lean
er #
2C
C2
EN
TE
CH
3513
0105
-261
21
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AP
re-C
once
ntra
tor
Air-
1E
NT
EC
H71
00#0
240
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Pre
-Con
cent
rato
rA
ir-2
EN
TE
CH
7100
A14
381
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AP
re-C
once
ntra
tor
Air-
4E
NT
EC
H71
00A
1385
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Pre
-Con
cent
rato
rS
tora
geE
NT
EC
H71
00#0
245
0no
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AS
ieve
rs in
terf
ace
cont
rolle
rA
ir-5
Sie
vers
255-
355
1705
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Sul
furC
hem
lum
ines
cenc
e C
ontr
olle
rA
ir-5
Sie
vers
SC
D-3
5503
0610
701
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AS
umm
a C
anis
ter
325
Can
iste
rsR
este
k/E
ntec
h6L
-Silc
oSte
elV
ario
usA
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Vac
uum
Pum
pA
ir-2
Edw
ards
E2M
1.5
7035
251
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AV
acuu
m P
ump
Air-
4E
dwar
ds1.
500
6840
244
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Vac
uum
Pum
pA
ir-1
Pfe
iffer
Duo
-2.5
2132
0965
0no
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AV
acuu
m P
ump
Air-
3E
dwar
ds1.
598
2169
849
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Vac
uum
Pum
pA
ir-1
Vac
uubr
and
ME
223
5836
091
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AV
acuu
m P
ump
Air-
2V
acuu
bran
dM
E2
2717
0702
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Vac
uum
Pum
pA
ir-4
Vac
uubr
and
ME
229
6906
041
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AV
acuu
m P
ump
CC
1V
acuu
bran
dM
Z2
2956
0805
1ye
s14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Vac
uum
Pum
pS
tora
geV
acuu
bran
dM
E2
3019
0020
0no
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AV
acuu
m P
ump
Sto
rage
Vac
uubr
and
ME
224
0581
090
no14
3A
IR L
abA
IRS
ilver
Aga
wam
,MA
Vac
uum
Pum
p sp
are
Vac
uubr
and
MZ
227
1765
041
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AV
acuu
m P
ump
CC
#2V
acuu
bran
dM
Z2N
T38
7899
041
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AV
acuu
m P
ump
TD
Bag
Vac
uubr
and
MZ
224
2526
051
yes
143
AIR
Lab
AIR
Silv
erA
gaw
am,M
AC
ell P
hone
413-
237-
4234
Mot
orol
aW
385
NA
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Cel
l Pho
ne41
3-23
7-77
36M
otor
ola
V32
5iA
0000
0234
B7D
511
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell P
hone
413-
237-
2270
Nok
ia72
05A
0000
0015
137a
11
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell P
hone
413-
896-
0910
Nok
ia72
05A
0000
9015
137C
61
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell p
hone
315-
405-
0825
Sam
sung
SC
H-U
640
A00
0002
A5D
5700
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Cel
l pho
ne31
5-40
5-08
26S
amsu
ngS
CH
-U64
0A
0000
02A
5D56
441
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell P
hone
315-
882-
2833
Sam
sung
SC
HU
640
A00
0002
A5D
3C5C
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Cel
l Pho
ne40
1-32
3-45
91S
amsu
ngS
CH
-U64
0N
A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell P
hone
413-
237-
2248
SA
MS
UN
GS
CH
-U64
0N
A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell P
hone
413-
348-
2933
Sam
sung
SC
H-U
640
NA
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Cel
l Pho
ne41
3-34
8-29
34S
amsu
ngS
CH
-U64
0A
0000
02A
3CA
4C0
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Cel
l Pho
ne41
3-47
8-69
70S
amsu
ngS
CH
-U64
0N
A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell P
hone
413-
654-
7322
Sam
sung
SC
H-U
640
A00
0002
9901
374
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Cel
l Pho
ne41
3-89
6-09
09S
amsu
ngS
CH
-U64
0N
A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AC
ell P
hone
413-
896-
4038
Sam
sung
SC
H-U
640
NA
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Cel
l Pho
neS
amsu
ngS
CH
-U64
0A
0000
0234
B7D
331
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AF
ork
lift
War
ehou
seB
T L
ifter
L200
0U10
8424
31
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AF
ork
lift
2R
ol-L
ift S
tach
er21
99P
SF
20T
20F
D36
151A
NN
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Uncon
trolle
d
68 6890
Cla
rus
5C V
-10-
CC
MV V
-100
vCC
M-
V-1
00vC
V-1
00-C
CM
-DV
-100
-CC
5973
5 5973
5973 975CC 5
000
000
01 #024
014
383813
8513
85#0
245
#024
517
05705
0306
1070
0306
1070
Var
ious
Ario
usA
3525
3525 40
244
4024
465
Cop1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s14
0no
143
0no
0no
143
no1
1ye
s14
3es
143
opy
1ye
s14
3A
IRye
s14
3ye
s14
3A
IR L
143
es11
6H
ealth
&11
6H
116
Hea
lth &
c11
6H
116
Hea
lth &
Hea
lth
116
Hea
lt16
Hea
16H
e16
GP
SN
Y C
ourie
rG
arm
inN
uvi 2
65w
t21
d253
515
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
GP
SC
ourie
r de
part
men
tT
om T
omxl
340
tru
4430
1092
341
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AG
PS
Cou
rier
depa
rtm
ent
Tom
Tom
xl 3
40t
ru22
40b0
3264
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
GP
S U
nit
Cou
rier
Dep
tG
arm
innu
viN
A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AG
PS
Uni
tC
ourie
r D
ept
Gar
min
Nuv
iN
A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AH
and
cart
van
2G
loba
l ind
ustr
ial
2413
01N
/A1
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AIc
e M
achi
neS
cotts
man
SLC
400A
E-1
A63
8919
-12L
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Ice
Mac
hine
Sto
rage
Bin
Man
itow
ocC
420
9511
2053
51
yes
116
Hea
lth &
co
uC
OU
RIE
RA
lmgr
enA
gaw
am,M
AP
acka
ge s
cale
Cou
rier
depa
rtm
ent
Pel
ouze
p100
s13
0000
0175
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Pac
kage
sca
leW
areh
ouse
Pel
ouze
p100
s10
0000
0143
1ye
s11
6H
ealth
& c
ou
CO
UR
IER
Alm
gren
Aga
wam
,MA
Gla
ss C
rush
erH
&S
Pro
deva
95-6
1285
41
yes
125
Gar
age
GA
RA
GE
Alm
gren
Aga
wam
,MA
Hyd
er P
rep
Sto
rage
Leem
an L
abs
Pre
p70
010
no50
1G
arag
eG
AR
AG
EA
lmgr
enA
gaw
am,M
AP
last
ic S
hedd
erH
&S
Pro
deva
315-
S12
855
1ye
s12
5G
arag
eG
AR
AG
EA
lmgr
enA
gaw
am,M
AS
onic
ator
Sto
rage
Bra
nson
Son
ifier
450
BI6
0237
0no
501
Gar
age
GA
RA
GE
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
pS
tora
geP
feiff
erD
uo-2
.521
2333
880
no50
1M
OE
Offi
ceG
AR
AG
EA
lmgr
enA
gaw
am,M
AA
utod
iges
tor
Aut
oblo
ck 2
Env
ironm
enta
l Exp
ress
SC
862
0605
DU
R08
41
yes
120
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AA
utos
ampl
eriC
AP
2C
ET
AC
AS
X-5
6007
1620
A56
01
yes
121
Met
als
Inst
ruIN
OR
GA
lmgr
enA
gaw
am,M
AA
utos
ampl
eriC
AP
CE
TA
CA
SX
-520
0312
148A
520
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
Aut
osam
pler
(Spa
re)
CE
TA
C T
ecno
logi
esA
SX
520
0811
05A
520
1ye
s12
1M
etal
s In
str u
INO
RG
Alm
gren
Aga
wam
,MA
Aut
osam
pler
ICA
P4
CE
TA
C T
ecno
logi
esA
SX
520
0213
764A
520
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
Aut
osam
pler
ME
RC
UR
Y4
Leem
an L
abs
Hyd
ra II
AA
4035
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
Aut
osam
pler
ICP
MS
2P
erki
n E
lmer
S10
102S
7093
702
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
2A
ND
ER
-60A
3492
967
0no
120
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AB
alan
ceS
cale
#12
Oha
usP
A11
483
2817
0194
1ye
s12
0M
etal
s P
rep
INO
RG
Alm
gren
Aga
wam
,MA
CE
M Io
nize
ran
ti-st
atic
ioni
zer
CE
M91
2490
N/A
1ye
s12
0M
etal
s P
rep
INO
RG
Alm
gren
Aga
wam
,MA
Chi
ller
ICP
MS
2P
oly
Sci
ence
N81
2224
73E
1111
254
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
Chi
ller
ICA
P1
The
rmo
The
rmoF
lex9
0012
7134
0114
0523
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
chill
erIC
AP
2T
herm
oT
herm
oFle
x900
1271
3570
1140
528
1ye
s12
1M
etal
s In
str u
INO
RG
Alm
gren
Aga
wam
,MA
chill
erIC
AP
4T
herm
oT
herm
oFle
x900
R08
2540
461
yes
121
Met
als
Inst
ruIN
OR
GA
lmgr
enA
gaw
am,M
AF
ume
Hoo
d23
Ham
ilton
PL-
260-
1N
/A1
yes
124
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AF
ume
Hoo
d24
Labc
onco
No
mar
king
sN
/A1
yes
120
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AH
ot P
late
Hot
Pla
teB
arns
tead
HP
4713
510
7303
0466
891
yes
124
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AH
ot P
late
Hot
Pla
teT
herm
olyn
eH
P47
135
1030
3028
4577
1ye
s12
0M
etal
s P
rep
INO
RG
Alm
gren
Aga
wam
,MA
Hot
bloc
kH
B2
Env
ironm
enta
l Exp
ress
SC
154
3826
CE
C18
191
yes
124
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AH
otbl
ock
HB
1E
nviro
nmen
tal E
xpre
ssS
C15
434
83C
EC
1685
1ye
s12
4M
etal
s P
rep
INO
RG
Alm
gren
Aga
wam
,MA
Hot
bloc
kH
B3
Env
ironm
enta
l Exp
ress
SC
154
3826
CE
C18
221
yes
120
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AIC
AP
ICA
PT
herm
o S
cien
tific
6500
2007
2108
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
Icap
ICA
P2
The
rmo
Sci
entif
ic65
0020
1127
051
yes
121
Met
als
Inst
ruIN
OR
GA
lmgr
enA
gaw
am,M
AIc
apIC
AP
4T
herm
o S
cien
tific
6500
IC5D
2011
4909
1ye
s12
1M
etal
s In
stru
INO
RG
Alm
gren
Aga
wam
,MA
ICP
-MS
ICP
MS
2P
erki
n E
lmer
Ela
n 90
00A
J100
5406
021
yes
121
Met
als
Inst
ruIN
OR
GA
lmgr
enA
gaw
am,M
AM
ars
Xpr
ess
Mic
row
ave
Mar
s M
icro
wav
eC
EM
9075
01M
D35
101
yes
120
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AM
ercu
ry A
naly
zer
(aut
omat
ic)
ME
RC
UR
Y3
Leem
an L
abs
Hyd
ra A
AH
A-7
019
1ye
s12
0M
etal
s P
rep
INO
RG
Alm
gren
Aga
wam
,MA
Mer
cury
Ana
lyze
r (a
utom
atic
)M
ER
CU
RY
4Le
eman
Lab
sH
ydra
II A
A51
591
yes
121
Met
als
Inst
ruIN
OR
GA
lmgr
enA
gaw
am,M
AO
xidi
zer
Var
iabl
e T
rans
form
erP
ower
stat
Pow
erst
at3p
n116
c1
yes
124
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am,M
AR
efrig
erat
or16
Tru
eG
DM
-69
1-26
6571
51
yes
130
Hal
lway
INO
RG
Alm
gren
Aga
wam
,MA
TC
LP R
otat
orR
otat
or #
3E
nviro
nmen
tal E
xpre
ss
GF
M06
05-J
IC75
2330
350
noW
et C
hem
INO
RG
Alm
gren
Aga
wam
,MA
TC
LP R
otat
orR
otat
or #
2E
nviro
nmen
tal E
xpre
ss
GF
M06
05-J
ICB
GF
M18
-060
SJI
C1
yes
Wet
Che
mIN
OR
GA
lmgr
enA
gaw
am,M
AT
CLP
Rot
ator
Rot
ator
#4
Env
ironm
enta
l Exp
ress
G
FM
0605
-JIC
EE
5511
1256
61
yes
124
Met
als
room
INO
RG
Alm
gren
Aga
wam
,MA
Hot
Blo
ckH
B4
Env
ironm
enta
l Exp
ress
SC
151
6791
CE
W3_
81
yes
124
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am, M
AA
utod
iges
ter
AB
+E
nviro
nmen
tal E
xpre
ssA
B40
01A
B40
01-1
212-
013
1ye
s12
0M
etal
s P
rep
INO
RG
Alm
gren
Aga
wam
, MA
Bal
ance
Sca
le #
15In
tell-
Lab
Bal
ance
PA
200
2125
71
yes
120
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am, M
AF
ume
Hoo
d28
Ham
ilton
No
Mar
king
sN
/A1
yes
124
Met
als
Pre
p IN
OR
GA
lmgr
enA
gaw
am, M
AA
utoc
lave
auto
1N
apco
8000
-DS
E60
1071
535
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Aut
ocla
veau
to2
Pel
ton
Cra
neO
CR
A4-
1856
91
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AA
utoc
lave
Par
tsP
elto
n C
rane
A43
5728
0no
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AA
utod
iges
ter
AB
+E
nviro
nmen
tal E
xpre
ss
AB
4001
AB
4001
-121
2-01
31
yes
120
Met
als
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
15In
telli
gent
Wei
ghin
g T
ech.
PA
200
0212
571
yes
120
Met
als
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Mic
Fis
her
No
Vis
ible
Num
bers
N/A
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Hot
Blo
ckH
B4
Env
ironm
enta
l Exp
ress
S
C15
167
91C
EC
W31
481
yes
124
Met
als
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Hot
Pla
teM
icC
orni
ngP
C10
1LR
3349
11
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AH
ot P
late
Mic
Cor
ning
PC
-620
3808
0501
1787
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Hot
Pla
teN
eed
repa
irC
orni
ngP
C-4
2041
0504
0966
940
no11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Hot
Pla
teN
eed
repa
irC
orni
ngP
C-4
2042
0504
1959
720
no11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Hot
Pla
teH
ot P
late
Vel
a 03
401-
4091
7040
4768
611
yes
124
Met
als
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rM
icN
uova
NA
NA
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Uncon
trolle
d
a9
Labs
Pre
pab
s31
5-S
3er
450
45 Duo
-2.5
Duo
-2.5
ssS
C86
2s
SC
862
AS
X-5
60A
SX
-560
AS
X-5
20A
SX
-520
AS
X52
0A
SX
520
X52
052
0 II A
AII
AA
3E 1271
1271
357
7135
R08
2540
4R
0825
404
N/A
N/A
N/A/A
1073
0304
6689
1073
0304
668
1030
3028
4577
1030
3028
457
826C
EC
1819
26C
EC
181
3CE
C16
853C
EC
1685
EC
182282
Copye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s12
opy
1ye
s12
01
yes
1ye
s12
11
yes
11
yes
124
es1
1ye
s13
0H
yes
130
0no
Wet
esW
et C
hW
py124
Met
als
roo
124
M12
4M
etal
s P
r24
Met
als
120
Met
als
Met
al12
0M
et20
y4M
Incu
bato
rM
icA
ttest
116
1693
701
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AIn
cuba
tor
Incu
bato
r1F
ishe
rIs
item
p 60
010
3N00
881
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AIn
cuba
tor
Mic
Sun
beam
1693
701
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AIn
cuba
tor
Incu
bato
r2T
helc
o#2
21A
B12
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Incu
bato
r w
ater
bat
h#2
Pre
cisi
on60
2061
055
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Mic
rosc
ope
Mic
Oly
mpu
s29
1652
N/A
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Mic
rosc
ope
w/c
amer
aM
icO
lym
pus
BH
2N
/A1
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AQ
uebe
c C
olon
y C
ount
erM
icA
O A
mer
ican
Opt
ical
3325
0852
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Ref
riger
ator
26M
agic
Che
f98
0W05
02M
CB
R98
0W01
708
1ye
s11
7M
icro
biol
ogy
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Ultr
avio
let L
amp
Mic
UV
PU
VL-
56J2
211
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AV
acuu
m P
ump
Filt
ratio
n P
ump
GA
ST
DO
A-P
704-
AA
0909
6012
741
yes
120
Met
als
MIC
RO
BIO
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
p (2
)M
icF
ishe
rA
A68
0JN
/A1
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AW
ater
Bat
h#1
Pre
cisi
on#1
83N
/A1
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AT
herm
ocou
ple
Dat
alog
ger
Mad
geT
ech
HiT
emp1
40P
0909
51
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AM
A R
eg 6
16-E
TT
Car
99
HT
For
d 20
09E
xplo
rer
1FM
EU
8584
9UA
0243
81
yes
108
Pre
side
nt, L
ACO
UR
IER
Silv
erA
gaw
am,M
AB
alan
ceS
cale
#6
Den
ver
Inst
rum
ents
P-4
002D
P4K
2D09
4003
1ye
s12
4R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Car
trid
ge P
ump
Pum
pC
ole-
Par
mer
7519
-25
H04
0040
781
yes
124
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AC
artr
idge
Pum
pP
ump
Col
e-P
arm
er75
19-2
5F
0500
2554
1ye
s12
4R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Car
trid
ge P
ump
Pum
pC
ole-
Par
mer
7519
-25
C05
0009
251
yes
124
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AC
linic
al R
otat
orO
rbita
l rot
ator
Bar
nste
ad23
1416
6506
0641
975
1ye
s12
3R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Clin
ical
Rot
ator
Orb
ital r
otat
orF
ishe
rN
one
502N
0006
1ye
s12
3R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Clin
ical
Rot
ator
Orb
ital r
otat
orF
ishe
rN
one
504N
0057
1ye
s12
3R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Clin
ical
Rot
ator
Orb
ital r
otat
orF
ishe
rN
one
506N
0079
1ye
s12
3R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Clin
ical
Rot
ator
Orb
ital r
otat
orF
ishe
rN
one
506N
0088
1ye
s12
3R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Con
duct
ivity
Met
erM
ulti-
met
erA
ccum
et50
C00
2472
71
yes
123
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AC
onso
le D
rive
Pum
p D
river
Col
e-P
arm
er75
20-4
0B
0500
4879
1ye
s12
3R
& D
Offi
c eR
&D
Alm
gren
Aga
wam
,MA
Con
sole
Driv
eP
ump
Driv
erC
ole-
Par
mer
7520
-40
G05
0032
391
yes
123
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AC
onso
le D
rive
Pum
p D
river
Col
e-P
arm
er75
20-4
0D
0500
2827
1ye
s12
3R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
econ
omy
Driv
eP
ump
Driv
erC
ole-
Par
mer
90F
0500
2411
1ye
s12
4R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Fum
e H
ood
22K
ewau
nee
N/A
N/A
1ye
s12
4R
& D
Offi
c eR
&D
Alm
gren
Aga
wam
,MA
Incu
bato
r#3
2F
ishe
rF
FU
2064
DW
1W
B50
3391
191
yes
124
Hal
lway
R&
DA
lmgr
enA
gaw
am,M
AO
pen-
Air
Pla
tform
Sha
kers
Orb
ital r
otat
orT
herm
oM
axq
2000
1410
0612
2350
61
yes
124
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AO
pen-
Air
Pla
tform
Sha
kers
Orb
ital r
otat
orT
herm
oM
axq
2000
1410
0610
0817
01
yes
124
R &
D O
ffic e
R&
DA
lmgr
enA
gaw
am,M
AO
pen-
Air
Pla
tform
Sha
kers
Orb
ital r
otat
orT
herm
oM
axq
2000
1410
0701
3253
41
yes
124
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AO
zone
Gen
erat
orO
zone
Gen
erat
orLo
ngev
ityH
T4-
500G
4471
51
yes
124
R &
D O
ffic e
R&
DA
lmgr
enA
gaw
am,M
AP
eris
talti
c P
ump
Pum
pS
pete
cP
erim
ax12
0301
0735
1ye
s12
4R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
pH /
Con
duct
ivity
met
erpH
met
erA
ccum
etA
R20
AR
9331
6734
1ye
s12
4R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Ref
riger
ator
23G
DM
-45
1-38
7319
61
yes
123
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AS
pect
roph
otom
eter
Spe
c3S
pect
roni
cG
enes
ys-5
3V8A
0800
021
yes
123
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AS
tir p
late
Stir
Pla
teC
orni
ngS
chol
ar 1
7143
1070
1745
51
yes
124
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AS
tir P
late
Stir
Pla
teF
ishe
r12
0580
9N20
221
yes
123
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AS
tir P
late
Stir
Pla
teF
ishe
r12
0S80
9N20
221
yes
126
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AS
tir p
late
Stir
rer
Cor
ning
Sch
olar
171
4401
331
yes
126
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
AS
urfa
ce T
ensi
omat
Ten
siom
atF
ishe
r21
505N
0022
1ye
s12
4R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Vis
com
eter
Vis
com
eter
Bro
okfie
ldLV
DV
-II+
PR
TP
6527
203
1ye
s12
4R
& D
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
YS
I Pro
OB
OD
PR
OB
EY
SID
OY
SI I
ncor
pora
ted
Pro
OD
O11
B 1
0062
61
yes
123
R &
D O
ffice
R&
DA
lmgr
enA
gaw
am,M
A11
Alm
gren
DR
Bui
ldin
gS
pect
rum
LA
BM
AR
C B
erge
ron
12,0
00.0
0 S
F B
uild
ing
2.0
AC
RE
S1
yes
103
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
830
Silv
er S
T B
uild
ing
Spe
ctru
m L
AB
MA
RC
Ber
gero
n10
,000
.00
2.5
AC
RE
S1
yes
103
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
Fre
ezer
Log
#25
Frig
idar
eF
FV
1152
DW
2W
B50
5238
641
yes
115
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
IR T
EM
P G
UN
Cic
ero
- s
ampl
e de
part
men
tF
luke
566
1901
0082
1ye
s11
5LO
GIN
SA
MP
LEA
lmgr
enA
gaw
am,M
AIR
TE
MP
GU
N 1
Logi
n 1
Flu
ke56
617
8200
311
yes
103
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
IR T
EM
P G
UN
2Lo
gin
2F
LUK
E56
617
8200
261
yes
103
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
IR T
herm
omet
er
(Cal
due
04/
19/0
8)G
un 1
Fis
her
06-6
64-3
861
6383
351
yes
115
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
Ref
riger
ator
#1G
DM
-69
1267
988
1ye
s11
5LO
GIN
SA
MP
LEA
lmgr
enA
gaw
am,M
AR
efrig
erat
or#1
1G
DM
-45
1387
3486
1ye
s11
5LO
GIN
SA
MP
LEA
lmgr
enA
gaw
am,M
AT
herm
ocou
ple
The
rmom
eter
3Lo
gin
Flu
ke51
/52-
II16
7102
251
yes
103
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
The
roco
uple
ther
mom
eter
4Lo
gin
Flu
ke51
/52
II16
7102
321
yes
103
LOG
INS
AM
PLE
Alm
gren
Aga
wam
,MA
Mer
cury
Ana
lyze
r (a
utom
atic
)M
ER
CU
RY
2Le
eman
Lab
sH
ydra
AA
HA
-400
70
no50
1G
arag
est
orag
eA
lmgr
enA
gaw
am,M
AV
acuu
m P
ump
Sto
rage
Edw
ards
1.5
0460
7166
30
no50
1W
es' o
ffice
stor
age
Silv
erA
gaw
am,M
AV
acuu
m P
ump
Sto
rage
Pfe
iffer
Duo
-2.5
2103
1618
0no
501
Wes
' offi
cest
orag
esi
lver
Aga
wam
,MA
4-P
os 2
-Lit
Sha
ker
Sha
ker#
1G
las-
Col
099A
VH
2000
S26
6868
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
4-P
os 2
-Lit
Sha
ker
Sha
ker#
2G
las-
Col
099A
VH
2000
s26
6869
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
8-P
os 2
-Lit
Sha
ker
Sha
ker#
3G
las-
Col
3-D
Sha
ker
4016
511
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AA
SE
200
AS
E1
Dio
nex
AS
E20
003
0202
871
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AA
SE
200
AS
E2
Dio
nex
AS
E20
004
0102
571
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AA
SE
200
AS
E3
Dio
nex
AS
E20
005
0100
461
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AA
SE
200
AS
E4
Dio
nex
AS
E 2
0098
0701
291
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-15
Agi
lent
G29
13A
CN
7023
8299
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Aut
osam
pler
HP
S-1
6A
gile
ntG
2913
AC
N70
2382
981
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-4A
gile
ntG
2913
AU
S12
4192
781
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-5A
gile
ntG
2913
AC
N72
9421
621
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-6A
gile
ntG
2913
AC
N73
0423
021
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AUnc
ontro
lled
rum
ents
rum
em
erm
erar
mer
me
7m
erm
er75
123
142 N
one
N Non
eN
one
Non
eN
one
Non
eN 5050 75
20-4
075
20-4
00-
40-40 4040
14 1410
4471
51503
0107
3503
0107
35A
R93
3167
34A
R93
316
1-38
7319
6-3
873
3V8A
0800
023V
8A08
0002
4310
7017
455
4310
7017
455
09N
2022
9N20
22N
2022
N20
223
23
Copye1
yes
1ye
s op1
yes
1ye
s1
yes
1ye
s10
1ye
s11
51
yes
1ye
s11
51
yes
11
yes
103
es1
1ye
s10
3LO
yes
103
yes
115
LOG
115 py
es11
5LO
GIN
115
L11
5LO
GIN
115
L10
3LO
GIN
03LO
GIN
103
LOG
INLO
GI
y
501
Gar
01W
Aut
osam
pler
HP
S8
Agi
lent
G45
13A
CN
1150
0142
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Aut
osam
pler
HP
S-1
1LE
AP
Tec
hnol
ogie
sG
C P
AL
1609
511
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-12
LEA
P T
echn
olog
ies
GC
PA
L16
0947
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Aut
osam
pler
HP
S-1
4ALE
AP
Tec
hnol
ogie
sG
C P
AL
1609
301
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-17
Leap
Tec
hnol
ogie
sG
C P
AL
1613
991
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-18
Leap
Tec
hnol
ogie
sG
CP
AL
1603
691
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-19
Leap
Tec
hnol
ogie
sG
CP
AL
1603
121
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-2LE
AP
Tec
hnol
ogie
sG
C P
AL
1609
561
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-3LE
AP
Tec
hnol
ogie
sG
C P
AL
1604
281
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
erH
PS
-7LE
AP
Tec
hnol
ogie
sG
C P
AL
1608
051
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
er T
ray
HP
S-1
5A
gile
ntG
2614
AC
N62
9404
961
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
er T
ray
HP
S-1
6A
gile
ntG
2614
AC
N70
2426
011
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
er T
ray
HP
S-4
Agi
lent
G26
14A
CN
7104
3246
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Aut
osam
pler
Tra
yH
PS
-5A
gile
ntG
2614
AC
N71
9439
371
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AA
utos
ampl
er T
ray
HP
S-6
Agi
lent
G26
14A
CN
7204
4008
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Aut
osam
pler
Tra
y 76
93H
PS
8A
gile
ntG
4519
AC
N11
5000
191
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AB
alan
ceS
cale
#11
Den
ver
Inst
rum
ents
DI
2255
0872
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
3M
ettle
rA
E20
0-S
K65
275
0no
122
Sto
rage
SV
OC
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
1AM
ettle
r T
oled
oX
S10
411
2842
0705
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
16In
telli
gent
Wei
ghin
g T
ech.
PA
200
0912
0111
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Cen
trifu
geC
entr
ifuge
Fis
her
226
2603
0no
122
Sto
rage
SV
OC
Alm
gren
Aga
wam
,MA
Cen
trifu
geC
entr
ifuge
Fis
her
228
FS
1766
10
no12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Chi
ller
Chi
ller
Pol
y S
cien
ceN
0691
883
G57
680
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Pre
p 31
fishe
r-H
amilt
onS
afea
ire II
2677
901
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AF
ume
Hoo
dP
rep
10La
bcon
co60
830-
00/D
NA
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Pre
p 18
Labc
onco
NA
NA
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Pre
p 19
Labc
onco
6083
0-00
/D26
7789
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Pre
p 25
Labc
onco
NA
NA
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Pre
p 27
Labc
onco
No
Vis
ible
Num
bers
N/A
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Pre
p16
Labc
onco
6083
0-00
/D26
7790
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Fum
e H
ood
Pre
p 20
NA
NA
NA
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
phS
tora
geP
erki
n E
lmer
N61
161
0N 4
0902
040
no13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
ph (
Dua
l EC
D)
HP
S-1
1A
gile
nt68
90 s
erie
sU
S00
0397
131
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(D
ual E
CD
)H
PS
-12
Agi
lent
6890
ser
ies
CN
1044
5021
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
ph (
Dua
l EC
D)
HP
S-1
4AA
gile
nt68
90N
CN
1060
2096
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
ph (
Dua
l EC
D)
HP
S-1
7A
gile
nt68
90N
US
1072
1002
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
ph (
Dua
l EC
D)
HP
S-1
9A
gile
nt78
90N
CN
1072
1099
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
ph (
Dua
l FID
)H
PS
-18
Agi
lent
6890
NC
N10
6020
351
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(F
ID)
HP
S-1
5A
gile
nt68
90N
US
1072
1003
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
ph (
FID
)H
PS
-16
Agi
lent
6890
NU
S10
7210
071
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(F
ID/M
S)
HP
S-2
Agi
lent
6890
NC
N10
4190
461
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(F
ID/M
S)
HP
S-3
Agi
lent
6890
NU
S10
1510
721
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(F
ID/M
S)
HP
S-5
Agi
lent
6890
NC
N10
6030
831
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(F
ID/M
S)
HP
S-7
Agi
lent
6890
US
0000
1599
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Gas
Chr
omat
ogra
ph (
MS
)H
PS
-4A
gile
nt68
90 s
erie
sU
S00
0410
571
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(M
S)
HP
S-6
Agi
lent
7890
NC
N10
7130
191
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AG
as C
hrom
atog
raph
(M
S)
HP
S8
Agi
lent
7890
AC
N12
0511
121
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AH
igh
Thr
ough
put 2
4-S
ampl
e R
otor
Rot
or (
hold
s ve
sses
l)M
ilest
one
Pro
-24
578
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hig
h T
hrou
ghpu
t 24-
Sam
ple
Rot
orR
otor
(ho
lds
vess
esl)
Mile
ston
eP
ro-2
458
91
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
3935
371
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
3915
141
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
4749
421
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
4749
431
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
4749
441
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
3935
291
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
4749
461
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-C
ol09
9A V
H 2
0005
4749
491
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-co
l3-
D40
1647
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hol
der
Pre
pG
las-
col
3-D
4016
481
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
olde
rP
rep
Gla
s-co
l3-
D40
1649
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hol
der
Pre
pG
las-
col
3-D
4016
501
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot B
lock
Hot
blo
ck 4
Env
ironm
enta
l Exp
ress
SC
100
145C
EC
0186
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
teS
oxhl
etC
ole
Par
mer
Vel
a03
401-
4091
7050
2492
081
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
Sox
hlet
Col
e P
arm
er V
ela
0340
1-40
9170
5024
803
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
teS
VO
CC
ole
Par
mer
Vel
a03
401-
4091
7047
6859
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
teS
VO
CC
ole
Par
mer
Vel
a03
401-
4091
7050
2477
981
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
SV
OC
Col
e P
arm
er V
ela
0340
1-40
9170
5024
7802
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
teS
VO
CC
ole
Par
mer
Vel
a03
401-
4091
7050
2478
031
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
SV
OC
Col
e P
arm
er V
ela
0340
1-40
9170
5204
9207
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
teS
VO
CC
ole
Par
mer
Vel
a03
401-
4091
7050
2492
101
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
Sox
hlet
Fis
her
NA
1000
170
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
teS
oxhl
etF
ishe
r11
-100
-100
SH
1886
0703
0321
11
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AUnc
ontro
lled
nstr
umen
tsst
rum
ents
Aol
edo
oled
oX
S1
eigh
ing
Tec
h.P
A20
0ei
ghin
g T
ech.
P 226
22 228
228
N06
9188
3N
0691
88S
afea
ire II
Saf
eaire
60
830-
00/D
6083
0-00
/DN
AN
A 830-
00/D
0-0
e N
umbe
rsum
be
U CN
1C
N10
6010
6U
S10
7210
US
1072
10C
N10
7210
99C
N10
721
CN
1060
2035
N10
6U
S10
7210
03U
S10
7210
03U
S10
7210
07U
S10
7210
07N
1041
9046
N10
4190
4601
5107
201
5107
203
08383
59999 7
Copye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s12
1ye
s12
21
yes op
y
1ye
s12
21
yes
11
yes
122
es1
1ye
s12
2P
yes
122
yes
122
Pre
p12
2es
122
Pre
p R
o12
2P
122
Pre
p R
oom
122
P12
2P
rep
Roo
22P
rep
R12
2P
rep
RP
rep y
122
Pre
22 2P
Hot
Pla
teS
VO
CF
ishe
r11
-498
-7S
561-
0097
11
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Soh
let
Fis
her
11-1
00-1
00S
H18
8607
3032
151
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8607
0303
193
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1886
0703
0194
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1886
0703
0320
61
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8607
0303
215
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
0-10
0SH
1886
0703
0319
71
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-4
98-7
556
1009
711
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8409
0804
190
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1880
9080
4182
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1884
0908
0959
11
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8409
0809
597
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1884
0908
0679
71
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8409
0809
593
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1884
0908
0679
21
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8409
0912
712
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1884
0907
1364
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1884
0908
3488
91
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8408
0615
029
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1884
0808
2234
01
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
Sox
hlet
Fis
her
11-1
00-1
00S
H18
8408
0221
362
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Hot
Pla
te/S
tirre
rS
oxhl
etF
ishe
r11
-100
-100
SH
1884
0806
1316
21
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AIn
terf
ace
Con
trol
ler
Sto
rage
Per
kin
Elm
er90
0 S
erie
s 97
023
5127
0996
0no
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
ALa
zy B
aki F
unne
l Hol
der
Sha
ker#
3M
oham
med
Bak
iN
AN
A1
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AM
ass
Spe
ctro
met
erH
PS
-2A
gile
nt59
73N
US
4064
6488
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
S-3
Agi
lent
5973
NU
S05
0401
141
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AM
ass
Spe
ctro
met
erH
PS
-4A
gile
nt59
73N
US
4404
7071
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
S-5
Agi
lent
5973
NU
S55
1422
221
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AM
ass
Spe
ctro
met
erH
PS
-6A
gile
nt59
75C
US
7331
7300
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Mas
s S
pect
rom
eter
Sto
rage
Agi
lent
5973
US
8232
1957
0no
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AM
ass
Spe
ctro
met
erH
PS
-7H
P59
75C
US
1102
7505
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Mas
s S
pect
rom
eter
(M
SD
)H
PS
8A
gile
nt59
75C
US
1147
3917
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Mic
row
ave
Con
trol
Ter
min
al 6
40S
oftw
are
Con
trol
Ter
min
alM
ilest
one
Eas
y C
ontr
ol12
0800
0026
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Mic
row
ave
Ext
ract
or
Mic
row
ave
1M
ilest
one
ET
HO
S E
X
1340
491
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AM
otor
- (
solid
pha
se)
Filt
ratio
n P
ump
Pre
pK
NF
Lab
(typ
e) U
N81
63K
T)
1190
1912
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Ove
n -
Isot
emp
500
serie
sS
tora
geF
ishe
r51
6G60
2000
570
no12
5G
arag
eS
VO
CA
lmgr
enA
gaw
am,M
AO
ven-
Isot
emp
seni
or m
odel
Gla
ssw
are
Fis
her
103
A10
11
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AR
ecyc
ler
Sto
rage
Ele
ctro
ther
mal
Em
300
0/C
X10
7253
110
no12
5G
arag
eS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or4
Bus
h35
103G
0390
5798
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Ref
riger
ator
2F
ishe
r13
-987
-348
G01
7736
251
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or6
Kel
vina
tor
UC
25R
F-F
MS
3819
341
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or14
Mag
ic C
hef
MC
BR
1010
W03
0728
402
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Ref
riger
ator
29M
agic
Che
fM
CB
R10
10W
0307
2840
21
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or15
Tru
eG
DM
-45
1-26
8070
71
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or17
Tru
eG
DM
6912
8245
991
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or7
Tru
eG
DM
691-
3226
065
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Ref
riger
ator
19U
nite
dN
/A1
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or3
Uni
vers
alU
CM
-46
4905
191
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AR
efrig
erat
or7a
Wel
Bilt
W8-
/332
019
9101
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Ref
riger
ator
5W
estin
ghou
seM
RT
13C
RB
W3
BA
6011
1729
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Son
ic D
isem
brat
orS
onic
#2
Fis
her
F55
0F
1808
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Son
ic D
isem
brat
orS
onic
#1
Tek
mar
NA
NA
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Sox
hlet
SV
OC
Ele
ctro
ther
mal
EM
EG
0250
/CE
MK
1N
A0
no12
2S
tora
geS
VO
CA
lmgr
enA
gaw
am,M
AS
oxhl
et (
2)S
VO
CE
lect
roth
erm
alE
ME
G02
50/C
EM
K1
N/A
0no
122
Sto
rage
SV
OC
Alm
gren
Aga
wam
,MA
Sox
hlet
168
Set
upS
VO
CA
MK
Gla
ssS
oxhl
etN
A1
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AT
urbo
Vap
SV
OC
Zym
ark
Tur
bo V
ap II
TV
0015
N95
210
no12
2S
tora
geS
VO
CA
lmgr
enA
gaw
am,M
AT
urbo
Vap
SV
OC
Zym
ark
Tur
bo V
ap II
TV
0018
N95
531
yes
122
Pre
p R
oom
SS
VO
CA
lmgr
enA
gaw
am,M
AT
urbo
Vap
SV
OC
Zym
ark
Tur
boV
ap II
TV
0625
N13
132
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Tur
bo V
apS
VO
CZ
ymar
kT
urbo
Vap
IIT
V99
07N
8670
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Tur
bo V
apS
VO
CZ
ymar
kT
urbo
Vap
IIT
V99
11N
8743
1ye
s12
2P
rep
Roo
m S
SV
OC
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
pH
PS
-2E
dwar
dsA
371-
24-9
0204
6032
716
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
pH
PS
-6E
dwar
dsA
371-
24-9
0202
7220
249
1ye
s12
2S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
pH
PS
-5E
dwar
dsA
371-
24-9
0201
7210
484
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
pH
PS
-4E
dwar
ds1.
546
0716
631
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AV
acuu
m P
ump
HP
S-7
Pfe
iffer
Duo
-2.5
2142
5042
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
pH
PS
-3P
feiff
erD
uo-2
.522
0078
281
yes
130
SV
OC
GC
RS
VO
CA
lmgr
enA
gaw
am,M
AV
acuu
m P
ump
HP
S-8
Pfe
iffer
Duo
-2.5
2179
7729
1ye
s13
0S
VO
C G
C R
SV
OC
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
p16
64M
056L
X2-
A1
yes
122
SV
OC
Pre
p S
VO
CA
lmgr
enA
gaw
am,M
AV
acuu
m P
ump
Pum
pF
ishe
r40
0190
1F
0400
2923
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Vac
uum
Pum
pP
ump
Fis
her
4001
901
L120
0406
51
yes
122
SV
OC
Pre
p S
VO
CA
lmgr
enA
gaw
am,M
AW
ater
Bat
hU
ltra
soni
c cl
eane
rF
ishe
rF
S22
0R
WB
1202
7847
81
yes
122
SV
OC
Pre
p S
VO
CA
lmgr
enA
gaw
am,M
AW
ater
Bat
hW
ater
Bat
hC
ole
Pal
mer
1250
0-00
1001
960
no12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Uncon
trolle
d
1 11-1
11-1
001 11
-100
-10
11 11-1
00-1
00S
11-1
0090
0 S
erie
s 97
090
0 S
erie
NA
N 5973
N59
73N
5973
N59
73N 3NN
12 1340
1190
19019
6020
0057
6020
0057
A10
1A
101
1072
5311
0725
9057
9890
5798
0177
3625
0177
3625
8193
419
3 7284
0272
8402
84022 7
Copye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s13
1ye
s13
01
yes
1ye
s13
01
yes
11
yes
122
es1
1ye
s12
2P
yes
122
opy
0no
122
Sto
ra12
2o
122
Sto
rage
122
S12
2P
rep
Roo
m12
2P
122
Sto
rage
22S
tora
ge12
2P
rep
RP
rep
122
Pre
22 2P
Tur
bo V
ap#6
Bio
tage
Tur
boV
ap II
TV
1246
N17
454
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Ove
nP
rep
room
gla
ssw
are
drye
rLa
b D
epot
Mod
el 3
0 G
C G
ravi
ty C
onve
ctio
n O
ven
G3-
0100
521
yes
122
SV
OC
Pre
p S
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
FID
-0E
ST
LGX
-50
LGX
1121
2221
51
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erH
P-9
ES
TA
rcho
n14
672
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
FID
-1T
ekm
ar20
32U
S03
1740
021
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erF
ID-1
Tek
mar
2016
US
0325
3003
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
FID
-2T
ekm
arS
ola-
Tek
72
US
0825
2003
R1
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erH
P-2
Tek
mar
2016
9926
7001
0no
144
Sto
rage
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
HP
-2T
ekm
ar20
3294
2980
010
no14
4S
tora
geV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erH
P-3
Tek
mar
2016
US
0018
2008
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
HP
-3T
ekm
ar20
3299
2670
021
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erH
P-5
Tek
mar
Sol
a-T
ek 7
2U
S05
1180
021
yes
139
VO
CV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erH
P-7
Tek
mar
Sol
a-T
ek 7
2U
S08
0040
021
yes
139
VO
CV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erH
P-8
ES
TC
entu
rion
CE
NT
W54
2122
315
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
Sto
rage
Tek
mar
2016
9314
9005
0no
144
VO
CV
OC
Silv
erA
gaw
am,M
AA
utos
ampl
erS
tora
geT
ekm
ar20
32U
S02
2630
010
no14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
/Con
cent
rato
rH
P-1
Tek
mar
Ato
mx
US
1408
6002
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
/Con
cent
rato
rH
P-2
Tek
mar
Ato
mx
US
1034
8002
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Aut
osam
pler
/Con
cent
rato
rH
P-4
Tek
mar
Ato
mx
US
1113
0002
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Bal
ance
Sca
le #
7F
ishe
rN
AW
W42
108B
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rH
P-9
ES
TE
ncon
#2A
2480
3240
6EP
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rF
ID-1
Tek
mar
3100
US
0123
9007
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rH
P-8
ES
TE
velo
utio
nE
V71
5121
715
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rH
P-2
Tek
mar
3100
9929
4009
0no
144
Sto
rage
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rH
P-3
Tek
mar
3100
US
0110
7015
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rH
P-7
Tek
mar
Str
atum
US
0801
6003
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rF
ID-2
Tek
mar
Str
atum
US
0722
6009
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rH
P-5
Tek
mar
Str
atum
US
1213
6003
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Con
cent
rato
rS
tora
geT
ekm
arV
eloc
ity X
PT
US
0526
6001
0no
144
VO
CV
OC
Silv
erA
gaw
am,M
AD
IH2o
AS
MM
illip
ore
Tan
kPE
030
FID
N01
197
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
DIH
2oE
lixM
illip
ore
ZLX
S6O
O5Y
F1H
NO
1233
D1
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AD
IH2o
Mill
iQM
illip
ore
ZM
QS
6000
YF
0NN
2309
6I1
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AF
ID/P
IDF
ID-2
O.I
Ana
lytic
al44
30C
3495
3094
01
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AF
ID/P
IDF
ID-0
OI
FID
/PID
C84
7530
448
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
FID
/PID
FID
-1O
IF
ID/P
IDC
1105
3089
81
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AF
reez
er#2
4T
raul
sen
G22
010
T17
227B
061
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AF
ume
Hoo
dP
rep
17F
ishe
rN
o V
isib
le N
umbe
rsN
/A1
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AG
as C
hrom
atog
raph
FID
-0A
gile
nt68
90U
S00
0095
521
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AG
as C
hrom
atog
raph
FID
-1A
gile
nt68
90N
US
1034
3008
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phF
ID-2
Agi
lent
6890
NC
N10
5460
661
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AG
as C
hrom
atog
raph
HP
-8A
gile
nt68
90N
CN
1050
3005
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phH
P-2
Agi
lent
7890
AC
N10
8050
061
yes
139
VO
CV
OC
Silv
erA
gaw
am,M
AG
as C
hrom
atog
raph
HP
-3A
gile
nt78
90A
CN
1071
9024
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phH
P-4
Agi
lent
7890
AC
N10
4111
91
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AG
as C
hrom
atog
raph
HP
-5A
gile
nt68
90N
CN
1050
5034
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phH
P-7
Agi
lent
7890
AC
N10
7210
911
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AG
as C
hrom
atog
raph
HP
-1A
gile
nt68
90N
US
1055
2068
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Gas
Chr
omat
ogra
phH
P-9
Agi
lent
6890
NC
N10
6210
671
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AH
eads
pace
Sto
rage
Tek
mar
7000
US
0035
7002
0no
144
VO
CV
OC
Silv
erA
gaw
am,M
AM
ass
Spe
ctro
met
erH
P-8
Agi
lent
5973
US
4464
6987
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
-2A
gile
nt59
75C
US
8081
8565
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
-3A
gile
nt59
75C
US
7121
5937
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
-4A
gile
nt59
75C
US
1043
7501
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
-7A
gile
nt59
75C
US
7121
5999
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
-1A
gile
nt59
73U
S54
4417
491
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AM
ass
Spe
ctro
met
erH
P-9
Agi
lent
5975
US
5442
1547
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Mas
s S
pect
rom
eter
HP
-5A
gile
nt59
73U
S10
4420
981
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AO
ven
VO
C1
Fis
her
516G
1020
0123
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Ref
riger
ator
#27
Gen
eral
Ele
ctric
SC
2SG
C80
1835
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Ref
riger
ator
#21
TR
UE
GD
M69
1-35
3015
51
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AR
efrig
erat
or#2
9T
RU
EG
DM
451-
4773
992
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Son
icat
orV
OC
F
ishe
rF
S20
RS
A07
0270
060
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Vac
uum
Pum
pH
P-9
Edw
ards
1.5
0462
8217
41
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AV
acuu
m P
ump
HP
-2E
dwar
ds1.
527
5816
761
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AV
acuu
m P
ump
HP
-3E
dwar
ds1.
597
2152
597
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Vac
uum
Pum
pH
P-4
Edw
ards
1.5
9860
1920
91
yes
144
VO
CV
OC
Silv
erA
gaw
am,M
AV
acuu
m P
ump
HP
-1E
dwar
ds1.
570
0135
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Vac
uum
Pum
pH
P-5
Pfe
iffer
Duo
-2.5
2104
2836
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Vac
uum
Pum
pH
P-7
Pfe
iffer
Duo
-2.5
2121
7234
1ye
s14
4V
OC
VO
CS
ilver
Aga
wam
,MA
Vac
uum
Pum
pH
P-9
Pfe
iffer
Duo
-2.5
2123
3388
0no
144
Sto
rage
VO
CS
ilver
Aga
wam
,MA
3 P
lace
Dig
este
rT
KN
#1G
las-
Col
104A
RL4
312
4720
511
yes
126
Wet
che
m A
CWE
T C
HE
MA
lmgr
enA
gaw
am,M
A3
Pla
ce D
iges
ter
TK
N#2
Gla
s-C
ol10
4A R
L431
238
5317
1ye
s12
6W
et c
hem
ACW
ET
CH
EM
Alm
gren
Aga
wam
,MA
rA A
tom
NA
N Enc
on #
2E 31
0031
00E
velo
utio
nE
velo
utio
3100
3 3100
3100
Str
atum
Str
atum
atumum mm
XP
T
C C84
7C
1105
305
3T
1722
7B0
T17
227B
0N
/AN
/AU
S00
0095
52S
000
US
1034
3008
US
1034
3008
CN
1054
6066
CN
1054
6066
N10
5030
05N
1050
3005
0805
006
0805
006
1902
424 1994
Copye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s14
0no
144
0no op
y
1ye
s14
41
yes
11
yes
144
es1
1ye
s14
4V
yes
144
yes
144
VO
C14
4es
144
VO
C14
4V
144
VO
C14
4V
144
VO
C44
VO
C14
4V
OC
VO
Cy
144
VO
44 4V
Am
mon
ia D
istil
ler
Am
m#1
Labc
onco
2128
5-01
2602
311
yes
126
Wet
che
m A
CWE
T C
HE
MA
lmgr
enA
gaw
am,M
AA
mm
onia
Dis
tille
r A
mm
#2La
bcon
co21
285-
0120
2799
1ye
s12
6W
et c
hem
ACW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Aut
osam
pler
Lach
at1
Aut
osam
pler
Cet
acA
SX
-250
0307
63A
520
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Aut
osam
pler
TO
C1
Aut
osam
pler
Tek
mar
ST
S-8
000
190D
1135
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Aut
osam
pler
DX
120
IC1
Dio
nex
AS
40-1
0307
0056
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Aut
osam
pler
ICS
2000
IC2
Dio
nex
AS
40-1
0104
0553
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Aut
osam
pler
TO
CT
OC
2 A
utos
ampl
erT
ekm
arS
TS
-800
019
0L83
400
no12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
5D
enve
r In
stru
men
tsM
-220
PO
1074
631
yes
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AB
alan
ceS
cale
#8
Den
ver
Inst
rum
ents
AP
X-2
00A
2403
4055
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
10M
ettle
r T
oled
oX
S20
411
2751
0277
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
9M
ettle
r T
oled
oX
S40
3S11
2602
1064
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
13O
hous
SC
6010
BJ4
3406
11
yes
126
Wet
che
m s
oWE
T C
HE
MA
lmgr
enA
gaw
am,M
AB
alan
ceS
cale
#17
Oha
usA
V21
0180
3319
1103
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Bal
ance
Sca
le #
1 D
enve
rA
PX
-402
A42
0660
111
yes
126
Wet
che
m s
oWE
T C
HE
MA
lmgr
enA
gaw
am,M
AB
alan
ceS
cale
#14
Oha
usA
V81
280
3315
1106
1ye
s12
6W
et c
hem
LeW
ET
CH
EM
Alm
gren
Aga
wam
,MA
BO
D In
cuba
tor
#5V
WR
2020
0200
692
1ye
s12
6H
allw
ayW
ET
CH
EM
Alm
gren
Aga
wam
,MA
BO
D L
ow T
emp
Incu
bato
r#3
4V
WR
Sci
entif
icP
F20
2008
0875
081
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AC
OD
Rea
ctor
#1H
ach
4560
0-00
9404
0001
0763
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
CO
D R
eact
or#2
Hac
h45
600-
0099
0900
0194
101
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AC
OD
Rea
ctor
#3H
ach
1650
0-10
8808
1129
01
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AC
ondu
ctiv
ity M
eter
pH /
cond
uctiv
ity m
eter
Met
tler
Tol
edo
Sev
enm
ulti
1227
3170
101
yes
126
Wet
che
m s
oWE
T C
HE
MA
lmgr
enA
gaw
am,M
AC
yani
de /
amm
onia
App
arat
usW
etK
onte
sM
idi-V
ap 2
000
706
1ye
s12
6W
et c
hem
acW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Cya
nide
App
arat
usW
etLa
b C
rest
/And
rew
s11
0-10
-RA
6R10
191
yes
126
Wet
che
m a
cWE
T C
HE
MA
lmgr
enA
gaw
am,M
AD
esic
cato
r C
abin
etW
etN
alge
ne53
17N
/A0
no12
6S
tora
geW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Des
icca
tor
Cab
inet
Wet
San
plat
ecD
ry K
eepe
rN
A3
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
DI W
ater
Sys
tem
DI s
yste
mE
lga
UID
203
042
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Dis
sica
tor
Met
al D
issi
cato
rB
oeke
l13
4410
3624
864
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Dis
solv
ed O
xyge
n M
eter
DO
met
erY
SI
5000
00G
1001
AU
1ye
s12
6W
et c
hem
ro
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AD
istil
latio
n (
Wat
er )
Stil
lC
orni
ngM
ega
6 Li
ter
Aut
o M
P6
0011
840
no12
6S
tora
geW
ET
CH
EM
Alm
gren
Aga
wam
,MA
DO
Met
erD
O M
eter
Acc
umet
XL4
0X
L940
0319
81
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AF
IDW
etF
oxbo
roO
VA
128
A41
900
1ye
s12
6W
et c
hem
ro
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AF
ID/P
ID (
Tox
ic V
apor
Ana
lyze
r)F
ID/P
IDF
oxbo
roT
VA
-100
010
2441
714
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Fla
sh T
este
rF
or P
arts
Koe
hler
K16
200
R61
0916
48A
0no
501
Sto
rage
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AF
lash
Tes
ter
For
Par
tsK
oehl
erK
1620
0R
6109
1929
0no
501
Sto
rage
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AF
lash
poin
tF
lash
#3K
oehl
erK
1620
0R
0700
211
yes
126
Wet
che
m s
oWE
T C
HE
MA
lmgr
enA
gaw
am,M
AG
lass
Des
icca
tor
Wet
2P
yrex
NA
NA
21
yes
126
Hal
lway
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AH
ood
Sel
f con
tain
edE
RLA
P/C
apta
irF
iltai
r-X
L810
410
9-19
981
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AH
ood
Wet
28
Fis
her
No
Vis
ible
Num
bers
N/A
1ye
s12
4W
et c
hem
ro
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AH
ood
#16
Fis
her
/ Ham
ilton
??
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Hoo
d#2
9F
ishe
r / H
amilt
on?
?1
yes
126
Wet
che
m A
CWE
T C
HE
MA
lmgr
enA
gaw
am,M
AH
ood
(6 ft
)21
No
mar
king
sN
o V
isib
le N
umbe
rsN
/A1
yes
126
Wet
che
m A
CWE
T C
HE
MA
lmgr
enA
gaw
am,M
AH
ot P
late
/Stir
rer
#9C
ole
Par
mer
51
450-
7298
1010
2223
431
yes
126
Wet
che
m A
CWE
T C
HE
MA
lmgr
enA
gaw
am,M
AIC
(D
ione
x)IC
1D
ione
x#D
X-1
2001
0313
760
no12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
IC D
ione
xIC
2D
ione
xIC
S-2
000
0304
0056
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Incu
bato
rIn
cuba
tor
2T
helc
o2
?1
yes
126
Wet
che
m s
oWE
T C
HE
MA
lmgr
enA
gaw
am,M
AIN
CU
TR
OL
Wet
Hac
h25
97-0
000
0700
0105
730
no12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
INC
UT
RO
LW
etH
ach
2597
A90
0107
979
0no
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AIo
n A
naly
zer
Mic
ro
Orio
n94
0S
X22
3A1
yes
117
Mic
robi
olog
yM
ICR
OB
IOA
lmgr
enA
gaw
am,M
AM
etro
hm 8
58 P
rofe
ssio
nal S
ampl
e P
roce
ssor
IC3
auto
sam
pler
Met
rohm
858
Pro
fess
iona
l18
5800
2003
675
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Ag
awam
,MA
Met
rohm
881
Com
pact
IC p
roIC
3M
etro
hm88
1 C
ompa
ct IC
pro
1881
0001
2411
71
yes
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AM
etro
hm a
utos
ampl
er a
uto-
dilu
tor
IC3
auto
-dilu
tor
Met
rohm
n/a
1800
0010
7230
81
yes
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AM
uffle
Fur
nace
Muf
fle fu
rnac
eT
herm
olyn
eF
3042
8C10
5901
0109
782
0no
126
Caf
eter
iaW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Muf
fle F
urna
ceM
uffle
furn
ace
The
rmol
yne
F30
428C
-78
7189
5080
9034
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Ove
n#2
Blu
e-M
OV
-490
A-3
OV
-684
71
yes
126
Wet
che
m s
oWE
T C
HE
MA
lmgr
enA
gaw
am,M
AO
ven
#1B
lue-
MO
V-4
90A
-3O
V-6
848
0no
126
Wet
che
m r
oW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Ove
n#5
Fis
her
Isot
emp
500
518G
803N
0090
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Ove
nT
OC
Ove
nF
ishe
r51
6G90
8N03
061
yes
126
Wet
che
m s
oWE
T C
HE
MA
lmgr
enA
gaw
am,M
AO
ven
#3T
helc
o65
5760
3354
-171
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
pH M
eter
pH m
eter
Oak
ton
pH27
0086
1795
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Pip
et W
ashe
r/R
inse
rW
etN
alge
ne54
25N
/A0
no12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Pos
itive
Dis
plac
emen
t TC
LP U
nit
Wet
Mill
ipor
eX
X67
00P
0594
--84
906-
296
0no
126
Wet
che
m L
eWE
T C
HE
MA
lmgr
enA
gaw
am,M
AP
ump
Pum
pB
arna
nt40
0-85
00N
A1
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Pum
pP
ump
Bar
nant
400-
1901
FO
4002
977
1ye
s12
6W
et c
hem
soW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Pum
p V
acuu
mW
etG
ast
Doa
p704
-AA
0311
0114
431
yes
126
Wet
che
m L
eWE
T C
HE
MA
lmgr
enA
gaw
am,M
AQ
uick
Che
m 8
500
Ser
ies
2La
chat
2La
chat
8500
Ser
ies
211
0200
0013
111
yes
126
Wet
che
m r
oW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Qui
ck C
hem
FIA
Lach
at 1
Lach
at80
00 S
erie
sA
8830
00-1
904
1ye
s12
6W
et c
hem
ro
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AR
eage
nt P
ump
Pum
pLa
chat
RP
-100
A82
000-
665
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Rea
gent
Pum
pP
ump
Lach
atR
P-1
50A
8200
0-24
501
yes
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AR
efrig
erat
or10
Tru
eG
DM
6912
0278
301
yes
130
Hal
lway
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AR
efrig
erat
or8
Whi
rlpoo
lE
T19
TK
XLN
R2
5511
2349
91
yes
130
Hal
lway
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AR
efrig
erat
or I
ncub
ator
#6A
VW
R S
cien
tific
2020
0502
092
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Rot
ator
#1H
ouse
mad
eno
neno
ne1
yes
126
Wet
che
m L
eWE
T C
HE
MA
lmgr
enA
gaw
am,M
AUnc
ontro
lled
entif
icen
tific
4 4560
1650
0-1 S
even
mul
S Mid
i-Vap
200
Mid
i-Va
110-
10-R
110-
10-R
5317
5317
Dry
Kee
per
Dry
Kee
per
4
Lite
r A
uto
MP
6A
uto
MP
6
R6
R61
0R
0700
2R
0700
2N
A2
NA
210
9-19
9810
9-19
98N
/AN
/A?? ??
/AA01
0222
343
0102
2234
337
6Copye
1ye
s1
yes op
0no
0no
0no
0no
1ye
s1
1ye
s1
yes
126
1ye
s1
yes
126
1ye
s1
1ye
s12
61
yes
10
no12
6C
no12
6ye
s12
6W
et
126 py
yes
126
Wet
che
126
W12
6W
et c
hem
126
W12
6W
et c
hem
26W
et c
h12
6W
et c
hW
et c
y
126
We
26 6W
Sie
ve S
hake
rW
etC
ombu
stio
n E
ngin
eerin
gM
obel
RX
-86
N/A
1ye
s12
6H
allw
ayW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Spe
ctro
phot
omet
erW
etH
ach
Dr/
3000
1960
0-00
9109
0316
01
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AS
pect
roph
otom
eter
Wet
The
rmo
Evo
lutio
n 30
0 B
BE
V31
5140
21
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AS
tir P
late
#10
Fis
her
1451
11A
123
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Stir
pla
te#1
Fis
her
11-6
00-1
6510
3N01
011
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AS
tir p
late
#2F
ishe
r14
-505
-21
902N
0060
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Stir
pla
te#3
Fis
her
11-6
00-1
6S10
3N00
911
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AS
tir p
late
#5F
ishe
r14
-511
-1A
?1
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AS
tir p
late
#6F
ishe
r14
-511
-IV
2?
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Stir
pla
te#7
The
rmo
S13
1125
C17
6010
0604
224
1ye
s12
6W
et c
hem
ACW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Stir
rer
(Mag
netic
)#4
Cor
ning
PC
-410
4409
351
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AS
tirrin
g ho
t pla
te#8
Lab
Dep
otH
4000
-HS
2012
0104
109
1ye
s12
6W
et c
hem
ACW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Stir
ring
hot p
late
#11
IKA
RT
15 P
S1
03.2
8275
81
yes
126
Wet
che
m L
eWE
T C
HE
MA
lmgr
enA
gaw
am,M
AT
itrat
orT
itrat
orM
ettle
r-T
oled
oD
L55
5127
1333
501
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AT
itrat
orT
itrat
or a
utos
ampl
erM
ettle
r-T
oled
oR
ondo
60
5127
4341
351
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AT
OC
Boa
t Sam
pler
TO
C s
oil s
ampl
erT
ekm
ar18
3U
S01
1300
111
yes
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AT
otal
Org
anic
Car
bon
Ana
lyze
rT
OC
2T
ekm
arA
pollo
900
0U
S06
2820
051
yes
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AT
otal
Org
anic
Car
bon
Ana
lyze
rT
OC
1T
ekm
arA
pollo
900
099
2070
041
yes
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AT
urbi
dim
eter
Tur
bidi
met
erH
AC
H21
00N
Tur
bid
0504
0001
0294
1ye
s12
6W
et c
hem
mW
ET
CH
EM
Alm
gren
Aga
wam
,MA
Wes
tco
Sm
art D
iges
ter
DIS
1W
estc
o40
/20
1509
1ye
s12
6W
et c
hem
ACW
ET
CH
EM
Alm
gren
Aga
wam
,MA
XY
Z S
ampl
erLa
chat
1La
chat
XY
Z-A
SX
500
A8-
5301
010
0no
126
Wet
che
m in
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AX
YZ
Sam
pler
Lach
at 2
Lach
atA
SX
520
0111
44A
520
1ye
s12
6W
et c
hem
inW
ET
CH
EM
Alm
gren
Aga
wam
,MA
pH M
eter
pH m
eter
Orio
n S
tar
A21
1X
1327
61
yes
126
Wet
che
m m
WE
T C
HE
MA
lmgr
enA
gaw
am,M
AA
utob
lock
sys
tem
Aut
oblo
ckE
nviro
nmen
tal E
xpre
ss
AB
4001
P.O
. 300
531
yes
Alm
gren
Aga
wam
,MA
Com
pute
rac
coun
ting
HP
DC
7700
MX
L751
0PM
H1
yes
107
Offi
ceA
ccou
ntin
gS
ilver
Aga
wam
,MA
LCD
acco
untin
gN
EC
Acc
uSyn
c LC
D72
VX
75D
1283
3NA
1ye
s10
7O
ffice
Acc
ount
ing
Silv
erA
gaw
am,M
AC
ompu
ter
acco
untin
g2H
P40
00 P
ro S
FF
2UA
2160
00L
1ye
s10
7C
ubes
Acc
ount
ing
Silv
erA
gaw
am,M
ALC
Dac
coun
ting2
Vie
wS
onic
VA
703b
Q85
0739
6183
31
yes
107
Cub
esA
ccou
ntin
gS
ilver
Aga
wam
,MA
Com
pute
rcs
cher
paH
P40
00 P
ro S
FF
MX
L220
16R
Q1
yes
107
Cub
esA
ccou
ntin
gS
ilver
Aga
wam
,MA
LCD
csch
erpa
Phi
lips
170S
BZ
0005
0821
8972
1ye
s10
7C
ubes
Acc
ount
ing
Silv
erA
gaw
am,M
AC
ompu
ter
jflor
esH
P40
00 P
ro S
FF
2UA
1280
SZ
21
yes
107
Offi
ceA
ccou
ntin
gS
ilver
Aga
wam
,MA
LCD
jflor
esV
iew
Son
icV
A70
3bQ
AG
0738
6397
51
yes
107
Offi
ceA
ccou
ntin
gS
ilver
Aga
wam
,MA
Prin
ter
jflor
esH
PLa
serJ
et P
2035
VN
B3D
4158
21
yes
107
Offi
ceA
ccou
ntin
gS
ilver
Aga
wam
,MA
Com
pute
rm
seve
ranc
eH
P40
00 P
ro S
FF
2UA
2051
4VY
1ye
s10
7O
ffice
Acc
ount
ing
Silv
erA
gaw
am,M
ALC
Dm
seve
ranc
eV
iew
Son
icV
A70
3bQ
8507
4961
887
1ye
s10
7O
ffice
Acc
ount
ing
Silv
erA
gaw
am,M
AP
rinte
rm
seve
ranc
eH
PLa
serJ
et 2
200
JPG
GB
4297
31
yes
107
Offi
ceA
ccou
ntin
gS
ilver
Aga
wam
,MA
Com
pute
rss
nope
kH
P40
00 P
ro S
FF
MX
L214
169W
1ye
s10
7O
ffice
Acc
ount
ing
Silv
erA
gaw
am,M
ALC
Dss
nope
kV
iew
Son
icV
A70
3bQ
8507
4961
880
1ye
s10
7O
ffice
Acc
ount
ing
Silv
erA
gaw
am,M
AP
rinte
rss
nope
kH
PLa
serJ
et P
2035
VN
B3D
4157
51
yes
107
Offi
ceA
ccou
ntin
gS
ilver
Aga
wam
,MA
Com
pute
rcw
hite
HP
4000
Pro
SF
FM
XL2
070L
K0
1ye
s10
7O
ffice
Adm
inA
lmgr
enA
gaw
am,M
ALC
Dcw
hite
LGE
2411
PB
303M
XW
E8M
057
1ye
s10
7O
ffice
Adm
inA
lmgr
enA
gaw
am,M
AP
rinte
rcw
hite
HP
Lase
rJet
220
0C
ND
RC
6617
31
yes
107
Offi
ceA
dmin
Alm
gren
Aga
wam
,MA
Com
pute
rgt
ayeh
HP
DC
7700
MX
L751
0V0X
1ye
s10
7O
ffice
Adm
inS
ilver
Aga
wam
,MA
LCD
gtay
ehV
iew
Son
icV
A70
3bQ
8507
4961
874
1ye
s10
7O
ffice
Adm
inS
ilver
Aga
wam
,MA
Com
pute
rjo
conn
orH
P40
00 P
ro S
FF
2UA
1331
KC
21
yes
107
Offi
ceA
dmin
Silv
erA
gaw
am,M
ALC
Djo
conn
orLG
Fla
tron
W24
42P
A-B
F10
5ND
PH
A62
401
yes
107
Offi
ceA
dmin
Silv
erA
gaw
am,M
ALC
Djo
conn
orLG
Fla
tron
E24
1140
1MX
TC
6954
51
yes
107
Offi
ceA
dmin
Silv
erA
gaw
am,M
AP
rinte
rjo
conn
orH
PLa
serJ
et 2
100
US
GX
0482
001
yes
107
Offi
ceA
dmin
Silv
erA
gaw
am,M
AC
ompu
ter
nlej
aH
PP
roD
esk
400
G1
SF
FM
XL4
211J
R4
1ye
s10
7O
ffice
Adm
inS
ilver
Aga
wam
,MA
LCD
nlej
aLG
Fla
tron
W24
42P
A-B
F10
3ND
HB
FE
137
1ye
s10
7O
ffice
Adm
inS
ilver
Aga
wam
,MA
LCD
nlej
aLG
Fla
tron
W24
42P
A-B
F10
6ND
SK
6975
01
yes
107
Offi
ceA
dmin
Silv
erA
gaw
am,M
AP
rinte
rnl
eja
HP
Lase
rJet
P20
55d
CN
BJC
0056
91
yes
107
Offi
ceA
dmin
Silv
erA
gaw
am,M
AC
ompu
ter
air1
Com
paq
Evo
D31
0U
SV
3160
1JK
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
LCD
air1
Vie
wS
onic
VA
703b
QA
G07
3863
492
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
Com
pute
rai
r2C
ompa
qE
vo D
510
6X31
-KN
9Z-G
02N
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
LCD
air2
Del
l19
08F
Pt
CN
-0F
P18
2-71
618-
7AT
-RM
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
Com
pute
rai
r3H
PD
C79
00 S
FF
MX
L917
12H
N1
yes
107
Air
Air
Silv
erA
gaw
am,M
ALC
Dai
r3H
PL1
702
CN
N51
514T
41
yes
107
Air
AIr
Silv
erA
gaw
am,M
AU
PS
air3
AP
CS
mar
t-U
PS
220
0US
WS
1308
1801
921
yes
107
Air
Air
Silv
erA
gaw
am,M
AC
ompu
ter
air4
HP
DC
7100
2UA
5410
XZ
V1
yes
107
Air
Air
Silv
erA
gaw
am,M
ALC
Dai
r4H
PL1
706
CN
C71
8PW
TQ
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
Com
pute
rai
r5C
ompa
qE
vo D
530
US
V33
203Z
F1
yes
107
Air
Air
Silv
erA
gaw
am,M
ALC
Dai
r5V
iew
Son
icV
A70
3bQ
AG
0738
6400
31
yes
107
Air
Air
Silv
erA
gaw
am,M
AC
ompu
ter
bfis
kH
P40
00 P
ro S
FF
2UA
1410
1PC
1ye
s10
7C
ubes
Air
Silv
erA
gaw
am,M
ALC
Dbf
isk
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1201
2034
81
yes
107
Cub
esA
irS
ilver
Aga
wam
,MA
LCD
bfis
kLG
Fla
tron
E24
1120
2ND
NU
2P55
91
yes
107
Cub
esA
irS
ilver
Aga
wam
,MA
Com
pute
rcl
eane
r1H
PP
roD
esk
400
G1
SF
F2U
A43
90X
3X1
yes
107
Air
Air
Silv
erA
gaw
am,M
ALC
Dcl
eane
r1D
ell
MX
05R
1084
7605
28G
CT
T3
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
Com
pute
rcl
eane
r2C
ompa
qD
eskp
ro E
N61
18-F
HG
Z-A
362
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
LCD
clea
ner2
Del
lU
ltraS
harp
MX
05R
1084
7605
28G
CT
T5
1ye
s10
7A
irA
irS
ilver
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
230
0C
NB
CC
2547
81
yes
107
Air
Air
Silv
erA
gaw
am,M
AC
ompu
ter
apar
edes
HP
Pro
Des
k 40
0 G
1 S
FF
MX
L412
0WC
C1
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Uncon
trolle
d
rA 21
0040
/20
4 XY
Z-A
SX
X
YA
SX
520
AS
X52
A21
1A
211
AB
4001
AB
4001
DC
7700
DC
7700
Acc
uSyn
c LC
D72
VX
Acc
uSyn
c LC
D72
0 P
ro S
FF
Pro
SF
F3b3b
SF
FF
V 2UA
Q85
074
5074
JPG
GB
42P
GG
B42
MX
L214
169W
MX
L214
1Q
8507
4961
880
8507
VN
B3D
4157
5V
NB
3D41
575
MX
L207
0LK
0M
XL2
070L
K0
03M
XW
E8M
057
3MX
WE
8M05
7D
RC
6617
3D
RC
6617
310
V0X
V0X
6187
418
74 220
Coye1
yes
1ye
s1
yes
1ye
s
Copy
1ye
s1
yes
101
yes
107
1ye
s1
yes
107
1ye
s1
1ye
s10
7es
11
yes
107
Oye
s10
7ye
s10
7A
ir10
7es
107
Air
107
A
py107
Air
107
A10
7A
ir07
Air
107
Air
7A
ir10
7A
ir07
y7A
LCD
apar
edes
LGF
latr
on E
2411
110N
DR
F44
094
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AC
ompu
ter
csH
PD
C77
00M
XL7
510R
YR
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
ALC
Dcs
Phi
lips
170S
BZ
0006
1411
6747
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AS
cann
ercs
Can
onC
anoS
can
LiD
E 2
10K
EK
A38
305
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AC
ompu
ter
dlitc
hfie
ldH
P43
00 P
ro S
FF
2UA
3380
YQ
L1
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Lapt
opdl
itchf
ield
IBM
Thi
nkP
ad R
60LV
-BG
660
1ye
s10
7M
obile
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
ALC
Ddl
itchf
ield
LGF
latr
on E
2411
202N
DK
D2P
989
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AC
ompu
ter
jhar
acz
HP
4000
Pro
SF
FM
XL2
070L
K2
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
ALC
Djh
arac
zV
iew
Son
icV
A70
2bP
SX
0535
0404
41
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
LCD
jhar
acz
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1215
2041
91
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Prin
ter
jhar
acz
HP
Lase
rJet
425
0C
NR
XX
2471
01
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Com
pute
rlc
haffe
eH
P40
00 P
ro S
FF
2UA
2291
C0Y
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
ALC
Dlc
haffe
eP
hilip
s17
0SB
Z00
0520
1360
791
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
LCD
lcha
ffee
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1215
2042
21
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Prin
ter
lcha
ffee
HP
Lase
rJet
425
0C
NG
XB
8312
91
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Com
pute
rm
butle
rH
PP
roD
esk
400
G1
SF
F2U
A44
00H
H5
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
ALC
Dm
butle
rV
iew
Son
icV
A22
23w
m-L
ED
ST
C12
1520
417
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
ALC
Dm
butle
rLG
Fla
tron
E24
1120
7ND
DM
DM
642
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AP
rinte
rm
butle
rH
PLa
serJ
et P
3015
VN
BC
C1J
1K8
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AC
ompu
ter
rmer
zH
PP
roD
esk
400
G1
SF
F2U
A42
11R
791
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
LCD
rmer
zLG
Fla
tron
W24
42P
A-B
F10
5ND
PH
5L37
61
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Fax
Mur
atec
MF
X-1
700
D88
3809
0064
027
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AF
axM
urat
ecM
FX
-145
090
1830
201
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
P20
35V
NB
3253
944
1ye
s10
7O
ffice
Clie
nt S
ervi
ces
Silv
erA
gaw
am,M
AP
rinte
rH
PC
olor
Las
erJe
t 465
0JP
CA
CC
0048
81
yes
107
Offi
ceC
lient
Ser
vice
sS
ilver
Aga
wam
,MA
Cop
ier
HP
Lase
rJet
500
MF
P M
525
MX
DC
F7J
02D
1ye
s10
7C
opy
SA
I1A
lmgr
enA
gaw
am,M
AC
opie
rK
onic
a M
inol
tabi
zhub
363
A1U
E01
1014
225
1ye
s10
7C
opy
SA
I1A
lmgr
enA
gaw
am,M
AF
axH
PLa
serJ
et M
2727
nfC
NC
Y77
90P
K1
yes
107
Cop
y S
AI1
Alm
gren
Aga
wam
,MA
Cop
ier
HP
Lase
rJet
500
MF
P M
525
MX
FC
G8F
1C2
1ye
s10
7C
opy
SA
I2S
ilver
Aga
wam
,MA
Fax
HP
Lase
rJet
M27
27nf
CN
D98
2V0C
01
yes
107
Cop
y S
AI2
Silv
erA
gaw
am,M
AC
ompu
ter
bbris
tol
HP
DC
7700
MX
L751
0V6J
1ye
s10
7O
ffice
Cou
rier
Silv
erA
gaw
am,M
ALC
Dbb
risto
lV
iew
Son
icV
A70
3bQ
AG
0738
6352
21
yes
107
Offi
ceC
ourie
rS
ilver
Aga
wam
,MA
Prin
ter
bbris
tol
HP
Lase
rJet
P20
35V
NB
3D97
079
1ye
s10
7O
ffice
Cou
rier
Silv
erA
gaw
am,M
AC
ompu
ter
kwhi
teH
PD
C78
00 U
SD
TM
XL8
0705
LN1
yes
107
Offi
ceC
ourie
rA
lmgr
enA
gaw
am,M
ALC
Dkw
hite
Vie
wS
onic
VA
703b
QA
G07
3961
193
1ye
s10
7O
ffice
Cou
rier
Alm
gren
Aga
wam
,MA
Com
pute
rpr
eser
vatio
nC
ompa
qE
vo D
510
6X31
-KN
9Z-W
1F3
1ye
s10
7A
irC
ourie
rS
ilver
Aga
wam
,MA
LCD
pres
erva
tion
Vie
wS
onic
VA
703b
QA
G07
3863
960
1ye
s10
7A
irC
ourie
rS
ilver
Aga
wam
,MA
Com
pute
rsh
ippi
ngH
PD
C58
502U
A90
61G
681
yes
107
Air
Cou
rier
Silv
erA
gaw
am,M
ALC
Dsh
ippi
ngP
hilip
s17
0B47
9174
411
yes
107
Air
Cou
rier
Silv
erA
gaw
am,M
AP
rinte
rsh
ippi
ngZ
ebra
ZP
450
26A
0852
0081
71
yes
107
Air
Cou
rier
Silv
erA
gaw
am,M
AC
ompu
ter
jmill
erH
PD
C78
00 U
SD
TM
XL8
0205
WJ
1ye
s10
7O
ffice
H&
SA
lmgr
enA
gaw
am,M
ALC
Djm
iller
Vie
wS
onic
VA
703b
QA
G07
3962
163
1ye
s10
7O
ffice
H&
SA
lmgr
enA
gaw
am,M
AN
AS
arch
ive
Buf
falo
TS
-H3.
0TG
L/R
595
8212
7870
1852
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AN
AS
arch
ive2
Buf
falo
TS
-XE
4.0T
L/R
595
8328
1040
0145
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AN
AS
arch
ive3
Buf
falo
TS
-XE
4.0T
L/R
595
8328
2030
0134
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AC
ompu
ter
dtay
ehH
PD
C77
00M
XL7
510P
GZ
1ye
s10
7IT
Silv
erA
gaw
am,M
ALC
Ddt
ayeh
Vie
wS
onic
VA
703b
Q85
0749
6190
91
yes
107
ITS
ilver
Aga
wam
,MA
Com
pute
rjn
avar
oli
HP
4000
Pro
SF
FM
XL1
260W
RK
1ye
s10
7O
ffice
ITS
ilver
Aga
wam
,MA
LCD
jnav
arol
iH
PL1
910
CN
K90
404C
S1
yes
107
Offi
ceIT
Silv
erA
gaw
am,M
ALC
Djn
avar
oli
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1224
0067
31
yes
107
Offi
ceIT
Silv
erA
gaw
am,M
AC
ompu
ter
mfe
llow
sH
P40
00 P
ro S
FF
2UA
2350
0RF
1ye
s10
7O
ffice
ITS
ilver
Aga
wam
,MA
LCD
mfe
llow
sV
iew
Son
icV
A70
3bQ
8507
4961
901
1ye
s10
7O
ffice
ITS
ilver
Aga
wam
,MA
LCD
mfe
llow
sV
iew
Son
icV
A22
23w
mS
TC
1228
0131
81
yes
107
Offi
ceIT
Silv
erA
gaw
am,M
ALC
Dtim
e1P
rince
ton
1510
JCC
F12
0198
71
yes
107
Logi
nIT
Alm
gren
Aga
wam
,MA
LCD
time2
Prin
ceto
n15
10JC
CF
1203
227
1ye
s10
7Lo
bby
SA
I2IT
Silv
erA
gaw
am,M
AS
erve
rvm
s1H
PP
roLi
ant D
L360
G6
US
E03
1N29
Z1
yes
107
Net
wor
k S
AII
TS
ilver
Aga
wam
,MA
Ser
ver
vms2
HP
Pro
Lian
t ML3
50 G
6M
XQ
1260
B6D
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AS
erve
rvm
s3H
PP
roLi
ant M
L350
G6
MX
Q20
30H
C9
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AA
SA
Cis
co55
05JM
X16
42Z
1JH
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AC
ompu
ter
HP
DC
5700
MX
M71
606R
S0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
HP
DC
7800
US
DT
MX
L802
05X
V0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
HP
DC
7800
US
DT
MX
L802
05Y
Z0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
HP
DC
7800
US
DT
MX
L807
05P
N0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
Del
lO
ptiP
lex
745
50P
6SC
10
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
HP
D22
0MM
XD
4100
32D
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Com
pute
rH
PD
C50
002U
B60
100Z
D0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
Del
lO
ptiP
lex
960
8M82
QL1
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Com
pute
rC
ompa
qE
vo D
5pS
X20
3JY
HZ
A91
80
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
Com
paq
Evo
D5p
SX
203J
YH
ZA
862
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Com
pute
rC
ompa
qE
vo D
510
V30
2KN
9ZB
663
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Com
pute
rH
PD
C78
00 U
SD
TM
XL8
0705
K3
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Com
pute
rH
PD
C50
00M
XL5
0901
BR
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Uncon
trolle
d
ccF La
sP
roD
eP F
latr
on W
Fl
MF
X-1
700
MF
X-1
MF
X-1
450
MF
X-1
45La
serJ
et P
2035
Lase
rJet
C
olor
Las
erJe
t 465
0C
olor
Las
erJe
t La
serJ
et 5
00 M
FP
M52
aser
Jet 5
00 M
Fhu
b 36
3b
3Je
t M27
27nf
et M
2727
nf50
0 M
FP
M52
500
MF
P M
525
2727
nf72
V MX
LQ
AG
07G
076X
31-K
N9Z
6X31
-KN
9Q
AG
0738
639
QA
G07
382U
A90
61G
68U
A90
4791
7441
4791
7441
26A
0852
0081
726
A08
5200
81M
XL8
0205
WJ
XL8
0205
WJ
G07
3962
163
G07
3962
163
2787
0185
270
1852
4001
4540
0145
0134
0134
Copye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s10
1ye
s10
71
yes
1ye
s10
71
yes
1
opy
1ye
s10
7es
11
yes
107
Oye
s10
7ye
s10
7O
ffic
107
es10
7Lo
gin
107
L10
7Lo
bby
SA
107
L10
7N
etw
ork
07N
etw
or10
7N
etw
o7
Net
wo
107
Net
07
y7N
Com
pute
rH
PD
C50
002U
B60
100V
80
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
HP
DC
5000
2UB
5520
FM
Y0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
Del
lO
ptiP
lex
790
6S91
WV
10
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AC
ompu
ter
Com
paq
Evo
D51
06X
26-K
N92
-M0X
C0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALa
ptop
Leno
voT
hink
Pad
T50
0L3
-A06
230
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALa
ptop
IBM
Thi
nkP
ad 1
860
L3-B
ZY
L40
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALa
ptop
HP
Pav
illio
n tx
2500
CN
F84
00LR
40
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALa
ptop
Ace
rE
xten
sa 4
230
LXE
BE
0Z00
6908
2698
B16
00
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALa
ptop
Ace
rE
xten
sa 4
230
LXE
BE
0Z00
6908
269B
F16
00
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A22
23w
m-L
ED
ST
C12
0620
597
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
Vie
wS
onic
VP
201M
BA
0F02
0910
252
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
NE
CA
ccuS
ync
LCD
72V
X73
F34
464N
A1
yes
107
Net
wor
k S
AII
TS
ilver
Aga
wam
,MA
LCD
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1211
2070
20
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A70
3bQ
AG
0738
6398
20
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DN
EC
Acc
uSyn
c LC
D72
VX
76M
0652
3NA
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1206
2081
90
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DD
ell
Ultr
aSha
rpM
X05
R10
8476
0535
6CL4
E0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A70
2bP
SX
0545
0528
00
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DN
EC
Mul
tiSyn
c 15
30V
2103
180T
A0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A70
3bQ
8508
0562
871
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
Vie
wS
onic
VA
703b
Q85
0739
6159
60
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A70
3bQ
8507
4961
893
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
NE
CA
ccuS
ync
LCD
72V
X75
D12
121N
A0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A70
3bQ
AG
0731
4520
70
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A70
3bQ
8507
3961
584
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
NE
CA
ccuS
ync
LCD
72V
X75
D04
590N
A0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DN
EC
Acc
uSyn
c LC
D72
VX
75D
1177
4NA
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
Vie
wS
onic
VA
703b
Q85
0739
6305
50
no10
7S
tora
geIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A22
23w
m-L
ED
ST
C12
2400
181
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
LCD
Phi
lips
170S
AU
4A06
1701
4508
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
P20
15C
NB
1N78
330
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
220
0JP
GG
H29
707
1ye
s10
7O
ffice
ITS
ilver
Aga
wam
,MA
Prin
ter
Eps
onA
rtis
an 5
0LC
JK10
7100
1ye
s10
7O
ffice
ITS
ilver
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
425
0C
NB
XB
2472
90
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 2
100
US
GX
1168
870
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AR
oute
rLi
nksy
sW
RT
54G
2 V
1C
SV
01H
B17
815
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AR
oute
rS
onic
WA
LLT
Z 2
05C
0EA
E42
3AB
941
yes
107
Net
wor
k S
AII
TS
ilver
Aga
wam
,MA
Rou
ter
Link
sys
EA
6350
14Y
10J0
9409
570
1ye
s10
7N
etw
ork
SA
IIT
Alm
gren
Aga
wam
,MA
Sca
nner
Can
onD
R-9
080C
CZ
2300
552
1ye
s10
7D
ola
Hom
eIT
Silv
erA
gaw
am,M
AS
cann
erC
anon
Can
oSca
n Li
DE
210
KE
KA
2804
80
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AS
erve
rH
PP
roLi
ant M
L350
G5
MX
Q74
6038
G0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AS
witc
hN
etge
arG
S74
8T36
U23
B39
5130
61
yes
107
Net
wor
k S
AII
TA
lmgr
enA
gaw
am,M
AS
witc
hN
etge
arG
S74
8T36
U23
B3D
512F
F1
yes
107
Net
wor
k S
AII
TA
lmgr
enA
gaw
am,M
AS
witc
hN
etge
arG
S74
8T36
U23
B37
5130
41
yes
107
Net
wor
k S
AII
TS
ilver
Aga
wam
,MA
Sw
itch
Net
gear
GS
748T
36U
1363
7508
051
yes
107
Net
wor
k S
AII
TS
ilver
Aga
wam
,MA
Sw
itch
HP
Pro
curv
e 41
08G
L J4
865A
SG
2400
2447
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Sw
itch
HP
Pro
curv
e 41
08G
L J4
865A
SG
316M
F02
E0
no10
7S
tora
geIT
Silv
erA
gaw
am,M
AS
witc
hH
PP
rocu
rve
2524
J48
13A
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Sw
itch
HP
Pro
curv
e 25
24 J
4813
AS
G43
1NV
03P
0no
107
Sto
rage
ITS
ilver
Aga
wam
,MA
Sw
itch
Net
gear
GS
748T
P1W
X82
55B
000C
31
yes
107
Net
wor
k S
AII
TS
ilver
Aga
wam
,MA
UP
SA
PC
Sm
art-
UP
S 2
200X
LQ
S06
3911
0214
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
AU
PS
AP
CS
mar
t-U
PS
220
0W
S08
0326
0139
1ye
s10
7N
etw
ork
SA
IIT
Silv
erA
gaw
am,M
ALC
DV
iew
Son
icV
A70
3bQ
8507
3961
605
0no
107
Sto
rage
IT
Silv
erA
gaw
am,M
AC
ompu
ter
auto
bloc
kC
ompa
qE
vo D
510
V30
2KN
9ZB
689
1ye
s10
7M
etal
s P
rep
Met
als
Alm
gren
Aga
wam
,MA
LCD
auto
bloc
kV
iew
Son
icV
A70
2bP
SX
0538
0582
01
yes
107
Met
als
Pre
pM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
icap
HP
DC
5000
MX
L509
018N
1ye
s10
7M
etal
sM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dic
apD
ell
1708
FP
tC
N-0
KU
789-
7161
8-71
8-A
H1
yes
107
Met
als
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
ric
ap2
Del
lO
ptiP
lex
960
5DD
MD
Q1
1ye
s10
7M
etal
sM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dic
ap2
Del
lP
1911
1ye
s10
7M
etal
sM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
icap
4D
ell
Opt
iPle
x 96
09H
Q1F
P1
1ye
s10
7M
etal
sM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dic
ap4
Del
lP
1911
CN
-08J
CG
H-7
4445
-156
-DY
1ye
s10
7M
etal
sM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
icpm
s2H
PD
220M
MX
D42
301T
X1
yes
107
Met
als
Met
als
Alm
gren
Aga
wam
,MA
LCD
icpm
s2V
iew
Son
icV
G71
0SA
2VV
0351
0040
61
yes
107
Met
als
Met
als
Alm
gren
Aga
wam
,MA
UP
Sic
pms2
AP
CS
mar
t-U
PS
300
0XLT
AS
1218
1425
281
yes
107
Met
als
Met
als
Alm
gren
Aga
wam
,MA
UP
Sic
pms2
AP
CS
mar
t-U
PS
500
0RM
TIS
1236
0014
651
yes
107
Met
als
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
rjc
lem
ent
HP
4000
Pro
SF
F2U
A12
80R
9D1
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
ALC
Djc
lem
ent
Vie
wS
onic
VS
1128
01Q
8507
3961
605
1ye
s10
7O
ffice
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
rm
ercu
ry3
Com
paq
Evo
D31
0U
SV
3190
BQ
11
yes
107
Met
als
Pre
pM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dm
ercu
ry3
Vie
wS
onic
VA
703b
Q85
0749
6192
21
yes
107
Met
als
Pre
pM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
mer
cury
4D
ell
Opt
iPle
x 74
53Q
47G
C1
1ye
s10
7M
etal
sM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dm
ercu
ry4
Del
lE
170S
cC
N-O
HF
OK
3-64
180-
22N
-1 1
yes
107
Met
als
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
rm
etal
s1D
ell
Opt
iPle
x G
X62
0H
23S
N91
1ye
s10
7O
ffice
Met
als
Alm
gren
Aga
wam
,MA
Uncon
trolle
d
onicc
V Mul
tV
A70
3V V
A70
3bV
AV
A70
3bV
A70
3A
ccuS
ync
LCD
7A
ccuS
ync
VA
703b
VA
703b
VA
703b
VA
703b
Acc
uSyn
c LC
D72
VX
Acc
uSyn
c LC
D7
cuS
ync
LCD
72V
XS
ync
LCD
72V
X3b3b
wm
-LE
DLE
D 5
LC CN
BU
SG
X1
GX
1C
SV
01H
BC
SV
01H
BC
0EA
E42
3AB
C0E
AE
4214
Y10
J094
0957
4Y10
CZ
2300
552
CZ
2300
552
KE
KA
2804
8K
EK
A28
048
MX
Q74
6038
GX
Q74
6038
G23
B39
5130
623
B39
5130
6B
3D51
2FF
512F
F75
1304
5130
480
580
5
Copye1
yes
1ye
s0
no0
no0
no0
no10
0no
107
0no
1ye
s10
71
yes
1
opy
1ye
s10
7es
11
yes
107
Nye
s10
7no
107
Sto
ra10
7es
107
Met
als
107
M10
7M
etal
s P
re10
7M
107
Met
als
07M
etal
s10
7M
etal
s7
Met
al10
7M
et07
y7M
LCD
met
als1
LGF
latr
on E
2411
309M
XW
E24
033
1ye
s10
7O
ffice
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
rm
etal
s2H
PD
C78
00 U
SD
TM
XL8
0504
XS
1ye
s10
7O
ffice
Met
als
Alm
gren
Aga
wam
,MA
LCD
met
als2
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1215
2038
31
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
met
als3
HP
4000
Pro
SF
FM
XL2
2016
951
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dm
etal
s3V
iew
Son
icV
S11
2801
Q85
0739
6160
51
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
met
als4
HP
4000
Pro
SF
FM
XL1
5129
F2
1ye
s10
7O
ffice
Met
als
Alm
gren
Aga
wam
,MA
LCD
met
als4
LGF
latr
on E
2411
206N
DG
L2F
351
1ye
s10
7O
ffice
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
rm
etal
s5H
P40
00 P
ro S
FF
MX
L140
0FV
S1
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dm
etal
s5LG
Fla
tron
W24
42P
A-B
F20
2ND
HB
2P56
91
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
met
alsp
rep1
HP
DC
7800
US
DT
MX
L805
04V
R1
yes
107
Met
als
Pre
pM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dm
etal
spre
p1V
iew
Son
icV
A70
3bQ
8507
3961
600
1ye
s10
7M
etal
s P
rep
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
rm
etal
spre
p2H
PD
C78
00 U
SD
TM
XL8
0504
XJ
1ye
s10
7M
etal
s P
rep
Met
als
Alm
gren
Aga
wam
,MA
LCD
met
alsp
rep2
Vie
wS
onic
VA
703b
Q85
0739
6158
01
yes
107
Met
als
Pre
pM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
met
alsp
rep3
HP
DC
7800
US
DT
MX
L807
05T
91
yes
107
Met
als
Pre
pM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dm
etal
spre
p3V
iew
Son
icV
A70
3bQ
8507
3961
599
1ye
s10
7M
etal
s P
rep
Met
als
Alm
gren
Aga
wam
,MA
Com
pute
rtc
ollin
sH
P40
00 P
ro S
FF
MX
L214
16F
B1
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
ALC
Dtc
ollin
sLG
Fla
tron
W24
42P
A-B
F20
2ND
PH
2P56
81
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 2
300
JPB
FG
1864
21
yes
107
Met
als
Pre
pM
etal
sA
lmgr
enA
gaw
am,M
AP
rinte
rD
ataM
axE
-Cla
ss 4
203
5388
4059
1ye
s10
7M
etal
s P
rep
Met
als
Alm
gren
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
P30
15V
NB
CC
1J1K
D1
yes
107
Offi
ceM
etal
sA
lmgr
enA
gaw
am,M
AC
ompu
ter
valg
arin
HP
DC
5000
2UB
6010
0VH
1ye
s10
7M
icro
Mic
roA
lmgr
enA
gaw
am,M
ALC
Dva
lgar
inV
iew
Son
icV
A70
3bQ
8507
4962
242
1ye
s10
7M
icro
Mic
roA
lmgr
enA
gaw
am,M
AP
rinte
rva
lgar
inH
PLa
serJ
et 1
300
CN
CB
8378
781
yes
107
Mic
roM
icro
Alm
gren
Aga
wam
,MA
Com
pute
rny
1H
PD
C50
00M
XL5
1805
FQ
1ye
s10
7N
YS
yrac
use
Syr
acus
e,N
YLC
Dny
1V
iew
Son
icV
A70
3bQ
AG
0731
4520
71
yes
107
NY
Syr
acus
eS
yrac
use,
NY
Hub
HP
J329
4AT
W13
7033
481
yes
107
NY
Syr
acus
eS
yrac
use,
NY
LCD
NE
CA
ccuS
ync
LCD
72V
X76
M06
515N
A1
yes
107
NY
Syr
acus
eS
yrac
use,
NY
Prin
ter
HP
Lase
rJet
410
0U
SJN
D17
996
1ye
s10
7N
YS
yrac
use
Syr
acus
e,N
YC
ompu
ter
klap
lant
eH
P40
00 P
ro S
FF
2UA
1410
1KK
1ye
s10
7O
ffice
QA
Silv
erA
gaw
am,M
ALC
Dkl
apla
nte
LGF
latr
on E
2411
209N
DM
TC
K59
51
yes
107
Offi
ceQ
AS
ilver
Aga
wam
,MA
Sca
nner
klap
lant
eC
anon
DR
-205
0CD
L314
542
1ye
s10
7O
ffice
QA
Silv
erA
gaw
am,M
AC
ompu
ter
sron
shau
gen
HP
4000
Pro
SF
F2U
A20
514T
S1
yes
107
Offi
ceQ
AS
ilver
Aga
wam
,MA
LCD
sron
shau
gen
LGF
latr
on W
2442
PA
-BF
105N
DV
WA
6239
1ye
s10
7O
ffice
QA
Silv
erA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 2
300
CN
BC
B25
309
1ye
s10
7O
ffice
QA
Silv
erA
gaw
am,M
AC
ompu
ter
mla
mbe
rto
HP
DC
7800
US
DT
MX
L807
05T
M1
yes
107
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
LCD
mla
mbe
rto
Vie
wS
onic
VA
703b
Q85
0739
6171
91
yes
107
Offi
ceR
&D
Alm
gren
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
220
0JP
GG
C79
165
1ye
s10
7O
ffice
R&
DA
lmgr
enA
gaw
am,M
AC
ompu
ter
aaha
med
HP
4000
Pro
SF
F2U
A14
10F
WD
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
LCD
aaha
med
Vie
wS
onic
VA
703b
QA
G07
3961
204
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Sca
nner
aaha
med
Can
onC
anoS
can
LiD
E 2
10K
EK
A24
643
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Com
pute
rem
akho
ulH
P40
00 P
ro S
FF
2UA
2051
4TZ
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
LCD
emak
houl
Vie
wS
onic
VA
703b
QA
G07
3961
178
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Sca
nner
emak
houl
Can
onC
anoS
can
LiD
E 2
10K
EK
B48
713
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Com
pute
rjh
offm
anH
PP
roD
esk
400
G1
SF
F2U
A40
90X
T3
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
LCD
jhof
fman
Vie
wS
onic
VA
703b
Q85
0739
6161
61
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
AS
cann
erjh
offm
anC
anon
Can
oSca
n Li
DE
210
KE
KC
0761
71
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
AC
ompu
ter
kwilk
inso
nH
P40
00 P
ro S
FF
2UA
1280
RC
71
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
ALC
Dkw
ilkin
son
Vie
wS
onic
VA
703b
QA
NO
8142
357
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Sca
nner
kwilk
inso
nC
anon
Can
oSca
n Li
DE
210
KE
KC
1553
31
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
AC
ompu
ter
sam
ple
HP
DC
7800
US
DT
MX
L807
05P
X1
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
ALC
Dsa
mpl
eV
iew
Son
icV
A70
3bQ
8507
3963
057
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Sca
nner
sam
ple
Can
onC
anoS
can
LiD
E 2
10K
EK
C06
235
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Com
pute
rvk
now
les
HP
DC
7800
US
DT
MX
L751
0J77
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
LCD
vkno
wle
sV
iew
Son
icV
A70
3bQ
AH
0738
6397
81
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
AS
cann
ervk
now
les
Can
onC
anoS
can
LiD
E 2
10K
EK
B37
888
1ye
s10
7O
ffice
Sam
ple
Alm
gren
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
425
0C
NR
XR
5554
91
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 4
250
CN
GX
L253
531
yes
107
Offi
ceS
ampl
eA
lmgr
enA
gaw
am,M
AC
ompu
ter
dsw
ist
HP
4000
Pro
SF
FM
XL2
290J
071
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dds
wis
tV
iew
Son
icV
A70
3bQ
AG
0730
2143
51
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dds
wis
tLG
Fla
tron
E24
1120
6ND
KD
4V89
31
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
AC
ompu
ter
hps1
1H
P40
00 P
ro S
FF
2UA
2051
4NN
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s11
Vie
wS
onic
VA
702b
PS
X05
4414
832
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s11
LGF
latr
on E
2411
206N
DLS
4V88
81
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s12
HP
4000
Pro
SF
F2U
A21
517B
21
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps1
2D
ell
CN
-OJ6
642-
7161
8-4A
S-A
G1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps1
2LG
Fla
tron
E24
1120
6ND
AY
1216
81
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s14
HP
DC
5700
MX
M74
406Z
R1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps1
4D
ell
CN
-0J6
642-
7161
8-55
U-A
G1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps1
4LG
Fla
tron
E24
111
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s15
HP
4000
Pro
SF
FM
XL2
290H
XF
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s15
LGF
latr
on E
2411
206N
DW
E4V
633
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s15
Phi
lips
170S
AU
4A06
1701
5052
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
AUnc
ontro
lled
L E-C
Lase
rJL D
C50
00D V
A70
3bV
A70
3La
serJ
et 1
300
Lase
rJet
D
C50
00D
C50
00V
A70
3bV
A70
3bJ3
294A
3294
Acu
Syn
c LC
D72
VX
Syn
c LC
D72
VX
Jet 4
100
et 4
100
SF
FF 111
FF10 C
NB
MX
L80
L80
Q85
0739
6Q
8507
396
JPG
GC
7916
JPG
GC
72U
A14
10F
WD
UA
14Q
AG
0739
6120
4Q
AG
0739
612
KE
KA
2464
3K
EK
A24
643
UA
2051
4TZ
A20
514T
ZG
0739
6117
8G
0739
6117
887
133 XT
3T
3 1616
Copye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s10
opy
1ye
s10
71
yes
1ye
s10
71
yes
11
yes
107
es1
1ye
s10
7O
yes
107
yes
107
Offi
c10
7es
107
Offi
ce10
7O
107
Offi
ce10
7O
107
Offi
ce07
Offi
cey
107
Offi
ce7
Offi
ce10
7O
ffi07 7
O
Com
pute
rhp
s16
HP
DC
7800
SF
F2U
A81
502T
S1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps1
6D
ell
1907
FP
cC
N-0
DC
323-
7161
8-71
D-A
C1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s17
Del
lO
ptiP
lex
745
F1T
X4D
11
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps1
7V
iew
Son
icV
A19
03w
bQ
J007
0521
711
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
AC
ompu
ter
hps1
8D
ell
Opt
iPle
x 74
532
TX
4D1
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s18
Vie
wS
onic
VA
1903
wb
QJ0
0705
2172
71
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s19
Del
lO
ptiP
lex
745
994T
FD
11
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps1
9V
iew
Son
icV
A19
03w
bQ
J007
2354
398
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
AC
ompu
ter
hps2
/hps
3H
PD
C50
00M
XL4
380R
SN
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s2/h
ps3
Vie
wS
onic
VA
703b
Q85
0749
6186
81
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s4H
PD
C57
00M
XM
7440
6WH
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s4V
iew
Son
icV
A70
3bQ
AG
0738
6379
91
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hp
s4LG
Fla
tron
E24
1120
8ND
WE
E30
971
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Prin
ter
hps4
HP
Lase
rJet
400
0U
SR
B04
8887
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
AU
PS
hps4
AP
CS
mar
t-U
PS
220
0US
WS
1245
1801
471
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s5H
P40
00 P
ro S
FF
2UA
2291
C4Q
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s5D
ell
CN
-OJ6
642-
7161
8-4A
S-A
C1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps5
LG24
MB
35P
-B40
6MX
ZJ7
2197
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
AC
ompu
ter
hps6
Del
lO
ptiP
lex
745
5F33
YD
11
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps6
Vie
wS
onic
VA
1903
wb
QJ0
0723
5440
81
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s7H
P40
00 P
ro S
FF
MX
L128
1D21
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dhp
s7D
ell
CN
-02Y
315-
7161
8-49
B-A
E1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rhp
s8H
P62
00 P
ro S
FF
MX
L212
0GR
11
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
hps8
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1206
2058
11
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rsm
atee
gaH
P40
00 P
ro S
FF
2UA
1410
1QM
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
LCD
smat
eega
LGF
latr
on W
2442
PA
-BF
110N
DG
LB08
951
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dsm
atee
gaV
iew
Son
icV
A22
23w
mS
F11
1340
2027
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rsv
oc1
HP
DC
5100
MX
L625
0MK
M1
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dsv
oc1
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1201
2036
91
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dsv
oc1
LGF
latr
on E
2411
202N
DU
N2P
558
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rsv
oc2
HP
DC
5700
MX
M72
603N
M1
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dsv
oc2
Vie
wS
onic
VA
702b
PS
X05
2306
038
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rsv
oc3
HP
4000
Pro
SF
F2U
A14
101M
V1
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dsv
oc3
Vie
wS
onic
VA
703b
QA
G07
3021
436
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rsv
oc4
HP
DC
5700
MX
M74
4073
11
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dsv
oc4
Vie
wS
onic
VA
703b
Q85
0739
6167
61
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
AP
rinte
rsv
oc4
HP
Lase
rJet
P20
35V
NB
3349
751
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
Sca
nner
svoc
4C
anon
DR
-C12
5F
P31
1019
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
Com
pute
rsv
oc5
HP
DC
5700
MX
M73
506C
N1
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
ALC
Dsv
oc5
Vie
wS
onic
VA
703b
QA
G07
3021
438
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
LCD
svoc
5LG
Fla
tron
E24
1120
8ND
BP
5788
51
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
AC
ompu
ter
svoc
prep
Com
paq
Evo
D51
06X
31-K
N92
-G02
P1
yes
107
SV
OC
SV
OC
Alm
gren
Aga
wam
,MA
LCD
svoc
prep
Del
lM
X03
2DV
X47
6052
1AB
8FD
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
AC
ompu
ter
tgio
nfrid
doH
P40
00 P
ro S
FF
2UA
1381
CJV
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
LCD
tgio
nfrid
doV
iew
Son
icV
A70
3bQ
8507
4961
896
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
LCD
tgio
nfrid
doLG
Fla
tron
E24
1120
6ND
GL4
V88
71
yes
107
Offi
ceS
VO
CA
lmgr
enA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 4
250
CN
RX
G78
983
1ye
s10
7O
ffice
SV
OC
Alm
gren
Aga
wam
,MA
Prin
ter
HP
Lase
rJet
904
0JP
FL6
DP
069
1ye
s10
7S
VO
CS
VO
CA
lmgr
enA
gaw
am,M
AC
ompu
ter
ekin
ney
HP
4000
Pro
SF
F2U
A13
81C
KY
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
LCD
ekin
ney
Vie
wS
onic
VA
2223
wm
-LE
DS
TC
1201
2135
41
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
ALC
Dek
inne
yLG
Fla
tron
W24
42P
A-B
F20
2ND
NU
1E07
91
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
fid0
Com
paq
Evo
D51
06X
31-K
N9Z
-G03
31
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
ALC
Dfid
0V
iew
Son
icV
A70
3bQ
AG
0738
6351
31
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
fid1
HP
DC
5100
MX
L638
0HF
51
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
ALC
Dfid
1P
hilip
s17
0SA
U4A
0615
0156
061
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
fid2
Del
lO
ptip
lex
755
534L
TH
11
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
ALC
Dfid
2D
ell
1908
WF
Pt
CN
-0G
435H
-728
72-8
8T-0
T1
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
galv
arez
HP
4000
Pro
SF
FM
XL2
070L
JZ1
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
ALC
Dga
lvar
ezD
ell
P22
11H
tC
N-0
TY
XD
9-74
445-
05T
-F7
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
LCD
galv
arez
LGF
latr
on W
2442
PA
-BF
201N
DU
N8R
270
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
Com
pute
rhp
v1H
PD
C57
00M
XM
7240
3ZJ
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
LCD
hpv1
Del
lM
X-O
H63
04-4
7603
-54F
-AP
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
UP
Shp
v1A
PC
Sm
art-
UP
S 2
200U
SW
S12
1718
0241
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
Com
pute
rhp
v2D
ell
Opt
iPle
x 75
594
QK
ZF
11
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
ALC
Dhp
v2D
ell
1908
WF
Pt
CN
-0N
Y13
4-71
618-
7BK
-71
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
Com
pute
rhp
v3D
ell
Opt
iPle
x 74
5D
2TX
4D1
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
LCD
hpv3
Phi
lips
170S
BZ
0005
0821
8971
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
Com
pute
rhp
v4D
ell
Opt
iPle
x 78
03Q
16W
N1
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
LCD
hpv4
Vie
wS
onic
VA
702b
PS
X05
2502
229
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
Com
pute
rhp
v5H
PD
C50
00M
XL5
2708
3B1
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
ALC
Dhp
v5D
ell
CN
-OJ6
642-
7161
8-52
E-A
991
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
hpv7
Del
lO
ptiP
lex
745
794T
FD
11
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
AUnc
ontro
lled
2 Opt
iV
A19
0V 40
00 P
ro
40 6200
Pro
SF
F62
00 P
roV
A22
23w
m-L
ED
VA
2223
w40
00 P
ro S
FF
4000
Pro
SF
FF
latr
on W
2442
PA
-BF
Fla
tron
W24
42P
A22
23w
m23 0000
wm
-LE
DLE
D111
2U QA
GM
XM
74M
74Q
8507
396
Q85
0739
6V
NB
3349
751
VN
B33
49F
P31
1019
P31
1M
XM
7350
6CN
MX
M73
506C
QA
G07
3021
438
QA
G07
3021
408
ND
BP
5788
58N
DB
P57
885
1-K
N92
-G02
P1-
KN
92-G
02P
DV
X47
6052
1AB
8FX
4760
521A
B8
CJVJV
96967
Coye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s10
1ye
s10
71
yes op
y
1ye
s10
71
yes
11
yes
107
1ye
s1
1ye
s10
7V
yes
107
yes
107
VO
C10
7es
107
VO
C10
7V
107
VO
C10
7V
107
VO
C07
VO
C10
7V
OC
7V
OCy
107
Cub
077
C
LCD
hpv7
Vie
wS
onic
VA
1903
wb
PS
X05
3616
878
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
Com
pute
rhp
v8H
PD
C57
00M
XM
7440
6YL
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
LCD
hpv8
NE
CA
ccuS
ync
LCD
72V
X75
D11
876N
A1
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
hpv9
HP
DC
5100
MX
L623
02C
W1
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
ALC
Dhp
v9V
iew
Son
icV
A70
3bQ
AG
0738
6349
01
yes
107
VO
CV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
mla
mbe
rto2
HP
4000
Pro
SF
F2U
A20
514Z
V1
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
ALC
Dm
lam
bert
o2V
iew
Son
icV
A19
03w
bQ
J007
0521
728
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
LCD
mla
mbe
rto2
LGF
latr
on E
2411
208N
DT
C58
233
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
Com
pute
rm
pica
rdH
PD
C57
00M
XM
7160
6X6
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
LCD
mpi
card
NE
CA
ccuS
ync
LCD
72V
X73
F34
462N
A1
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
ALC
Dm
pica
rdLG
Fla
tron
E24
1120
8ND
DM
5849
81
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
nalm
eida
HP
4000
Pro
SF
FM
XL1
5129
DJ
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
LCD
nalm
eida
LGF
latr
on W
2442
PA
-BF
201N
DX
Q8R
274
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
LCD
nalm
eida
Vie
wS
onic
VA
703b
Q85
0749
6194
71
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
AC
ompu
ter
sbar
aH
P40
00 P
ro S
FF
2UA
2051
4P7
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
LCD
sbar
aV
iew
Son
icV
A70
3bQ
AG
0738
6398
51
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
ALC
Dsb
ara
LGF
latr
on E
2411
208N
DM
T58
499
1ye
s10
7C
ubes
VO
CS
ilver
Aga
wam
,MA
Com
pute
rw
bryo
nH
P40
00 P
ro S
FF
MX
L137
0CS
B1
yes
107
Offi
ceV
OC
Silv
erA
gaw
am,M
ALC
Dw
bryo
nV
iew
Son
icV
1903
WB
QJ0
0723
5940
21
yes
107
Offi
ceV
OC
Silv
erA
gaw
am,M
ALC
Dw
bryo
nLG
Fla
tron
W24
42P
A-B
F10
9ND
VW
E82
871
yes
107
Offi
ceV
OC
Silv
erA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 9
040
JPF
L6D
P0F
S1
yes
107
Cub
esV
OC
Silv
erA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 2
420
CN
GK
C98
332
1ye
s10
7V
OC
VO
CS
ilver
Aga
wam
,MA
Com
pute
ric
2C
ompa
qE
vo D
510
6X27
-KN
9Z-B
683
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dic
2V
iew
Son
icV
A70
3bQ
8507
4961
873
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
AC
ompu
ter
ic3
Del
lO
ptip
lex
7020
BZ
YM
T12
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dic
3D
ell
E20
11H
CN
0ND
MR
P74
2612
8H2K
K1
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rla
chat
Gat
eway
LP M
ini T
ower
TB
3 P
erfo
rman
ce 5
0000
1641
7771
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dla
chat
Vie
wS
onic
VA
703b
Q85
0749
6190
51
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rla
chat
2C
ompa
qE
vo D
5pS
X20
3JY
HZ
A93
01
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
lach
at2
Vie
wS
onic
VA
703b
Q85
0749
6189
21
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rso
lids1
Com
paq
Evo
D51
06X
31-K
N9Z
-G01
V1
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
solid
s1V
iew
Son
icV
A70
3bQ
8507
3961
571
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
AC
ompu
ter
solid
s2C
ompa
qE
vo D
510
V30
2KN
9ZB
700
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dso
lids2
Vie
wS
onic
VA
703b
QA
G07
3863
518
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
AC
ompu
ter
spec
1C
ompa
qE
vo D
510
6X31
-KN
9Z-G
02B
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dsp
ec1
Vie
wS
onic
VA
703b
Q85
0749
6213
81
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rtd
unn
HP
4000
Pro
SF
F2U
A20
514X
K1
yes
107
Offi
ceW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
tdun
nLG
Fla
tron
E24
1140
3MX
VW
1Q11
91
yes
107
Offi
ceW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rtit
rato
rH
PD
C77
00M
XL7
3130
J1
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
titra
tor
Vie
wS
onic
VA
703b
QA
G07
3522
596
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
AC
ompu
ter
toc1
HP
DC
5000
2UB
5520
CN
C1
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
toc1
Vie
wS
onic
VA
703b
Q85
0749
6187
71
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rto
c2C
ompa
qE
vo D
5pS
X20
3JY
HZ
A93
51
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
toc2
Vie
wS
onic
VA
703b
QA
G07
3863
962
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dto
c2V
iew
Son
icV
A70
3bQ
8507
4961
869
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
AC
ompu
ter
wet
chem
_lab
HP
4000
Pro
SF
FM
XL2
1416
BW
1ye
s10
7O
ffice
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dw
etch
em_l
abV
iew
Son
icF
latr
on E
2411
211N
DX
QC
R53
01
yes
107
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rw
etch
em1
HP
DC
7800
US
DT
MX
L807
05JY
1ye
s10
7O
ffice
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dw
etch
em1
Vie
wS
onic
VA
703b
Q85
0749
6191
21
yes
107
Offi
ceW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rw
etch
em2
HP
DC
5700
MX
M74
406Y
41
yes
107
Offi
ceW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
wet
chem
2V
iew
Son
icV
A70
3bQ
8507
4961
867
1ye
s10
7O
ffice
Wet
Che
mA
lmgr
enA
gaw
am,M
AC
ompu
ter
wet
chem
3H
P40
00 P
ro S
FF
MX
L220
168H
1ye
s10
7O
ffice
Wet
Che
mA
lmgr
enA
gaw
am,M
ALC
Dw
etch
em3
Vie
wS
onic
VG
2228
wm
-LE
DS
TB
1310
4114
31
yes
107
Offi
ceW
et C
hem
Alm
gren
Aga
wam
,MA
Com
pute
rw
etch
em4
HP
4000
Pro
SF
F2U
A14
10G
211
yes
107
Offi
ceW
et C
hem
Alm
gren
Aga
wam
,MA
LCD
wet
chem
4V
iew
Son
icV
A70
3bQ
8507
4961
936
1ye
s10
7O
ffice
Wet
Che
mA
lmgr
enA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 4
250
CN
RX
X06
377
1ye
s10
7O
ffice
Wet
Che
mA
lmgr
enA
gaw
am,M
AP
rinte
rH
PLa
serJ
et 4
200
US
DN
X03
566
1ye
s10
7W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
AV
ehic
le1
For
dT
rans
it C
argo
NM
0LS
7DN
XA
T01
5026
1ye
sP
arki
ng lo
tC
ourie
rA
lmgr
enA
gaw
am,M
AV
ehic
le2
Nis
san
NV
200
3N6C
M0K
N3E
K70
1087
1ye
sP
arki
ng lo
tC
ourie
rA
lmgr
enA
gaw
am,M
AV
ehic
le3
For
dT
rans
it C
argo
NM
OLS
7DN
1BT
0527
091
yes
Par
king
lot
Cou
rier
Alm
gren
Aga
wam
,MA
Veh
icle
5F
ord
Tra
nsit
Car
goN
M0L
S7E
76F
1119
0280
1ye
sP
arki
ng lo
tC
ourie
rA
lmgr
enA
gaw
am,M
AV
ehic
le6
For
dT
rans
it C
argo
NM
0LS
7F78
E11
3480
71
yes
Par
king
lot
Cou
rier
Alm
gren
Aga
wam
,MA
Veh
icle
8N
issa
nN
V20
03N
6CM
0KN
9DK
6927
651
yes
Par
king
lot
Cou
rier
Alm
gren
Aga
wam
,MA
Veh
icle
9F
ord
Eco
nolin
e1F
TN
E14
WX
7DB
3950
41
yes
Par
king
lot
Cou
rier
Alm
gren
Aga
wam
,MA
Veh
icle
10N
issa
nN
V20
03N
6CM
0KN
7DK
6966
361
yes
Par
king
lot
Cou
rier
Alm
gren
Aga
wam
,MA
Veh
icle
11F
ord
Tra
nsit
Car
goN
M0L
S7D
N9C
T09
0108
1ye
sP
arki
ng lo
tC
ourie
rA
lmgr
enA
gaw
am,M
AV
ehic
le12
For
dE
xplo
rer
1FM
5K8F
85D
GB
0228
41
yes
Par
king
lot
Cou
rier
NJ
NJ
Veh
icle
4F
ord
Tra
nsit
Car
goN
M0L
S7D
N6C
T11
7779
1ye
sP
arki
ng lo
tC
ourie
rN
YN
YV
ehic
le7
For
dT
rans
it C
argo
NM
0LS
7DN
9CT
1013
511
yes
Par
king
lot
Cou
rier
Alm
gren
Aga
wam
,MA
iCA
PiC
AP
5T
herm
o74
00IC
74D
C16
0411
1ye
s10
7M
etal
sM
etal
sA
lmgr
enA
gaw
am,M
AC
hille
riC
AP
5T
herm
oT
herm
oFle
x900
0111
0133
0116
0328
1ye
s10
7m
etal
sM
etal
sA
lmgr
enA
gaw
am,M
AA
utos
ampl
eriC
AP
5T
eled
yne
CE
TA
CA
SX
-560
0116
12A
560
1ye
s10
7m
etal
sM
etal
sA
lmgr
enA
gaw
am,M
AUnc
ontro
lled
4cc
V19
Fla
tron
F Lase
rJet
La La
serJ
et 2
42La
serJ
Evo
D51
0E
vo D
510
VA
703b
VA
703b
Opt
iple
x 70
20O
ptip
lex
7020
E20
11H
E20
11H
Min
i Tow
er T
B3
Per
form
ni T
ower
TB
3 P
3b3bS
V QA
G6X
31-K
31-K
Q85
0749
6Q
8507
496
2UA
2051
4XK
2UA
2051
403M
XV
W1Q
1103
MX
MX
L731
30J
MX
L731
30J
QA
G07
3522
596
QA
G07
3522
5U
B55
20C
NC
B55
20C
NC
0749
6187
707
4961
877
YH
ZA
935
A9
6396
263
962
6969
Copye1
yes
1ye
s1
yes
1ye
s1
yes
1ye
s1
yes
101
yes
107
1ye
s opy
1ye
s10
71
yes
11
yes
107
es1
1ye
s10
7O
yes
107
yes
107
Offi
c10
7es
107
Offi
ce10
7O
107
Offi
ce10
7O
107
Offi
ce07
Offi
ce10
7W
et C
7W
et C
Par
P
Met
rohm
ICIC
4M
etro
hm76
117
6100
2121
195
1ye
s12
6W
et C
hem
Wet
Che
mA
lmgr
enA
gaw
am,M
AM
etro
hm IC
IC5
Met
rohm
761
1761
0020
2113
01
yes
126
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Met
rohm
IC A
utos
ampl
erIC
4 or
IC5
Met
rohm
813
1813
0010
0718
81
yes
126
Wet
Che
mW
et C
hem
Alm
gren
Aga
wam
,MA
Mic
row
ave
SV
OC
mic
row
ave
2C
EM
230/
60 9
1090
0M
J714
11
yes
122
SV
OC
Pre
p S
VO
CA
lmgr
enA
gaw
am,M
AR
ocke
tVap
Roc
ketV
ap 1
The
rmo
RK
TS
-120
60-S
PW
RK
0504
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Roc
ketV
apR
ocke
tVap
2T
herm
oR
KT
S-1
2060
-SP
WR
K05
471
yes
122
SV
OC
Pre
p S
VO
CA
lmgr
enA
gaw
am,M
AR
ocke
tVap
Roc
ketV
ap 3
The
rmo
RK
TS
-120
60-S
PW
RK
0545
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Roc
ketV
apR
ocke
tVap
4
The
rmo
RK
TS
-120
60-S
PW
RK
0546
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Roc
ketV
apR
ocke
tVap
5T
herm
oR
KT
S-1
2060
-SP
WR
K05
481
yes
122
SV
OC
Pre
p S
VO
CA
lmgr
enA
gaw
am,M
AR
ocke
tVap
Roc
ketV
ap 6
The
rmo
RK
TS
-120
60-S
PW
RK
0554
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Spe
ed T
rap
Spe
ed T
rap
1 T
herm
oM
ST
1202
0-C
00M
ST
0616
1021
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Spe
ed T
rap
Spe
ed T
rap
2 T
herm
oM
ST
1202
0-C
00M
ST
0616
1020
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Spe
ed T
rap
Spe
ed T
rap
3 T
herm
oM
ST
1202
0-C
00M
ST
0616
1015
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Spe
ed T
rap
Spe
ed T
rap
4 T
herm
oM
ST
1202
0-C
00M
ST
0616
1017
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Spe
ed T
rap
Spe
ed T
rap
5 T
herm
oM
ST
1202
0-C
00M
ST
0616
1022
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Spe
ed T
rap
Spe
ed T
rap
6 T
herm
oM
ST
1202
0-C
00M
ST
0616
1019
1ye
s12
2S
VO
C P
rep
SV
OC
Alm
gren
Aga
wam
,MA
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX H
Section 12 Attachments
Uncon
trolle
d Cop
yments ments
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.1 Concentration Levels for QC Samples
Sample Type
PurposeConcentration
LevelMethod
Reference
Matrix Spike (MS) Accuracy Mid Level EPA 500 & 600 Series;EPA SW-846 Methods
Matrix Spike Duplicate (MSD) Precision/Accuracy Mid Level
EPA 500 & 600 Series; EPA SW-846 Methods
Blank Spike Accuracy Mid Level EPA 500 & 600 Series; EPA SW-846 Methods
EPA TO Methods
Duplicate Precision Mid Level EPA SW-846 Methods
EPA TO Methods
QC Checks AccuracyLow/Mid/HighLevel
EPA 500 & 600 Series: EPA SW-846 Methods
EPA TO Methods
Notes:Low Level = Concentrations from the minimum detection limit to a level five times the MDL Mid Level = Mean level between the minimum detection level and the upper end of the linear
rangeHigh Level = Concentrations at the upper end of the linear range
Low/Mid/How/Mid/HLevelLevel
ons from the mns from the mvel between thebetween th
ncentrations at ntrations at
lle
onon
CopyEPA 500 500
EPA SW-8PA SW
EPA TO MEPA TO M
vel l EPA EPA
EP
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.2 QC Frequency Information: Method Blanks
LaboratoryDepartment
Method Frequency
Air APH Minimum 5%
Air TO-15 Minimum 5%
Air TO-18 Minimum 5%
Volatile 524.2/624 Minimum 5%
Volatile 8260 Minimum 5%
Volatile VPH MA DEP Method/GRO
Minimum 5%
Semi-volatile 504.1/625 Minimum 5%
Semi-volatile 608 (PCBs/Pesticides) Minimum 5%
Semi-volatile 8270 Minimum 5%
Semi-volatile NJ EPH/MA DEP EPH/ Method/DRO/8100M/8015D/TPH1664B/TPH 8100 by GC
Minimum 5%
Semi-volatile 8151, 8081, 8082, Herbicides/Pesticides/PCB
Minimum 5%
OrganicCharacterization
Oil & Grease - EPA 1664 Minimum 5%
OrganicCharacterization
SM5310B Total Organic Carbon (TOC) Minimum 10%
Inorganic200.7, 6010 ICP, 200.8, 6020 ICP-MS Metals
Minimum 5%
Inorganic245.1, 7470, 7471 Mercury by CV-AAS (A)
Minimum 5%
Inorganic 300.0 Sulfate Minimum 10%
Inorganic 300.0 Chloride Minimum 10%
Inorganic 300.0 Fluoride Minimum 10%
Inorganic 300.0 Nitrate/Nitrite Minimum 10%
Uncon
trolle
d MM
) MiniMini
A DEP EPH/ EP EPH/ DRO/RO/
M/8015D/TPH015D/TPH64B/TPH 810B/TPH 81
8151, 8081151, 8081HerbicidHerbici
OO
Copym 5% %
mum 5% mum 5%
mum 5%mum
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.2 QC Frequency Information: Method Blanks
LaboratoryDepartment
Method Frequency
Inorganic 9012B/335.4 Cyanide Minimum 10%
Note that QC frequency may vary depending on matrix and/or specific federal or state agency requirements (as noted in QC box on Chain of Custody).
Uncon
trolle
d Cop
y
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.3 QC Frequency Information: Fortified Blank Spikes also known as Laboratory
Control Samples (BS/BSD)* and Standard Reference Materials (SRM)**
LaboratoryDepartment
Method Frequency
Air APH Minimum 5% (BS)
Air TO-15 Minimum 5% (BS)
Air TO-18 Minimum 5% (BS)
Volatile GC/MS 524.2Minimum 5% (BS)
Volatile GC/MS 624/8260Minimum 5% (BS/BSD pair)
Volatile GC VPH MA DEP Method/GRO
Minimum 5% (BS/BSD pair)
Semi-volatile GC/MS 625 Minimum 5% (BS)
Semi-volatile GC/MS 504.1 Minimum 10% (BS)
Semi-volatile GC 608 (PCBs, Pesticides)
Minimum 5% (BS/BSD pair)
Semi-volatile GC/MS 8270 Minimum 5% (BS/BSD pair)
Semi-volatile GC NJ EPH/MA DEP EPH Method
Minimum 5% (BS/BSD pair)
Semi-volatile GC DRO/8100M /8015D/ TPH 8100 by GC
Minimum 5% (BS)
Semi-volatile GC 8081/8082(Pesticides/PCBs)
Minimum 5% (BS/BSD pair)
Semi-volatile GC 8151A (Herbicides) Minimum 5% (BS/BSD pair)
OrganicCharacterization
TPH by 1664B, Oil & Grease EPA 1664B
Minimum 5% (BS)
OrganicCharacterization
SM5310B Total Organic Carbon
Minimum 5% (BS)
Uncon
trolle
d Minimunimu
MiniMin
608 (PCBs, 8 (PCBsPesticidesPesticides
MS 8270S 8270
Copy(BS) S)
m 5% (BS) m 5% (BS)
5% (B
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.3 QC Frequency Information: Fortified Blank Spikes also known as Laboratory
Control Samples (BS/BSD)* and Standard Reference Materials (SRM)**
LaboratoryDepartment
Method Frequency
Inorganic 200.7 ICP, 200.8 ICP-MS Metals
Minimum 5% (Aqueous BS) (Soil SRM)
Inorganic6010 ICP/6020 ICP-MS Metals
Minimum 5% (Aqueous BS/BSD) (Soil SRM)
Inorganic245.1, 7470, 7471 Mercury by CV-AAS (A)
Minimum 5% (Aqueous BS) (Soil SRM)
Inorganic 300.0 Sulfate Minimum 10% (BS/SRM)
Inorganic 300.0 Chloride Minimum 10% (BS/SRM)
Inorganic 300.0 Fluoride Minimum 10% (BS/SRM)
Inorganic 300.0 Nitrate/Nitrite Minimum 10% (BS/SRM)
Inorganic 9012B/335.4 CyanideMinimum 10% (Aqueous BS) (Soil SRM)
Notes: * BS sample = deionized water fortified with target compounds and surrogate standards. **SRM sample = deionized water fortified with SRM solution. Note that QC frequencies may vary depending on matrix and/or specific federal or state agency requirements (as noted in QC box on Chain of Custody). QCs are the same for both soil and aqueous samples, except where noted.
UnUnUnconwater fortified wr fortified
ater fortified wfortified way vary dependry depen
n QC box on Chn QC box on Che noted. oted.
ontro
lled
inimnim
MinimumMinimum
MinimMini
/Nitrite Mitrite
/335.4 Cyani5.4 Cyan
on
Un
Copy
eou
5% (Aqueous B(Aqueous B
m 10% (Bm 10%
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.4 QC Frequency Information:
Matrix Spikes (MS), Matrix Spike Duplicates (MSD)* and/or Post Spikes (PS)**
LaboratoryDepartment
Method Frequency
Air APH N/A
Air TO-15 N/A
Air TO-18 N/A
Volatile 524.2/624/8260 Minimum 5% (MS/MSD pair)
Volatile VPH MADEP Method/GRO
Minimum 5% (MS)
Semi-volatile 504.1/625.2/8270Minimum 5% (MS/MSD pair)
Semi-volatile 608 (PCBs, Pesticides) Minimum 10% (MS)***
OrganicCharacterization NJ EPH/MADEP EPH
Minimum 5% (MS)
EPH only if client requested, then (MS/MSD pair)
Semi-volatile 8151A/8081/8082(Herbicides/Pesticides/PCB)
Minimum 5% (MS)***
OrganicCharacterization
Oil & Grease EPA 1664B Minimum 5% (MS/MSD pair)***
OrganicCharacterization
SM5310B Total Organic Carbon (TOC)
Minimum 10%
Inorganic6010 ICP, 6020 ICP-MS Metals
Minimum 5% (MS/MSD/PS)
Inorganic200.7 ICP, 200.8 ICP-MS Metals
Minimum 10% (MS/PS)
Inorganic7470, 7471 Mercuryby CV-AAS (A)
Minimum 5% (MS/MSD/PS)
Inorganic245.1 Mercuryby CV-AAS (A)
Minimum 10% (MS/ PS)
Inorganic 300.0 Sulfate Minimum 10% (MS/MSD)
Uncon
trolle
dMinMi
esticides) cides)
H/MADEP EMADEP
8151A/808151A/80(Herbici(HerbiPCB)PCB
Copy
imum 5% (MS/Mum 5% (MS/M
Minimum 5%Minimum
mu
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.4 QC Frequency Information:
Matrix Spikes (MS), Matrix Spike Duplicates (MSD)* and/or Post Spikes (PS)**
LaboratoryDepartment
Method Frequency
Inorganic 300.0 Chloride Minimum 10% (MS/MSD)
Inorganic 300.0 Fluoride Minimum 10% (MS/MSD)
Inorganic 300.0 Nitrate/Nitrite Minimum 10% (MS/MSD)
Inorganic 9012B/335.4 CyanideMinimum 10% (MS/MSD/PS)
Notes:
* MS/MSD sample – sample spiked with target compounds used for Precision/Accuracy and to determine if there is matrix interference.
** PS sample – sample spiked with target compounds after digestion/extraction to determine if there is matrix interference due to the digestion/extraction procedure.
***Submittal of sufficient sample volume/weight is required to run QC sample spikes and duplicates.
Note that QC frequencies may vary depending on matrix and/or specific federal or state agency requirements (as noted in QC box on Chain of Custody).
Uncon
trolle
d stion/tion
.
red to run QC d to run QC
trix and/or specrix and/or sptody).y)
olollCop
yrecision/Accuracyrecision/Accuracy
traction totraction
opy
(
10% % SD/PS)/PS)
opy
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix H Rev 3/27/17
Table 12.5 QC Frequency Information: Duplicates*
LaboratoryDepartment
Method Frequency
Air APH Minimum 5%
Air TO-15 Minimum 5%
Air TO-18 Minimum 5%
Semi-volatile 625.2/8270 Minimum 5%
Semi-volatile 608 (PCBs, Pesticides) Minimum 5%
Semi-volatile 8081/8082(Pesticides/PCBs)
Minimum 5%
Semi-volatile 8151A (Herbicides) Minimum 5%
Inorganic200.7, 6010 ICP, 200.8, 6020 ICP-MS Metals
Minimum 5%
Inorganic245.1, 7470, 7471 Mercury by CV-AAS (A)
Minimum 5%
Inorganic 300.0 Chloride Minimum 5%
Inorganic 300.0 Sulfate Minimum 5%
Inorganic 300.0 Nitrate/Nitrite Minimum 5%
Inorganic 300.0 Fluoride Minimum 5%
OrganicCharacterization
NJ EPH/MADEP VPH /GRO/DRO/8100M/8015D/TPH 8100 by GC
Minimum 5%
(Soils: only if sufficient sample is submitted)
Notes:
Note that QC frequency may vary depending on matrix and/or specific federal or state agency requirements (as noted in QC box on Chain of Custody).
*Submittal of sufficient sample volume/weight is required to run duplicates and QC sample spikes.
Uncon
trolle
dMinimMinim
200.8, 200.8, Metals als
MM
70, 7471 0, 7471 y by CV-AAby CV-A
300.0 Chlori0 Chlor
300.0 Su300.0
300300
Copy%
um 5% 5%
nimum 5% imum 5
m
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX I
Section 13 Attachments
Uncon
trolle
d Cop
ynts s
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.1 QC Sample Acceptance Criteria and Corrective Action: Method Blanks
Department Method Acceptance Criteria Corrective Action
Air APH All surrogates within control limits (CL); TCL< Detection Limits (DL)
Reanalyze and/or flag non-conforming data, as appropriate or narrate as appropriate.
Air TO-15 All surrogates within CLs; TCL<DL Reanalyze and/or flag non-conforming data, as appropriate or narrate as appropriate.
Air TO-18 All surrogates within CLs; TCL<DL Reanalyze and/or flag non-conforming data, as appropriate or narrate as appropriate.
Volatile 524.2 All surrogates within CLs; TCL<DL
Decontaminate lines & traps. Flush trap and column. Reanalyze until blank meets criteria or narrate as appropriate.
Volatile 624 All surrogates within CLs; TCL<DL
Decontaminate lines & traps. Flush trap and column. Reanalyze until blank meets criteria or narrate as appropriate.
Volatile 8260
All surrogates within CLs; TCLs < DL except common laboratory contaminants (acetone, methylene chloride, and MEK) which must be <5X the DL.
Decontaminate lines and trap. Flush column. Reanalyze until blank meets all criteria or narrate as appropriate.
Volatile VPH/GRO All surrogates within CLs; TCL<DL
Decontaminate lines and trap. Flush column. Reanalyze until blank meets all criteria or narrate as appropriate.
Semi-volatile 504.1TCL < DL
Halt analysis until the problem is identified and corrected. Re-extract entire batch or narrate as appropriate.
Semi-volatile 608
Surrogates within Cls All TCLs <DL
Halt analysis until the problem is identified and corrected. Re-extract entire batch or narrate as appropriate.
Uncon
trolle
dhin CLs; TCLs; TC
l surrogates wurrogates
82608260
All sAllD
Copy
onor narrna
L<DL DL ReanalyzReanalconformconformor nor n
D
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.1 QC Sample Acceptance Criteria and Corrective Action: Method Blanks
Department Method Acceptance Criteria Corrective Action
Semi-volatile 625 All surrogates within CLs; TCL<DL
Halt analysis until the problem is identified and corrected. Re-extract entire batch or narrate as appropriate.
Semi-volatile 8270
All surrogates within CLs All TCLs <DL except common laboratory contaminants phthalates) which must be <5X DL.
Halt analysis until the problem is identified and corrected. Re-extract entire batch or narrate as appropriate.
Semi-volatile 8100Surrogates within CLs All TCLs <DL
Halt analysis until the problem is identified and corrected. Re-extract entire batch or narrate as appropriate.
Semi-volatile 8151A,
8081/8082
Surrogates within CLs All TCLs <DL
Halt analysis until the problem is identified and corrected. Re-extract entire batch or narrate as appropriate.
Organic Charact. TPH/EPH/
DROAll surrogates within CLs; TCL<DL
Prepare and reanalyze entire batch or narrate as appropriate.
Organic Charact. NJ EPH All surrogates within CLs; TCL<DL Prepare and reanalyze entire batch or narrate as appropriate.
OrganicCharact.
Oil & Grease < 1.0 ppm Prepare and reanalyze entire batch or narrate as appropriate.
Organic Charact. Total Organic
Carbon(TOC)
< 1.0 ppm < 50 ppm
Prepare and reanalyze samples or narrate as appropriate.
Inorganic
200.7, 6010 ICP Metals;
200.8, 6020 ICP-MSMetals
<CRDL or reporting limit* Prepare and reanalyze entire batch or narrate as appropriate.
Inorganic Mercury <CRDL or reporting limit* Prepare and reanalyze entire batch or narrate as appropriate.
Inorganic Sulfate <reporting limit Prepare and reanalyze entire batch or narrate as appropriate.
Uncon
trolle
d within CLs thin CLs
s <DL DL
All surrogaAll surroga
EPH AllEPH All
GreaGrea
Copys)
Halt alt is identis idenRe-extracRe-extrnarratenarrate
H
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.1 QC Sample Acceptance Criteria and Corrective Action: Method Blanks
Department Method Acceptance Criteria Corrective Action
Inorganic Bromide <reporting limit* Prepare and reanalyze entire batch or narrate as appropriate.
Inorganic Chlorides <reporting limit* Prepare and reanalyze entire batch or narrate as appropriate.
Inorganic Fluoride <CRDL or reporting limit Prepare and reanalyze entire batch or narrate as appropriate.
Inorganic Nitrate/Nitrite <reporting limit* Prepare and reanalyze batch or narrate as appropriate.
Inorganic Cyanides <CRDL or reporting limit Prepare and reanalyze entire batch or narrate as appropriate.
Notes: *If sample concentration is 10 times the concentration of the preparation blank, do not prepare samples again.
Target Compound Lists = TCLs
Uncon
trolle
d rting limit rting limit
s the concentrathe concentrlle
onon
Copy
Prepapbatch orbatch
PreparePreparebatchbat
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.2 QC Sample Acceptance Criteria and
Corrective Action: Blank Spikes/Laboratory Control Samples (BS/BSD) and Standard Reference Materials (SRM)***
Department Method Acceptance Criteria Corrective Action
Air APH 70-130% RecoveryReanalyze and/or flag non-conforming data, as appropriate.
Air TO-15 50-150% Recovery for analytes*****,70-130% for all other TCLs.
Reanalyze and/or flag non-conforming data, as appropriate.
Air TO-18 70-130% Recovery Reanalyze and/or flag non-conforming data, as appropriate.
Volatile 524.270-130% for analytes****;80-120% for all other TCLs.
Analytes that do fall outside of acceptable limits are qualified. Samples that contain compounds outside of acceptable limits are reanalyzed with acceptable QCs.
Volatile 624
All spike recoveries must be within method set control limits (see lab for specific analyte limits). RPD 30%
Analytes that do fall outside of acceptable limits are qualified. Samples that contain compounds outside of acceptable limits are reanalyzed with acceptable QCs.
Volatile 8260*
No more than 10% target analytes outside of control limits (70-130%; difficult analytes may be 40-160%). RPD 25%
Analytes that do fall outside of acceptable limits are qualified. Samples that contain compounds outside of acceptable limits are reanalyzed with acceptable QCs.
Volatile VPH/GRO 70-130% Recovery; RPD 25%
Reanalyze entire batch.
Semi-volatile 504.1 70-130% Recovery If a second BS fails, locate and correct the source of the problem and re-extract/reanalyze.
Semi-volatile 608
All spike recoveries must be within method set control limits (see lab for specific analyte limits). RPD 20%
Analytes that do fall outside of acceptable limits are qualified. Samples that contain compounds outside of acceptable limits are reanalyzed with acceptable QCs.
Uncon
trolle
d es****;**;ther TCLs. ther TCLs.
ke recoveriee recoveriein method semethod s
see lab for spe lab for limits). RPmits). RP
260*260
No mNo mana
Copy
alyze ae anforming datrming d
Reanalyze anReanalyze anconforminconformin
AnalyAac
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.2 QC Sample Acceptance Criteria and
Corrective Action: Blank Spikes/Laboratory Control Samples (BS/BSD) and Standard Reference Materials (SRM)***
Department Method Acceptance Criteria Corrective Action
Semi-volatile 625
All spike recoveries must be within method set control limits (see lab for specific analyte limits).
Flag non-conforming data.
Semi-volatile 8270
All spike recoveries must be within control limits (40-140% for base compounds and 30-130% for acids). RPD 20% for waters; 30% for soils.
Flag non-conforming data.
Semi-volatile 8100M 40-140% Recovery Flag non-conforming data.
Semi-volatile 8151A/8081/
8082
All spike recoveries must be within control limits (not greater than 40-140%).
Halt analysis until the problem is identified and corrected. Re-extract/reanalyze entire batch to verify system control restored.
Organic Charact. TPH/EPH/DRO
40-140% Recovery; RPD not greater than 30%
Prepare and reanalyze entire batch.
Organic Charact. NJ EPH 40-140% Recovery; RPD not greater than 25%
Prepare and reanalyze entire batch.
Organic Charact. Oil & Grease
166483-101%, RPD 11%
Correct problem, re-extract entire analytical batch and repeat the ongoing precision and recovery test.
Organic Charact. Total Organic
Carbon(TOC)
85-115% Recovery for Soils and Waters. Soil SRM within vendor limits.
Prepare and reanalyze calibration.
Inorganic200.7/6010ICP Metals + 15% true Prepare and reanalyze entire batch.
Inorganic200.8/6020
ICP-MSMetals
+ 15% true Prepare and reanalyze entire batch.
Inorganic Mercury + 15% true Prepare and reanalyze entire batch.
Inorganic Sulfate + 10% true Flag non-conforming data.
Inorganic Bromide*** + 10% true Flag non-conforming data.
+ 10% true Flag non-conforming data.
Uncon
trolle
d es must be must be imits (not imits (not
40-140%). 140%).
% Recovery% Recoveryater than 30%r than 30%
40-140% Re-140% Regreater thgreater
rease se
664664838
rgan
CopyFlag non-conforg non-conf
Flag nFl
H
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.2 QC Sample Acceptance Criteria and
Corrective Action: Blank Spikes/Laboratory Control Samples (BS/BSD) and Standard Reference Materials (SRM)***
Department Method Acceptance Criteria Corrective Action
Inorganic Chlorides
Inorganic Fluoride + 10% true Flag non-conforming data.
Inorganic Nitrate/Nitrite + 10% true Flag non-conforming data.
Inorganic Cyanides + 10% true Prepare and reanalyze entire batch. Notes: * 8260 difficult analytes are Acetone, Bromomethane, Chloroethane, Dichlorodifluoromethane, Ethyl ether,
Hexachlorobutadiene, MEK, MIBK 1,4-Dioxane, Trichlorofluoromethane.
**The criteria listed is for the CCC, there is no difference from the Laboratory Fortified Blank or Blank Spike (BS) and the CCC as noted in the applicable method.
***QC sample acceptance criteria may vary for Department of Defense work; these limits are available upon request.
****Acetone, Acrylonitrile, MBK, MEK, MIBK, Carbon disulfide, Tetrahydrofuran, Ethyl ether, TAME, ETBE, DIPE, TBA, Ethanol.
*****Acrylonitrile, 1,4-Dioxane, 1,1,1,2-Tetrachloroethane, Isopropylbenzene, Naphthalene, sec-Butylbenzene, 4-Isopropyltoluene, n-Butylbenzene.
Uncon
trolle
darbon disulfidn disulfi
rachloroethaneachloroethane
ololCop
yare and randDichlorodifluoromlorodifluor
ethane. e
the Laboratory Forhe Laboratory F
f Defense worDefense
T
y
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.3 QC Sample Acceptance Criteria and
Corrective Action: Matrix Spikes (MS), MS/MSD Pair*
Department Method Acceptance Criteria Corrective Action
Volatile 524.2 80-120% Recovery; RPD 20% Flag non-conforming data.
Volatile 624 Method set recovery; RPD 30% Flag non-conforming data.
Volatile 826070-130% Recovery; 20% RPD Waters; 30% RPD Soils
Flag non-conforming data.
Volatile VPH/GRO 70-130% Recovery; RPD 30% Flag non-conforming data.
Semi-volatile 504.1 65-135% Recovery Flag non-conforming data.
Semi-volatile 608
All spike recoveries must be within method set control limits (see lab for specific analyte limits); RPD 50%
Flag non-conforming data.
Semi-volatile 625 30-140% Recovery Flag non-conforming data.
Semi-volatile 8270
40-140% recovery for base compounds and 30-130% for acids;
20% RPD Waters; 30% RPD Soils
Flag non-conforming data.
Semi-volatile 8151A/8081/
8082Recovery not greater than 30-150%; 30% RPD
Analyze CCC. If CCC is acceptable, report MS/MSD and LCS with data qualifier.
Organic Charact. TPH/EPH/
DRO40-140% recovery; <25% RPD
Analyze LCS or re-prepare and reanalyze MS/MSD
Organic Charact. NJ EPH 40-140% recovery; <50% RPD Analyze LCS or re-prepare and reanalyze MS/MSD
Organic Charact. Oil & Grease
166478-114% recovery; <18% RPD
Analyze LCS or re-prepare and reanalyze MS/MSD
Organic Charact. TOC 70-130% recovery; <30% RPD Analyze LCS or re-prepare and reanalyze MS/MSD.
Inorganic
200.7/200.8ICP/ICP-MS
Metals 70-130% recovery ** Flag non-conforming data.
Inorganic 6010/6020 75-125% recovery** Flag non-conforming data.
Uncon
trolle
dy
very for basevery for bass and 30-130nd 30-13
PD Waters; D Waters;
Recovery necovery n150%;150%;
EPH/EPH/DRODRO
4
PHPH
Copy
Flag nonno
Flag non-coFlag non
ithin n ee lab e labRPD RP
FlagF
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.3 QC Sample Acceptance Criteria and
Corrective Action: Matrix Spikes (MS), MS/MSD Pair*
Department Method Acceptance Criteria Corrective Action
ICP/ICP-MSMetals
Inorganic Mercury 80-120% recovery** Flag non-conforming data.
Inorganic Sulfate 90-110% recovery*** Flag non-conforming data.
Inorganic Bromide 90-110% recovery*** Flag non-conforming data.
Inorganic Chlorides 90-110% recovery*** Flag non-conforming data.
Inorganic Fluoride 90-110% recovery** Flag non-conforming data.
Inorganic Nitrate/Nitrite 90-110% recovery*** Flag non-conforming data.
Inorganic Cyanide 90-110% recovery** Flag non-conforming data.
Notes:* Submittal of sufficient sample volume/weight is required to run QC sample spikes and duplicates. QC sample acceptance
criteria may vary for Department of Defense work; these limits are available upon request.
** A majority of percent recoveries (%R) must fall within the acceptance range, or representation of the batch must occur. If recovery is not within acceptance criteria, the batch quality control data is flagged with a qualifier. If the sample concentration exceeds the spike concentration the data is not flagged, even if the spike recovery is outside the acceptance range.
*** Based on a standard aqueous sample matrix or documented methods for solid preparations. Unusual practices may create interference that require different acceptance criteria. The batch quality control data will be flagged with a qualifier.
UnUnUncon
trolle
drequired to runuired to ru
work; these limrk; these lim
must fall withint fall withteria, the batcha, the batch
oncentration thentration th
ous sample masample mre different acc different ac
ed **
ed
Un
CopyFlag nonno
Flag non-coFlag non
Flag nFlag
F
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.4 QC Sample Acceptance Criteria and
Corrective Action: Duplicates*
Department Method Acceptance Criteria** Corrective Action
Air APH 30% RPD Flag non-conforming data.
Air TO-15 30% RPD Flag non-conforming data.
Air TO-18 30% RPD Flag non-conforming data.
Volatile 524.2****30% for analytes***; 20% for all other TCLs
Flag non-conforming data.
Volatile 624**** 30% RPD Flag non-conforming data.
Volatile 8260****20% RPD Waters;
30% RPD Soils Flag non-conforming data.
Volatile VPH/GRO 50% RPD Flag non-conforming data.
Semi-volatile 608 30% RPD Flag non-conforming data.
Semi-volatile 625 30% RPD Flag non-conforming data.
Semi-volatile 827020% RPD Waters;
30% RPD Soils Flag non-conforming data.
Semi-volatile 8100 50% RPD Flag non-conforming data.
Semi-volatile 8151A/8081 30% RPD Flag non-conforming data.
Semi-volatile 8082 40% RPD Flag non-conforming data.
Organic Charact. NJ EPH/MA EPH/
DRO50% RPD Flag non-conforming data.
Organic Charact. TOC 20% RPD Flag non-conforming data.
Inorganic200.7/6010ICP metals
20% RPD Flag non-conforming data.
Inorganic200.8/6020 ICP-
MS Metals 20% RPD Flag non-conforming data.
Inorganic Mercury 20% RPD Flag non-conforming data.
Inorganic. Sulfates 20% RPD Flag non-conforming data.
Inorganic Bromide 20% RPD Flag non-conforming data.
Inorganic Chlorides 20% RPD Flag non-conforming data.
Inorganic Fluoride 20% RPD Flag non-conforming data.
Inorganic Nitrate/Nitrite 20% RPD Flag non-conforming data.
Uncon
trolle
dD
RPD WaterRPD Water
0% RPD SoRPD So
50% RPD50% RP
30%30%
2
PH/MA EPHMA EPDRODRO
TOTO
20
Copy
ag nonno
Flag non-coFlag non-
Flag nFlag n
Fl
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix I
Revised 3-27-17
Table 13.4 QC Sample Acceptance Criteria and
Corrective Action: Duplicates*
Department Method Acceptance Criteria** Corrective Action
Inorganic Cyanide 20% RPD Flag non-conforming data.
Notes: * Submittal of sufficient sample volume/weight is required to run QC sample spikes and duplicates.
** The majority of RPDs must meet acceptance criteria. Data will be accepted if the RPD of the batch LCS/LCSD and/or MS/MSD is within 20%. All RPD exceedances will be flagged with a qualifier.
***Acetone, Acrylonitrile, MBK, MEK, MIBK, Carbon disulfide, Tetrahydrofuran, TAME, ETBE, DIPE, TBA
****Duplicate performed upon request.
Uncon
trolle
d Cop
ypypyTAME, EE, E
py
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX J
List of Acronyms
Uncon
trolle
d Cop
y
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix J
Rev 9/29/15
Appendix J Acronyms & Abbreviations
AA Atomic Absorption ACS American Chemical Society APHA American Public Health Association ASTM American Society for Testing and Materials AWWA American Water Works Association BOD Biological Oxygen Demand BRL Below Reporting Limit oC degree(s) Celsius CAR Corrective Action Report CEO Chief Executive Officer COC Chain of Custody COD Chemical Oxygen Demand conc concentration CMR Code of Massachusetts Regulations d day DEP (State of Massachusetts) Department of Environmental Protection DER (State of Florida) Department of Environmental Regulation DI De-ionized DO Dissolved Oxygen DoD Department of Defense DOH (State of New York) Department of Health ECD Electron Capture Detector ELAP Environmental Laboratory Approval Program EMSL (City of Cincinnati) Environmental Monitoring Systems Laboratory EPA Environmental Protection Agency EPH Extractable Petroleum Hydrocarbons FID Flame Ionization Detector FTIR Infrared Spectrophotometer g gram(s) GC Gas Chromatograph GC / MS Gas Chromatograph / Mass Spectrometer h hour HAAs Haloacetic Acids IC Ion Chromatograph ICP Inductively Coupled Plasma ICV Initial Calibration Verification Id Identification IS Internal Standard kg kilogram(s) L liter(s) LIMS Laboratory Information Management System LOD Limit of Detection, also known as MDL LOQ Limit of Quantitation, also known as MRL and PQL m meter(s) MCL Maximum Contaminant Level
Uncon
trolle
dt of Envf Env
Environmentvironmen
Department oepartment oetector ctor
Laboratory Aoratory Annati) Enviroati) Envir
ental Protectial Protecable Petroleue Petrole
e Ionization e Ionization frared Spectrfrared Specm(s) m(s)
hroh
Copy
onmen
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix J
Rev 9/29/15
MDL Minimum Detection Limit, also known as LOD MRL Minimum Reporting Limit, also known as PQL and LOQ mg milligram(s) min minute mL milliliter(s) mm millimeter(s) MS Mass Spectrometer MS Matrix Spike MSD Matrix Spike Duplicate um micrometer(s) NBS National Bureau of Standards NELAC National Environmental Laboratory Accreditation Conference NELAP National Environmental Laboratory Approval Program NTU Nephelometric Turbidity Units OSHA Occupational Safety and Health Administration PAHs Polynuclear Aromatic Hydrocarbons PCBs Polychlorinated Biphenyls ppb parts per billion ppm parts per million PID Photo Ionization Detector PQL Practical Quantitation Limit, also known as LOQ and MRL QA Quality Assurance QA / QC Quality Assurance / Quality Control QAO Quality Assurance Officer QC Quality Control QMP Quality Management Program R Recovery (%R: Percent Recovery) RDL Reportable Detection Limit RSD Relative Standard Deviation SD Standard Deviation SDI Sludge Density Index s second(s) SVI Sludge Volume Index SM Standard Method SOP Standard Operating Procedure SMART Self Monitoring Analytical Report Tracking SRM Standard Reference Material SW Solid Waste TCL Target Compound List THM Trihalomethane(s) TOC Total Organic Carbon TOX Total Organic Halogen TPH Total Petroleum Hydrocarbons TPH-GC Total Petroleum Hydrocarbons by Gas Chromatography TPH-IR Total Petroleum Hydrocarbons by Infrared u units USEPA United States Environmental Protection Agency VOA Volatile Organic Amber
Uncon
trolle
d so known asso known as
ity Control Control ficer icer
ment Programnt ProgramR: Percent RPercent R
Detection Letection Standard Dndard
ard Deviatioard Deviatioudge Densityudge Densiond(s) ond(s)
e VV
Copy
renm
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix J
Rev 9/29/15
VOC Volatile Organic Compound VPH Volatile Petroleum Hydrocarbons WS Water Supply WP Water Pollution WPA Water Potability Analysis
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX K
Definitions
Uncon
trolle
d Cop
y
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix K
Rev 9/29/15
Appendix K Definitions
Accuracy: The closeness of agreement between an observed value and an accepted reference value. When applied to a set of observed values, accuracy will be a combination of a random component and of a common systematic error (or bias) component.
Batch: A group of samples which behave similarly with respect to the sampling or the testing procedures being employed and which are processed as a unit.
Bias: The deviation due to matrix effects of the measured value (Xs - Xu) from a known spike amount. Bias can be assessed by comparing a measured value to an accepted reference value in a sample of known concentration or by determining the recovery of a known amount of a contaminant spiked into a sample (a matrix spike). Thus, the bias (B) due to matrix effects based on a matrix spike is calculated as:
B = (Xs - Xu) - K where:
Xs = measured value for a spike sample,Xu = measured value for unspiked sample, and K = known value of the spike sample.
Using the following equation yields the percent recovery (%R).
%R = 100 (Xs - Xu) / K
Blank: see Equipment Blank, Method Blank, Trip Blank.
Calibration Check: Verification of the ratio of instrument response to analyte amounts
Carry Over: Contamination which is transmitted from one sample to another, typically from improperly or insufficiently cleaned glassware or equipment or highly contaminated samples.
Control Sample: A QC sample introduced into the process to monitor the performance of the system.
Duplicate: see Matrix Duplicate, Field Duplicate, Matrix Spike Duplicate.
Equipment A sample of analyte-free media which has been used to rinse the sampling Blank: equipment. It is collected after completion of decontamination and prior to
sampling. This blank is useful in documenting adequate decontamination of sampling equipment.
Field Duplicate: Independent samples which are collected as close as possible to the same point in space and time. They are two separate samples taken from the same source,
Uncon
trolle
d for a spike safor a spike sue for unspike for unspi
ue of the spikof the sp
llowing equawing equa
= 100 (X100 (Xs - -
ee Equipmenquipmen
VerificaVerifica
CoCo
Copy
edcomparpa
wn concentraconcentaminant spikedinant spike
x effects based ffects bas
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix K
Rev 9/29/15
stored in separate containers, and analyzed independently. These duplicates are useful in documenting the precision of the sampling process.
ICV Initial calibration verification: A standard obtained or prepared from a source independent of the source of standards for the initial calibration. Its concentration should be at or near the middle of the calibration range. It is done after the initial calibration.
Laboratory Control A known matrix spiked with compound(s) representative of the target Sample (LCS): analytes. This is used to document laboratory performance also known as a
Blank Spike (BS).
Matrix: The component or substrate (e.g., waste water, drinking water) which contains the analyte of interest.
Matrix Duplicate: An intra laboratory split sample which is used to document the precision of a method in a given sample matrix.
Matrix Spike: An aliquot of a sample spiked with a known concentration of target analyte(s).The spiking occurs prior to sample preparation and analysis. A matrix spike is used to document the bias of a method in a given sample matrix.
Matrix Spike Intra laboratory split of samples spiked with identical concentrations of Duplicates: target analyte(s). The spiking occurs prior to sample preparation ana analysis.
They are used to document the precision and bias of a method in a given sample matrix.
Method Blank: An analyte-free matrix to which all reagents are added in the same volumes or proportions as used in sample processing. The method blank should be carried through the complete sample preparation and analytical procedure. The method blank is used to document contamination resulting from the analytical process.
For a method blank to be acceptable for use with the accompanying samples, the concentration in the blank of any analyte of concern should not be higher than the highest of either:
1 - The method detection limit, or
2 - Five percent of the regulatory limit for that analyte, or
3 - Five percent of the measured concentration in the sample.
Method Detection The minimum concentration of a substance that can be measured and Limit (MDL/LOD): reported with 99% confidence that the analyte concentration is greater than zero
and is determined from analysis of a sample in a given matrix type containing the analyte.
Practical Quantitation The lowest concentration that can be reliably achieved within specified
Uncon
trolle
dwith awith
sample premple pras of a methoas of a metho
lit of sampleof sampl). The spikinThe spikin
d to documeno documen
analyte-free malyte-free mroportions asrtions as
through thehrough theblank is blank is
FoFo
Copy
drinkinki
is used to docuused to do
known cknowara
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix K
Rev 9/29/15
Limit (PQL/LOQ): limits of precision and accuracy during routine laboratory operating conditions.The PQL is generally 5 to 10 times the MDL. However, it may be nominally chosen within these guidelines to simplify data reporting. For many analytes the PQL analyte concentration is selected as the lowest non-zero standard in the calibration curve. Sample PQLs are highly matrix-dependent. PQL also known as the Minimum Reporting Limit (MRL) or Limit of Quanitation (LOQ).
Precision: The agreement among a set of replicate measurements without assumption of knowledge of the true value. Precision is estimated by means of duplicate/replicate analyses. These samples should contain concentrations of analyte above the MDL, and may involve the use of matrix spikes. The Relative Percent Difference (%RPD) is used to estimate the precision between two samples. The formula for determining %RPD is:
%RPD = (value 1 - value 2) -------------------- * 100% average value
Reagent Blank: see Method Blank.
Reagent Grade: Analytical reagent (AR) grade, ACS reagent grade, and reagent grade are synonymous terms for reagents which conform to the current specifications of the Committee on Analytical Reagents of the American Chemical Society.
Reagent Water: Water that has been generated by any method which would achieve the performance specifications for ASTM Type II water.
Split Samples: Aliquot of samples taken from the same container and analyzed independently.In cases where aliquot of samples is impossible to obtain, field duplicate samples should be taken for the matrix duplicate analysis.
Standard Addition: The practice of adding a known amount of an analyte to a sample immediately prior to analysis. It is typically used to evaluate interferences.
Standard Curve: A plot of concentrations of known analyte standards versus the instrument response to the analyte. Calibration standards are prepared by successively diluting a standard solution to produce working standards which cover the range of the instrument.
Surrogate: An organic compound which is similar to the target analyte(s) in chemical composition and behavior in the analytical process, but which is not normally found in environmental samples. These compounds are spiked into all blanks, standards, and samples prior to analysis. Percent recoveries are calculated for each surrogate.
Trip Blank: A sample of analyte-free media taken from the laboratory to the sampling site and returned to the laboratory unopened. A trip blank is used to document
Uncon
trolle
d grade, ACS grade, ACSr reagents whreagents w
Analytical Rnalytical R
as been generbeen genernce specificatspecificat
quot of samplt of sampln cases whereses where
should be thould be t
: The p: The ppripri
Copy
eis:
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix K
Rev 9/29/15
contamination attributable to shipping and field handling procedures. This type of blank is useful in documenting contamination of volatile organic samples.
Uncon
trolle
d Cop
y
Document Title: Comprehensive Quality Assurance Manual
Eurofins Document Reference: Not Applicable
Revision: May, 2017 Effective Date: 5/01/17
COMPANY CONFIDENTIAL
Comprehensive Quality Assurance Manual
APPENDIX L
Analytical Method References
Uncon
trolle
d Cop
yerences nces
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix L
Analytical Method References
SW 846 Test Methods for Evaluating Solid Waste. Third edition, 1998
40 CFR 136
Guidelines Establishing Test Procedures for the Analysis of Pollutants Under the Clean Water Act
40 CFR 141 National Primary Drinking Water Regulations
40 CFR 143 National Secondary Drinking Water Regulations
40 CFR 160
Federal Insecticide, Fungicide and Rodenticide Act (FIFRA), Good Laboratory Practice Standards
310 CMR 42.00
Massachusetts. Department of Environmental Protection. 310 CMR 42.00: Certification and Operation of Environmental Analysis Laboratories, 10/05/2007.
APHA-AWWA-WPCF
Standard Methods for the Examination of Water and Wastes
ASTM D 3328 Standard Methods for the Comparison of Waterborn Petroleum Oils by Gas Chromatography
EPA 540/G-87/003 Data Quality Objectives for Remediation Response Activities, Development Process
EPA 600/4-79-012 Quality Assurance Handbook for Analytical Quality Control in Water and Wastewater Laboratories
EPA 600/4-79-019 Handbook for Analytical Quality Control in Water and Wastewater Laboratories
EPA 600/4-79-020 Method for the Chemical Analysis of Water and Wastes
EPA 600/4-82-057 Methods for Organic Chemical Analysis of Municipal and Industrial Wastewater
EPA 600/4-85/056 Choosing Cost-Effective QA/QC (Quality Assurance/Quality Control) Programs for Chemical Analysis
EPA 600/4-88/039 Method for the Determination of Organic Compounds in Drinking Water
MADEP EPH Method for the Determination of Extractable Petroleum Hydrocarbons (EPH)
MADEP VPH Method for the Determination of Volatile Petroleum Hydrocarbons (VPH)
NELAC National Environmental Laboratory Accreditation Conference. NELAC Standard., Quality Systems, 06/05/2003 and 09/08/2009.
NJ EPH Method for the Determination of Extractable Petroleum Hydrocarbons (EPH)
DOD Department of Defense Quality Systems Manual for Environmental Laboratories, most current revision
UUUnnt
ronce Handb
ded
parison of
lleddd
olle
for Reme
trollelle
ont
Laboratoritrotro
ncncok for Anaono
Uncethod for ncncUnMethodUnUnUU
pyypyCopop
yotection. 3
Copy
AnalysispypyCCoof WateCoCo
Eurofins Spectrum Analytical Comprehensive Quality Assurance Manual
Appendix L
Analytical Method References
QAMS 004/80 Guidelines and Specifications for Preparing Quality Assurance Program Plans, USEPA Office of Monitoring System and Quality Assurance
USACE RIM US Army Corp of Engineers, Regional Implementation Manual
US Coast Guard GC-D-52-77
Oil Spill Identification System
Copy